UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number   811-01355

The Alger Funds

(Exact name of registrant as specified in charter)

100 Pearl Street, New York, New York 10004
(Address of principal executive offices) (Zip code)

Mr. Hal Liebes
Fred Alger Management, LLC
100 Pearl Street
New York, New York 10004
(Name and address of agent for service)

Registrant’s telephone number, including area code: 212-806-8800

Date of fiscal year end: October 31

Date of reporting period: April 30, 2022

Form N-CSR is to be used by management investment companies to file reports with the Commission, not later than 10 days after the transmission to Stockholders of any report to be transmitted to Stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e1).  The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.



ITEM 1.
REPORT(S) TO STOCKHOLDERS.


(a)
 The following is a copy of the report transmitted to shareholders pursuant to Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1).


Table of Contents

The Alger Funds

 
1
   
21
   
43
   
45
   
83
   
95
   
101
   
112
   
156
   
201

Shareholders’ Letter (Unaudited)
April 30, 2022

Dear Shareholders,

Many Investors Shun Powerful Wealth Creator
In 1924, economist John Maynard Keynes wrote that companies that reinvest profits can create “an element of compound interest operating in favour of a sound industrial investment.” At Alger, we believe reinvesting profits and producing compounding earnings growth is a powerful wealth creator. To that end, we seek companies that we believe have strong potential for compounding earnings growth, and we seek to avoid cyclical companies, including “short-duration” companies, or businesses with high current earnings that return most of their profits to shareholders. In most instances, these cyclical companies, in our view, have little or no potential for future long-term earnings growth.
 
As Warren Buffett has observed, investors “occasionally do crazy things” which creates opportunities for investors who can “disregard mob fears or enthusiasms….and focus on a few simple fundamentals.” We believe recent concerns about interest rates, inflation and valuations have caused many investors to act irrationally by focusing on cyclical short-duration companies while shunning the “sound industrial investment” identified by Keynes.
 
Setting the Stage for a Difficult Six-Month Period
The strong trend of investors rejecting the appeal of long-term earnings growth, in our view, played a major role in our disappointing fund performance during the fiscal six-month period ended April 30, 2022. The fiscal period included the continuation of a dramatic rotation by many investors seeking instant gratification by favoring companies with high current earnings. This rotation was initially fueled prior to the reporting period by optimism that scaling back or eliminating measures to curtail the COVID-19 pandemic combined with unprecedented levels of fiscal stimulus would drive strong economic growth. More recently, however, optimism gave way to concerns that equities may be overvalued at a time when the economy could overheat and require the U.S. Federal Reserve (the “Fed”) to continue to raise interest rates to fight inflation.
 
These concerns were supported by the following developments:
 

U.S. gross domestic product (“GDP”), which declined 3.4% in 2020 due to the economy shutting down to contain the pandemic, jumped 5.7% in 2021.
 

After climbing to 6.3% at the end of 2020, the seasonally adjusted unemployment rate declined to 4.2% as of the November 2021 start of the fiscal six-month reporting period. It eventually reached 3.6% as of the end of the six-month period, during which concerns about inflation grew, a result of a tight labor market, among other things.


Data appeared to validate inflation concerns. After hitting a 6.8% year-over-year increase (or increase during the past 12-month period) in November 2021 and increasing each subsequent month, the Consumer Price Index hit 8.5% as of March 2022.

In response, the Fed shifted its outlook-it no longer maintained that inflation was a transitory result of supply chain issues and the economy reopening, and in March, the Fed raised the federal funds rate by 25 basis points (“BPS”), its first hike since cutting the rate to zero in 2020. Furthermore, Fed statements in March led many investors to anticipate a 50BPS rate hike in May and 200BPS in aggregate hikes by the end of 2022. Fears that rate hikes could eventually spark a recession also weighed upon investor sentiment.
 
Interest Rates Support Rotation Away from Quality
The rotation to short-duration companies was also partially supported by investors reacting to higher interest rates in a fairly typical fashion-they adjusted their cash flow modeling by increasing the rate at which they discount future cash flows back to the present, thereby lowering the value of long-duration companies. This process is similar to how long-term bonds are impacted more by rising rates than short-term bonds.
 
Not Just Growth, But High-Quality Small Cap Growth, Underperforms
Many small cap growth companies tend to have little or no current earnings, but strong potential for significant sales and earnings growth. Within the Russell 2000 Growth Index, for example, we believe many Healthcare companies are high-quality businesses even though they may not generate profits due to their investments in new initiatives, their products or potential products can have high gross margins and potential for capturing market share.
As a result of investors dismissing the appeal of potential earnings growth, the Healthcare sector was one of the worst performing sectors within the small cap growth category. From a broader perspective, sectors that generally consist of companies that provide dividends and appear to be less susceptible to inflation, such as Energy and Consumer Staples, led.
 
Also during the fiscal six-month period, growth underperformed value across the market cap spectrum, with the -26.77% return of the Russell 2000 Growth Index being a noteworthy laggard when compared to the -9.5% return of the Russell 2000 Value Index. The broad market, as measured by the S&P 500 Index, dropped 8.17%.
 
International Markets Also Struggle
Concerns about interest rates, inflation and the Russian invasion of Ukraine also extended beyond the U.S. Investors also assessed the spread of COVID-19 in China. Among non-U.S. equities, emerging markets significantly underperformed with the MSCI Emerging Markets Index declining 14.04% during the fiscal six-month reporting period. Within the index, the Utilities sector was the only sector to generate positive performance, as investors focused on companies that they perceived as having recession resistant fundamentals that provide a relatively high return of cash to shareholders. Consumer Discretionary, Healthcare and Energy were among the worst performing sectors. The selloff also included developed markets with the MSCI EAFE Index declining 11.58%. From a broader perspective, the MSCI ACWI Index declined 11.45%.
 
Irrational Behavior Creates Opportunity
As a result of investors’ rotation out of quality companies, growth equities, we believe, are trading at attractive valuations. Notably, the Russell 2000 Growth Index price-to-earnings (P/E) ratio based on the next 12-months’ earnings, declined from 50.2x to approximately 33.5x during the six-month fiscal reporting period while the Russell 1000 Growth Index declined from 30.7x to 23.8x.

Navigating Fed Rate Hikes
Investors who are concerned about monetary policy may want to consider two points:
 
First, Fed rate increases don’t always lead to recessions. In fact, since 1965 there have been three instances in which the Fed increased the federal funds rate 300 BPS or more that resulted in continued real economic growth and slowing inflation rather than recessions. Additionally, during the 12-months following the end of Fed tightening in 1985 and 1995, as well as after the Fed relented in 2018, equities generated double-digit returns.
 
Second, the later phases of monetary tightening have been accompanied by growth stocks outperforming value equities. The six-month periods starting approximately three months after the beginning of Fed tightening cycles initiated in 1994, 1999, 2004 and 2015 illustrate this point. Based on the returns of the Russell 3000 Growth and Russell 3000 Value indices, the median outperformance of growth during those periods was 400BPS. During later phases of rate hikes, economic growth slows, so investors may be more willing to pay a premium for companies that can increase their earnings.
 
Going Forward
We continue to believe that unprecedented levels of innovation, such as healthcare advancements in genetic science, and digital technologies including artificial intelligence, e-commerce, the metaverse, streaming entertainment, and cloud computing are providing opportunities for leading companies to reward investors by generating long-term earnings growth. We will continue to focus on conducting in-depth fundamental research as we seek leaders of innovation rather than take short-term bets on the fickle nature of investor sentiment. We believe doing so is the best strategy for helping our valued shareholders reach their investment goals.
 
Portfolio Matters
 
Alger Capital Appreciation Fund
The Alger Capital Appreciation Fund returned -26.67% for the fiscal six-month period ended April 30, 2022, compared to the -17.84% return of its benchmark, the Russell 1000 Growth Index.
 
During the reporting period, the largest portfolio sector weightings were Information Technology and Consumer Discretionary. The largest sector overweight was Information Technology and the largest sector underweight was Consumer Staples.
 
Contributors to Performance
The Communication Services and Real Estate sectors provided the largest contributions to relative performance. Regarding individual positions, Alibaba Group Holding Ltd. Sponsored ADR; AbbVie, Inc.; UnitedHealth Group, Inc.; Vertex Pharmaceuticals, Inc.; and Qualcomm, Inc. were the top contributors to absolute performance. AbbVie is a global biopharmaceutical company that had been shunned by many investors due to the potential for the company’s Humira treatment to face increased competition in 2023. Humira is used for rheumatology, dermatology, gastroenterology and ophthalmology. We believe, however, that AbbVie has significantly diversified its revenue and that its launch of Rinvoq for psoriatic arthritis and atopic dermatitis is promising. We believe these developments contributed to the company’s release in early 2022 of favorable quarterly results and investor confidence in the company, which supported the performance of AbbVie shares.

Detractors from Performance
The Information Technology and Financials sectors were the largest detractors from relative performance. Regarding individual positions, Amazon.com, Inc.; Microsoft Corp.; Shopify, Inc. Cl. A; Alphabet, Inc., Cl. C; and PayPal Holdings, Inc. were among the top detractors from absolute performance. Shopify provides a full-service, cloud-based software platform for small and medium-sized businesses to establish and conduct e-commerce operations. Shopify’s solutions enable merchants to run their businesses across a multitude of channels by facilitating merchants’ ability to manage products and inventory, process orders and payments, build customer relationships, automate marketing campaigns and leverage analytics and reporting. Shopify is an innovation-led company that is generating high unit volume growth as it benefits from the positive dynamic change of consumer adoption of e-commerce. The company also generates attractive free cash flow. Shopify’s share price declined during the second half of the reporting period after the company announced it would reinvest gross profits into research and development, hire more engineers and salespeople, and introduce new marketing programs in order to expedite its growth. The level of investment was more than many investors had contemplated, which hurt the performance of Shopify shares.
 
Alger 35 Fund
The Alger 35 Fund generated a -32.01% return during the fiscal six-month period ended April 30, 2022, compared to the -9.65% return of its benchmark, the S&P 500 Index. During the reporting period, the largest sector weightings were Information Technology and Healthcare. The largest sector overweight was Information Technology. The Fund had no exposure to the Materials or Utilities sectors.
 
Contributors to Performance
The Consumer Discretionary and Industrials sectors provided the greatest contributions to relative performance. Regarding individual positions, Diamondback Energy, Inc.; Qualcomm, Inc.; Vail Resorts, Inc.; Alibaba Group Holding Ltd. Sponsored ADR; and Xilinx, Inc. were among the top contributors to absolute performance. Alibaba is a leading e-commerce and cloud computing company in China. It also serves the big data analytics, digital media and entertainment markets. Alibaba’s shares have previously suffered from concerns about heightened regulatory oversight of the Chinese internet sector by the Chinese Communist Party. Additionally, many investors became concerned about the potential for U.S. exchange listed Chinese ADRs to be delisted if they failed to meet U.S. financial reporting standards by 2024. These issues caused investors to sell shares of Alibaba, which we believe created attractive valuations. In the later portion of the fiscal six-month reporting period, the shares outperformed in response to statements by the Chinese government supporting stable markets and overseas listings. The Chinese government also stated that its intensified regulatory efforts aimed at tech companies may end soon.
 
Detractors from Performance
Information Technology and Healthcare were among the sectors that detracted from relative performance. Regarding individual positions, Shopify, Inc., Cl. A; Marqeta, Inc., Cl A; Natera, Inc.; Upstart Holdings, Inc.; and Amazon.com, Inc. were among the top detractors from absolute performance. Shares of Shopify underperformed in response to developments identified in the Alger Capital Appreciation Fund discussion.
 
Alger Growth & Income Fund
The Alger Growth & Income Fund returned -6.49% for the fiscal six-month period ended April 30, 2022, compared to the -9.65% return of its benchmark, the S&P 500 Index. 

During the reporting period, the largest portfolio sector weightings were Information Technology and Financials. The largest sector overweight was Financials and the largest sector underweight was Consumer Discretionary.

Contributors to Performance
The Information Technology and Healthcare sectors provided the largest contributions to relative performance. Regarding individual positions, Chevron Corp.; AbbVie, Inc.; Apple, Inc.; UnitedHealth Group, Inc.; and Exxon Mobil Corp. were top contributors to absolute performance. Shares of AbbVie outperformed in response to developments identified in the Alger Capital Appreciation Fund discussion.
 
Detractors from Performance
The Financial and Utilities sectors were the most significant detractors from relative performance. Regarding individual positions, Microsoft Corp.; JPMorgan Chase & Co.; Alphabet, Inc., Cl. A; Alphabet, Inc., Cl. C; and BlackRock, Inc. were the top detractors from absolute performance. Microsoft is a positive dynamic change beneficiary of corporate America’s transformative digitization. In a previous earnings call, Microsoft’s CEO said he expects that technology spending as a percent of GDP is likely to jump from about 5% today to 10% in a few years, and that Microsoft will continue to take market share within the technology industry. Microsoft’s enterprise cloud product, Azure, is rapidly growing and accruing market share. Microsoft reported that Azure grew 46% in the quarter ended December 31, 2021, and the company’s total revenue growth exceeded 20%. Microsoft’s share price declined despite its high unit volume growth as the broad equity market and technology stocks declined due to higher interest rates and the Russia/Ukraine conflict.
 
Alger Mid Cap Growth Fund
The Alger Mid Cap Growth Fund returned -34.18% for the fiscal six-month period ended April 30, 2022, compared to the -25.44% return of its benchmark, the Russell Midcap Growth Index. During the reporting period, the largest sector weightings were Information Technology and Healthcare. The largest sector overweight was Energy and the largest underweight was Industrials.
 
Contributors to Performance
The Consumer Discretionary and Real Estate sectors provided the largest contributions to relative performance. Regarding individual positions, Diamondback Energy, Inc.; Vail Resorts, Inc.; Palo Alto Networks, Inc.; Xilinx, Inc.; and Lucid Group, Inc. were among the top contributors to absolute performance. Vail Resorts is a premier luxury mountain resort operator whose properties include locations in Vail, Breckenridge, Beaver Creek, Park City, and Whistler. Given its strong industry position, shares of Vail Resorts contributed to portfolio performance as the company capitalized on consumers’ embrace of travel and social activity with the economy reopening from pandemic restrictions.
 
Detractors from Performance
The Information Technology and Healthcare sectors were among the sectors that detracted from relative performance. Regarding individual positions, Upstart Holdings, Inc.; Natera, Inc.; Marqeta, Inc., Cl. A; Paycom Software, Inc.; and Affirm Holdings, Inc., Cl. A were the top detractors from absolute performance. Natera is a specialty lab providing genetic testing services in reproductive health, oncology and transplant. Non-invasive prenatal testing (NIPT), part of the company’s reproductive health franchise, has generated the majority of revenue historically; however, we believe Natera’s oncology business has potential to contribute toward a larger share of revenue as customers increasingly adopt these tests following positive insurance reimbursement decisions and favorable clinical trial results. Natera’s share underperformed after the publication of a short report by Hindenburg Research. The company also lost a false advertisement lawsuit by CareDx, and high-growth, high-valuation companies were out of favor with investors during the fiscal reporting period. We believe many of the allegations in the short report regarding sales and the company’s relationship with a third-party billing vendor are irrelevant to Natera’s outlook and its oncology franchise, which we view as the company’s key growth engine.

Alger Mid Cap Focus Fund
The Alger Mid Cap Focus Fund generated a -33.38% return for the fiscal six-month period ended April 30, 2022, compared to the -25.44% return of its benchmark, the Russell Midcap Growth Index. During the reporting period, the largest portfolio sector weightings were Information Technology and Industrials. The largest sector overweight was Industrials and the largest sector underweight was Information Technology.
 
Contributors to Performance
The Communications Services and Consumer Discretionary sectors provided the largest contributions to relative performance. Regarding individual positions, Vocera Communications, Inc.; Anaplan, Inc.; Baker Hughes Company, Cl. A; Booking Holdings, Inc.; and CF Industries Holdings, Inc. were among the top contributors to absolute performance. Anaplan is a leading provider of cloud-based business planning software. Its software is a “connected planning” platform, enabling all parts of business planning to become a more dynamic, collaborative and integrated process across the enterprise. Unlike traditional business planning, Anaplan’s proprietary technology is designed to enable broader enterprise participation and better workforce collaboration during the business planning process.
 
Performance of Anaplan shares benefited from the company improving its sales execution which resulted in an increasing billing growth acceleration and a new record for the number of accounts with over $1 million in revenues. On March 20, 2022, subject to shareholder approval, Anaplan agreed to be acquired by private equity firm Thoma Bravo for $66 a share, an approximately 31% premium to the previous trading day’s close.
 
Detractors from Performance
The Industrials and Information Technology sectors were among the top detractors from relative performance. Regarding individual positions, Confluent, Inc., Cl. A; Herc Holdings, Inc.; XPO Logistics, Inc.; Generac Holdings, Inc.; and SiteOne Landscape Supply, Inc. were among the top detractors from absolute performance. Confluent is pioneering a new category of data infrastructure focused on data in motion (being transferred among locations) for software developers and enterprises. Confluent was founded by the original creators of event streaming company Apache Kafka and it is a large contributor to the open-source community and a leading commercial vendor behind Kafka. Confluent is designed to be the connective tissue by having real-time data from multiple sources constantly streamed across the enterprise for real-time analysis and data processing, powering smarter, faster and more modern digital applications.
 
The company’s cloud service is the only cloud-native Apache Kafka solution, a fully managed service that is serverless, infinitely scalable, elastic and secure. The stock underperformed during the first quarter because its revenue growth slowed. Cloud revenue recognition is consumption-based and Confluent stated that its fourth quarter 2021 was impacted by the holidays and workloads being shut off. However, billings for Confluent continued to grow at an elevated level and other metrics were also encouraging.

Alger Weatherbie Enduring Growth Fund
The Alger Weatherbie Enduring Growth Fund generated returned -22.00% from its December 17, 2021, inception date to April 30, 2022, compared to the -19.89% return of its benchmark, the Russell Midcap Growth Index.
 
During the reporting period, the largest sector weightings were Industrials and Information Technology. The largest sector overweight was Industrials. The Fund had no exposure to the Communication Services, Consumer Staples, Materials or Utilities sectors.
 
Contributors to Performance
The Information Technology sector and the Fund’s lack of Communication Services holdings provided the greatest contributions to relative performance.
 
The Fund’s contributors to absolute performance were limited to Waste Connection, Inc. and Vertex, Inc. during an abbreviated reporting period in which markets declined substantially. Vertex provides comprehensive tax solutions. Companies with complex tax operations rely on Vertex to automate their end-to-end indirect tax processes. The addressable market for Vertex is sizable, at approximately $7 billion globally. Vertex offers a solution in indirect tax – the largest corporate tax category (which includes sales tax and value-added tax), accounting for approximately $3.5 trillion of taxes annually.
 
Vertex reported better-than-expected results for the first quarter of 2022 and maintained full-year guidance. Its total revenue of $115.0 million was $2.0 million above publicly available Wall Street estimates and the midpoint of the company’s guidance. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $19.1 million was approximately $2.3 million above consensus estimates.
 
Detractors from Performance
The Real Estate and Financials sectors were the most significant detractors from relative performance. Regarding individual positions, FirstService Corp.; Upstart Holdings, Inc.; HubSpot, Inc.; EPAM Systems, Inc.; and Progyny were the top detractors from absolute performance. FirstService is a leading provider of property management services to owners and homeowners associations of community and high-rise properties, as well as the provider of branded services such as California Closets and CertaPro Painters for residential homeowners. Services also include home restoration after fires, flooding or other events. FirstService continues to extend its significant scale advantage as it rolls up the property management industry and provides higher quality and greater breadth of services than its competition, while using its free cash and strong balance sheet to continue to make what we believe are attractive value-enhancing acquisitions.
 
FirstService’s share price declined in early 2022 market turmoil due in part to inflation concerns. The company’s fourth quarter was in-line with its internal budget and its revenues exceeded guidance. Wage inflation has been discussed across the recent period of rising inflation, but management reported improved employee retention and more favorable conditions for filling open positions. FirstService’s residential business has continued to grow faster than the overall market, and the company’s branded services continue to experience very strong demand in home improvement and other areas, which we believe should help offset a tougher near-term year-over-year comparison in restoration services due to last year’s increased demand caused by the freezing weather in Texas.

Alger Weatherbie Specialized Growth Fund
The Alger Weatherbie Specialized Growth Fund generated a -37.12% return during the fiscal six-month period ended April 30, 2022, compared to the -25.96% return of its benchmark, the Russell 2500 Growth Index.
 
During the reporting period, the largest portfolio sector weightings were Information Technology and Industrials. The largest sector overweight was Financials. The Fund had no exposure to Consumer Staples or Utilities sectors and insignificant exposures to the Communication Services sector.
 
Contributors to Performance
The Healthcare and the Communication Services sectors provided the greatest contributions to relative performance. Regarding individual positions, Apria, Inc., Signature Bank; U.S. Physical Therapy, Inc.; Petco Health & Wellness Co., Inc., Cl. A; and Sweetgreen, Inc., Cl. A. were among top contributors to absolute performance. Apria is a durable medical equipment company that provides equipment, supplies, and services prescribed by doctors for patients to home medical care for respiratory issues, obstructive sleep apnea and wounds. In early January, healthcare logistics and medical device provider Owens & Minor announced plans to acquire Apria for $1.6 billion in cash, an approximately 26% premium to the prior day’s closing price.
 
Detractors from Performance
The Financials sector was the largest detractor from relative performance. Regarding individual positions, Natera, Inc.; SiteOne Landscape Supply, Inc.; Latham Group Inc.; FirstService Corp.; Chegg, Inc.; and StepStone Group, Inc., Cl. A were the most significant detractors from absolute performance. Shares of Natera underperformed in response to developments identified in the Alger Mid Cap Growth Fund discussion.
 
Alger Small Cap Growth Fund
The Alger Small Cap Growth Fund returned -34.49% for the fiscal six-month period ended April 30, 2022, compared to the -26.77% return of its benchmark, the Russell 2000 Growth Index. During the reporting period, the largest portfolio sector weightings were Healthcare and Information Technology. The largest sector overweight was Healthcare and the largest underweight was Industrials.
 
Contributors to Performance
The Financials and Industrials sectors provided the greatest contributions to relative performance. Regarding individual positions, Vocera Communications, Inc.; Magnolia Oil & Gas Corp., Cl. A; US Foods Holding Corp.; Chefs’ Warehouse, Inc.; and HealthEquity Inc. were the top contributors to absolute performance. Vocera Communications is a leading provider of cloud-based communication and workflow solutions, primarily for the healthcare industry. Vocera’s core solution is an enterprise-class server software platform that allows users to communicate and collaborate using voice or Health Insurance Portability and Accountability Act (HIPAA) compliant secure texting through a variety of Vocera-designed and third-party devices. On January 6, 2022, Stryker Corporation announced an agreement to acquire Vocera for $79.25 per share, or an approximate $3.1 billion enterprise value, which was a 26.8% premium to the prior day’s closing price. The deal was completed on February 23, 2022.

Detractors from Performance
The Information Technology and Healthcare sectors were among the sectors that detracted from relative performance. Regarding individual positions, InMode Ltd.; HubSpot, Inc.; Joint Corp.; Neogen Corp.; and NanoString Technologies, Inc. were the top detractors from absolute performance.
 
InMode designs, develops, manufactures and commercializes innovative minimally invasive and non-invasive aesthetic medical products. InMode’s platforms harness novel radio frequency (RF) technology for emerging minimally invasive procedures that bridge the gap between temporary treatments like facials and more invasive surgical procedures like facelifts across several specialty categories such as plastic surgery, gynecology, dermatology, ophthalmology and otolaryngology (ear, nose and throat care). The aesthetics market experienced strong tailwinds coming out of the COVID-19 pandemic. These tailwinds include the “Zoom effect,” or dissatisfaction with one’s personal appearance after viewing one’s own face on Zoom, which resulted in more people deciding to undergo aesthetic procedures. De-stigmatization of aesthetics procedures, aided by social media platforms, has also supported InMode’s results. However, the stock price declined during the first quarter, in part due to a rotation out of high-valuation names. Some investors also feared a wallet share shift away from aesthetics and have concerns about InMode’s exposure to international markets due to the Ukraine/Russia conflict; however, our research suggests the company’s revenue exposure to Europe is minimal.
 
Alger Small Cap Focus Fund
The Alger Small Cap Focus Fund returned -40.96% during the fiscal six-month period ended April 30, 2022, compared to the -26.77% return of its benchmark, the Russell 2000 Growth Index. During the reporting period, the Healthcare and Information Technology sectors were the largest portfolio sector weightings. The largest sector overweight was Healthcare. The Fund had no exposure to the Materials, Real Estate or Utilities sectors and insignificant exposure to the Communication Services sector.
 
Contributors to Performance
The Consumer Discretionary and Financials sectors provided the greatest contributions to relative performance. During a quarter in which equity markets declined substantially, PDC Energy, Inc.; Viper Energy Partners LP; and Allbirds, Inc., Cl. A. were the only individual positions that contributed to absolute performance. PDC Energy acquires, explores and develops properties for the production of crude oil and natural gas, including the liquid components of natural gas. It has operations in the Wattenberg Field in Colorado and the Delaware Basin in West Texas. The company’s drilling locations are split approximately 75%/25% between Colorado and West Texas. Recently, PDC Energy acquired Great Western Petroleum, LLC. The acquisition materially increased PDC Energy’s scale by adding 315 identified locations and bringing the company’s pro forma combined drilled uncompleted (DUC) and approved permit count to approximately 500 locations at year-end 2021. The stock performed strongly during the second half of the reporting period after the company announced it will link the return of capital to shareholders to 60% of free cash flow remaining after paying its base dividend, with the potential to move higher over time once the company has paid down debt to a level of approximately $1 billion. Management also suggested that the primary mode of cash return would remain share buybacks and special dividends if needed. In addition, the company raised its base dividend and increased the share buyback authorization to $1.25 billion over the next two years.

Detractors from Performance
The Healthcare and Information Technology sectors were among the top detractors from relative performance. Regarding individual positions, CryoPort, Inc.; Natera, Inc.; Heska Corporation; Everbridge, Inc.; and Paycom Software, Inc. were the top detractors from absolute performance. Shares of Natera underperformed in response to developments identified in the Alger Mid Cap Growth Fund discussion.
 
Alger International Focus Fund
The Alger International Focus Fund recorded a -25.33% return for the fiscal six-month reporting period ended April 30, 2022, compared to the -11.68% return of its benchmark, the MSCI ACWI ex USA Index.
 
During the quarter, the largest portfolio sector weightings were Consumer Discretionary and Industrials. The largest sector overweight was Consumer Discretionary and the largest sector underweight was Financials.
 
Contributors to Performance
The Energy and Real Estate sectors provided the greatest contributions to relative performance. From a country perspective, the Fund’s lack of exposure to Russia and Canada and its underweight of Japan supported relative performance. The Fund’s underweight of Japan was also beneficial, while stock selection in the United Kingdom and South Korea provided additional support to relative performance.
 
Regarding individual positions, Angel One Limited; Schlumberger NV; London Stock Exchange Group plc; Samsonite International S.A.; and Core Laboratories NV were the top contributors to absolute performance. London Stock Exchange Group is a global leader in financial markets infrastructure across the exchange, trading, clearing, data, analytics and platform services. The stock outperformed during the later portion of the fiscal reporting period due to resilient earnings. Most importantly, the company delivered strong cost synergy realization related to its acquisition of Refinitiv, while also raising the guidance on total cost synergies related to the deal. This restored both confidence in management, as well as the deal rationale and created renewed investor interest in the stock, which has been rangebound for the past several months on a reduced valuation relative to global peers.
 
Detractors from Performance
The Industrials and Information Technology sectors were among the sectors that detracted from results. From a country perspective, Singapore, Switzerland, Australia, the Netherlands and Norway were among the top detractors from relative performance.
 
Regarding individual positions, Sea Ltd. (Singapore) ADR, Cl. A; EPAM Systems, Inc.; ASML Holding NV; AutoStore Holdings Ltd.; and Adyen NV were the top detractors from absolute performance. EPAM Systems provides software product development and digital platform engineering services. The company continues to benefit from secular growth in corporate digital initiatives, delivering 2021 earnings that beat consensus expectations. However, geopolitical conflict in Russia and Ukraine forced the company to cancel its earnings and sales guidance and shift its focus to business continuity plans in the first quarter of 2022. While less than 5% of revenues are exposed to Russia, Ukraine and Belarus, the company has operating exposure to those countries as its software engineers are located within the region. Demand remains strong and management has focused on relocating talent outside of conflict zones, along with recruitment across non-conflict regions, to maintain project delivery timelines. The stock de-rated significantly during the early part of 2022 as investors weighed uncertainties related to EPAM’s business operations.

Alger Health Sciences Fund
The Alger Health Sciences Fund returned -28.50% for the fiscal six-month period ended April 30, 2022, compared to the -9.65% return of the S&P 500 Index and the -7.91% return of the Russell 3000 Healthcare Index.
 
Contributors to Performance
Regarding individual positions, AbbVie, Inc.; Bristol-Myers Squibb Co.; McKesson Corp.; Intra-Cellular Therapies, Inc.; and Bayer AG. were the top contributors to absolute performance. Shares of AbbVie outperformed in response to developments identified in the Alger Capital Appreciation Fund discussion.
 
Detractors from Performance
InMode Ltd.; Azenta, Inc.; DexCom, Inc.; Celldex Therapeutics, Inc.; and Edwards Lifesciences Corp. were the top detractors from absolute performance. Shares of InMode underperformed in response to developments identified in the Alger Small Cap Growth Fund discussion.

I thank you for putting your trust in Alger.

Sincerely,
 
 
   
Daniel C. Chung, CFA
 
Chief Executive Officer
 
Fred Alger Management, LLC
 

Investors cannot invest directly in an index. Index performance does not reflect the deduction for fees, expenses, or taxes.
 
This report and the financial statements contained herein are submitted for the general information of shareholders of the funds. This report is not authorized for distribution to prospective investors in a fund unless preceded or accompanied by an effective prospectus for the fund. Performance of funds discussed above other than the Alger 35 Fund and the Alger Mid Cap Focus Fund represents the return of Class A shares prior to the deduction of any sales charges and includes the reinvestment of any dividends or distributions. Performance for the Alger 35 Fund represents Class Z shares. Performance for the Alger Mid Cap Focus Fund represents Class I shares.
 
The performance data quoted represents past performance, which is not an indication or guarantee of future results.
Standardized performance results can be found on the following pages. The investment return and principal value of an investment in a fund will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted. For performance data current to the most recent month-end, visit us at www.alger.com or call us at (800) 992-3863.

The views and opinions of the funds’ management in this report are as of the date of the Shareholders’ Letter and are subject to change at any time subsequent to this date. There is no guarantee that any of the assumptions that formed the basis for the opinions stated herein are accurate or that they will materialize. Moreover, the information forming the basis for such assumptions is from sources believed to be reliable; however, there is no guarantee that such information is accurate. Any securities mentioned, whether owned in a fund or otherwise, are considered in the context of the construction of an overall portfolio of securities and therefore reference to them should not be construed as a recommendation or offer to purchase or sell any such security. Inclusion of such securities in a fund and transactions in such securities, if any, may be for a variety of reasons, including, without limitation, in response to cash flows, inclusion in a benchmark, and risk control. The reference to a specific security should also be understood in such context and not viewed as a statement that the security is a significant holding in a fund. Please refer to the Schedule of Investments for each fund which is included in this report for a complete list of fund holdings as of April 30, 2022. Securities mentioned in the Shareholders’ Letter, if not found in the Schedule of Investments, may have been held by the funds during the fiscal six-month period ended April 30, 2022.
 
Risk Disclosures

Alger Capital Appreciation Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility.
 
Alger 35 Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of small and medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. The Fund is classified as a “non-diversified fund” under federal securities laws because it can invest in fewer individual companies than a diversified fund. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.

Alger Growth & Income Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Income-producing securities may cut or fail to declare dividends due to market downturns or for other reasons. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.
 
Alger Mid Cap Growth Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.
 
Alger Mid Cap Focus Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Investing in companies of medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. A significant portion of assets may be invested in securities of companies in related sectors or industries, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector or industry developments.

The Fund is classified as a “non-diversified fund” under federal securities laws because it can invest in fewer individual companies than a diversified fund. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.
 
Alger Weatherbie Enduring Growth Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Weatherbie Capital, LLC’s use of an environmental, social, and governance (“ESG”) rating agency to implement the investment strategy may result in the selection or exclusion of securities for reasons other than financial performance and the strategy may underperform strategies that do not utilize an ESG rating agency or employ another type of ESG investment strategy. In evaluating a particular issuer’s ESG rating, as well as the account’s weighted average ESG rating, Weatherbie Capital, LLC relies exclusively on the ESG rating agency and, therefore, is dependent upon information and data from the ESG rating agency that may be incomplete or inaccurate, or that may present conflicting information and data with respect to an issuer than other third party ESG data providers utilized throughout the industry. Investing in companies of medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Investing in new issues involves special risks including lack of trading history, limited information and availability, and volatility. Cash positions may underperform relative to equity and fixed-income securities. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment. The Fund is classified as a “non-diversified fund” under federal securities laws because it can invest in fewer individual companies than a diversified fund.
 
Alger Weatherbie Specialized Growth Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of small and medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Foreign securities and emerging markets involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility.

Alger Small Cap Growth Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors or industries, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector or industry developments. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.
 
Alger Small Cap Focus Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors or industries, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector or industry developments. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.
 
Alger International Focus Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Foreign securities and emerging markets involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.

Alger Health Sciences Fund
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. A significant portion of assets will be invested in healthcare companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies. A significant portion of assets may be invested in securities of companies in related industries, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable industry developments. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Private placements are offerings of a company’s securities not registered with the SEC and not offered to the public, for which limited information may be available. Such investments are generally considered to be illiquid. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.
 
For a more detailed discussion of the risks associated with a fund, please see the prospectus.
 
Before investing, carefully consider a fund’s investment objective, risks, charges, and expenses. For a prospectus and summary prospectus containing this and other information or for the Alger Funds’ most recent month-end performance data, visit www.alger.com, call (800) 992-3863 or consult your financial advisor. Read the prospectus and summary prospectus carefully before investing.

Distributor: Fred Alger & Company, LLC
 
NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE
 
Definitions:
 

The Consumer Price Index (CPI) is a measure of the average change over time in the prices paid by urban consumers for a market basket of consumer goods and services.
 

Price-to-earnings is the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
 

The Russell 3000 Growth Index combines the large-cap Russell 1000 Growth, the small-cap Russell 2000 Growth and the Russell Microcap Growth Index. It includes companies that are considered more growth oriented relative to the overall market as defined by Russell’s leading style methodology. The Russell 3000 Growth Index is constructed to provide a comprehensive, unbiased, and stable barometer of the growth opportunities within the broad market.
 

The Russell 3000 Value Index measures the performance of the broad value segment of the US equity value universe. It includes those Russell 3000 companies with lower price-to-book ratios and lower forecasted growth values. The Russell 3000 Value Index is constructed to provide a comprehensive, unbiased and stable barometer of the broad value market.


The MSCI ACWI Index (gross) is a free float-adjusted market capitalization weighted index that is designed to measure the equity market performance of developed and emerging markets. The MSCI ACWI captures large and mid-cap representation across developed markets and emerging markets countries.
 

The MSCI ACWI ex USA Index (gross) captures large and mid cap representation across developed markets countries (excluding the US) and emerging markets countries. The index covers approximately 85% of the global equity opportunity set outside the US.
 

The MSCI EAFE Index is designed to represent the performance of large and mid-cap securities across developed markets, including countries in Europe, Australasia and the Far East, excluding the U.S. and Canada.
 

The MSCI Emerging Markets Index (gross) is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global emerging markets.
 

The Russell 1000 Growth Index measures the performance of the large-cap growth segment of the U.S. equity universe. It includes those Russell 1000 companies with higher growth earning potential as defined by Russell’s leading style methodology. The Russell 1000 Growth Index is constructed to provide a comprehensive and unbiased barometer for the large-cap growth segment.
 

The S&P 500 Growth Index is an unmanaged index considered representative of large-cap growth stocks.
 

The Russell Midcap Growth Index measures the performance of the mid-cap growth segment of the U.S. equity universe. It includes those Russell Midcap Index companies with higher growth earning potential as defined by Russell’s leading style methodology. The Russell Midcap Growth Index is constructed to provide a comprehensive and unbiased barometer of the mid-cap growth market.


The Russell 2500 Growth Index measures the performance of the small to mid-cap growth segment of the U.S. equity universe. It includes those Russell 2500 companies with higher growth earning potential as defined by Russell’s leading style methodology. The Russell 2500 Growth Index is constructed to provide a comprehensive and unbiased barometer of the small to mid-cap growth market.


The Russell 2000 Growth Index measures the performance of the small-cap growth segment of the U.S. equity universe. It includes those Russell 2000 companies with higher growth earning potential as defined by Russell’s leading style methodology. The Russell 2000 Growth Index is constructed to provide a comprehensive and unbiased barometer for the small-cap growth segment.


The Russell 2000 Value Index measures the performance of the small cap value segment of the U.S. equity universe. It includes those Russell 2000 companies with lower price-to-book ratios and lower forecasted growth values. The Russell 2000 Value Index is constructed to provide a comprehensive and unbiased barometer for the large-cap growth segment.
 

The Russell 3000 Healthcare Index is an unmanaged index that measures the performance of those companies in the Russell 3000 Index involved in the medical services or healthcare field. Also included are companies involved in research, development and production of pharmaceuticals and biotechnology

FUND PERFORMANCE AS OF 3/31/22 (Unaudited)
AVERAGE ANNUAL TOTAL RETURNS

     
1
YEAR
     
5
YEARS
     
10
YEARS
      SINCE INCEPTION  
Alger Capital Appreciation Class A (Inception 12/31/96)
   
(3.61
)%
   
16.52
%
   
14.63
%
   
10.52
%
Alger Capital Appreciation Class C (Inception 7/31/97)*
   
0.22
%
   
16.90
%
   
14.39
%
   
10.35
%
Alger Capital Appreciation Class Z (Inception 12/29/10)
   
2.07
%
   
18.17
%
   
15.64
%
   
15.27
%
Alger 35 Fund Class Z (Inception 10/31/18)**
   
(4.16
)%
   
n/a
     
n/a
     
19.50
%
Alger Growth & Income Class A (Inception 12/31/96)
   
11.48
%
   
13.94
%
   
12.85
%
   
9.30
%
Alger Growth & Income Class C (Inception 7/31/97)*
   
15.76
%
   
14.30
%
   
12.61
%
   
9.13
%
Alger Growth & Income Class Z (Inception 3/1/12)
   
18.00
%
   
15.57
%
   
13.80
%
   
13.94
%
Alger Mid Cap Growth Class A (Inception 12/31/96)
   
(15.17
)%
   
14.86
%
   
12.46
%
   
9.51
%
Alger Mid Cap Growth Class B (Inception 5/24/93)
   
(13.18
)%
   
15.60
%
   
12.51
%
   
9.48
%
Alger Mid Cap Growth Class C (Inception 7/31/97)*
   
(11.71
)%
   
15.17
%
   
12.16
%
   
8.87
%
Alger Mid Cap Growth Class Z (Inception 5/28/15)
   
(10.25
)%
   
16.43
%
   
n/a
     
11.92
%
Alger Mid Cap Focus Class A (Inception 7/29/21)
   
n/a
     
n/a
     
n/a
     
(16.72
)%
Alger Mid Cap Focus Class C (Inception 7/29/21)
   
n/a
     
n/a
     
n/a
     
(13.33
)%
Alger Mid Cap Focus Class I (Inception 6/14/19)
   
(7.34
)%
   
n/a
     
n/a
     
24.48
%
Alger Mid Cap Focus Class Y (Inception 2/26/21)
   
(7.10
)%
   
n/a
     
n/a
     
(10.58
)%
Alger Mid Cap Focus Class Z (Inception 6/14/19)
   
(7.05
)%
   
n/a
     
n/a
     
24.79
%
Alger Weatherbie Enduring Growth Class A (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(13.74
)%
Alger Weatherbie Enduring Growth Class C (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(10.11
)%
Alger Weatherbie Enduring Growth Class I (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(9.00
)%
Alger Weatherbie Enduring Growth Class Y (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(8.90
)%
Alger Weatherbie Enduring Growth Class Z (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(8.90
)%
Alger Weatherbie Specialized Growth Class A (Inception 5/8/02)
   
(16.59
)%
   
17.75
%
   
12.97
%
   
10.37
%
Alger Weatherbie Specialized Growth Class C (Inception 5/8/02)
   
(13.31
)%
   
18.12
%
   
12.71
%
   
10.16
%
Alger Weatherbie Specialized Growth Class I (Inception 8/5/07)
   
(12.02
)%
   
19.04
%
   
13.59
%
   
10.71
%
Alger Weatherbie Specialized Growth Class Y (Inception 8/31/17)
   
(11.72
)%
   
n/a
     
n/a
     
18.04
%
Alger Weatherbie Specialized Growth Class Z (Inception 12/29/10)
   
(11.75
)%
   
19.42
%
   
13.95
%
   
13.21
%
Alger Small Cap Growth Class A (Inception 12/31/96)
   
(24.69
)%
   
14.27
%
   
11.04
%
   
6.27
%
Alger Small Cap Growth Class B (Inception 11/11/86)
   
(24.01
)%
   
14.89
%
   
11.01
%
   
6.25
%
Alger Small Cap Growth Class C (Inception 7/31/97)*
   
(21.84
)%
   
14.62
%
   
10.76
%
   
6.12
%
Alger Small Cap Growth Class Y (Inception 12/31/21)
   
n/a
     
n/a
     
n/a
     
(15.90
)%
Alger Small Cap Growth Class Z (Inception 12/29/10)
   
(20.20
)%
   
15.94
%
   
12.06
%
   
11.45
%
Alger Small Cap Focus Class A (Inception 3/3/08)
   
(29.94
)%
   
11.61
%
   
11.18
%
   
9.36
%
Alger Small Cap Focus Class C (Inception 3/3/08)
   
(27.21
)%
   
12.01
%
   
11.01
%
   
9.10
%
Alger Small Cap Focus Class I (Inception 3/3/08)
   
(26.00
)%
   
12.86
%
   
11.91
%
   
9.93
%
Alger Small Cap Focus Class Y (Inception 2/28/17)
   
(25.76
)%
   
13.23
%
   
n/a
     
13.43
%
Alger Small Cap Focus Class Z (Inception 12/29/10)
   
(25.76
)%
   
13.22
%
   
12.23
%
   
11.60
%
Alger International Focus Class A (Inception 12/31/96)
   
(10.01
)%
   
8.18
%
   
5.58
%
   
5.68
%
Alger International Focus Class B (Inception 11/11/86)
   
(9.30
)%
   
8.84
%
   
5.64
%
   
5.65
%
Alger International Focus Class C (Inception 7/31/97)*
   
(6.59
)%
   
8.48
%
   
5.32
%
   
5.51
%
Alger International Focus Class I (Inception 5/31/13)
   
(5.05
)%
   
9.53
%
   
n/a
     
6.63
%
Alger International Focus Class Z (Inception 12/29/10)
   
(4.67
)%
   
9.81
%
   
6.61
%
   
7.06
%
Alger Health Sciences Fund Class A (Inception 5/1/02)
   
(9.68
)%
   
11.80
%
   
13.06
%
   
11.73
%
Alger Health Sciences Fund Class C (Inception 5/1/02)
   
(6.01
)%
   
12.15
%
   
12.81
%
   
11.53
%
Alger Health Sciences Fund Class Z (Inception 5/28/15)
   
(4.33
)%
   
13.41
%
   
n/a
     
9.71
%

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains.
 
Beginning August 7, 2015, the Alger Small Cap Focus Fund (formerly, Alger Growth Opportunities Fund) changed its investment strategy to normally invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies that, at the time of purchase of the securities, have a total market capitalization within the range of companies included in the Russell 2000 Growth Index.
 
Before March 28, 2018, the Alger International Focus Fund followed different investment strategies and was managed by different portfolio managers. Prior to May 31, 2013 the Fund was named “Alger Large Cap Growth Fund,” and from May 31, 2013 to August 15, 2018 the Fund was named “Alger International Growth Fund.” Performance prior to March 28, 2018 reflects these prior management styles and does not reflect the Fund’s current investment strategies and investment personnel.
 
Previously, the Alger Growth & Income Fund followed a different investment objective and different strategies under the name “Alger Balanced Fund.” Performance prior to April 1, 2011 does not reflect the Fund’s current investment objective and strategies.
 
From August 30, 2017 to September 30, 2019, the Alger Weatherbie Specialized Growth Fund was named “Alger SMid Cap Focus Fund.” Prior to August 30, 2017, the Fund followed different investment strategies under the name “Alger SMid Cap Growth Fund” and prior to March 1, 2017 was managed by different portfolio managers. Accordingly, performance prior to those dates does not reflect the Fund’s current investment strategies and investment personnel.
 
Effective May 7, 2021, Class P shares of the Alger 35 Fund were reclassified as Class Z shares of the Fund. Class P-2 Shares of the Alger 35 Fund were converted to Class Z Shares after the close of business on October 29, 2021.
 
*
Historical performance prior to the inception of the Class, is that of the Fund’s Class A shares, which has been adjusted to remove the sales charge imposed by Class A shares and adding the higher operating expenses of the Class C shares.
**
Historical performance prior to May 7, 2021 is that of the Fund’s Class P shares.

ALGER CAPITAL APPRECIATION FUND
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS A SHARES


The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Capital Appreciation Fund Class A shares, with a maximum sales charge of 5.25%, and the Russell 1000 Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Figures for the Alger Capital Appreciation Fund Class A shares and the Russell 1000 Growth Index include reinvestment of dividends. Figures for the Alger Capital Appreciation Fund Class A shares also include reinvestment of capital gains. Performance for Alger Capital Appreciation Fund Class C and Class Z shares will vary from the results shown above due to differences in expenses and sales charges those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER CAPITAL APPRECIATION FUND
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

    1 YEAR     5 YEARS     10 YEARS    
Since
11/1/1993
 
Class A (Inception 12/31/96)
   
(22.53
)%
   
12.32
%
   
12.94
%
   
9.81
%
Class C (Inception 7/31/97)*
   
(19.39
)%
   
12.72
%
   
12.71
%
   
9.63
%
Russell 1000 Growth Index
   
(5.35
)%
   
17.28
%
   
15.56
%
   
9.23
%
 
   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
12/29/2010
 
Class Z (Inception 12/29/10)
   
(17.95
)%
   
13.93
%
   
13.94
%
   
13.57
%
Russell 1000 Growth Index
   
(5.35
)%
   
17.28
%
   
15.56
%
   
15.21
%

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
 
*
Since inception performance is calculated since the inception of the Class A shares. Historical performance prior to July 31,  1997, inception of the class, is that of the Fund’s Class A shares, reduced to reflect the current maximum sales charge and the higher operating expenses of Class C shares.

ALGER 35 FUND
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS Z SHARES

 
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger 35 Fund Class Z shares and the S&P 500 Index (an unmanaged index of common stocks) from March 29, 2018, the inception date of the Alger 35 Fund Class Z shares, through April 30, 2022. Effective May 7, 2021, Class P shares of the Alger 35 Fund were reclassified as Class Z shares. The reclassified Class Z shares have the same annual returns as the Class P shares because the shares are invested in the same portfolio of securities and the reclassified Class Z shares have the same expenses as the Fund’s Class P shares. Historical performance prior to May 7, 2021 is that of the Fund’s Class P shares. Figures for the Alger 35 Fund Class Z shares and the S&P 500 Index include reinvestment of dividends. Figures for the Alger 35 Fund Class Z shares also include reinvestment of capital gains. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER 35 FUND
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

    1 YEAR    
5 YEARS
   
10 YEARS
   
Since
3/29/2018
 
Class Z (Inception 3/29/18)
   
(23.96
)%
   
n/a
     
n/a
     
14.37
%
S&P 500 Index
   
0.21
%
   
n/a
     
n/a
     
13.55
%
 
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Effective May 7, 2021, Class P shares of the Alger 35 Fund were reclassified as Class Z shares. The reclassified Class Z shares have the same annual returns as the Class P shares because the shares are invested in the same portfolio of securities and the reclassified Class Z shares have the same expenses as the Fund’s Class P shares. Historical performance prior to May 7, 2021 is that of the Fund’s Class P shares. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.

ALGER GROWTH & INCOME FUND
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS A SHARES



The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Growth & Income Fund Class A shares, with a maximum sales charge of 5.25%, and the S&P 500 Index (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Figures for the Alger Growth & Income Fund Class A shares and the S&P 500 Index include reinvestment of dividends. Figures for the Alger Growth & Income Fund Class A shares also include reinvestment of capital gains. Performance for the Alger Growth & Income Fund Class C and Class Z shares will vary from the results shown above due to differences in expenses and sales charges those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER GROWTH & INCOME FUND
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)

 
PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
12/31/1996
 
Class A (Inception 12/31/96)
   
(1.33
)%
   
11.94
%
   
12.16
%
   
8.95
%
Class C (Inception 7/31/97)*
   
2.34
%
   
12.30
%
   
11.92
%
   
8.78
%
S&P 500 Index
   
0.21
%
   
13.66
%
   
13.67
%
   
9.03
%

   
1 YEAR
    5 YEARS     10 YEARS    
Since
3/1/2012
 
Class Z (Inception 3/1/12)
   
4.45
%
   
13.55
%
   
13.10
%
   
12.99
%
S&P 500 Index
   
0.21
%
   
13.66
%
   
13.67
%
   
13.65
%
 
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Previously, Alger Growth & Income Fund followed a different investment objective and different strategies under the name “Alger Balanced Fund.” Performance prior to April 1, 2011 does not reflect the Fund’s current investment objective and strategies. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
 
*
Since inception performance is calculated since the inception of the Class A shares. Historical performance prior to July 31,  1997, inception of the class, is that of the Fund’s Class A shares, reduced to reflect the current maximum sales charge and the higher operating expenses of Class C shares.

ALGER MID CAP GROWTH FUND**
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS A SHARES


The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Mid Cap Growth Fund Class A shares, with a maximum sales charge of 5.25%, and the Russell Midcap Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Figures for the Alger Mid Cap Growth Fund Class A shares and Russell Midcap Growth Index include reinvestment of dividends. Figures for the Alger Mid Cap Growth Fund Class A shares also include reinvestment of capital gains. Performance for the Alger Mid Cap Growth Fund Class B, Class C and Class Z shares will vary from the results shown above due to differences in expenses and sales charges those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER MID CAP GROWTH FUND**
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


 PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
12/31/1996
 
Class A (Inception 12/31/96)
   
(30.31
)%
   
10.94
%
   
10.65
%
   
8.81
%
Class B (Inception 5/24/93)
   
(28.73
)%
   
11.66
%
   
10.71
%
   
8.77
%
Class C (Inception 7/31/97)*
   
(27.47
)%
   
11.22
%
   
10.34
%
   
8.16
%
Russell Midcap Growth Index
   
(16.73
)%
   
12.06
%
   
12.17
%
   
9.21
%
 
   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
5/28/2015
 
Class Z (Inception 5/28/15)
   
(26.27
)%
   
12.45
%
   
n/a
     
9.26
%
Russell Midcap Growth Index
   
(16.73
)%
   
12.06
%
   
n/a
     
9.94
%
 
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class B and C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
 
*
Since inception performance is calculated since the inception of  the Class A shares. Historical performance prior to July 31,  1997, inception of the class, is that of the Fund’s Class A shares, reduced to reflect the current maximum sales charge and the higher operating expenses of Class C shares.
**
Pursuant to the U.S. Securities and Exchange Commission’s rules on Fair Fund and Disgorgement Plans, the Alger Mid Cap Growth Fund received a Fair Fund distribution of $9,346,397, which contributed approximately 3.89% to its annual return in 2021.

ALGER MID CAP FOCUS FUND
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS I SHARES

 
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Mid Cap Focus Fund Class I shares and the Russell Midcap Growth Index (an unmanaged index of common stocks) from June 14, 2019, the inception date of the Alger Mid Cap Focus Fund Class I shares, through April 30, 2022. Figures for the Alger Mid Cap Focus Fund Class I shares and the Russell Midcap Growth Index include reinvestment of dividends. Figures for the Alger Mid Cap Focus Fund Class I shares also include reinvestment of capital gains. Performance for the Alger Mid Cap Focus Fund Class A, C, Y and Z shares will vary from the results shown above due to differences in the expenses and sales charges that those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER MID CAP FOCUS FUND
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
6/14/2019
 
Class I (Inception 6/14/19)
   
(22.27
)%
   
n/a
     
n/a
     
17.33
%
Class Z (Inception 6/14/19)
   
(22.01
)%
   
n/a
     
n/a
     
17.64
%
Russell Midcap Growth Index
   
(16.73
)%
   
n/a
     
n/a
     
9.49
%
 
   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
2/26/2021
 
Class Y (Inception 2/26/21)
   
(22.03
)%
   
n/a
     
n/a
     
(20.84
)%
Russell Midcap Growth Index
   
(16.73
)%
   
n/a
     
n/a
     
(11.89
)%

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
7/29/2021
 
Class A (Inception 7/29/21)
   
n/a
     
n/a
     
n/a
     
(28.47
)%
Class C (Inception 7/29/21)
   
n/a
     
n/a
     
n/a
     
(25.57
)%
Russell Midcap Growth Index
   
n/a
     
n/a
     
n/a
     
9.49
%

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.

ALGER WEATHERBIE ENDURING GROWTH FUND
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS A SHARES

 
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Weatherbie Enduring Growth Fund Class A shares, with a maximum sales charge of 5.25%, and the Russell Midcap Growth Index (an unmanaged index of common stocks) from December 17, 2021, the inception date of the Alger Weatherbie Enduring Growth Fund, through April 30, 2022. Figures for the Alger Weatherbie Enduring Growth Fund Class A shares and Russell Midcap Growth Index include reinvestment of dividends. Figures for the Alger Weatherbie Enduring Growth Fund Class A shares also include reinvestment of capital gains. Performance for Alger Weatherbie Enduring Growth Fund Class C, Class I, Class Y and Class Z shares will vary from the results shown above due to differences in expenses and sales charges those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER WEATHERBIE ENDURING GROWTH FUND
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
12/17/2021
 
Class A (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(26.07
)%
Class C (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(22.98
)%
Class I (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(22.00
)%
Class Y (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(21.90
)%
Class Z (Inception 12/17/21)
   
n/a
     
n/a
     
n/a
     
(21.90
)%
Russell Midcap Growth Index
   
n/a
     
n/a
     
n/a
     
(19.89
)%
 
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.

ALGER WEATHERBIE SPECIALIZED GROWTH FUND
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS A SHARES


The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Weatherbie Specialized Growth Fund Class A shares, with a maximum sales charge of 5.25%, and the Russell 2500 Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2022. From August 30, 2017 to September 30, 2019, the Fund was named “Alger SMid Cap Focus Fund.” Prior to August 30, 2017, the Fund followed different investment strategies under the name “Alger SMid Cap Growth Fund” and prior to March 1, 2017 was managed by different portfolio managers. Accordingly, performance prior to those dates does not reflect the Fund’s current investment strategies and investment personnel. Figures for the Alger Weatherbie Specialized Growth Fund Class A shares and the Russell 2500 Growth Index include reinvestment of dividends. Figures for the Alger Weatherbie Specialized Growth Fund Class A shares also include reinvestment of capital gains. Performance for the Alger Weatherbie Specialized Growth Fund Class C, Class I, Class Y and Class Z shares will vary from the results shown above due to differences in expenses and sales charges those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

- 33 -

ALGER WEATHERBIE SPECIALIZED GROWTH FUND
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
5/8/2002
 
Class A (Inception 5/8/02)
   
(33.69
)%
   
13.28
%
   
11.05
%
   
9.37
%
Class C (Inception 5/8/02)
   
(31.11
)%
   
13.66
%
   
10.80
%
   
9.17
%
Class I (Inception 8/5/07)*
   
(30.05
)%
   
14.54
%
   
11.67
%
   
9.71
%
Russell 2500 Growth Index
   
(23.08
)%
   
10.12
%
   
11.43
%
   
9.27
%
 

 
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
8/30/2017
 
Class Y (Inception 8/30/17)
   
(29.82
)%
   
n/a
     
n/a
     
13.41
%
Russell 2500 Growth Index
   
(23.08
)%
   
n/a
     
n/a
     
10.26
%
 
   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
12/29/2010
 
Class Z (Inception 12/29/10)
   
(29.81
)%
   
14.90
%
   
12.03
%
   
11.41
%
Russell 2500 Growth Index
   
(23.08
)%
   
10.12
%
   
11.43
%
   
11.05
%

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. From August 30, 2017 to September 30, 2019, the Fund was named “Alger SMid Cap Focus Fund.” Prior to August 30, 2017, the Fund followed different investment strategies under the name “Alger SMid Cap Growth Fund” and prior to March 1, 2017 was managed by different portfolio managers. Accordingly, performance prior to those dates does not reflect the Fund’s current investment strategies and investment personnel. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
 
*
Historical performance prior to August 5, 2007, inception of the class, is that of the Fund’s Class A shares, which has been adjusted to remove the sales charge imposed by Class A shares.

ALGER SMALL CAP GROWTH FUND**
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS A SHARES
 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Small Cap Growth Fund Class A shares, with a maximum sales charge of 5.25%, and the Russell 2000 Growth Index (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Figures for the Alger Small Cap Growth Fund Class A shares and the Russell 2000 Growth Index include reinvestment of dividends. Figures for the Alger Small Cap Growth Fund Class A shares also include reinvestment of capital gains. Performance for the Alger Small Cap Growth Fund Class B, Class C, Class Y and Class Z shares will vary from the results shown above due to differences in expenses and sales charges those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER SMALL CAP GROWTH FUND**
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
12/31/1996
 
Class A (Inception 12/31/96)
   
(37.28
)%
   
10.79
%
   
9.56
%
   
5.65
%
Class B (Inception 11/11/86)
   
(36.72
)%
   
11.34
%
   
9.54
%
   
5.64
%
Class C (Inception 7/31/97)*
   
(34.87
)%
   
11.12
%
   
9.27
%
   
5.51
%
Russell 2000 Growth Index
   
(26.44
)%
   
7.08
%
   
9.95
%
   
6.67
%
 
   
 
1 YEAR
   
 
5 YEARS
   
 
10 YEARS
   
Since
12/31/2021
 
Class Y (Inception 12/31/21)
   
n/a
     
n/a
     
n/a
     
(26.95
)%
Russell 2000 Growth Index
   
n/a
     
n/a
     
n/a
     
(23.35
)%

   
 
1 YEAR
   
 
5 YEARS
   
 
10 YEARS
   
Since
12/29/2010
 
Class Z (Inception 12/29/10)
   
(33.57
)%
   
12.39
%
   
10.53
%
   
9.98
%
Russell 2000 Growth Index
   
(26.44
)%
   
7.08
%
   
9.95
%
   
9.40
%

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class B and C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
 
*
Since inception performance is calculated since the inception of the Class A shares. Historical performance prior to July 31, 1997, inception of the class, is that of the Fund’s Class A shares, reduced to reflect the current maximum sales charge and the higher operating expenses of Class C shares.
**
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Small Cap Growth Fund received a Fair Fund distribution of $3,738,004, which contributed approximately 0.72% to its annual return in 2021.

ALGER SMALL CAP FOCUS FUND
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS A SHARES


The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Small Cap Focus Fund Class A shares, with an initial 5.25% maximum sales charge, and the Russell 2000 Growth (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Prior to August 7, 2015, the Fund followed different investment strategies under the name “Alger Growth Opportunities Fund” and prior to February 12, 2015 was managed by a different portfolio manager. Accordingly, performance prior to those dates does not reflect the Fund’s current investment strategies and investment personnel. Figures for the Alger Small Cap Focus Fund Class A shares and the Russell 2000 Growth Index include reinvestment of dividends. Figures for the Alger Small Cap Focus Fund Class A shares also include reinvestment of capital gains. Performance for the Alger Small Cap Focus Fund Class C, Class I, Class Y and Class Z shares will vary from the results shown above due to differences in expenses and sales charges those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER SMALL CAP FOCUS FUND
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
3/3/2008
 
Class A (Inception 3/3/08)
   
(44.83
)%
   
7.54
%
   
9.23
%
   
7.95
%
Class C (Inception 3/3/08)
   
(42.72
)%
   
7.91
%
   
9.05
%
   
7.69
%
Class I (Inception 3/3/08)
   
(41.76
)%
   
8.73
%
   
9.95
%
   
8.51
%
Russell 2000 Growth Index
   
(26.44
)%
   
7.08
%
   
9.95
%
   
9.04
%
 
   
 
1 YEAR
   
 
5 YEARS
   
 
10 YEARS
   
Since
2/28/2017
 
Class Y (Inception 2/28/17)
   
(41.55
)%
   
9.09
%
   
n/a
     
9.41
%
Russell 2000 Growth Index
   
(26.44
)%
   
7.08
%
   
n/a
     
7.47
%

   
 
1 YEAR
   
 
5 YEARS
   
 
10 YEARS
   
Since
12/29/2010
 
Class Z (Inception 12/29/10)
   
(41.53
)%
   
9.09
%
   
10.27
%
   
9.79
%
Russell 2000 Growth Index
   
(26.44
)%
   
7.08
%
   
9.95
%
   
9.40
%
 
The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Prior to August 7, 2015, the Fund followed different investment strategies under the name “Alger Growth Opportunities Fund” and prior to February 12, 2015 was managed by a different portfolio manager. Accordingly, performance prior to those dates does not reflect the Fund’s current investment strategies and investment personnel. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.

ALGER INTERNATIONAL FOCUS FUND**
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS A SHARES
 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger International Focus Fund Class A shares, with a maximum sales charge of 5.25%, and MSCI AC World Index ex USA (an unmanaged index of common stocks) for the ten years ended April 30, 2022. Before March 28, 2018, the Fund followed different investment strategies and was managed by different portfolio managers. Prior to May 31, 2013, the Fund was named “Alger Large Cap Growth Fund,” and from May 31, 2013 to August 15, 2018 the Fund was named “Alger International Growth Fund.” Performance prior to March 28, 2018 reflects these prior management styles and does not reflect the Fund’s current investment strategies and investment personnel. Figures for the Alger International Focus Fund Class A shares and the index include reinvestment of dividends. Figures for the Alger International Focus Fund Class A shares also include reinvestment of capital gains. Performance for the Alger International Focus Fund Class B, Class C, Class I and Class Z shares will vary from the results shown above due to differences in expenses and sales charges those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER INTERNATIONAL FOCUS FUND**
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
12/31/1996
 
Class A (Inception 12/31/96)
   
(21.17
)%
   
5.54
%
   
4.71
%
   
5.25
%
Class B (Inception 11/11/86)
   
(20.55
)%
   
6.15
%
   
4.77
%
   
5.22
%
Class C (Inception 7/31/97)*
   
(18.17
)%
   
5.83
%
   
4.44
%
   
5.09
%
MSCI AC World Index ex USA
   
(9.90
)%
   
5.43
%
   
5.52
%
   
5.38
%
 
   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
5/31/2013
 
Class I (Inception 5/31/13)
   
(16.85
)%
   
6.84
%
   
n/a
     
5.40
%
MSCI AC World Index ex USA
   
(9.90
)%
   
5.43
%
   
n/a
     
4.86
%

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
12/29/2010
 
Class Z (Inception 12/29/10)
   
(16.52
)%
   
7.14
%
   
5.72
%
   
6.10
%
MSCI AC World Index ex USA
   
(9.90
)%
   
5.43
%
   
5.52
%
   
4.44
%

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class B and C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Before March 28, 2018, the Fund followed different investment strategies and was managed by different portfolio managers. Prior to May 31, 2013, the Fund was named “Alger Large Cap Growth Fund,” and from May 31, 2013 to August 15, 2018 the Fund was named “Alger International Growth Fund.” Performance prior to March 28, 2018 reflects these prior management styles and does not reflect the Fund’s current investment strategies and investment personnel. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
 
*
Since inception performance is calculated since the inception of the Class A shares. Historical performance prior to July 31, 1997, inception of the class, is that of the Fund’s Class A shares, reduced to reflect the current maximum sales charge and the higher operating expenses of Class C shares.
**
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger International Focus Fund received a Fair Fund distribution of $159,091, which contributed approximately 0.11% to its annual return in 2021.

ALGER HEALTH SCIENCES FUND*
Fund Highlights Through April 30, 2022 (Unaudited)


HYPOTHETICAL $10,000 INVESTMENT IN CLASS A SHARES


 
The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Health Sciences Fund Class A shares, with a maximum sales charge of 5.25%, the Russell 3000 Healthcare Index and the S&P 500 Index (each an unmanaged index of common stocks) for the ten years ended April 30, 2022. Figures for the Alger Health Sciences Fund Class A shares, the Russell 3000 Healthcare Index and the S&P 500 Index include reinvestment of dividends. Figures for the Alger Health Sciences Fund Class A shares also include reinvestment of capital gains. Performance for the Alger Health Sciences Fund Class C and Class Z shares will vary from the results shown above due to differences in expenses and sales charges those classes bear. Investors cannot invest directly in any index. Index performance does not reflect deduction for fees, expenses, or taxes.

ALGER HEALTH SCIENCES FUND*
Fund Highlights Through April 30, 2022 (Unaudited) (Continued)


PERFORMANCE COMPARISON AS OF 4/30/22
AVERAGE ANNUAL TOTAL RETURNS

   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
5/1/2002
 
Class A (Inception 5/1/02)
   
(25.47
)%
   
8.34
%
   
11.85
%
   
10.99
%
Class C (Inception 5/1/02)
   
(22.48
)%
   
8.67
%
   
11.60
%
   
10.78
%
Russell 3000 Healthcare Index
   
(0.11
)%
   
12.72
%
   
15.02
%
   
n/a
 
S&P 500 Index
   
0.21
%
   
13.66
%
   
13.67
%
   
9.05
%
 
   
1 YEAR
   
5 YEARS
   
10 YEARS
   
Since
5/28/2015
 
Class Z (Inception 5/28/15)
   
(21.10
)%
   
9.89
%
   
n/a
     
7.63
%
Russell 3000 Healthcare Index
   
(0.11
)%
   
12.72
%
   
n/a
     
9.48
%
S&P 500 Index
   
0.21
%
   
13.66
%
   
n/a
     
12.21
%

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. Class A returns reflect the maximum initial sales charge and Class C returns reflect the applicable contingent deferred sales charge. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For updated performance, visit us at www.alger.com or call us at (800) 992-3863.
 
*
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Health Sciences Fund received a Fair Fund distribution of $179,832, which contributed approximately 0.07% to its annual return in 2021.

PORTFOLIO SUMMARY†
April 30, 2022 (Unaudited)


SECTORS
 
Alger Capital
Appreciation Fund
   
Alger 35 Fund
   
Alger Growth &
Income Fund
   
Alger Mid Cap
Growth Fund
 
Communication Services
   
7.3
%
   
9.4
%
   
9.4
%
   
4.8
%
Consumer Discretionary
   
19.7
     
15.8
     
7.0
     
13.9
 
Consumer Staples
   
0.4
     
2.3
     
7.7
     
0.5
 
Energy
   
2.4
     
5.3
     
4.9
     
8.1
 
Financials
   
3.1
     
7.0
     
11.3
     
4.2
 
Healthcare
   
14.8
     
11.7
     
14.7
     
16.2
 
Industrials
   
8.3
     
5.6
     
6.2
     
11.4
 
Information Technology
   
42.2
     
35.5
     
25.5
     
29.1
 
Materials
   
1.1
     
0.0
     
2.0
     
1.6
 
Real Estate
   
0.3
     
4.0
     
4.1
     
0.5
 
Utilities
   
0.3
     
0.0
     
1.4
     
2.6
 
Short-Term Investments and
                               
Net Other Assets
   
0.1
     
3.4
     
5.8
     
7.1
 
     
100.0
%
   
100.0
%
   
100.0
%
   
100.0
%

SECTORS
 
Alger Mid Cap
Focus Fund
   
Alger Weatherbie
Enduring Growth
Fund
   
Alger Weatherbie
Specialized Growth
Fund
   
Alger Small Cap
Growth Fund
 
Communication Services
   
1.0
%
   
0.0
%
   
0.3
%
   
6.3
%
Consumer Discretionary
   
14.4
     
7.4
     
12.6
     
12.1
 
Consumer Staples
   
0.0
     
0.0
     
0.0
     
5.2
 
Energy
   
4.8
     
5.7
     
6.1
     
5.4
 
Financials
   
3.1
     
13.5
     
13.1
     
1.1
 
Healthcare
   
16.1
     
8.8
     
15.3
     
30.2
 
Industrials
   
15.5
     
30.3
     
22.0
     
6.8
 
Information Technology
   
37.6
     
18.0
     
20.7
     
25.4
 
Materials
   
2.4
     
0.0
     
0.7
     
3.4
 
Real Estate
   
0.0
     
7.8
     
5.8
     
1.0
 
Utilities
   
2.6
     
0.0
     
0.0
     
0.0
 
Short-Term Investments and
                               
Net Other Assets
   
2.5
     
8.5
     
3.4
     
3.1
 
     
100.0
%
   
100.0
%
   
100.0
%
   
100.0
%

SECTORS
 
Alger Small Cap
Focus Fund
   
Alger Health Sciences
Fund
 
Communication Services
   
0.5
%
   
0.0
%
Consumer Discretionary
   
5.9
     
0.0
 
Consumer Staples
   
1.6
     
0.0
 
Energy
   
7.6
     
0.0
 
Financials
   
2.3
     
0.0
 
Healthcare
   
38.9
     
95.6
 
Industrials
   
14.7
     
0.0
 
Information Technology
   
26.9
     
0.9
 
Materials
   
0.0
     
1.7
 
Short-Term Investments and
               
Net Other Assets
   
1.6
     
1.8
 
     
100.0
%
   
100.0
%

PORTFOLIO SUMMARY†
April 30, 2022 (Unaudited) (Continued)


COUNTRY
 
Alger International
Focus Fund
 
Argentina
   
1.5
%
Australia
   
5.0
 
Belgium
   
0.4
 
Brazil
   
1.4
 
China
   
5.9
 
France
   
14.2
 
Germany
   
7.0
 
Hong Kong
   
7.3
 
India
   
6.1
 
Ireland
   
2.4
 
Italy
   
6.2
 
Japan
   
4.6
 
Netherlands
   
8.7
 
Norway
   
3.9
 
South Korea
   
2.2
 
Spain
   
2.2
 
Sweden
   
1.4
 
Switzerland
   
6.0
 
Taiwan
   
2.9
 
United Kingdom
   
4.0
 
United States
   
4.0
 
Short-Term Investments, Cash and Net Other Assets
   
2.7
 
     
100.0
%
 
Based on net assets for each Fund.

THE ALGER FUNDS
ALGER CAPITAL APPRECIATION FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—99.3%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—3.2%
           
HEICO Corp.
   
90,271
   
$
12,748,974
 
Lockheed Martin Corp.
   
35,385
     
15,290,566
 
Raytheon Technologies Corp.
   
66,353
     
6,297,563
 
Textron, Inc.
   
34,657
     
2,399,997
 
TransDigm Group, Inc.*
   
58,663
     
34,893,339
 
             
71,630,439
 
AGRICULTURAL & FARM MACHINERY—0.5%
               
Deere & Co.
   
29,097
     
10,985,572
 
AIR FREIGHT & LOGISTICS—0.1%
               
GXO Logistics, Inc.*
   
47,556
     
2,814,840
 
ALUMINUM—0.1%
               
Alcoa Corp.
   
34,220
     
2,320,116
 
APPAREL ACCESSORIES & LUXURY GOODS—1.7%
               
Capri Holdings Ltd.*
   
260,688
     
12,434,818
 
Lululemon Athletica, Inc.*
   
16,261
     
5,766,638
 
LVMH Moet Hennessy Louis Vuitton SE
   
29,557
     
19,124,658
 
             
37,326,114
 
APPLICATION SOFTWARE—8.3%
               
Adobe, Inc.*
   
69,201
     
27,400,136
 
Atlassian Corp., PLC, Cl. A*
   
53,712
     
12,076,069
 
Bill.com Holdings, Inc.*
   
42,682
     
7,286,244
 
Cadence Design Systems, Inc.*
   
124,286
     
18,748,543
 
Confluent, Inc , Cl. A*
   
100,645
     
3,144,150
 
Datadog, Inc., Cl. A*
   
140,840
     
17,010,655
 
Intuit, Inc.
   
157,543
     
65,971,131
 
Salesforce, Inc.*
   
97,079
     
17,080,079
 
Unity Software, Inc.*
   
130,508
     
8,667,037
 
Zendesk, Inc.*
   
46,623
     
5,689,871
 
             
183,073,915
 
AUTOMOBILE MANUFACTURERS—3.3%
               
General Motors Co.*
   
137,955
     
5,229,874
 
Tesla, Inc.*
   
77,427
     
67,420,335
 
             
72,650,209
 
BIOTECHNOLOGY—3.1%
               
AbbVie, Inc.
   
215,437
     
31,643,386
 
Horizon Therapeutics PLC*
   
107,087
     
10,554,495
 
Natera, Inc.*
   
118,353
     
4,156,557
 
Vertex Pharmaceuticals, Inc.*
   
77,130
     
21,073,459
 
             
67,427,897
 
CASINOS & GAMING—2.6%
               
MGM Resorts International
   
1,371,029
     
56,267,030
 
CONSUMER FINANCE—0.4%
               
Upstart Holdings, Inc.*
   
125,144
     
9,388,303
 
COPPER—0.4%
               
Freeport-McMoRan, Inc.
   
212,814
     
8,629,608
 


THE ALGER FUNDS
ALGER CAPITAL APPRECIATION FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—99.3%
  SHARES     VALUE  
DATA PROCESSING & OUTSOURCED SERVICES—4.5%
           
Block, Inc., Cl. A*
   
100,063
   
$
9,960,271
 
Marqeta, Inc., Cl. A*
   
1,171,899
     
10,898,661
 
PayPal Holdings, Inc.*
   
176,607
     
15,529,054
 
Visa, Inc., Cl. A
   
296,096
     
63,106,940
 
             
99,494,926
 
DIVERSIFIED SUPPORT SERVICES—0.3%
               
Cintas Corp.
   
16,768
     
6,661,256
 
ELECTRIC UTILITIES—0.3%
               
NextEra Energy, Inc.
   
103,429
     
7,345,528
 
ELECTRICAL COMPONENTS & EQUIPMENT—2.8%
               
AMETEK, Inc.
   
122,199
     
15,428,845
 
Eaton Corp., PLC
   
253,240
     
36,724,865
 
Generac Holdings, Inc.*
   
48,568
     
10,654,848
 
             
62,808,558
 
FINANCIAL EXCHANGES & DATA—1.5%
               
S&P Global, Inc.
   
89,813
     
33,814,594
 
FOOTWEAR—0.7%
               
NIKE, Inc., Cl. B
   
127,877
     
15,946,262
 
HEALTHCARE DISTRIBUTORS—0.9%
               
McKesson Corp.
   
66,961
     
20,731,795
 
HEALTHCARE EQUIPMENT—2.8%
               
Dexcom, Inc.*
   
8,606
     
3,516,240
 
Edwards Lifesciences Corp.*
   
194,748
     
20,600,443
 
Intuitive Surgical, Inc.*
   
158,709
     
37,979,064
 
             
62,095,747
 
HEALTHCARE FACILITIES—0.7%
               
Acadia Healthcare Co., Inc.*
   
193,906
     
13,162,339
 
Tenet Healthcare Corp.*
   
33,015
     
2,393,918
 
             
15,556,257
 
HOTELS RESORTS & CRUISE LINES—1.4%
               
Airbnb, Inc., Cl. A*
   
81,729
     
12,521,700
 
Expedia Group, Inc.*
   
39,833
     
6,960,817
 
Hilton Worldwide Holdings, Inc.*
   
77,323
     
12,007,488
 
             
31,490,005
 
HYPERMARKETS & SUPER CENTERS—0.4%
               
Costco Wholesale Corp.
   
16,766
     
8,914,817
 
INTERACTIVE MEDIA & SERVICES—5.8%
               
Alphabet, Inc., Cl. C*
   
46,184
     
106,192,257
 
Meta Platforms, Inc., Cl. A*
   
31,667
     
6,348,283
 
Snap, Inc., Cl. A*
   
549,658
     
15,643,267
 
             
128,183,807
 
INTERNET & DIRECT MARKETING RETAIL—7.9%
               
Alibaba Group Holding Ltd.#,*
   
231,619
     
22,487,889
 
Altaba, Inc.*,(a)
   
259,825
     
911,986
 
Amazon.com, Inc.*
   
57,599
     
143,169,802
 
MercadoLibre, Inc.*
   
9,557
     
9,304,982
 
             
175,874,659
 

THE ALGER FUNDS
ALGER CAPITAL APPRECIATION FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—99.3% (CONT.)
 
SHARES
   
VALUE
 
INTERNET SERVICES & INFRASTRUCTURE—2.4%
           
MongoDB, Inc., Cl. A*
   
56,071
   
$
19,901,280
 
Shopify, Inc., Cl. A*
   
38,061
     
16,245,196
 
Snowflake, Inc , Cl. A*
   
103,298
     
17,709,409
 
             
53,855,885
 
LEISURE FACILITIES—1.2%
               
Vail Resorts, Inc.
   
106,312
     
27,020,258
 
LIFE SCIENCES TOOLS & SERVICES—1.9%
               
Danaher Corp.
   
167,217
     
41,993,205
 
MANAGED HEALTHCARE—3.1%
               
UnitedHealth Group, Inc.
   
135,083
     
68,696,460
 
MOVIES & ENTERTAINMENT—1.5%
               
Live Nation Entertainment, Inc.*
   
319,223
     
33,480,108
 
OIL & GAS EXPLORATION & PRODUCTION—1.7%
               
Pioneer Natural Resources Co.
   
165,464
     
38,465,416
 
OIL & GAS STORAGE & TRANSPORTATION—0.7%
               
Cheniere Energy, Inc.
   
118,378
     
16,076,916
 
PHARMACEUTICALS—2.3%
               
AstraZeneca PLC#
   
246,498
     
16,367,467
 
Bayer AG*
   
507,618
     
33,432,572
 
             
49,800,039
 
REGIONAL BANKS—1.2%
               
Signature Bank
   
108,555
     
26,297,449
 
RESTAURANTS—0.9%
               
Chipotle Mexican Grill, Inc., Cl. A*
   
3,183
     
4,633,207
 
Shake Shack, Inc., Cl. A*
   
204,998
     
11,855,034
 
Yum China Holdings, Inc.
   
82,412
     
3,444,822
 
             
19,933,063
 
SEMICONDUCTOR EQUIPMENT—2.1%
               
Applied Materials, Inc.
   
159,287
     
17,577,321
 
ASML Holding NV#
   
9,713
     
5,475,898
 
Enphase Energy, Inc.*
   
26,166
     
4,223,193
 
Lam Research Corp.
   
24,765
     
11,534,546
 
SolarEdge Technologies, Inc.*
   
27,408
     
6,863,237
 
             
45,674,195
 
SEMICONDUCTORS—4.8%
               
Advanced Micro Devices, Inc.*
   
581,646
     
49,742,366
 
NVIDIA Corp.
   
215,050
     
39,885,324
 
QUALCOMM, Inc.
   
122,919
     
17,170,555
 
             
106,798,245
 
SPECIALTY CHEMICALS—0.6%
               
Albemarle Corp.
   
62,712
     
12,092,755
 
SYSTEMS SOFTWARE—13.6%
               
Crowdstrike Holdings, Inc., Cl. A*
   
109,700
     
21,803,972
 
Microsoft Corp.
   
984,278
     
273,156,830
 
Palo Alto Networks, Inc.*
   
9,832
     
5,518,505
 
             
300,479,307
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—6.2%
               
Apple, Inc.
   
874,205
     
137,818,418
 

THE ALGER FUNDS
ALGER CAPITAL APPRECIATION FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—99.3% (CONT.)
  SHARES     VALUE  
TRUCKING—1.4%
           
Uber Technologies, Inc.*
 

   
$
18,716,497
 
XPO Logistics, Inc.*
   
214,767
     
11,552,317
 
             
30,268,814
 
TOTAL COMMON STOCKS
               
(Cost $1,622,701,364)
           
2,200,182,787
 
PREFERRED STOCKS—0.1%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—0.1%
               
Chime Financial, Inc., Series G*,@,(a)
   
27,841
     
1,656,261
 
(Cost $1,922,972)
           
1,656,261
 
REAL ESTATE INVESTMENT TRUST—0.3%
 
SHARES
   
VALUE
 
SPECIALIZED—0.3%
               
Crown Castle International Corp.
   
42,478
     
7,867,350
 
(Cost $7,681,618)
           
7,867,350
 
SPECIAL PURPOSE VEHICLE—0.2%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—0.2%
               
Crosslink Ventures Capital LLC, Cl. A*,@,(a),(b)
   
111
     
3,874,677
 
(Cost $2,775,000)
           
3,874,677
 
Total Investments
               
(Cost $1,635,080,954)
   
99.9
%
 
$
2,213,581,075
 
Affiliated Securities (Cost $2,775,000)
           
3,874,677
 
Unaffiliated Securities (Cost $1,632,305,954)
           
2,209,706,398
 
Other Assets in Excess of Liabilities
   
0.1
%
   
2,336,975
 
NET ASSETS
   
100.0
%
 
$
2,215,918,050
 
 
#
American Depositary Receipts.
(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 – Affiliated Securities.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

Security
Acquisition
Date(s)
 
Acquisition Cost
   
% of net assets
(Acquisition
Date)
   
Market
Value
   
% of net assets
as of
4/30/2022
 
Chime Financial, Inc., Series G
8/24/21
 
$
1,922,972
     
0.06
%
 
$
1,656,261
     
0.07
%
Crosslink Ventures Capital LLC, Cl. A
10/2/20
   
2,775,000
     
0.08
%
   
3,874,677
     
0.18
%
Total
 
                 
$
5,530,938
     
0.25
%
 
See Notes to Financial Statements.

THE ALGER FUNDS
ALGER 35 FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—95.1%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—5.6%
           
HEICO Corp.
   
11,768
   
$
1,661,995
 
APPLICATION SOFTWARE—2.0%
               
Datadog, Inc., Cl. A*
   
5,017
     
605,953
 
BIOTECHNOLOGY—2.4%
               
AbbVie, Inc.
   
2,958
     
434,471
 
Natera, Inc.*
   
8,444
     
296,553
 
             
731,024
 
CASINOS & GAMING—4.5%
               
MGM Resorts International
   
32,465
     
1,332,364
 
CONSUMER FINANCE—0.7%
               
Upstart Holdings, Inc.*
   
2,950
     
221,309
 
DATA PROCESSING & OUTSOURCED SERVICES—3.8%
               
Block, Inc., Cl. A*
   
8,838
     
879,735
 
Marqeta, Inc., Cl. A*
   
28,647
     
266,417
 
             
1,146,152
 
FINANCIAL EXCHANGES & DATA—3.0%
               
S&P Global, Inc.
   
2,417
     
910,001
 
HEALTHCARE EQUIPMENT—3.0%
               
Intuitive Surgical, Inc.*
   
3,792
     
907,426
 
HEALTHCARE TECHNOLOGY—2.1%
               
Veeva Systems, Inc., Cl. A*
   
3,401
     
618,812
 
HYPERMARKETS & SUPER CENTERS—2.3%
               
Costco Wholesale Corp.
   
1,267
     
673,689
 
INTERACTIVE HOME ENTERTAINMENT—2.0%
               
Take-Two Interactive Software, Inc.*
   
5,004
     
598,028
 
INTERACTIVE MEDIA & SERVICES—2.0%
               
Alphabet, Inc., Cl. C*
   
263
     
604,724
 
INTERNET & DIRECT MARKETING RETAIL—9.0%
               
Alibaba Group Holding Ltd.#,*
   
15,133
     
1,469,263
 
Amazon.com, Inc.*
   
494
     
1,227,901
 

           
2,697,164
 
INTERNET SERVICES & INFRASTRUCTURE—1.7%
               
Shopify, Inc., Cl. A*
   
1,173
     
500,660
 
LEISURE FACILITIES—2.3%
               
Vail Resorts, Inc.
   
2,758
     
700,973
 
LIFE SCIENCES TOOLS & SERVICES—1.8%
               
Bio-Techne Corp.
   
1,389
     
527,389
 
MOVIES & ENTERTAINMENT—5.4%
               
Live Nation Entertainment, Inc.*
   
11,504
     
1,206,540
 
The Walt Disney Co.*
   
3,513
     
392,156
 
             
1,598,696
 
OIL & GAS EQUIPMENT & SERVICES—1.3%
               
ChampionX Corp.
   
18,121
     
382,353
 
OIL & GAS EXPLORATION & PRODUCTION—4.0%
               
Diamondback Energy, Inc.
   
9,481
     
1,196,787
 
PHARMACEUTICALS—2.4%
               
Catalent, Inc.*
   
7,808
     
707,092
 

THE ALGER FUNDS
ALGER 35 FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—95.1% (CONT.)
 
SHARES
   
VALUE
 
REAL ESTATE SERVICES—2.5%
           
FirstService Corp.
   
5,869
   
$
732,979
 
REGIONAL BANKS—3.3%
               
Signature Bank
   
4,073
     
986,684
 
SEMICONDUCTOR EQUIPMENT—7.3%
               
Applied Materials, Inc.
   
12,613
     
1,391,844
 
SolarEdge Technologies, Inc.*
   
3,195
     
800,060
 
             
2,191,904
 
SEMICONDUCTORS—3.4%
               
Advanced Micro Devices, Inc.*
   
10,290
     
880,001
 
NVIDIA Corp.
   
781
     
144,852
 
             
1,024,853
 
SYSTEMS SOFTWARE—9.7%
               
Crowdstrike Holdings, Inc., Cl. A*
   
3,037
     
603,634
 
Microsoft Corp.
   
8,284
     
2,298,976
 
             
2,902,610
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—7.6%
               
Apple, Inc.
   
14,367
     
2,264,958
 
TOTAL COMMON STOCKS
               
(Cost $30,469,705)
           
28,426,579
 
REAL ESTATE INVESTMENT TRUST—1.5%
 
SHARES
   
VALUE
 
SPECIALIZED—1.5%
               
Crown Castle International Corp.
   
2,472
     
457,839
 
(Cost $479,053)
           
457,839
 
Total Investments
               
(Cost $30,948,758)
   
96.6
%
 
$
28,884,418
 
Unaffiliated Securities (Cost $30,948,758)
           
28,884,418
 
Other Assets in Excess of Liabilities
   
3.4
%
   
1,004,584
 
NET ASSETS
   
100.0
%
 
$
29,889,002
 
 
*
Non-income producing security.
#
American Depositary Receipts.

See Notes to Financial Statements.

THE ALGER FUNDS
ALGER GROWTH & INCOME FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—88.8%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—1.9%
           
General Dynamics Corp.
   
5,087
   
$
1,203,228
 
Raytheon Technologies Corp.
   
10,977
     
1,041,827
 
TransDigm Group, Inc.*
   
2,073
     
1,233,041
 
             
3,478,096
 
ASSET MANAGEMENT & CUSTODY BANKS—2.8%
               
BlackRock, Inc., Cl. A
   
4,034
     
2,519,959
 
Blackstone, Inc.
   
18,966
     
1,926,377
 
The Carlyle Group, Inc.
   
16,707
     
606,297
 
             
5,052,633
 
AUTOMOBILE MANUFACTURERS—0.2%
               
General Motors Co.*
   
8,849
     
335,466
 
BIOTECHNOLOGY—2.9%
               
AbbVie, Inc.
   
26,319
     
3,865,735
 
Amgen, Inc.
   
3,714
     
866,067
 
Gilead Sciences, Inc.
   
10,829
     
642,593
 
             
5,374,395
 
BROADCASTING—0.4%
               
Paramount Global, Cl. B
   
25,823
     
751,966
 
BUILDING PRODUCTS—0.5%
               
Johnson Controls International PLC
   
15,378
     
920,681
 
CABLE & SATELLITE—1.1%
               
Comcast Corp., Cl. A
   
49,588
     
1,971,619
 
COMMODITY CHEMICALS—0.4%
               
Dow, Inc.
   
11,480
     
763,420
 
COMMUNICATIONS EQUIPMENT—1.0%
               
Cisco Systems, Inc.
   
37,621
     
1,842,677
 
CONSUMER ELECTRONICS—0.5%
               
Garmin Ltd.
   
7,584
     
832,268
 
COPPER—0.4%
               
Southern Copper Corp.
   
12,988
     
808,763
 
DATA PROCESSING & OUTSOURCED SERVICES—1.5%
               
Visa, Inc., Cl. A
   
12,744
     
2,716,129
 
DIVERSIFIED BANKS—3.8%
               
Bank of America Corp.
   
65,789
     
2,347,352
 
JPMorgan Chase & Co.
   
37,976
     
4,532,815
 
             
6,880,167
 
ELECTRIC UTILITIES—0.7%
               
NextEra Energy, Inc.
   
17,155
     
1,218,348
 
ELECTRICAL COMPONENTS & EQUIPMENT—1.2%
               
Eaton Corp., PLC
   
14,897
     
2,160,363
 
FINANCIAL EXCHANGES & DATA—1.3%
               
CME Group, Inc., Cl. A
   
10,481
     
2,298,902
 
FOOD DISTRIBUTORS—0.6%
               
Sysco Corp.
   
13,317
     
1,138,337
 
GENERAL MERCHANDISE STORES—0.5%
               
Target Corp.
   
3,958
     
904,997
 
GOLD—0.3%
               
Newmont Corp.
   
8,279
     
603,125
 

THE ALGER FUNDS
ALGER GROWTH & INCOME FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—88.8% (CONT.)
 
SHARES
   
VALUE
 
HEALTHCARE EQUIPMENT—0.8%
           
Medtronic PLC
   
13,750
   
$
1,434,950
 
HEALTHCARE SERVICES—1.4%
               
CVS Health Corp.
   
26,041
     
2,503,321
 
HOME IMPROVEMENT RETAIL—2.3%
               
The Home Depot, Inc.
   
14,261
     
4,284,004
 
HOUSEHOLD PRODUCTS—1.7%
               
The Procter & Gamble Co.
   
19,806
     
3,179,853
 
HYPERMARKETS & SUPER CENTERS—0.9%
               
Walmart, Inc.
   
10,230
     
1,565,088
 
INDUSTRIAL CONGLOMERATES—1.9%
               
Honeywell International, Inc.
   
17,510
     
3,388,360
 
INDUSTRIAL GASES—0.9%
               
Air Products & Chemicals, Inc.
   
7,365
     
1,723,925
 
INTEGRATED OIL & GAS—3.6%
               
Chevron Corp.
   
20,685
     
3,240,719
 
Exxon Mobil Corp.
   
25,123
     
2,141,736
 
TotalEnergies SE#
   
23,961
     
1,167,140
 
             
6,549,595
 
INTEGRATED TELECOMMUNICATION SERVICES—1.6%
               
AT&T, Inc.
   
38,776
     
731,316
 
Verizon Communications, Inc.
   
47,491
     
2,198,833
 
             
2,930,149
 
INTERACTIVE MEDIA & SERVICES—6.3%
               
Alphabet, Inc., Cl. A*
   
2,220
     
5,066,462
 
Alphabet, Inc., Cl. C*
   
2,084
     
4,791,803
 
Meta Platforms, Inc., Cl. A*
   
8,566
     
1,717,226
 
             
11,575,491
 
INTERNET & DIRECT MARKETING RETAIL—1.8%
               
Amazon.com, Inc.*
   
1,321
     
3,283,517
 
INVESTMENT BANKING & BROKERAGE—2.2%
               
Morgan Stanley
   
49,758
     
4,009,997
 
LEISURE FACILITIES—0.5%
               
Vail Resorts, Inc.
   
3,706
     
941,917
 
MANAGED HEALTHCARE—3.1%
               
UnitedHealth Group, Inc.
   
10,938
     
5,562,520
 
MULTI-LINE INSURANCE—0.5%
               
The Hartford Financial Services Group, Inc.
   
13,959
     
976,153
 
MULTI-UTILITIES—0.7%
               
Sempra Energy
   
7,506
     
1,211,168
 
OIL & GAS EXPLORATION & PRODUCTION—0.3%
               
Pioneer Natural Resources Co.
   
2,264
     
526,312
 
OIL & GAS STORAGE & TRANSPORTATION—0.4%
               
ONEOK, Inc.
   
11,926
     
755,274
 

THE ALGER FUNDS
ALGER GROWTH & INCOME FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—88.8% (CONT.)
 
SHARES
   
VALUE
 
PHARMACEUTICALS—6.5%
           
AstraZeneca PLC#
   
18,483
   
$
1,227,271
 
Bristol-Myers Squibb Co.
   
15,695
     
1,181,363
 
Eli Lilly & Co.
   
5,058
     
1,477,594
 
GlaxoSmithKline PLC#
   
23,059
     
1,044,112
 
Johnson & Johnson
   
19,201
     
3,465,012
 
Merck & Co., Inc.
   
12,218
     
1,083,614
 
Novartis AG#
   
9,116
     
802,481
 
Pfizer, Inc.
   
31,644
     
1,552,771
 
             
11,834,218
 
RAILROADS—0.7%
               
Union Pacific Corp.
   
5,755
     
1,348,339
 
RESTAURANTS—1.2%
               
McDonald’s Corp.
   
5,344
     
1,331,511
 
Starbucks Corp.
   
12,617
     
941,733
 
             
2,273,244
 
SEMICONDUCTOR EQUIPMENT—2.2%
               
KLA Corp.
   
12,722
     
4,061,626
 
SEMICONDUCTORS—4.6%
               
Broadcom, Inc.
   
7,347
     
4,073,104
 
QUALCOMM, Inc.
   
22,257
     
3,109,080
 
Taiwan Semiconductor Manufacturing Co., Ltd.#
   
13,371
     
1,242,567
 
             
8,424,751
 
SOFT DRINKS—3.2%
               
PepsiCo, Inc.
   
18,725
     
3,215,270
 
The Coca-Cola Co.
   
40,544
     
2,619,548
 
             
5,834,818
 
SYSTEMS SOFTWARE—8.2%
               
Microsoft Corp.
   
53,911
     
14,961,381
 
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—8.0%
               
Apple, Inc.
   
92,286
     
14,548,888
 
TOBACCO—1.3%
               
Altria Group, Inc.
   
26,983
     
1,499,445
 
Philip Morris International, Inc.
   
8,907
     
890,700
 
             
2,390,145
 
TOTAL COMMON STOCKS
               
(Cost $81,924,021)
           
162,131,356
 
MASTER LIMITED PARTNERSHIP—0.6%
 
SHARES
   
VALUE
 
OIL & GAS STORAGE & TRANSPORTATION—0.6%
               
Cheniere Energy Partners LP
   
19,132
     
1,028,536
 
(Cost $672,536)
           
1,028,536
 
REAL ESTATE INVESTMENT TRUST—4.8%
 
SHARES
   
VALUE
 
HEALTHCARE—0.7%
               
Welltower, Inc.
   
13,782
     
1,251,544
 
INDUSTRIAL—0.6%
               
Prologis, Inc.
   
6,529
     
1,046,533
 
MORTGAGE—0.7%
               
Blackstone Mortgage Trust, Inc., Cl. A
   
45,066
     
1,353,783
 

THE ALGER FUNDS
ALGER GROWTH & INCOME FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

REAL ESTATE INVESTMENT TRUST—4.8% (CONT.)
 
SHARES
   
VALUE
 
RETAIL—0.7%
           
Simon Property Group, Inc.
   
10,827
   
$
1,277,586
 
SPECIALIZED—2.1%
               
Crown Castle International Corp.
   
15,032
     
2,784,077
 
Lamar Advertising Co., Cl. A
   
10,274
     
1,134,352
 
             
3,918,429
 
TOTAL REAL ESTATE INVESTMENT TRUST
               
(Cost $6,722,100)
           
8,847,875
 
Total Investments
               
(Cost $89,318,657)
   
94.2
%
 
$
172,007,767
 
Unaffiliated Securities (Cost $89,318,657)
           
172,007,767
 
Other Assets in Excess of Liabilities
   
5.8
%
   
10,514,646
 
NET ASSETS
   
100.0
%
 
$
182,522,413
 

#
American Depositary Receipts.
*
Non-income producing security.

See Notes to Financial Statements.

THE ALGER FUNDS
ALGER MID CAP GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)
 
COMMON STOCKS—91.1%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—5.2%
           
Axon Enterprise, Inc.*
   
9,396
   
$
1,054,231
 
HEICO Corp.
   
39,405
     
5,565,168
 
TransDigm Group, Inc.*
   
7,524
     
4,475,351
 
             
11,094,750
 
AIR FREIGHT & LOGISTICS—0.4%
               
GXO Logistics, Inc.*
   
13,972
     
827,003
 
APPAREL ACCESSORIES & LUXURY GOODS—2.8%
               
Lululemon Athletica, Inc.*
   
12,249
     
4,343,863
 
Moncler SpA
   
33,374
     
1,738,328
 
             
6,082,191
 
APPAREL RETAIL—2.2%
               
Aritzia, Inc.*
   
85,986
     
3,062,323
 
Burlington Stores, Inc.*
   
7,906
     
1,609,345
 
             
4,671,668
 
APPLICATION SOFTWARE—10.9%
               
Avalara, Inc.*
   
12,708
     
966,698
 
Bill.com Holdings, Inc.*
   
14,503
     
2,475,807
 
Cadence Design Systems, Inc.*
   
22,490
     
3,392,616
 
Datadog, Inc., Cl. A*
   
17,776
     
2,146,985
 
Manhattan Associates, Inc.*
   
26,436
     
3,451,220
 
Paycom Software, Inc.*
   
13,150
     
3,701,331
 
Sprout Social, Inc., Cl. A*
   
41,344
     
2,533,560
 
Synopsys, Inc.*
   
10,024
     
2,874,783
 
The Trade Desk, Inc., Cl. A*
   
30,798
     
1,814,618
 
             
23,357,618
 
AUTOMOTIVE RETAIL—1.4%
               
O’Reilly Automotive, Inc.*
   
4,885
     
2,962,997
 
BIOTECHNOLOGY—3.6%
               
Alkermes PLC*
   
28,838
     
831,976
 
Apellis Pharmaceuticals, Inc.*
   
21,376
     
930,497
 
BioMarin Pharmaceutical, Inc.*
   
14,819
     
1,205,526
 
BioNTech SE#,*
   
5,210
     
723,044
 
Celldex Therapeutics, Inc.*
   
34,137
     
1,042,885
 
Natera, Inc.*
   
58,990
     
2,071,729
 
Prometheus Biosciences, Inc.*
   
32,928
     
866,007
 
             
7,671,664
 
BUILDING PRODUCTS—0.7%
               
Trex Co., Inc.*
   
27,721
     
1,613,085
 
CASINOS & GAMING—1.9%
               
MGM Resorts International
   
102,249
     
4,196,299
 
CONSUMER FINANCE—1.3%
               
Upstart Holdings, Inc.*
   
37,861
     
2,840,332
 
DATA PROCESSING & OUTSOURCED SERVICES—1.4%
               
Marqeta, Inc., Cl. A*
   
322,242
     
2,996,851
 
DIVERSIFIED METALS & MINING—1.6%
               
MP Materials Corp.*
   
89,229
     
3,394,271
 
ELECTRIC UTILITIES—1.9%
               
NextEra Energy, Inc.
   
58,433
     
4,149,912
 

THE ALGER FUNDS
ALGER MID CAP GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—91.1% (CONT.)
 
SHARES
   
VALUE
 
ELECTRICAL COMPONENTS & EQUIPMENT—2.2%
           
AMETEK, Inc.
   
18,714
   
$
2,362,830
 
Generac Holdings, Inc.*
   
11,330
     
2,485,575
 
             
4,848,405
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.3%
               
908 Devices, Inc.*
   
127,617
     
2,265,202
 
Trimble, Inc.*
   
6,709
     
447,490
 
             
2,712,692
 
FINANCIAL EXCHANGES & DATA—0.7%
               
MSCI, Inc., Cl. A
   
3,654
     
1,539,247
 
HEALTHCARE DISTRIBUTORS—2.2%
               
AmerisourceBergen Corp., Cl. A
   
15,136
     
2,289,926
 
McKesson Corp.
   
7,699
     
2,383,687
 
             
4,673,613
 
HEALTHCARE EQUIPMENT—2.1%
               
Dexcom, Inc.*
   
5,265
     
2,151,174
 
Insulet Corp.*
   
10,056
     
2,403,283
 
             
4,554,457
 
HEALTHCARE SERVICES—0.3%
               
Guardant Health, Inc.*
   
9,923
     
612,249
 
HEALTHCARE TECHNOLOGY—0.7%
               
Veeva Systems, Inc., Cl. A*
   
8,448
     
1,537,114
 
HOTELS RESORTS & CRUISE LINES—1.0%
               
Airbnb, Inc., Cl. A*
   
6,955
     
1,065,576
 
Expedia Group, Inc.*
   
6,232
     
1,089,042
 
             
2,154,618
 
HYPERMARKETS & SUPER CENTERS—0.5%
               
BJ’s Wholesale Club Holdings, Inc.*
   
16,223
     
1,043,950
 
INTERACTIVE HOME ENTERTAINMENT—1.8%
               
Take-Two Interactive Software, Inc.*
   
33,215
     
3,969,525
 
INTERACTIVE MEDIA & SERVICES—0.3%
               
Snap, Inc., Cl. A*
   
19,280
     
548,709
 
INTERNET SERVICES & INFRASTRUCTURE—1.2%
               
MongoDB, Inc., Cl. A*
   
7,006
     
2,486,640
 
LEISURE FACILITIES—1.1%
               
Vail Resorts, Inc.
   
8,972
     
2,280,323
 
LIFE SCIENCES TOOLS & SERVICES—4.1%
               
10X Genomics, Inc., Cl. A*
   
11,777
     
562,470
 
Azenta, Inc.
   
22,056
     
1,653,318
 
Bio-Techne Corp.
   
12,241
     
4,647,785
 
Repligen Corp.*
   
6,903
     
1,085,428
 
West Pharmaceutical Services, Inc.
   
2,922
     
920,605
 
             
8,869,606
 
MOVIES & ENTERTAINMENT—2.7%
               
Liberty Media Corp.-Liberty Formula One, Cl. C*
   
35,533
     
2,214,772
 
Live Nation Entertainment, Inc.*
   
33,810
     
3,545,993
 
             
5,760,765
 

THE ALGER FUNDS
ALGER MID CAP GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—91.1% (CONT.)
 
SHARES
   
VALUE
 
OIL & GAS EQUIPMENT & SERVICES—4.2%
           
Baker Hughes Co., Cl. A
   
141,882
   
$
4,401,180
 
ChampionX Corp.
   
160,333
     
3,383,026
 
ProPetro Holding Corp.*
   
90,360
     
1,277,690
 
             
9,061,896
 
OIL & GAS EXPLORATION & PRODUCTION—3.9%
               
Diamondback Energy, Inc.
   
33,949
     
4,285,382
 
Pioneer Natural Resources Co.
   
17,738
     
4,123,553
 
             
8,408,935
 
PHARMACEUTICALS—3.0%
               
Catalent, Inc.*
   
43,465
     
3,936,190
 
Green Thumb Industries, Inc.*
   
70,945
     
994,644
 
Jazz Pharmaceuticals PLC*
   
5,173
     
828,818
 
Pacira BioSciences, Inc.*
   
10,526
     
784,924
 
             
6,544,576
 
REGIONAL BANKS—2.2%
               
Signature Bank
   
19,682
     
4,767,964
 
RENEWABLE ELECTRICITY—0.7%
               
NextEra Energy Partners LP
   
21,825
     
1,454,854
 
RESEARCH & CONSULTING SERVICES—0.6%
               
CoStar Group, Inc.*
   
18,883
     
1,201,336
 
RESTAURANTS—3.5%
               
Chipotle Mexican Grill, Inc., Cl. A*
   
1,627
     
2,368,277
 
Shake Shack, Inc., Cl. A*
   
66,855
     
3,866,225
 
The Cheesecake Factory, Inc.*
   
34,654
     
1,279,079
 
             
7,513,581
 
SEMICONDUCTOR EQUIPMENT—5.0%
               
Applied Materials, Inc.
   
15,537
     
1,714,508
 
Enphase Energy, Inc.*
   
7,394
     
1,193,392
 
KLA Corp.
   
7,198
     
2,298,034
 
Lam Research Corp.
   
2,438
     
1,135,523
 
Onto Innovation, Inc.*
   
8,459
     
601,773
 
SolarEdge Technologies, Inc.*
   
15,562
     
3,896,880
 
             
10,840,110
 
SEMICONDUCTORS—3.4%
               
Advanced Micro Devices, Inc.*
   
36,069
     
3,084,621
 
Microchip Technology, Inc.
   
36,219
     
2,361,479
 
SiTime Corp.*
   
11,247
     
1,895,906
 
             
7,342,006
 
SYSTEMS SOFTWARE—4.8%
               
Crowdstrike Holdings, Inc., Cl. A*
   
17,507
     
3,479,691
 
Fortinet, Inc.*
   
9,005
     
2,602,535
 
Palo Alto Networks, Inc.*
   
7,731
     
4,339,256
 
             
10,421,482
 

THE ALGER FUNDS
ALGER MID CAP GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—91.1% (CONT.)
 
SHARES
   
VALUE
 
TRUCKING—2.3%
           
Old Dominion Freight Line, Inc.
   
13,649
   
$
3,823,358
 
Uber Technologies, Inc.*
   
35,392
     
1,114,140
 
             
4,937,498
 
TOTAL COMMON STOCKS
               
(Cost $216,640,667)
           
195,944,792
 
PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
219,610
     
 
(Cost $988,245)
           
 
RIGHTS—0.2%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.2%
               
Tolero CDR*,@,(a),(c)
   
590,059
     
424,842
 
(Cost $315,501)
           
424,842
 
REAL ESTATE INVESTMENT TRUST—0.5%
 
SHARES
   
VALUE
 
SPECIALIZED—0.5%
               
Crown Castle International Corp.
   
6,120
     
1,133,485
 
(Cost $1,211,790)
           
1,133,485
 
SPECIAL PURPOSE VEHICLE—1.1%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—1.1%
               
Crosslink Ventures Capital LLC, Cl. A*,@,(a),(b)
   
48
     
1,675,536
 
Crosslink Ventures Capital LLC, Cl. B*,@,(a),(b)
   
19
     
690,175
 
             
2,365,711
 
TOTAL SPECIAL PURPOSE VEHICLE
               
(Cost $1,675,000)
           
2,365,711
 
Total Investments
               
(Cost $220,831,203)
   
92.9
%
 
$
199,868,830
 
Affiliated Securittes (Cost $2,663,245)
           
2,365,711
 
Unaffiliated Securities (Cost $218,167,958)
           
197,503,119
 
Other Assets in Excess of Liabilities
   
7.1
%
   
15,257,676
 
NET ASSETS
   
100.0
%
 
$
215,126,506
 

#
American Depositary Receipts.
(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - qffiliated Securities.
(c)
Contingent Deferred Rights.
*
Non-income producing security.

THE ALGER FUNDS
ALGER MID CAP GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

Security
Acquisition 
Date(s)
 
Acquisition
Cost
   
% of net assets
(Acquisition
Date)
   
Market
Value
   
% of net assets
as of
4/30/2022
 
Crosslink Ventures Capital LLC, Cl. A
10/2/20
 
$
1,200,000
     
0.50
%
 
$
1,675,536
     
0.78
%
Crosslink Ventures Capital LLC, Cl. B
12/16/20
   
475,000
     
0.19
%
   
690,175
     
0.32
%
Prosetta Biosciences, Inc., Series D
2/6/15
   
988,245
     
0.50
%
   
0
     
0.00
%
Tolero CDR
2/6/17
   
315,501
     
0.19
%
   
424,842
     
0.20
%
Total
 
                 
$
2,790,553
     
1.30
%

See Notes to Financial Statements.

THE ALGER FUNDS
ALGER MID CAP FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—97.5%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—3.5%
           
HEICO Corp.
   
45,840
   
$
6,473,983
 
Mercury Systems, Inc.*
   
248,923
     
13,887,414
 
             
20,361,397
 
APPAREL ACCESSORIES & LUXURY GOODS—2.2%
               
Lululemon Athletica, Inc.*
   
36,280
     
12,865,976
 
APPLICATION SOFTWARE—19.8%
               
Alteryx, Inc., Cl. A*
   
205,099
     
13,167,356
 
Bentley Systems, Inc., Cl. B
   
424,752
     
18,005,237
 
Bill.com Holdings, Inc.*
   
42,332
     
7,226,496
 
Confluent, Inc , Cl. A*
   
291,030
     
9,091,777
 
Coupa Software, Inc.*
   
113,874
     
9,827,326
 
Everbridge, Inc.*
   
331,616
     
14,292,650
 
Paylocity Holding Corp.*
   
52,618
     
9,977,951
 
Splunk, Inc.*
   
93,944
     
11,463,047
 
Tyler Technologies, Inc.*
   
30,794
     
12,154,700
 
Zendesk, Inc.*
   
83,802
     
10,227,196
 
             
115,433,736
 
AUTOMOTIVE RETAIL—1.8%
               
O’Reilly Automotive, Inc.*
   
17,527
     
10,631,002
 
BIOTECHNOLOGY—3.1%
               
CareDx, Inc.*
   
203,175
     
6,184,647
 
Natera, Inc.*
   
340,547
     
11,960,011
 
             
18,144,658
 
CASINOS & GAMING—3.8%
               
MGM Resorts International
   
534,846
     
21,950,080
 
DATA PROCESSING & OUTSOURCED SERVICES—1.4%
               
Marqeta, Inc., Cl. A*
   
870,973
     
8,100,049
 
DEPARTMENT STORES—1.4%
               
Kohl’s Corp.
   
138,435
     
8,012,618
 
DISTRIBUTORS—2.1%
               
Pool Corp.
   
30,894
     
12,518,867
 
DIVERSIFIED METALS & MINING—1.2%
               
MP Materials Corp.*
   
189,883
     
7,223,149
 
ELECTRIC UTILITIES—2.6%
               
Constellation Energy Corp.
   
259,470
     
15,363,219
 
ELECTRICAL COMPONENTS & EQUIPMENT—1.5%
               
Generac Holdings, Inc.*
   
40,378
     
8,858,126
 
ENVIRONMENTAL & FACILITIES SERVICES—1.9%
               
Waste Connections, Inc.
   
81,715
     
11,274,218
 
FERTILIZERS & AGRICULTURAL CHEMICALS—1.2%
               
CF Industries Holdings, Inc.
   
69,864
     
6,764,931
 
HEALTHCARE EQUIPMENT—5.5%
               
Cutera, Inc.*
   
113,681
     
6,174,015
 
Dexcom, Inc.*
   
25,830
     
10,553,621
 
Insulet Corp.*
   
65,198
     
15,581,670
 
             
32,309,306
 

THE ALGER FUNDS
ALGER MID CAP FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—97.5% (CONT.)
 
SHARES
   
VALUE
 
HEALTHCARE TECHNOLOGY—2.8%
           
Doximity, Inc., Cl. A*
   
270,635
   
$
10,790,217
 
Omnicell, Inc.*
   
53,244
     
5,812,648
 
             
16,602,865
 
INTERNET SERVICES & INFRASTRUCTURE—5.7%
               
Cloudflare, Inc , C A*
   
118,456
     
10,203,800
 
MongoDB, Inc., Cl. A*
   
32,652
     
11,589,174
 
VeriSign, Inc.*
   
65,789
     
11,755,837
 
             
33,548,811
 
LIFE SCIENCES TOOLS & SERVICES—4.7%
               
Avantor, Inc.*
   
632,398
     
20,160,848
 
Azenta, Inc.
   
95,172
     
7,134,093
 
             
27,294,941
 
MOVIES & ENTERTAINMENT—1.0%
               
Liberty Media Corp.-Liberty Formula One, Cl. C*
   
91,952
     
5,731,368
 
OIL & GAS EQUIPMENT & SERVICES—2.1%
               
Baker Hughes Co., Cl. A
   
398,422
     
12,359,050
 
OIL & GAS EXPLORATION & PRODUCTION—2.7%
               
Diamondback Energy, Inc.
   
123,778
     
15,624,497
 
REGIONAL BANKS—3.1%
               
Signature Bank
   
74,292
     
17,997,237
 
SEMICONDUCTOR EQUIPMENT—3.3%
               
Enphase Energy, Inc.*
   
40,069
     
6,467,137
 
KLA Corp.
   
39,550
     
12,626,733
 
             
19,093,870
 
SEMICONDUCTORS—1.2%
               
Universal Display Corp.
   
56,968
     
7,276,523
 
SPECIALTY STORES—3.1%
               
Petco Health & Wellness Co., Inc., Cl. A*
   
549,432
     
10,582,060
 
Ulta Beauty, Inc.*
   
18,581
     
7,372,941
 
             
17,955,001
 
SYSTEMS SOFTWARE—6.2%
               
Crowdstrike Holdings, Inc., Cl. A*
   
64,760
     
12,871,698
 
CyberArk Software Ltd.*
   
63,353
     
9,955,290
 
Palo Alto Networks, Inc.*
   
23,787
     
13,351,167
 
             
36,178,155
 
TRADING COMPANIES & DISTRIBUTORS—6.1%
               
Herc Holdings, Inc.
   
147,087
     
18,800,660
 
United Rentals, Inc.*
   
52,159
     
16,509,367
 
             
35,310,027
 
TRUCKING—2.5%
               
XPO Logistics, Inc.*
   
268,162
     
14,424,434
 
TOTAL COMMON STOCKS
               
(Cost $621,914,220)
           
569,208,111
 

THE ALGER FUNDS
ALGER MID CAP FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

     
VALUE
 
Total Investments
           
(Cost $621,914,220)
   
97.5
%
 
$
569,208,111
 
Unaffiliated Securities (Cost $621,914,220)
           
569,208,111
 
Other Assets in Excess of Liabilities
   
2.5
%
   
14,656,708
 
NET ASSETS
   
100.0
%
 
$
583,864,819
 

*
Non-income producing security.

- 62 -

THE ALGER FUNDS
ALGER WEATHERBIE ENDURING GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—91.5%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—4.8%
           
TransDigm Group, Inc.*
   
342
   
$
203,425
 
APPLICATION SOFTWARE—18.0%
               
Avalara, Inc.*
   
510
     
38,796
 
HubSpot, Inc.*
   
350
     
132,800
 
Paylocity Holding Corp.*
   
1,814
     
343,989
 
SPS Commerce, Inc.*
   
1,175
     
140,565
 
The Trade Desk, Inc., Cl. A*
   
656
     
38,652
 
Vertex, Inc., Cl. A*
   
5,132
     
73,028
 
             
767,830
 
ASSET MANAGEMENT & CUSTODY BANKS—5.7%
               
Hamilton Lane, Inc., Cl. A
   
1,946
     
133,457
 
StepStone Group, Inc., Cl. A
   
4,300
     
110,166
 
             
243,623
 
CONSUMER FINANCE—3.2%
               
Upstart Holdings, Inc.*
   
1,820
     
136,536
 
EDUCATION SERVICES—5.6%
               
Chegg, Inc.*
   
9,684
     
239,582
 
ENVIRONMENTAL & FACILITIES SERVICES—20.7%
               
Casella Waste Systems, Inc., Cl. A*
   
3,863
     
317,693
 
Montrose Environmental Group, Inc.*
   
3,849
     
174,629
 
Waste Connections, Inc.
   
2,844
     
392,387
 
             
884,709
 
GENERAL MERCHANDISE STORES—1.2%
               
Ollie’s Bargain Outlet Holdings, Inc.*
   
1,057
     
50,789
 
HEALTHCARE EQUIPMENT—3.2%
               
Insulet Corp.*
   
143
     
34,176
 
Nevro Corp.*
   
1,644
     
101,418
 
             
135,594
 
INTERNET & DIRECT MARKETING RETAIL—0.6%
               
Wayfair, Inc., Cl. A*
   
336
     
25,852
 
MANAGED HEALTHCARE—5.6%
               
Progyny, Inc.*
   
6,249
     
240,274
 
OIL & GAS EQUIPMENT & SERVICES—5.7%
               
Core Laboratories NV
   
6,863
     
178,438
 
Dril-Quip, Inc.*
   
2,268
     
65,500
 
             
243,938
 
REAL ESTATE SERVICES—7.8%
               
FirstService Corp.
   
2,647
     
330,584
 
REGIONAL BANKS—4.6%
               
Signature Bank
   
808
     
195,738
 
TRADING COMPANIES & DISTRIBUTORS—2.5%
               
SiteOne Landscape Supply, Inc.*
   
741
     
104,503
 
TRUCKING—2.3%
               
XPO Logistics, Inc.*
   
1,855
     
99,780
 
TOTAL COMMON STOCKS
               
(Cost $4,897,525)
           
3,902,757
 

- 63 -

THE ALGER FUNDS
ALGER WEATHERBIE ENDURING GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

 
   
VALUE
 
Total Investments
               
(Cost $4,897,525)
   
91.5
%
 
$
3,902,757
 
Unaffiliated Securities (Cost $4,897,525)
           
3,902,757
 
Other Assets in Excess of Liabilities
   
8.5
%
   
361,392
 
NET ASSETS
   
100.0
%
 
$
4,264,149
 

*
Non-income producing security.

- 64 -

THE ALGER FUNDS
ALGER WEATHERBIE ENDURING GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—96.6%
 
SHARES
   
VALUE
 
ADVERTISING—0.3%
           
TechTarget, Inc.*
   
48,941
   
$
3,294,219
 
AEROSPACE & DEFENSE—0.7%
               
Kratos Defense & Security Solutions, Inc.*
   
448,932
     
6,810,298
 
APPAREL ACCESSORIES & LUXURY GOODS—0.8%
               
Canada Goose Holdings, Inc.*
   
366,257
     
7,973,415
 
APPAREL RETAIL—1.3%
               
MYT Netherlands Parent BV#,*
   
1,087,076
     
12,979,687
 
APPLICATION SOFTWARE—8.5%
               
BTRS Holdings, Inc., Cl. 1*
   
552,785
     
3,714,715
 
Ebix, Inc.
   
125,736
     
3,746,933
 
Everbridge, Inc.*
   
44,682
     
1,925,794
 
SEMrush Holdings, Inc., Cl. A*
   
147,137
     
1,436,057
 
SPS Commerce, Inc.*
   
438,031
     
52,401,648
 
Vertex, Inc., Cl. A*
   
1,373,885
     
19,550,384
 
             
82,775,531
 
ASSET MANAGEMENT & CUSTODY BANKS—8.2%
               
Hamilton Lane, Inc., Cl. A
   
623,708
     
42,773,895
 
StepStone Group, Inc., Cl. A
   
1,434,579
     
36,753,914
 
             
79,527,809
 
BIOTECHNOLOGY—2.5%
               
ACADIA Pharmaceuticals, Inc.*
   
601,770
     
11,096,639
 
Natera, Inc.*
   
168,484
     
5,917,158
 
Ultragenyx Pharmaceutical, Inc.*
   
105,896
     
7,485,788
 
             
24,499,585
 
CONSTRUCTION & ENGINEERING—2.7%
               
Ameresco, Inc., Cl. A*
   
515,859
     
26,019,928
 
CONSUMER FINANCE—0.8%
               
LendingTree, Inc.*
   
101,610
     
8,069,866
 
EDUCATION SERVICES—4.3%
               
Chegg, Inc.*
   
1,700,983
     
42,082,319
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—3.2%
               
Novanta, Inc.*
   
239,533
     
30,827,897
 
ENVIRONMENTAL & FACILITIES SERVICES—11.5%
               
Casella Waste Systems, Inc., Cl. A*
   
710,370
     
58,420,829
 
Montrose Environmental Group, Inc.*
   
1,184,288
     
53,731,146
 
             
112,151,975
 
GENERAL MERCHANDISE STORES—0.9%
               
Ollie’s Bargain Outlet Holdings, Inc.*
   
183,394
     
8,812,082
 
HEALTHCARE DISTRIBUTORS—0.4%
               
PetIQ, Inc., Cl. A*
   
209,792
     
4,174,861
 
HEALTHCARE EQUIPMENT—4.8%
               
Glaukos Corp.*
   
371,678
     
17,576,652
 
Impulse Dynamics NV, Series E*,@,(a)
   
904,912
     
2,986,210
 
Inogen, Inc.*
   
160,297
     
4,052,308
 
Nevro Corp.*
   
354,130
     
21,846,280
 
             
46,461,450
 
HEALTHCARE FACILITIES—1.1%
               
US Physical Therapy, Inc.
   
103,816
     
10,772,986
 

- 65 -

Table of Contents
THE ALGER FUNDS
ALGER WEATHERBIE ENDURING GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—96.6% (CONT.)
 
SHARES
   
VALUE
 
HEALTHCARE TECHNOLOGY—1.2%
               
Inspire Medical Systems, Inc.*
   
49,448
   
$
10,174,420
 
Tabula Rasa HealthCare, Inc.*
   
463,234
     
1,561,099
 
             
11,735,519
 
INSURANCE BROKERS—0.4%
               
Goosehead Insurance, Inc., Cl. A
   
59,020
     
3,393,060
 
IT CONSULTING & OTHER SERVICES—5.7%
               
CI&T, Inc., Cl. A*
   
818,389
     
10,401,724
 
Globant SA*
   
202,288
     
43,692,185
 
Grid Dynamics Holdings, Inc.*
   
59,361
     
826,305
 
             
54,920,214
 
LEISURE FACILITIES—2.2%
               
Planet Fitness, Inc., Cl. A*
   
268,408
     
21,480,692
 
LEISURE PRODUCTS—2.8%
               
Latham Group, Inc.*
   
2,238,426
     
26,861,112
 
LIFE SCIENCES TOOLS & SERVICES—0.2%
               
NeoGenomics, Inc.*
   
190,268
     
1,798,033
 
MANAGED HEALTHCARE—4.8%
               
Progyny, Inc.*
   
1,208,879
     
46,481,398
 
OIL & GAS EQUIPMENT & SERVICES—6.1%
               
Core Laboratories NV
   
1,514,299
     
39,371,774
 
Dril-Quip, Inc.*
   
702,821
     
20,297,470
 
             
59,669,244
 
PAPER PACKAGING—0.7%
               
Ranpak Holdings Corp., Cl. A*
   
450,162
     
6,788,443
 
PHARMACEUTICALS—0.3%
               
Aerie Pharmaceuticals, Inc.*
   
376,904
     
2,679,787
 
REAL ESTATE SERVICES—5.8%
               
FirstService Corp.
   
454,238
     
56,729,784
 
REGIONAL BANKS—2.3%
               
Seacoast Banking Corp. of Florida
   
690,425
     
22,438,813
 
RESTAURANTS—0.3%
               
Wingstop, Inc.
   
36,302
     
3,331,072
 
SEMICONDUCTORS—1.6%
               
Impinj, Inc.*
   
311,849
     
15,361,682
 
SYSTEMS SOFTWARE—1.7%
               
Rapid7, Inc.*
   
175,948
     
16,806,553
 
THRIFTS & MORTGAGE FINANCE—1.4%
               
Axos Financial, Inc.*
   
356,720
     
13,512,554
 
TRADING COMPANIES & DISTRIBUTORS—7.1%
               
SiteOne Landscape Supply, Inc.*
   
354,788
     
50,035,752
 
Transcat, Inc.*
   
257,877
     
18,825,021
 
             
68,860,773
 
TOTAL COMMON STOCKS
               
(Cost $1,134,184,197)
           
940,082,641
 

- 66 -

Table of Contents
THE ALGER FUNDS
ALGER WEATHERBIE SPECIALIZED GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%            
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
231,474
   
$
 
(Cost $1,041,633)
           
 
Total Investments                
(Cost $1,135,225,830)
   
96.6
%
 
$
940,082,641
 
Affiliated Securities (Cost $1,041,633)
           
 
Unaffiliated Securities (Cost $1,134,184,197)
           
940,082,641
 
Other Assets in Excess of Liabilities
   
3.4
%
   
32,746,949
 
NET ASSETS
   
100.0
%
 
$
972,829,590
 

#
American Depositary Receipts.
(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Affiliated Securities.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
 

Security
Acquisition
Date(s)
 
Acquisition
Cost
   
% of net assets
(Acquisition
Date)
   
Market
Value
   
% of net assets
as of
4/30/2022
 
Impulse Dynamics NV, Series E
2/11/22
 
$
2,986,210
     
0.24
%
  $ 2,986,210      
0.31
%
Prosetta Biosciences, Inc., Series D
2/6/15
   
1,041,633
     
0.10
%
    0
     
0.00
%
Total
                    $ 2,986,210      
0.31
%

See Notes to Financial Statements.

- 67 -

THE ALGER FUNDS
ALGER SMALL CAP GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—95.2%
 
SHARES
   
VALUE
 
ADVERTISING—0.4%
           
Magnite, Inc.*
   
182,376
   
$
1,759,928
 
AEROSPACE & DEFENSE—4.3%
               
HEICO Corp.
   
90,915
     
12,839,925
 
Hexcel Corp.
   
35,283
     
1,917,984
 
Mercury Systems, Inc.*
   
72,121
     
4,023,631
 
             
18,781,540
 
AGRICULTURAL & FARM MACHINERY—0.2%
               
Hydrofarm Holdings Group, Inc.*
   
89,343
     
853,226
 
APPAREL ACCESSORIES & LUXURY GOODS—1.5%
               
Capri Holdings Ltd.*
   
139,974
     
6,676,760
 
APPAREL RETAIL—2.2%
               
Aritzia, Inc.*
   
107,440
     
3,826,389
 
Victoria’s Secret & Co.*
   
122,732
     
5,783,132
 
             
9,609,521
 
APPLICATION SOFTWARE—20.2%
               
ACI Worldwide, Inc.*
   
260,589
     
7,197,468
 
Avalara, Inc.*
   
77,434
     
5,890,404
 
Bill.com Holdings, Inc.*
   
52,645
     
8,987,028
 
Blackbaud, Inc.*
   
80,261
     
4,655,941
 
Blackline, Inc.*
   
56,471
     
3,786,381
 
Digital Turbine, Inc.*
   
54,797
     
1,734,325
 
Everbridge, Inc.*
   
83,142
     
3,583,420
 
ForgeRock, Inc., Cl. A*
   
30,846
     
630,184
 
Guidewire Software, Inc.*
   
37,384
     
3,250,165
 
HubSpot, Inc.*
   
16,546
     
6,278,049
 
Manhattan Associates, Inc.*
   
71,517
     
9,336,544
 
Paycom Software, Inc.*
   
21,558
     
6,067,930
 
Paycor HCM, Inc.*
   
9,906
     
243,985
 
Q2 Holdings, Inc.*
   
110,365
     
5,709,182
 
SEMrush Holdings, Inc., Cl. A*
   
95,594
     
932,997
 
Smartsheet, Inc., Cl. A*
   
72,621
     
3,509,773
 
Sprout Social, Inc., Cl. A*
   
74,483
     
4,564,318
 
SPS Commerce, Inc.*
   
73,066
     
8,740,886
 
Vertex, Inc., Cl. A*
   
263,710
     
3,752,593
 
             
88,851,573
 
ASSET MANAGEMENT & CUSTODY BANKS—0.2%
               
Affiliated Managers Group, Inc.
   
7,858
     
986,729
 
BIOTECHNOLOGY—2.8%
               
Alkermes PLC*
   
41,481
     
1,196,727
 
CareDx, Inc.*
   
262,342
     
7,985,690
 
Celldex Therapeutics, Inc.*
   
33,247
     
1,015,696
 
Karuna Therapeutics, Inc.*
   
12,932
     
1,441,401
 
Turning Point Therapeutics, Inc.*
   
19,625
     
577,760
 
             
12,217,274
 
DATA PROCESSING & OUTSOURCED SERVICES—1.2%
               
DLocal Ltd., Cl. A*
   
175,466
     
3,977,814
 
Marqeta, Inc., Cl. A*
   
164,098
     
1,526,112
 
             
5,503,926
 

THE ALGER FUNDS
ALGER SMALL CAP GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)
 
COMMON STOCKS—95.2% (CONT.)
 
SHARES
   
VALUE
 
DIVERSIFIED SUPPORT SERVICES—0.4%
           
IAA, Inc.*
   
43,162
   
$
1,581,887
 
ELECTRICAL COMPONENTS & EQUIPMENT—0.3%
               
Sunrun, Inc.*
   
67,621
     
1,351,068
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.4%
               
908 Devices, Inc.*
   
53,247
     
945,134
 
Cognex Corp.
   
77,560
     
5,245,383
 
             
6,190,517
 
FOOD DISTRIBUTORS—2.3%
               
The Chefs’ Warehouse, Inc.*
   
95,783
     
3,505,658
 
US Foods Holding Corp.*
   
173,126
     
6,513,000
 
             
10,018,658
 
HEALTHCARE DISTRIBUTORS—0.3%
               
PetIQ, Inc., Cl. A*
   
62,859
     
1,250,894
 
HEALTHCARE EQUIPMENT—8.5%
               
CryoPort, Inc.*
   
117,316
     
2,646,649
 
Impulse Dynamics NV, Series E*,@,(a)
   
1,105,151
     
3,646,998
 
Inmode Ltd.*
   
193,402
     
4,856,324
 
Inogen, Inc.*
   
6,491
     
164,093
 
Insulet Corp.*
   
47,002
     
11,233,008
 
Mesa Laboratories, Inc.
   
28,104
     
6,003,858
 
Paragon 28, Inc.*
   
76,519
     
1,375,046
 
Tandem Diabetes Care, Inc.*
   
80,607
     
7,776,963
 
             
37,702,939
 
HEALTHCARE FACILITIES—1.2%
               
The Joint Corp.*
   
167,422
     
5,109,719
 
HEALTHCARE SERVICES—1.0%
               
Biodesix, Inc.*
   
63,254
     
101,839
 
Guardant Health, Inc.*
   
55,649
     
3,433,544
 
Privia Health Group, Inc.*
   
48,972
     
1,076,894
 
             
4,612,277
 
HEALTHCARE SUPPLIES—4.5%
               
Neogen Corp.*
   
449,145
     
11,857,428
 
Quidel Corp.*
   
80,633
     
8,113,292
 
             
19,970,720
 
HEALTHCARE TECHNOLOGY—2.9%
               
Convey Health Solutions Holdings, Inc.*
   
137,010
     
697,381
 
Definitive Healthcare Corp , Cl. A*
   
34,409
     
813,773
 
Doximity, Inc., Cl. A*
   
18,514
     
738,153
 
Renalytix PLC#,*
   
167,540
     
849,428
 
Sophia Genetics SA*
   
80,712
     
518,978
 
Veeva Systems, Inc., Cl. A*
   
50,876
     
9,256,888
 
             
12,874,601
 
HOMEBUILDING—0.3%
               
Skyline Champion Corp.*
   
24,213
     
1,235,832
 
HOMEFURNISHING RETAIL—0.7%
               
Arhaus, Inc., Cl. A*
   
51,287
     
367,728
 
Bed Bath & Beyond, Inc.*
   
215,866
     
2,937,936
 
             
3,305,664
 

THE ALGER FUNDS
ALGER SMALL CAP GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—95.2% (CONT.)
 
SHARES
   
VALUE
 
HUMAN RESOURCE & EMPLOYMENT SERVICES—1.1%
           
LegalZoom.com, Inc.*
   
146,039
   
$
2,095,660
 
Upwork, Inc.*
   
135,234
     
2,835,857
 
             
4,931,517
 
HYPERMARKETS & SUPER CENTERS—2.5%
               
BJ’s Wholesale Club Holdings, Inc.*
   
173,698
     
11,177,466
 
INDUSTRIAL MACHINERY—0.5%
               
Gates Industrial Corp. PLC*
   
163,155
     
2,080,226
 
INTERACTIVE HOME ENTERTAINMENT—1.0%
               
Take-Two Interactive Software, Inc.*
   
35,756
     
4,273,200
 
INTERACTIVE MEDIA & SERVICES—1.7%
               
Bumble, Inc., Cl. A*
   
43,761
     
1,049,826
 
Eventbrite, Inc., Cl. A*
   
117,706
     
1,245,330
 
Genius Sports Ltd.*
   
538,894
     
2,058,575
 
Tripadvisor, Inc.*
   
129,510
     
3,324,522
 
             
7,678,253
 
INTERNET & DIRECT MARKETING RETAIL—0.7%
               
Farfetch Ltd., Cl. A*
   
138,803
     
1,554,593
 
The RealReal, Inc.*
   
270,685
     
1,467,113
 
             
3,021,706
 
INTERNET SERVICES & INFRASTRUCTURE—0.6%
               
BigCommerce Holdings, Inc.*
   
148,823
     
2,659,467
 
LEISURE FACILITIES—0.7%
               
Planet Fitness, Inc., Cl. A*
   
40,770
     
3,262,823
 
LIFE SCIENCES TOOLS & SERVICES—7.6%
               
Akoya Biosciences, Inc.*
   
141,514
     
1,331,647
 
Alpha Teknova, Inc.*
   
32,364
     
363,448
 
Bio-Techne Corp.
   
38,184
     
14,498,083
 
Codex DNA, Inc.*
   
80,605
     
298,238
 
Cytek Biosciences, Inc.*
   
56,527
     
534,180
 
ICON PLC*
   
9,708
     
2,196,047
 
Maravai LifeSciences Holdings, Inc., Cl. A*
   
39,236
     
1,205,722
 
MaxCyte, Inc.*
   
48,750
     
270,075
 
NanoString Technologies, Inc.*
   
235,342
     
4,419,723
 
NeoGenomics, Inc.*
   
177,510
     
1,677,469
 
Personalis, Inc.*
   
111,165
     
622,524
 
Rapid Micro Biosystems, Inc., Cl. A*
   
65,516
     
381,958
 
Repligen Corp.*
   
35,207
     
5,535,949
 
             
33,335,063
 
MANAGED HEALTHCARE—1.4%
               
HealthEquity, Inc.*
   
97,624
     
6,083,928
 
MOVIES & ENTERTAINMENT—3.2%
               
Live Nation Entertainment, Inc.*
   
135,810
     
14,243,753
 
OIL & GAS EQUIPMENT & SERVICES—0.9%
               
ChampionX Corp.
   
80,702
     
1,702,812
 
ProPetro Holding Corp.*
   
168,473
     
2,382,208
 
             
4,085,020
 

THE ALGER FUNDS
ALGER SMALL CAP GROWTH FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—95.2% (CONT.)
 
SHARES
   
VALUE
 
OIL & GAS EXPLORATION & PRODUCTION—4.5%            
Coterra Energy, Inc.
   
86,935
   
$
2,502,859
 
Magnolia Oil & Gas Corp., Cl. A
   
740,959
     
17,219,887
 
             
19,722,746
 
PERSONAL PRODUCTS—0.4%                
The Beauty Health Co.*
   
124,143
     
1,626,273
 
PRECIOUS METALS & MINERALS—0.5%                
Xometry, Inc., Cl. A*
   
63,018
     
2,068,251
 
REGIONAL BANKS—0.9%                
Webster Financial Corp.
   
80,814
     
4,039,892
 
RESTAURANTS—4.7%                
Shake Shack, Inc., Cl. A*
   
153,637
     
8,884,828
 
Sweetgreen, Inc., Cl. A*
   
40,563
     
1,095,201
 
The Cheesecake Factory, Inc.*
   
176,680
     
6,521,259
 
Wingstop, Inc.
   
44,443
     
4,078,089
 
             
20,579,377
 
SEMICONDUCTOR EQUIPMENT—0.6%                
SolarEdge Technologies, Inc.*
   
10,950
     
2,741,989
 
SEMICONDUCTORS—0.7%                
Universal Display Corp.
   
22,795
     
2,911,605
 
SPECIALTY CHEMICALS—2.9%                
Balchem Corp.
   
105,570
     
13,006,224
 
SPECIALTY STORES—1.3%                
Brilliant Earth Group, Inc., Cl. A*
   
23,896
     
183,999
 
Five Below, Inc.*
   
34,664
     
5,445,715
 
             
5,629,714
 
TOTAL COMMON STOCKS                
(Cost $458,480,798)
           
419,603,746
 
PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%                
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
50,688
     
 
(Cost $228,096)
           
 
RIGHTS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Tolero CDR*,@,(a),(c)
   
174,782
     
125,843
 
(Cost $94,483)
           
125,843
 
REAL ESTATE INVESTMENT TRUST—1.0%
 
SHARES
   
VALUE
 
RETAIL—1.0%                
Tanger Factory Outlet Centers, Inc.
   
262,068
     
4,227,157
 
(Cost $4,316,432)
           
4,227,157
 
SPECIAL PURPOSE VEHICLE—0.7%
 
SHARES
   
VALUE
 
DATA PROCESSING & OUTSOURCED SERVICES—0.7%                
Crosslink Ventures Capital LLC, Cl. A*,@,(a),(b)
   
72
     
2,513,304
 
Crosslink Ventures Capital LLC, Cl. B*,@,(a),(b)
   
19
     
690,175
 
             
3,203,479
 
TOTAL SPECIAL PURPOSE VEHICLE                
(Cost $2,275,000)
           
3,203,479
 
     
VALUE
 
Total Investments            
(Cost $465,394,809)
   
96.9
%
 
$
427,160,225
 
Affiliated Securities (Cost $2,503,096)
           
3,203,479
 
Unaffiliated Securities (Cost $462,891,713)
           
423,956,746
 
Other Assets in Excess of Liabilities
   
3.1
%
   
13,499,127
 
NET ASSETS
   
100.0
%
 
$
440,659,352
 

THE ALGER FUNDS
ALGER SMALL CAP FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

#
American Depositary Receipts.
(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Affiliated Securities.
(c)
Contingent Deferred Rights.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
 

Security
Acquisition
Date(s)
 
Acquisition
Cost
   
% of net assets
(Acquisition
Date)
   
Market
Value
   
% of net assets
as of
4/30/2022
 
Crosslink Ventures Capital LLC, Cl. A
10/2/20
 
$
1,800,000
     
0.49
%
 
$
2,513,304
     
0.57
%
Crosslink Ventures Capital LLC, Cl. B
12/16/20
   
475,000
     
0.10
%
   
690,175
     
0.16
%
Impulse Dynamics NV, Series E
2/11/22
   
3,646,998
     
0.69
%
   
3,646,998
     
0.83
%
Prosetta Biosciences, Inc., Series D
2/6/15
   
228,096
     
0.10
%
   
0
     
0.00
%
Tolero CDR 2/6/17     94,483
      0.08 %     125,843
      0.02 %
Total
                    $ 6,976,320       1.58 %

See Notes to Financial Statements.

THE ALGER FUNDS
ALGER SMALL CAP FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—98.4%
 
SHARES
   
VALUE
 
AEROSPACE & DEFENSE—1.2%
           
Mercury Systems, Inc.*
   
781,879
   
$
43,621,029
 
APPAREL ACCESSORIES & LUXURY GOODS—1.5%
               
Capri Holdings Ltd.*
   
1,177,460
     
56,164,842
 
APPAREL RETAIL—1.0%
               
Aritzia, Inc.*
   
1,027,460
     
36,592,165
 
APPLICATION SOFTWARE—20.5%
               
Avalara, Inc.*
   
727,891
     
55,370,668
 
Blackline, Inc.*
   
1,458,474
     
97,790,682
 
Clearwater Analytics Holdings, Inc., Cl. A*
   
3,908,663
     
68,557,949
 
Everbridge, Inc.*
   
676,660
     
29,164,046
 
Guidewire Software, Inc.*
   
1,235,361
     
107,402,285
 
Paycom Software, Inc.*
   
349,665
     
98,420,208
 
PROS Holdings, Inc.*
   
3,436,480
     
95,980,886
 
Q2 Holdings, Inc.*
   
1,320,723
     
68,321,001
 
Smartsheet, Inc., Cl. A*
   
1,586,956
     
76,697,583
 
Sprout Social, Inc., Cl. A*
   
1,140,717
     
69,903,138
 
             
767,608,446
 
BIOTECHNOLOGY—5.2%
               
CareDx, Inc.*
   
2,366,561
     
72,038,117
 
Natera, Inc.*
   
2,050,146
     
72,001,127
 
Vericel Corp.*
   
1,702,582
     
48,523,587
 
             
192,562,831
 
BUILDING PRODUCTS—1.3%
               
Trex Co., Inc.*
   
865,437
     
50,359,779
 
DATA PROCESSING & OUTSOURCED SERVICES—1.3%
               
TaskUS, Inc., Cl. A*
   
1,739,708
     
50,260,164
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.6%
               
Cognex Corp.
   
899,290
     
60,818,983
 
ENVIRONMENTAL & FACILITIES SERVICES—1.1%
               
Casella Waste Systems, Inc., Cl. A*
   
521,270
     
42,869,245
 
HEALTHCARE EQUIPMENT—11.9%
               
AtriCure, Inc.*
   
2,206,555
     
114,586,401
 
CryoPort, Inc.*
   
2,824,632
     
63,723,698
 
Heska Corp.*
   
833,571
     
91,559,439
 
Inmode Ltd.*
   
573,997
     
14,413,065
 
Insulet Corp.*
   
333,527
     
79,709,618
 
Shockwave Medical, Inc.*
   
528,911
     
79,934,319
 
             
443,926,540
 
HEALTHCARE FACILITIES—0.8%
               
The Joint Corp.*
   
943,391
     
28,792,293
 
HEALTHCARE SUPPLIES—5.7%
               
BioLife Solutions, Inc.*
   
1,561,529
     
19,784,572
 
Neogen Corp.*
   
2,814,615
     
74,305,836
 
Quidel Corp.*
   
1,178,227
     
118,553,201
 
             
212,643,609
 

THE ALGER FUNDS
ALGER SMALL CAP FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)
 
COMMON STOCKS—98.4% (CONT.)
 
SHARES
   
VALUE
 
HEALTHCARE TECHNOLOGY—6.2%
               
Evolent Health, Inc., Cl. A*
   
2,128,115
   
$
58,565,725
 
Inspire Medical Systems, Inc.*
   
652,109
     
134,177,948
 
Veeva Systems, Inc., Cl. A*
   
219,604
     
39,956,948
 
             
232,700,621
 
INDUSTRIAL MACHINERY—4.9%
               
RBC Bearings, Inc.*
   
1,090,032
     
183,506,887
 
INTERACTIVE MEDIA & SERVICES—0.5%
               
Genius Sports Ltd.*
   
5,066,599
     
19,354,408
 
LIFE SCIENCES TOOLS & SERVICES—6.8%
               
Bio-Techne Corp.
   
354,656
     
134,659,337
 
NanoString Technologies, Inc.*
   
2,248,544
     
42,227,656
 
Repligen Corp.*
   
490,126
     
77,067,412
 
             
253,954,405
 
MANAGED HEALTHCARE—2.3%
               
HealthEquity, Inc.*
   
1,377,578
     
85,850,661
 
OIL & GAS EQUIPMENT & SERVICES—2.7%
               
ChampionX Corp.
   
4,734,428
     
99,896,431
 
OIL & GAS EXPLORATION & PRODUCTION—4.9%
               
PDC Energy, Inc.
   
1,521,897
     
106,137,097
 
Viper Energy Partners LP
   
2,688,621
     
77,244,081
 
             
183,381,178
 
PACKAGED FOODS & MEATS—1.6%
               
Freshpet, Inc.*
   
655,781
     
61,217,156
 
REGIONAL BANKS—2.3%
               
Popular, Inc.
   
1,086,358
     
84,725,061
 
RESTAURANTS—3.4%
               
Shake Shack, Inc., Cl. A*
   
1,231,360
     
71,209,549
 
Wingstop, Inc.
   
616,603
     
56,579,491
 
             
127,789,040
 
SEMICONDUCTORS—2.2%
               
Monolithic Power Systems, Inc.
   
204,845
     
80,348,403
 
SYSTEMS SOFTWARE—1.3%
               
Tenable Holdings, Inc.*
   
846,061
     
46,727,949
 
TRADING COMPANIES & DISTRIBUTORS—4.1%
               
Herc Holdings, Inc.
   
1,196,444
     
152,929,472
 
TRUCKING—2.1%
               
Saia, Inc.*
   
385,607
     
79,419,618
 
TOTAL COMMON STOCKS
               
(Cost $3,918,199,649)
           
3,678,021,216
 
RIGHTS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Tolero CDR*,@,(a),(b)
   
11,905
     
8,572
 
(Cost $6,436)
           
8,572
 
Total Investments
               
(Cost $3,918,206,085)
   
98.4
%
 
$
3,678,029,788
 
Unaffiliated Securities (Cost $3,918,206,085)
           
3,678,029,788
 
Other Assets in Excess of Liabilities
   
1.6
%
   
58,872,919
 
NET ASSETS
   
100.0
%
 
$
3,736,902,707
 

THE ALGER FUNDS
ALGER SMALL CAP FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)
 
(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Contingent Deferred Rights.
*
Non-income producing security.
@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

 

Security
Acquisition
Date(s)
 
Acquisition
Cost
   
% of net assets
(Acquisition
Date)
   
Market
Value
   
% of net assets
as of
4/30/2022
 
Tolero CDR
2/6/17
 
$
6,436
     
0.00
%
 
$
8,572
     
0.00
%
Total                     $ 8,572       0.00 %

See Notes to Financial Statements.

THE ALGER FUNDS
ALGER INTERNATIONAL FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)
 
COMMON STOCKS—97.3%
 
SHARES
   
VALUE
 
ARGENTINA—1.5%
           
INTERNET & DIRECT MARKETING RETAIL—1.5%
               
MercadoLibre, Inc.*
   
2,350
   
$
2,288,030
 
(Cost $3,784,277)
               
AUSTRALIA—5.0%                
APPLICATION SOFTWARE—2.0%
               
Xero Ltd.*
   
46,600
     
3,073,121
 
HEALTHCARE SUPPLIES—1.3%
               
Nanosonics Ltd.*
   
694,062
     
1,918,018
 
HEALTHCARE TECHNOLOGY—1.7%
               
Pro Medicus Ltd.
    81,000
      2,649,189
 
TOTAL AUSTRALIA
               
(Cost $7,093,135)
           
7,640,328
 
BELGIUM—0.4%
               
APPLICATION SOFTWARE—0.4%
               
Unifiedpost Group SA*
   
94,778
     
598,628
 
(Cost $2,388,301)
               
BRAZIL—1.4%
               
DIVERSIFIED CAPITAL MARKETS—1.4%
               
Banco BTG Pactual SA
   
454,000
     
2,121,092
 
(Cost $2,572,288)
               
CHINA—5.9%
               
AUTOMOBILE MANUFACTURERS—2.4%
               
BYD Co., Ltd., Cl. H
   
126,084
     
3,669,285
 
DIVERSIFIED METALS & MINING—1.3%
               
Ganfeng Lithium Co., Ltd., Cl. H
   
167,000
     
1,998,872
 
FINANCIAL EXCHANGES & DATA—2.2%
               
East Money Information Co., Ltd., Cl. A
   
1,024,797
     
3,463,623
 
TOTAL CHINA
               
(Cost $9,701,104)
           
9,131,780
 
FRANCE—14.2%
               
APPAREL ACCESSORIES & LUXURY GOODS—4.9%
               
EssilorLuxottica SA
    22,300
      3,795,986
 
LVMH Moet Hennessy Louis Vuitton SE
   
5,900
     
3,817,555
 
             
7,613,541
 
ELECTRICAL COMPONENTS & EQUIPMENT—2.4%
               
Schneider Electric SE
   
25,200
     
3,614,907
 
LIFE SCIENCES TOOLS & SERVICES—3.6%
               
Eurofins Scientific SE
   
60,300
     
5,603,353
 
RESEARCH & CONSULTING SERVICES—3.3%
               
Teleperformance
   
14,157
     
5,080,381
 
TOTAL FRANCE
               
(Cost $16,624,881)
           
21,912,182
 
GERMANY—7.0%
               
AEROSPACE & DEFENSE—1.8%
               
Hensoldt AG
   
98,000
     
2,728,812
 

- 76 -

Table of Contents
THE ALGER FUNDS
ALGER INTERNATIONAL FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—97.3% (CONT.)
  SHARES     VALUE  
GERMANY—7.0% (CONT.)
           
FOOTWEAR—1.9%
           
Puma SE
   
40,600
   
$
2,986,867
 
OIL & GAS REFINING & MARKETING—3.3%
               
VERBIO Vereinigte BioEnergie AG
   
71,000
     
5,030,656
 
TOTAL GERMANY
               
(Cost $8,731,251)
           
10,746,335
 
HONG KONG—7.3%
               
APPAREL ACCESSORIES & LUXURY GOODS—3.2%
               
Samsonite International SA*
   
2,240,157
     
4,909,487
 
BREWERS—2.1%
               
Budweiser Brewing Co. APAC Ltd.
   
1,290,000
     
3,209,795
 
INDUSTRIAL MACHINERY—2.0%
               
Techtronic Industries Co., Ltd.
   
237,000
     
3,163,521
 
TOTAL HONG KONG
               
(Cost $8,248,946)
           
11,282,803
 
INDIA—6.1%
               
DIVERSIFIED BANKS—2.4%
               
HDFC Bank Ltd.#
   
66,800
     
3,688,028
 
INTERNET & DIRECT MARKETING RETAIL—1.0%
               
FSN E-Commerce Ventures Ltd.*
   
71,000
     
1,552,669
 
INVESTMENT BANKING & BROKERAGE—2.7%
               
Angel One Ltd.
   
169,000
     
4,246,721
 
TOTAL INDIA
               
(Cost $7,815,330)
           
9,487,418
 
IRELAND—2.4%
               
PACKAGED FOODS & MEATS—2.4%
               
Kerry Group PLC, Cl. A
   
33,741
     
3,723,287
 
(Cost $3,756,244)
               
ITALY—6.2%
               
APPAREL ACCESSORIES & LUXURY GOODS—3.2%
               
Moncler SpA
   
94,386
     
4,916,217
 
AUTOMOBILE MANUFACTURERS—3.0%
               
Ferrari NV
   
22,162
     
4,648,258
 
TOTAL ITALY
               
(Cost $7,526,807)
           
9,564,475
 
JAPAN—4.6%
               
HEALTHCARE SUPPLIES—1.7%
               
Hoya Corp.
   
26,900
     
2,669,819
 
INDUSTRIAL MACHINERY—1.9%
               
Ebara Corp.
   
63,000
     
2,893,648
 
SEMICONDUCTOR EQUIPMENT—1.0%
               
Lasertec Corp.
   
11,400
     
1,523,174
 
TOTAL JAPAN
               
(Cost $8,003,579)
           
7,086,641
 

THE ALGER FUNDS
ALGER INTERNATIONAL FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—97.3% (CONT.)
 
SHARES
   
VALUE
 
NETHERLANDS—8.7%
           
DATA PROCESSING & OUTSOURCED SERVICES—2.0%
           
Adyen NV*
   
1,875
   
$
3,144,478
 
HEAVY ELECTRICAL EQUIPMENT—2.8%
               
Alfen Beheer BV*
   
48,600
     
4,370,143
 
SEMICONDUCTOR EQUIPMENT—3.9%
               
ASML Holding NV#
   
10,500
     
5,958,307
 
TOTAL NETHERLANDS
               
(Cost $5,201,935)
           
13,472,928
 
NORWAY—3.9%
               
ENVIRONMENTAL & FACILITIES SERVICES—2.0%
               
Aker Carbon Capture ASA*
   
1,560,510
     
3,152,068
 
INDUSTRIAL MACHINERY—1.9%
               
AutoStore Holdings Ltd.*,(a)
   
1,289,036
     
2,874,465
 
TOTAL NORWAY
               
(Cost $8,449,242)
           
6,026,533
 
SOUTH KOREA—2.2%
               
SPECIALTY CHEMICALS—2.2%
               
Chunbo Co., Ltd.
   
15,800
     
3,412,075
 
(Cost $2,580,839)
               
SPAIN—2.2%
               
BIOTECHNOLOGY—2.2%
               
Grifols SA#
   
309,741
     
3,323,521
 
(Cost $5,399,542)
               
SWEDEN—1.4%
               
ASSET MANAGEMENT & CUSTODY BANKS—1.4%
               
EQT AB
   
74,298
     
2,102,865
 
(Cost $755,883)
               
SWITZERLAND—6.0%
               
ASSET MANAGEMENT & CUSTODY BANKS—1.6%
               
Partners Group Holding AG
   
2,284
     
2,420,017
 
LIFE SCIENCES TOOLS & SERVICES—2.1%
               
PolyPeptide Group AG
   
36,406
     
3,186,045
 
SPECIALTY CHEMICALS—2.3%
               
Sika AG
   
11,800
     
3,604,593
 
TOTAL SWITZERLAND
               
(Cost $6,419,571)
           
9,210,655
 
TAIWAN—2.9%
               
SEMICONDUCTORS—2.9%
               
Taiwan Semiconductor Manufacturing Co., Ltd.#
   
48,400
     
4,497,812
 
(Cost $4,564,011)
               
UNITED KINGDOM—4.0%
               
FINANCIAL EXCHANGES & DATA—4.0%
               
London Stock Exchange Group PLC
   
63,200
     
6,230,998
 
(Cost $5,453,181)
               

THE ALGER FUNDS
ALGER INTERNATIONAL FOCUS FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—97.3% (CONT.)
 
SHARES
   
VALUE
 
UNITED STATES—4.0%
           
IT CONSULTING & OTHER SERVICES—1.6%
           
EPAM Systems, Inc.*
   
9,550
   
$
2,530,654
 
OIL & GAS EQUIPMENT & SERVICES—2.4%
               
Schlumberger NV
   
94,500
     
3,686,445
 
TOTAL UNITED STATES
               
(Cost $7,901,501)
           
6,217,099
 
TOTAL COMMON STOCKS
               
(Cost $132,971,848)
           
150,077,485
 
Total Investments
               
(Cost $132,971,848)
   
97.3
%
 
$
150,077,485
 
Unaffiliated Securities (Cost $132,971,848)
           
150,077,485
 
Other Assets in Excess of Liabilities
   
2.7
%
   
4,198,993
 
NET ASSETS
   
100.0
%
 
$
154,276,478
 

#
American Depositary Receipts.
(a)
Pursuant to Securities and Exchange Commission Rule 144A, this security may be sold prior to its maturity only to qualified institutional buyers. This security represents 1.9% of the net assets of the Fund.
*
Non-income producing security.

See Notes to Financial Statements.

THE ALGER FUNDS
ALGER HEALTH SCIENCES FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—97.5%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—29.9%
           
AbbVie, Inc.
   
75,862
   
$
11,142,611
 
Abivax SA*
   
29,483
     
592,202
 
Aerovate Therapeutics, Inc.*
   
167,007
     
2,129,339
 
Alkermes PLC*
   
226,224
     
6,526,562
 
Apellis Pharmaceuticals, Inc.*
   
85,737
     
3,732,132
 
Celldex Therapeutics, Inc.*
   
119,161
     
3,640,369
 
Coherus Biosciences, Inc.*
   
155,763
     
1,408,098
 
Compass Therapeutics, Inc.*
   
608,536
     
894,548
 
HilleVax, Inc.*
   
125,000
     
2,386,250
 
Icosavax, Inc.*
   
156,673
     
1,135,879
 
IGM Biosciences, Inc.*
   
62,152
     
1,040,424
 
Ionis Pharmaceuticals, Inc.*
   
141,459
     
5,200,033
 
IVERIC bio, Inc.*
   
293,575
     
4,066,014
 
Kezar Life Sciences, Inc.*
   
184,619
     
2,193,274
 
Mersana Therapeutics, Inc.*
   
323,068
     
1,124,277
 
PDS Biotechnology Corp.*
   
119,082
     
658,523
 
Prometheus Biosciences, Inc.*
   
150,642
     
3,961,885
 
Vaxcyte, Inc.*
   
83,573
     
2,023,302
 
Vertex Pharmaceuticals, Inc.*
   
24,361
     
6,655,912
 
             
60,511,634
 
ELECTRONIC EQUIPMENT & INSTRUMENTS—0.9%
               
908 Devices, Inc.*
   
103,236
     
1,832,439
 
FERTILIZERS & AGRICULTURAL CHEMICALS—1.7%
               
Corteva, Inc.
   
58,681
     
3,385,307
 
HEALTHCARE DISTRIBUTORS—7.7%
               
AmerisourceBergen Corp., Cl. A
   
41,544
     
6,285,192
 
McKesson Corp.
   
30,309
     
9,383,969
 
             
15,669,161
 
HEALTHCARE EQUIPMENT—11.5%
               
Boston Scientific Corp *
   
96,842
     
4,078,017
 
Edwards Lifesciences Corp.*
   
73,772
     
7,803,602
 
Glaukos Corp.*
   
23,840
     
1,127,393
 
Heska Corp.*
   
6,717
     
737,795
 
Impulse Dynamics NV, Series E*,@,(a)
   
1,515,152
     
5,000,002
 
iRhythm Technologies, Inc.*
   
36,624
     
4,518,303
 
             
23,265,112
 
HEALTHCARE FACILITIES—5.7%
               
Acadia Healthcare Co., Inc.*
   
154,695
     
10,500,696
 
Tenet Healthcare Corp.*
   
14,541
     
1,054,368
 
             
11,555,064
 
HEALTHCARE SERVICES—5.9%
               
Amedisys, Inc.*
   
29,763
     
3,799,247
 
CVS Health Corp.
   
23,033
     
2,214,162
 
Guardant Health, Inc.*
   
30,507
     
1,882,282
 
Signify Health, Inc., Cl. A*
   
285,610
     
3,941,418
 
             
11,837,109
 
HEALTHCARE TECHNOLOGY—2.3%
               
Inspire Medical Systems, Inc.*
   
22,352
     
4,599,148
 

THE ALGER FUNDS
ALGER HEALTH SCIENCES FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

COMMON STOCKS—97.5% (CONT.)
 
SHARES
   
VALUE
 
LIFE SCIENCES TOOLS & SERVICES—1.1%
               
10X Genomics, Inc., Cl. A*
   
25,481
   
$
1,216,973
 
Standard BioTools, Inc.*
   
400,288
     
1,060,763
 
             
2,277,736
 
MANAGED HEALTHCARE—9.1%
               
Centene Corp.*
   
111,927
     
9,015,720
 
UnitedHealth Group, Inc.
   
18,484
     
9,400,038
 
             
18,415,758
 
PHARMACEUTICALS—21.7%
               
AstraZeneca PLC
   
84,502
     
11,276,052
 
Axsome Therapeutics, Inc.*
   
30,527
     
969,232
 
Bayer AG*
   
164,923
     
10,862,105
 
Bristol-Myers Squibb Co.
   
118,226
     
8,898,871
 
EyePoint Pharmaceuticals, Inc.*
   
72,100
     
814,730
 
Intra-Cellular Therapies, Inc.*
   
79,987
     
4,048,142
 
Ipsen SA
   
25,259
     
2,618,071
 
Jazz Pharmaceuticals PLC*
   
27,259
     
4,367,437
 
             
43,854,640
 
TOTAL COMMON STOCKS
               
(Cost $202,605,387)
           
197,203,108
 
PREFERRED STOCKS—0.0%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.0%
               
Prosetta Biosciences, Inc., Series D*,@,(a),(b)
   
897,366
     
 
(Cost $4,038,147)
           
 
RIGHTS—0.7%
 
SHARES
   
VALUE
 
BIOTECHNOLOGY—0.7%
               
Tolero CDR*,@,(a),(c)
   
1,956,996
     
1,409,037
 
(Cost $1,044,370)
           
1,409,037
 
Total Investments
               
(Cost $207,687,904)
   
98.2
%
 
$
198,612,145
 
Affiliated Securities (Cost $4,038,147)
           
 
Unaffiliated Securities (Cost $203,649,757)
           
198,612,145
 
Other Assets in Excess of Liabilities
   
1.8
%
   
3,611,070
 
NET ASSETS
   
100.0
%
 
$
202,223,215
 

(a)
Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Board.
(b)
Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 11 - Affiliated Securities.
(c)
Contingent Deferred Rights.
*
Non-income producing security.

THE ALGER FUNDS
ALGER HEALTH SCIENCES FUND
Schedule of Investments April 30, 2022 (Unaudited) (Continued)

@
Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.
 
 

Acquisition
 
Acquisition
   
% of net assets
(Acquisition
   
Market
   
% of net assets
as of
 
Security
Date(s)
 
Cost
   
Date)
   
Value
   
4/30/2022
 
Impulse Dynamics NV, Series E
2/11/22
 
$
5,000,002
     
2.07
%
 
$
5,000,002
     
2.47
%
Prosetta Biosciences, Inc., Series D
2/6/15
   
4,038,147
     
2.00
%
   
0
     
0.00
%
Tolero CDR
2/6/17
   
1,044,370
     
0.90
%
   
1,409,037
      0.70 %
Total
                   
$
6,409,039
      3.17 %

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited)


 
Alger Capital
Appreciation Fund
   
Alger 35 Fund
 
ASSETS:
 
   
 
Investments in unaffiliated securities, at value (identified cost below)* see accompanying schedules of investments
 
$
2,209,706,398
   
$
28,884,418
 
Investments in affiliated securities, at value (identified cost below)** see accompanying schedules of investments
   
3,874,677
     
 
Cash and cash equivalents
   
34,984,044
     
10,183
 
Foreign cash †
   
257,323
     
 
Receivable for investment securities sold
   
8,251,737
     
3,200,220
 
Receivable for shares of beneficial interest sold
   
1,601,129
     
 
Dividends and interest receivable
   
654,061
     
8,242
 
Receivable from Investment Manager
   
     
16,062
 
Prepaid expenses
   
278,620
     
3,657
 
Total Assets
   
2,259,607,989
     
32,122,782
 
                 
LIABILITIES:
               
Payable for investment securities purchased
   
34,471,528
     
2,182,795
 
Payable for shares of beneficial interest redeemed
   
5,881,548
     
 
Accrued investment advisory fees
   
1,572,757
     
12,249
 
Accrued distribution fees
   
322,242
     
 
Accrued shareholder administrative fees
   
26,354
     
272
 
Accrued administrative fees
   
55,412
     
749
 
Accrued custodian fees
   
26,176
     
601
 
Accrued transfer agent fees
   
1,118,753
     
496
 
Accrued printing fees
   
58,538
     
695
 
Accrued professional fees
   
40,649
     
23,183
 
Accrued trustee fees
   
6,462
     
81
 
Accrued fund accounting fees
   
105,628
     
11,344
 
Accrued other expenses
   
3,892
     
1,315
 
Total Liabilities
   
43,689,939
     
2,233,780
 
NET ASSETS
 
$
2,215,918,050
   
$
29,889,002
 
                 
NET ASSETS CONSIST OF:
               
Paid in capital (par value of $.001 per share)
   
1,431,941,826
     
41,642,370
 
Distributable earnings (Distributions in excess of earnings)
   
783,976,224
     
(11,753,368
)
NET ASSETS
 
$
2,215,918,050
   
$
29,889,002
 
* identified cost
 
$
1,632,305,954(a
)
 
$
30,948,758(b
)
** identified cost
 
$
2,775,000(a
)
 
$
 
† Cost of foreign cash
 
$
256,262(a
)
 
$
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)

   
Alger Capital
Appreciation Fund
   
Alger 35 Fund
 
NET ASSETS BY CLASS:
           
Class A
 
$
926,444,825
   
$
 
Class C
 
$
121,682,919
   
$
 
Class Z
 
$
1,167,790,306
   
$
29,889,002
 
   
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6:
 
Class A
   
39,607,795
     
 
Class C
   
8,523,502
     
 
Class Z
   
46,867,727
     
2,804,918
 
                 
NET ASSET VALUE PER SHARE:
               
Class A — Net Asset Value Per Share Class A
 
$
23.39
   
$
 
Class A — Offering Price Per Share
               
(includes a 5.25% sales charge)
 
$
24.69
   
$
 
Class C — Net Asset Value Per Share Class C
 
$
14.28
   
$
 
Class Z — Net Asset Value Per Share Class Z
 
$
24.92
   
$
10.66
 

See Notes to Financial Statements.
 
(a)
At April 30, 2022, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $1,651,500,270, amounted to $562,080,805 which consisted of aggregate gross unrealized appreciation of $738,299,897 and aggregate gross unrealized depreciation of $176,219,092.
(b)
At April 30, 2022, the net unrealized depreciation on investments, based on cost for federal income tax purposes of $30,975,843, amounted to $2,091,425 which consisted of aggregate gross unrealized appreciation of $1,845,932 and aggregate gross unrealized depreciation of $3,937,357.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)


   
Alger Growth &
Income Fund
   
Alger Mid Cap
Growth Fund
 
ASSETS:
               
Investments in unaffiliated securities, at value (identified cost below)* see accompanying schedules of investments
 
$
172,007,767
   
$
197,503,119
 
Investments in affiliated securities, at value (identified cost below)** see accompanying schedules of investments
   
     
2,365,711
 
Cash and cash equivalents
   
10,098,440
     
7,457,733
 
Receivable for investment securities sold
   
     
8,328,133
 
Receivable for shares of beneficial interest sold
   
798,103
     
72,402
 
Dividends and interest receivable
   
257,606
     
14,192
 
Receivable from Investment Manager
   
     
5,886
 
Prepaid expenses
   
64,145
     
83,429
 
Total Assets
   
183,226,061
     
215,830,605
 
                 
LIABILITIES:
               
Payabl for shares of beneficial interest redeemed
   
468,992
     
294,611
 
Accrued investment advisory fees
   
77,928
     
148,285
 
Accrued distribution fees
   
39,745
     
50,576
 
Accrued shareholder administrative fees
   
2,269
     
2,996
 
Accrued administrative fees
   
4,286
     
5,366
 
Accrued custodian fees
   
2,352
     
36,376
 
Accrued transfer agent fees
   
54,268
     
86,962
 
Accrued printing fees
   
8,104
     
19,692
 
Accrued professional fees
   
25,129
     
32,087
 
Accrued trustee fees
   
311
     
630
 
Accrued fund accounting fees
   
19,063
     
23,682
 
Accrued other expenses
   
1,201
     
2,836
 
Total Liabilities
   
703,648
     
704,099
 
NET ASSETS
 
$
182,522,413
   
$
215,126,506
 
                 
NET ASSETS CONSIST OF:
               
Paid in capital (par value of $.001 per share)
   
98,367,190
     
261,851,821
 
Distributable earnings (Distributions in excess of earnings)
   
84,155,223
     
(46,725,315
)
NET ASSETS
 
$
182,522,413
   
$
215,126,506
 
* identified cost
 
$
89,318,657(a
)
 
$
218,167,958(b
)
** identified cost
 
$
   
$
2,663,245(b
)

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)

   
Alger Growth &
Income Fund
   
Alger Mid Cap
Growth Fund
 
NET ASSETS BY CLASS:
           
Class A
 
$
107,650,381
   
$
162,256,540
 
Class B
 
$
   
$
10,018,476
 
Class C
 
$
19,374,229
   
$
5,267,347
 
Class Z
 
$
55,497,803
   
$
37,584,143
 
   
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6:
 
Class A
   
1,934,410
     
13,868,875
 
Class B
   
     
1,366,711
 
Class C
   
354,046
     
765,506
 
Class Z
   
995,916
     
3,119,606
 
                 
NET ASSET VALUE PER SHARE:
               
Class A — Net Asset Value Per Share Class A
 
$
55.65
   
$
11.70
 
Class A — Offering Price Per Share (includes a 5.25% sales charge)
 
$
58.73
   
$
12.35
 
Class B — Net Asset Value Per Share Class B
 
$
   
$
7.33
 
Class C — Net Asset Value Per Share Class C
 
$
54.72
   
$
6.88
 
Class Z — Net Asset Value Per Share Class Z
 
$
55.73
   
$
12.05
 

See Notes to Financial Statements.

(a)
At April 30, 2022, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $88,631,417, amounted to $83,376,350 which consisted of aggregate gross unrealized appreciation of $84,542,456 and aggregate gross unrealized depreciation of $1,166,106.
(b)
At April 30, 2022, the net unrealized depreciation on investments, based on cost for federal income tax purposes of $222,471,466, amounted to $22,602,636 which consisted of aggregate gross unrealized appreciation of $6,884,196 and aggregate gross unrealized depreciation of $29,486,832.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)


 
Alger Mid Cap Focus
Fund
   
Alger Weatherbie
Enduring Growth
Fund
 
ASSETS:
 
   
 
Investments in unaffiliated securities, at value (identified cost below)* see accompanying schedules of investments
 
$
569,208,111
   
$
3,902,757
 
Cash and cash equivalents
   
17,373,083
     
295,078
 
Foreign cash †
   
345
     
 
Receivable for shares of beneficial interest sold
   
1,255,841
     
 
Dividends and interest receivable
   
42,112
     
452
 
Receivable from Investment Manager
   
     
21,145
 
Prepaid expenses
   
138,360
     
77,822
 
Total Assets
   
588,017,852
     
4,297,254
 
                 
LIABILITIES:
               
Payable for investment securities purchased
   
1,207,691
     
 
Payable for shares of beneficial interest redeemed
   
2,457,378
     
 
Due to investment advisor
   
6
     
 
Accrued investment advisory fees
   
308,617
     
2,704
 
Accrued distribution fees
   
23,405
     
117
 
Accrued shareholder administrative fees
   
5,386
     
40
 
Accrued administrative fees
   
14,714
     
106
 
Accrued custodian fees
   
4,770
     
1,555
 
Accrued transfer agent fees
   
45,848
     
113
 
Accrued printing fees
   
27,811
     
201
 
Accrued professional fees
   
26,869
     
13,934
 
Accrued trustee fees
   
1,727
     
15
 
Accrued fund accounting fees
   
23,960
     
13,873
 
Accrued other expenses
   
4,851
     
447
 
Total Liabilities
   
4,153,033
     
33,105
 
NET ASSETS
 
$
583,864,819
   
$
4,264,149
 
                 
NET ASSETS CONSIST OF:
               
Paid in capital (par value of $.001 per share)
   
663,824,492
     
5,452,241
 
Distributions in excess of earnings
   
(79,959,673
)
   
(1,188,092
)
NET ASSETS
 
$
583,864,819
   
$
4,264,149
 
* identified cost
 
$
621,914,220(a
)
 
$
4,897,525(b
)
† Cost of foreign cash
 
$
363(a
)
 
$
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)

   
Alger Mid Cap Focus
Fund
   
Alger Weatherbie
Enduring Growth Fund
 
NET ASSETS BY CLASS:
           
Class A
 
$
3,270,684
   
$
126,450
 
Class C
 
$
2,934,129
   
$
77,803
 
Class I
 
$
86,918,488
   
$
78,019
 
Class Y
 
$
89,795
   
$
390,667
 
Class Z
 
$
490,651,723
   
$
3,591,210
 
   
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6:
 
Class A
   
233,479
     
16,209
 
Class C
   
210,681
     
10,000
 
Class I
   
6,203,671
     
10,000
 
Class Y
   
6,359
     
50,000
 
Class Z
   
34,733,515
     
459,708
 
                 
NET ASSET VALUE PER SHARE:
               
Class A — Net Asset Value Per Share Class A
 
$
14.01
   
$
7.80
 
Class A — Offering Price Per Share (includes a 5.25% sales charge)
 
$
14.78
   
$
8.23
 
Class C — Net Asset Value Per Share Class C
 
$
13.93
   
$
7.78
 
Class I — Net Asset Value Per Share Class I
 
$
14.01
   
$
7.80
 
Class Y — Net Asset Value Per Share Class Y
 
$
14.12
   
$
7.81
 
Class Z — Net Asset Value Per Share Class Z
 
$
14.13
   
$
7.81
 

See Notes to Financial Statements.

(a)
At April 30, 2022, the net unrealized depreciation on investments, based on cost for federal income tax purposes of $625,220,219, amounted to $56,012,108 which consisted of aggregate gross unrealized appreciation of $11,851,598 and aggregate gross unrealized depreciation of $67,863,706.
(b)
At April 30, 2022, the net unrealized depreciation on investments, based on cost for federal income tax purposes of $4,897,525, amounted to $994,768 which consisted of aggregate gross unrealized appreciation of $29,673 and aggregate gross unrealized depreciation of $1,024,441.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)


 
Alger Weatherbie
Specialized Growth
Fund
   
Alger Small Cap
Growth Fund
 
ASSETS:
 
   
 
Investments in unaffiliated securities, at value (identified cost below)* see accompanying schedules of investments
 
$
940,082,641
   
$
423,956,746
 
Investments in affiliated securities, at value (identified cost below)** see accompanying schedules of investments
   
     
3,203,479
 
Cash and cash equivalents
   
34,529,431
     
13,616,237
 
Receivable for investment securities sold
   
10,143,187
     
213,156
 
Receivable for shares of beneficial interest sold
   
2,133,845
     
496,909
 
Dividends and interest receivable
   
18,090
     
52,414
 
Receivable from Investment Manager
   
2,292
     
1,870
 
Prepaid expenses
   
144,547
     
133,225
 
Total Assets
   
987,054,033
     
441,674,036
 
                 
LIABILITIES:
               
Payable for investment securities purchased
   
9,294,026
     
 
Payable for shares of beneficial interest redeemed
   
3,631,083
     
333,094
 
Accrued investment advisory fees
   
733,799
     
322,156
 
Accrued distribution fees
   
94,652
     
60,947
 
Accrued shareholder administrative fees
   
10,335
     
5,079
 
Accrued administrative fees
   
25,098
     
10,937
 
Accrued custodian fees
   
12,526
     
45,062
 
Accrued transfer agent fees
   
262,507
     
136,181
 
Accrued printing fees
   
68,793
     
26,217
 
Accrued professional fees
   
28,645
     
37,471
 
Accrued trustee fees
   
3,224
     
1,281
 
Accrued fund accounting fees
   
56,359
     
30,792
 
Accrued other expenses
   
3,396
     
5,467
 
Total Liabilities
   
14,224,443
     
1,014,684
 
NET ASSETS
 
$
972,829,590
   
$
440,659,352
 
                 
NET ASSETS CONSIST OF:
               
Paid in capital (par value of $.001 per share)
   
1,194,336,506
     
478,520,987
 
Distributions in excess of earnings
   
(221,506,916
)
   
(37,861,635
)
NET ASSETS
 
$
972,829,590
   
$
440,659,352
 
* identified cost
 
$
1,134,184,197(a
)
 
$
462,891,713(b
)
** identified cost
 
$
1,041,633(a
)
 
$
2,503,096(b
)

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)


   
Alger Weatherbie
Specialized Growth
Fund
   
Alger Small Cap
Growth Fund
 
NET ASSETS BY CLASS:
           
Class A
 
$
144,960,122
   
$
159,923,997
 
Class B
 
$
   
$
3,315,039
 
Class C
 
$
55,627,473
   
$
24,194,374
 
Class I
 
$
40,920,311
   
$
 
Class Y
 
$
53,757,621
   
$
365,137
 
Class Z
 
$
677,564,063
   
$
252,860,805
 
   
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6:
 
Class A
   
11,551,397
     
16,625,405
 
Class B
   
     
512,174
 
Class C
   
8,127,586
     
4,019,055
 
Class I
   
3,147,593
     
 
Class Y
   
4,040,893
     
36,127
 
Class Z
   
49,174,963
     
25,036,646
 
                 
NET ASSET VALUE PER SHARE:
               
Class A — Net Asset Value Per Share Class A
 
$
12.55
   
$
9.62
 
Class A — Offering Price Per Share (includes a 5.25% sales charge)
 
$
13.24
   
$
10.15
 
Class B — Net Asset Value Per Share Class B
 
$
   
$
6.47
 
Class C — Net Asset Value Per Share Class C
 
$
6.84
   
$
6.02
 
Class I — Net Asset Value Per Share Class I
 
$
13.00
   
$
 
Class Y — Net Asset Value Per Share Class Y
 
$
13.30
   
$
10.11
 
Class Z — Net Asset Value Per Share Class Z
 
$
13.78
   
$
10.10
 

See Notes to Financial Statements.

(a)
At April 30, 2022, the net unrealized depreciation on investments, based on cost for federal income tax purposes of $1,151,719,833, amounted to $211,637,192 which consisted of aggregate gross unrealized appreciation of $53,838,949 and aggregate gross unrealized depreciation of $265,476,141.
(b)
At April 30, 2022, the net unrealized depreciation on investments, based on cost for federal income tax purposes of $466,196,297, amounted to $39,036,072 which consisted of aggregate gross unrealized appreciation of $71,770,127 and aggregate gross unrealized depreciation of $110,806,199.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)

   
Alger Small Cap
Focus Fund
   
Alger International
Focus Fund
 
ASSETS:
           
Investments in unaffiliated securities, at value (identified cost below)* see accompanying schedules of investments
 
$
3,678,029,788
   
$
150,077,485
 
Cash and cash equivalents
   
2,281,562
     
4,703,152
 
Foreign cash †
   
     
83,010
 
Receivable for investment securities sold
   
68,150,834
     
 
Receivable for shares of beneficial interest sold
   
6,842,347
     
4,669
 
Dividends and interest receivable
   
     
359,891
 
Receivable from Investment Manager
   
     
12,061
 
Prepaid expenses
   
443,755
     
72,510
 
Total Assets
   
3,755,748,286
     
155,312,778
 
                 
LIABILITIES:
               
Payable for investment securities purchased
   
     
566,479
 
Payable for shares of beneficial interest redeemed
   
14,154,992
     
26,888
 
Foreign capital gain tax payable
   
     
129,152
 
Accrued investment advisory fees
   
2,644,781
     
97,072
 
Accrued distribution fees
   
230,822
     
41,728
 
Accrued shareholder administrative fees
   
37,756
     
2,134
 
Accrued administrative fees
   
96,975
     
3,760
 
Accrued custodian fees
   
21,994
     
30,666
 
Accrued transfer agent fees
   
1,274,083
     
51,852
 
Accrued printing fees
   
234,850
     
14,814
 
Accrued professional fees
   
37,626
     
37,306
 
Accrued trustee fees
   
14,218
     
408
 
Accrued fund accounting fees
   
93,309
     
22,112
 
Accrued other expenses
   
4,173
     
11,929
 
Total Liabilities
   
18,845,579
     
1,036,300
 
NET ASSETS
 
$
3,736,902,707
   
$
154,276,478
 
                 
NET ASSETS CONSIST OF:
               
Paid in capital (par value of $.001 per share)
   
4,175,906,120
     
142,916,733
 
Distributable earnings (Distributions in excess of earnings)
   
(439,003,413
)
   
11,359,745
 
NET ASSETS
 
$
3,736,902,707
   
$
154,276,478
 
* Identified cost
 
$
3,918,206,085(a
)
 
$
132,971,848(b
)
† Cost of foreign cash
 
$
   
$
82,804(b
)

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)

   
Alger Small Cap
Focus Fund
   
Alger International
Focus Fund
 
NET ASSETS BY CLASS:
           
Class A
 
$
276,127,045
   
$
115,194,483
 
Class B
 
$
   
$
15,440,081
 
Class C
 
$
132,929,860
   
$
2,361,797
 
Class I
 
$
177,353,394
   
$
1,284,231
 
Class Y
 
$
267,292,206
   
$
 
Class Z
 
$
2,883,200,202
   
$
19,995,886
 
   
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6:
 
Class A
   
15,796,324
     
6,659,794
 
Class B
   
     
1,042,228
 
Class C
   
8,692,654
     
167,385
 
Class I
   
9,850,071
     
74,014
 
Class Y
   
14,494,099
     
 
Class Z
   
156,356,579
     
1,134,449
 
                 
NET ASSET VALUE PER SHARE:
               
Class A — Net Asset Value Per Share Class A
 
$
17.48
   
$
17.30
 
Class A — Offering Price Per Share (includes a 5.25% sales charge)
 
$
18.45
   
$
18.26
 
Class B — Net Asset Value Per Share Class B
 
$
   
$
14.81
 
Class C — Net Asset Value Per Share Class C
 
$
15.29
   
$
14.11
 
Class I — Net Asset Value Per Share Class I
 
$
18.01
   
$
17.35
 
Class Y — Net Asset Value Per Share Class Y
 
$
18.44
   
$
 
Class Z — Net Asset Value Per Share Class Z
 
$
18.44
   
$
17.63
 

See Notes to Financial Statements.
 
(a)
At April 30, 2022, the net unrealized depreciation on investments, based on cost for federal income tax purposes of $3,929,674,891, amounted to $251,645,103 which consisted of aggregate gross unrealized appreciation of $502,500,045 and aggregate gross unrealized depreciation of $754,145,148.
(b)
At April 30, 2022, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $135,027,897, amounted to $15,049,588 which consisted of aggregate gross unrealized appreciation of $38,066,605 and aggregate gross unrealized depreciation of $23,017,017.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)


 
Alger Health
Sciences Fund
 
ASSETS:
       
Investments in unaffiliated securities, at value (identified cost below)* see accompanying schedule of investments
 
$
198,612,145
 
Investments in affiliated securities, at value (identified cost below)** see accompanying schedules of investments
   
 
Cash and cash equivalents
   
3,211,001
 
Receivable for investment securities sold
   
1,824,785
 
Receivable for shares of beneficial interest sold
   
1,653,248
 
Dividends and interest receivable
   
252,429
 
Prepaid expenses
   
61,932
 
Total Assets
   
205,615,540
 
         
LIABILITIES:
       
Payable for investment securities purchased
   
2,744,352
 
Payable for shares of beneficial interest redeemed
   
334,885
 
Accrued investment advisory fees
   
101,981
 
Accrued distribution fees
   
29,665
 
Accrued shareholder administrative fees
   
2,473
 
Accrued administrative fees
   
5,099
 
Accrued custodian fees
   
4,779
 
Accrued transfer agent fees
   
92,139
 
Accrued printing fees
   
16,496
 
Accrued professional fees
   
31,180
 
Accrued trustee fees
   
640
 
Accrued fund accounting fees
   
21,256
 
Accrued other expenses
   
7,380
 
Total Liabilities
   
3,392,325
 
NET ASSETS
 
$
202,223,215
 
         
NET ASSETS CONSIST OF:
       
Paid in capital (par value of $.001 per share)
   
228,047,162
 
Distributions in excess of earnings
   
(25,823,947
)
NET ASSETS
 
$
202,223,215
 
* identified cost
 
$
203,649,757(a
)
** identified cost
 
$
4,038,147(a
)

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Assets and Liabilities April 30, 2022 (Unaudited) (Continued)

   
Alger Health Sciences
Fund
 
NET ASSETS BY CLASS:
     
Class A
 
$
96,938,503
 
Class C
 
$
8,495,387
 
Class Z
 
$
96,789,325
 
         
SHARES OF BENEFICIAL INTEREST OUTSTANDING — NOTE 6:
       
Class A
   
4,720,487
 
Class C
   
657,020
 
Class Z
   
4,635,040
 
         
NET ASSET VALUE PER SHARE:
       
Class A — Net Asset Value Per Share Class A
 
$
20.54
 
Class A — Offering Price Per Share (includes a 5.25% sales charge)
 
$
21.67
 
Class C — Net Asset Value Per Share Class C
 
$
12.93
 
Class Z — Net Asset Value Per Share Class Z
 
$
20.88
 

See Notes to Financial Statements.

(a)
At April 30, 2022, the net unrealized depreciation on investments, based on cost for federal income tax purposes of $208,400,210, amounted to $9,788,065 which consisted of aggregate gross unrealized appreciation of $11,995,504 and aggregate gross unrealized depreciation of $21,783,569.

THE ALGER FUNDS
Statements of Operations for the six months ended April 30, 2022 (Unaudited)



 
Alger Capital
Appreciation Fund
   
Alger 35 Fund
 
INCOME:
           
Dividends (net of foreign withholding taxes*)
 
$
6,639,363
   
$
72,420
 
Interest
   
3,277
     
37
 
Total Income
   
6,642,640
     
72,457
 
                 
EXPENSES:
               
Investment advisory fees — Note 3(a)
   
10,929,047
     
82,772
 
Distribution fees — Note 3(c)
               
Class A
   
1,586,831
     
 
Class C
   
828,853
     
 
Shareholder administrative fees — Note 3(f)
   
190,871
     
1,839
 
Administration fees — Note 3(b)
   
396,620
     
5,058
 
Custodian fees
   
54,634
     
1,853
 
Interest expenses
   
42,308
     
188
 
Transfer agent fees — Note 3(f)
   
667,070
     
1,061
 
Printing fees
   
61,460
     
2,373
 
Professional fees
   
68,833
     
16,751
 
Registration fees
   
58,852
     
45,225
 
Trustee fees — Note 3(g)
   
43,124
     
589
 
Fund accounting fees
   
217,933
     
19,850
 
Other expenses
   
34,958
     
3,331
 
Total Expenses
   
15,181,394
     
180,890
 
Less, expense reimbursements/waivers — Note 3(a)
   
     
(79,319
)
Net Expenses
   
15,181,394
     
101,571
 
NET INVESTMENT LOSS
   
(8,538,754
)
   
(29,114
)
   
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY:
 
Net realized gain (loss) on unaffiliated investments
   
231,226,884
     
(1,266,357
)
Net realized gain on foreign currency transactions
   
9,026
     
 
Net change in unrealized (depreciation) on unaffiliated investments
   
(1,075,421,383
)
   
(12,841,009
)
Net change in unrealized (depreciation) on affiliated investments
   
(568,431
)
   
 
Net change in unrealized (depreciation) on foreign currency
   
(5,118
)
   
(43
)
Net realized and unrealized (loss) on investments and foreign currency
   
(844,759,022
)
   
(14,107,409
)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS
 
$
(853,297,776
)
 
$
(14,136,523
)
* Foreign withholding taxes
 
$
86,816
   
$
293
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Operations for the six months ended April 30, 2022 (Unaudited) (Continued)

   
Alger Growth &
Income Fund
   
Alger Mid Cap Growth
Fund
 
INCOME:
           
Dividends (net of foreign withholding taxes*)
 
$
1,812,222
   
$
417,187
 
Interest
   
1,660
     
1,400
 
Income from securities lending
   
24
     
 
Total Income
   
1,813,906
     
418,587
 
                 
EXPENSES:
               
Investment advisory fees — Note 3(a)
   
445,381
     
1,031,552
 
Distribution fees — Note 3(c)
               
Class A
   
138,303
     
256,430
 
Class B
   
     
67,568
 
Class C
   
96,559
     
33,143
 
Shareholder administrative fees — Note 3(f)
   
13,131
     
20,895
 
Administration fees — Note 3(b)
   
24,496
     
37,326
 
Custodian fees
   
6,539
     
21,630
 
Interest expenses
   
     
1,877
 
Transfer agent fees — Note 3(f)
   
40,563
     
70,116
 
Printing fees
   
7,115
     
12,871
 
Professional fees
   
18,624
     
15,846
 
Registration fees
   
23,932
     
37,352
 
Trustee fees — Note 3(g)
   
2,526
     
4,043
 
Fund accounting fees
   
38,882
     
39,529
 
Other expenses
   
4,106
     
10,754
 
Total Expenses
   
860,157
     
1,660,932
 
Less, expense reimbursements/waivers — Note 3(a)
   
     
(44,286
)
Net Expenses
   
860,157
     
1,616,646
 
NET INVESTMENT INCOME (LOSS)
   
953,749
     
(1,198,059
)
   
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY:
 
Net realized gain (loss) on unaffiliated investments
   
467,615
     
(22,920,745
)
Net realized (loss) on foreign currency transactions
   
     
(572
)
Net change in unrealized (depreciation) on unaffiliated investments
   
(14,551,686
)
   
(90,301,368
)
Net change in unrealized (depreciation) on affiliated investments
   
     
(356,996
)
Net change in unrealized (depreciation) on foreign currency
   
     
(244
)
Net realized and unrealized (loss) on investments and foreign currency
   
(14,084,071
)
   
(113,579,925
)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS
 
$
(13,130,322
)
 
$
(114,777,984
)
* Foreign withholding taxes
 
$
12,988
   
$
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Operations for the six months ended April 30, 2022 (Unaudited) (Continued)



 
Alger Mid Cap Focus
Fund
   
Alger Weatherbie
Enduring Growth Fund
 

 
   
From
December 17, 2021
(commencement of
operations to
April 30, 2022
 
INCOME:
           
Dividends (net of foreign withholding taxes*)
 
$
1,035,344
   
$
3,752
 
Interest
   
7,900
     
 
Total Income
   
1,043,244
     
3,752
 
                 
EXPENSES:
               
Investment advisory fees — Note 3(a)
   
2,169,161
     
12,518
 
Distribution fees — Note 3(c)
               
Class A
   
3,483
     
117
 
Class C
   
14,979
     
330
 
Class I
   
144,235
     
82
 
Shareholder administrative fees — Note 3(f)
   
38,558
     
184
 
Administration fees — Note 3(b)
   
105,516
     
492
 
Custodian fees
   
17,491
     
2,351
 
Transfer agent fees — Note 3(f)
   
57,236
     
214
 
Printing fees
   
39,140
     
8,710
 
Professional fees
   
29,121
     
13,957
 
Registration fees
   
73,507
     
14,768
 
Trustee fees — Note 3(g)
   
11,583
     
56
 
Fund accounting fees
   
80,691
     
22,176
 
Listing fees
   
     
5,245
 
Pricing service fees
   
     
11
 
Financial services fees
   
     
13
 
Other expenses
   
13,315
     
245
 
Total Expenses
   
2,798,016
     
81,469
 
Less, expense reimbursements/waivers — Note 3(a)
   
     
(67,472
)
Net Expenses
   
2,798,016
     
13,997
 
NET INVESTMENT LOSS
   
(1,754,772
)
   
(10,245
)
   
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY:
 
Net realized (loss) on unaffiliated investments
   
(22,199,342
)
   
(183,079
)
Net realized gain on foreign currency transactions
   
11,332
     
 
Net change in unrealized (depreciation) on unaffiliated investments
   
(287,377,634
)
   
(994,768
)
Net change in unrealized (depreciation) on foreign currency
   
(15,565
)
   
 
Net realized and unrealized (loss) on investments and foreign currency
   
(309,581,209
)
   
(1,177,847
)
NET DECREASE IN NET ASSETS RESULTING FROM
               
OPERATIONS
 
$
(311,335,981
)
 
$
(1,188,092
)
* Foreign withholding taxes
 
$
   
$
376
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Operations for the six months ended April 30, 2022 (Unaudited) (Continued)



 
Alger Weatherbie
Specialized Growth
Fund
   
Alger Small Cap
Growth Fund
 
INCOME:
           
Dividends (net of foreign withholding taxes*)
 
$
1,475,726
   
$
644,338
 
Interest
   
19,281
     
4,442
 
Total Income
   
1,495,007
     
648,780
 
                 
EXPENSES:
               
Investment advisory fees — Note 3(a)
   
5,324,012
     
2,227,592
 
Distribution fees — Note 3(c)
               
Class A
    244,837      
257,435
 
Class B
   
     
21,898
 
Class C
   
380,481
     
154,072
 
Class I
   
70,307
     
 
Shareholder administrative fees — Note 3(f)
   
75,859
     
35,338
 
Administration fees — Note 3(b)
   
184,305
     
75,628
 
Custodian fees
   
51,905
     
22,035
 
Interest expenses
   
1,775
     
65
 
Transfer agent fees — Note 3(f)
   
195,749
     
123,075
 
Printing fees
   
65,275
     
33,714
 
Professional fees
   
35,645
     
34,082
 
Registration fees
   
94,573
     
62,173
 
Trustee fees — Note 3(g)
   
20,649
     
8,224
 
Fund accounting fees
   
120,678
     
56,049
 
Other expenses
   
18,452
     
18,238
 
Total Expenses
   
6,884,502
     
3,129,618
 
Less, expense reimbursements/waivers — Note 3(a)
   
( 7,565
)
   
( 13,736
)
Net Expenses
   
6,876,937
     
3,115,882
 
NET INVESTMENT LOSS
   
( 5,381,930
)
   
( 2,467,102
)
                 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY:
               
Net realized (loss) on unaffiliated investments
   
(4,478,642
)
   
5,689,003
 
Net realized gain on foreign currency transactions
   
84
     
15,433
 
Net change in unrealized (depreciation) on unaffiliated investments
   
( 616,862,972
)
   
( 238,108,189
)
Net change in unrealized (depreciation) on affiliated investments
   
     
(479,900
)
Net realized and unrealized (loss) on investments and foreign currency
   
(621,341,530
)
   
(232,883,653
)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS
 
$
(626,723,460
)
 
$
(235,350,755
)
* Foreign withholding taxes
 
$
32,187
   
$
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Operations for the six months ended April 30, 2022 (Unaudited) (Continued)


   
Alger Small Cap Focus
Fund
   
Alger International
Focus Fund
 
INCOME:
           
Dividends (net of foreign withholding taxes*)
 
$
7,363,442
   
$
499,493
 
Interest
   
46,418
     
560
 
Total Income
   
7,409,860
     
500,053
 
                 
EXPENSES:
               
Investment advisory fees — Note 3(a)
   
20,497,434
     
664,974
 
Distribution fees — Note 3(c)
               
Class A
   
491,768
     
172,889
 
Class B
   
     
93,788
 
Class C
   
951,856
     
17,998
 
Class I
   
345,084
     
1,515
 
Shareholder administrative fees — Note 3(f)
   
292,272
     
14,587
 
Administration fees — Note 3(b)
   
751,572
     
25,756
 
Custodian fees
   
75,685
     
30,854
 
Interest expenses
   
6,680
     
19
 
Transfer agent fees — Note 3(f)
   
860,508
     
42,125
 
Printing fees
   
229,253
     
9,403
 
Professional fees
   
114,652
     
26,555
 
Registration fees
   
193,767
     
41,669
 
Trustee fees — Note 3(g)
   
81,904
     
2,769
 
Fund accounting fees
   
362,649
     
38,925
 
Other expenses
   
72,631
     
24,638
 
Total Expenses
   
25,327,715
     
1,208,464
 
Less, expense reimbursements/waivers — Note 3(a)
   
     
( 72,639
)
Net Expenses
   
25,327,715
     
1,135,825
 
NET INVESTMENT LOSS
   
( 17,917,855
)
   
( 635,772
)
                 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, FORWARD FOREIGN CURRENCY
               
CONTRACTS AND FOREIGN CURRENCY:
               
Net realized (loss) on unaffiliated investments
   
( 106,294,898
)
   
( 2,192,498
)**
Net realized gain on forward foreign currency contracts
   
     
219
 
Net realized gain (loss) on foreign currency transactions
   
93,366
     
( 16,071
)
Net change in unrealized (depreciation) on unaffiliated investments
   
( 2,843,810,998
)
   
( 50,155,943
)
Net change in unrealized (depreciation) on foreign currency
   
     
( 9,849
)
Net realized and unrealized (loss) on investments, forward foreign currency contracts and foreign currency
   
( 2,950,012,530
)
   
( 52,374,142
)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS
 
$
(2,967,930,385
)
 
$
(53,009,914
)
* Foreign withholding taxes
 
$
59,750
   
$
63,827
 

See Notes to Financial Statements.

**
Includes capital gain tax of $198,489.
 
THE ALGER FUNDS
Statements of Operations for the six months ended April 30, 2022 (Unaudited) (Continued)


 

 
Alger Health Sciences
Fund
 
INCOME:
       
Dividends (net of foreign withholding taxes*)
 
$
749,324
 
Interest
   
392
 
Total Income
   
749,716
 
         
EXPENSES:
       
Investment advisory fees — Note 3(a)
   
722,050
 
Distribution fees — Note 3(c)
       
Class A
   
146,993
 
Class C
   
53,739
 
Shareholder administrative fees — Note 3(f)
   
17,299
 
Administration fees — Note 3(b)
   
36,102
 
Custodian fees
   
12,897
 
Interest expenses
   
2,079
 
Transfer agent fees — Note 3(f)
   
53,004
 
Printing fees
   
23,346
 
Professional fees
   
20,310
 
Registration fees
   
33,386
 
Trustee fees — Note 3(g)
   
3,950
 
Fund accounting fees
   
44,119
 
Other expenses
   
8,417
 
Total Expenses
   
1,177,691
 
NET INVESTMENT LOSS
   
(427,975
)
         
REALIZED AND UNREALIZED (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY:
       
Net realized (loss) on unaffiliated investments
   
(15,601,744
)
Net realized (loss) on foreign currency transactions
   
(5,373
)
Net change in unrealized (depreciation) on unaffiliated investments
   
(77,149,958
)
Net change in unrealized (depreciation) on foreign currency
   
(161
)
Net realized and unrealized (loss) on investments and foreign currency
   
(92,757,236
)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS
 
$
(93,185,211
)
* Foreign withholding taxes
 
$
(99
)

See Notes to Financial Statements.
 
THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited)


   
Alger Capital Appreciation Fund
 

 
For the
Six Months Ended
   
For the
Year Ended
 

 
April 30, 2022
   
October 31, 2021
 
Net investment loss
 
$
(8,538,754
)
 
$
(18,111,841
)
Net realized gain on investments and foreign currency
   
231,235,910
     
722,556,860
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(1,075,994,932
)
   
296,147,744
 
Net increase (decrease) in net assets resulting from operations
   
(853,297,776
)
   
1,000,592,763
 
                 
Dividends and distributions to shareholders:
               
Class A
   
(284,398,857
)
   
(192,316,638
)
Class C
   
(53,540,254
)
   
(41,889,152
)
Class Z
   
(297,591,139
)
   
(187,550,241
)
Total dividends and distributions to shareholders
   
(635,530,250
)
   
(421,756,031
)
                 
Increase (decrease) from shares of beneficial interest transactions:
               
Class A
   
64,353,039
     
(35,800,613
)
Class C
   
12,088,635
     
(14,687,747
)
Class Z
   
205,582,484
     
(453,649,540
)
Net increase (decrease) from shares of beneficial interest transactions — Note 6
   
282,024,158
     
(504,137,900
)
Total increase (decrease)
   
(1,206,803,868
)
   
74,698,832
 
                 
Net Assets:
               
Beginning of period
   
3,422,721,918
     
3,348,023,086
 
END OF PERIOD
 
$
2,215,918,050
   
$
3,422,721,918
 

See Notes to Financial Statements.
 
:D
THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)


    Alger 35 Fund  
   
For the
Six Months Ended
April 30, 2022
   
For the
Year Ended
October 31, 2021
 
Net investment loss
 
$
(29,114
)
 
$
(29,841
)
Net realized gain (loss) on investments and foreign currency
   
(1,266,357
)
   
10,555,178
 
Net change in unrealized (depreciation) on investments and foreign currency
   
(12,841,052
)
   
(1,103,828
)
Net increase (decrease) in net assets resulting from operations
   
(14,136,523
)
   
9,421,509
 
                 
Dividends and distributions to shareholders:
               
Class Z*
   
(10,551,417
)
   
(2,452,471
)
Class P-2*
   
     
(51,070
)
Total dividends and distributions to shareholders
   
(10,551,417
)
   
(2,503,541
)
                 
Increase (decrease) from shares of beneficial interest transactions:
               
Class Z*
   
10,417,970
     
23,183,654
 
Class P-2*
   
     
(321,436
)
Net increase from shares of beneficial interest transactions -Note 6
   
10,417,970
     
22,862,218
 
Total increase (decrease)
   
(14,269,970
)
   
29,780,186
 
                 
Net Assets:
               
Beginning of period
   
44,158,972
     
14,378,786
 
END OF PERIOD
 
$
29,889,002
   
$
44,158,972
 

See Notes to Financial Statements.

*
On May 7, 2021, Class P Shares of the Alger 35 Fund were reclassified as Class Z Shares of the Fund. After the close of business on October 29, 2021, Class P-2 Shares of the Fund were converted to Class Z Shares.

- 102 -

Table of Contents
THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)


   
Alger Growth & Income Fund
 

 
For the
Six Months Ended
   
For the
Year Ended
 
   
April 30, 2022
   
October 31, 2021
 
Net investment income
 
$
953,749
   
$
1,562,657
 
Net realized gain on investments and foreign currency
   
467,615
     
5,495,295
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(14,551,686
)
   
41,033,641
 
Net increase (decrease) in net assets resulting from operations
   
(13,130,322
)
   
48,091,593
 
                 
Dividends and distributions to shareholders:
               
Class A
   
(4,089,519
)
   
(2,056,460
)
Class C
   
(645,012
)
   
(252,675
)
Class Z
   
(1,582,544
)
   
(730,285
)
Total dividends and distributions to shareholders
   
(6,317,075
)
   
(3,039,420
)
                 
Increase (decrease) from shares of beneficial interest transactions:
               
Class A
   
12,861,625
     
1,774,061
 
Class C
   
3,249,272
     
(172,021
)
Class Z
   
23,204,123
     
6,950,403
 
Net increase from shares of beneficial interest transactions - Note 6
   
39,315,020
     
8,552,443
 
Total increase
   
19,867,623
     
53,604,616
 
                 
Net Assets:
               
Beginning of period
   
162,654,790
     
109,050,174
 
END OF PERIOD
 
$
182,522,413
   
$
162,654,790
 

See Notes to Financial Statements.

- 103 -

Table of Contents
THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)


   
Alger Mid Cap Growth Fund
 
   
For the
Six Months Ended
   
For the
Year Ended
 
   
April 30, 2022
   
October 31, 2021
 
Net investment income (loss)
 
$
(1,198,059
)
 
$
6,653,774
 
Net realized gain (loss) on investments and foreign currency
   
(22,921,317
)
   
89,927,726
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(90,658,608
)
   
7,163,383
 
Net increase (decrease) in net assets resulting from operations
   
(114,777,984
)
   
103,744,883
 
                 
Dividends and distributions to shareholders:
               
Class A
   
(67,153,291
)
   
(20,930,151
)
Class B
   
(6,406,978
)
   
(2,145,611
)
Class C
   
(2,944,693
)
   
(835,010
)
Class Z
   
(15,837,405
)
   
(3,167,651
)
Total dividends and distributions to shareholders
   
(92,342,367
)
   
(27,078,423
)
                 
Increase (decrease) from shares of beneficial interest transactions:
               
Class A
   
55,928,574
     
12,073,737
 
Class B
   
3,868,366
     
(1,268,494
)
Class C
   
2,783,235
     
949,265
 
Class Z
   
20,506,091
     
15,282,249
 
Net increase from shares of beneficial interest transactions -Note 6
   
83,086,266
     
27,036,757
 
Total increase (decrease)
   
(124,034,085
)
   
103,703,217
 
                 
Net Assets:
               
Beginning of period
   
339,160,591
     
235,457,374
 
END OF PERIOD
 
$
215,126,506
   
$
339,160,591
 

See Notes to Financial Statements.

- 104 -

Table of Contents
THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)



Alger Mid Cap Focus Fund

   
For the
Six Months Ended
   
For the
Year Ended
 
   
April 30, 2022
   
October 31, 2021
 
Net investment loss
 
$
(1,754,772
)
 
$
(4,374,822
)
Net realized gain (loss) on investments and foreign currency
   
(22,188,010
)
   
85,655,529
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(287,393,199
)
   
185,806,424
 
Net increase (decrease) in net assets resulting from operations
   
(311,335,981
)
   
267,087,131
 
                 
Dividends and distributions to shareholders:
               
Class A
   
(237,662
)
   
 
Class C
   
(228,199
)
   
 
Class I
   
(12,826,323
)
   
(1,305,962
)
Class Y
   
(12,097
)
   
 
Class Z
   
(70,824,262
)
   
(5,908,321
)
Total dividends and distributions to shareholders
   
(84,128,543
)
   
(7,214,283
)
                 
Increase (decrease) from shares of beneficial interest transactions:
               
Class A
   
2,963,315
     
1,561,701
 
Class C
   
2,052,993
     
2,225,078
 
Class I
   
915,998
     
35,683,690
 
Class Y
   
9,307
     
119,925
 
Class Z
   
28,246,587
     
270,350,323
 
Net Increase from shares of beneficial interest transactions - Note 6
   
34,188,200
     
309,940,717
 
Total increase (decrease)
   
(361,276,324
)
   
569,813,565
 
                 
Net Assets:
               
Beginning of period
   
945,141,143
     
375,327,578
 
END OF PERIOD
 
$
583,864,819
   
$
945,141,143
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)

   
Alger Weatherbie Enduring Growth Fund
 
   
From
December 17, 2021
(commencement of
operations) to
April 30, 2022
 
Net investment loss
 
$
(10,245
)
Net realized loss on investments and foreign currency
   
(183,079
)
Net change in unrealized depreciation on investments and foreign currency
   
(994,768
)
Net decrease in net assets resulting from operations
   
(1,188,092
)
         
Increase (decrease) from shares of beneficial interest transactions:
       
Class A
   
152,000
 
Class C
   
100,000
 
Class I
   
100,000
 
Class Y
   
500,000
 
Class Z
   
4,600,241
 
Net increase from shares of beneficial interest transactions - Note 6
   
5,452,241
 
Total increase
   
4,264,149
 
         
Net Assets:
       
Beginning of period
   
 
END OF PERIOD
 
$
4,264,149
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)

   
Alger Weatherbie Specialized Growth Fund
 
   
For the
Six Months Ended
   
For the
Year Ended
 
 
April 30, 2022
   
October 31, 2021
 
Net investment loss
 
$
(5,381,930
)
 
$
(12,388,903
)
Net realized gain (loss) on investments and foreign currency
   
(4,478,558
)
   
337,344,305
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(616,862,972
)
   
197,674,887
 
Net increase (decrease) in net assets resulting from operations
   
(626,723,460
)
   
522,630,289
 
                 
Dividends and distributions to shareholders:
               
Class A
   
(45,296,523
)
   
(9,723,657
)
Class C
   
(27,504,338
)
   
(5,566,217
)
Class I
   
(12,964,988
)
   
(3,675,447
)
Class Y
   
(10,407,118
)
   
(1,800,147
)
Class Z
   
(205,452,142
)
   
(33,989,310
)
Total dividends and distributions to shareholders
   
(301,625,109
)
   
(54,754,778
)
                 
Increase (decrease) from shares of beneficial Interest transactions:
               
Class A
   
22,864,369
     
8,382,707
 
Class C
   
15,904,797
     
11,840,459
 
Class I
   
3,185,948
     
(14,587,055
)
Class Y
   
29,079,226
     
12,611,659
 
Class Z
   
51,465,967
     
334,347,543
 
Net increase from shares of beneficial interest transactions - Note 6
   
122,500,307
     
352,595,313
 
Total increase (decrease)
   
(805,848,262
)
   
820,470,824
 
                 
Net Assets:
               
Beginning of period
   
1,778,677,852
     
958,207,028
 
END OF PERIOD
 
$
972,829,590
   
$
1,778,677,852
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)


   
Alger Small Cap Growth Fund
 
   
For the
Six Months Ended
   
For the
Year Ended
 
   
April 30, 2022
   
October 31, 2021
 
Net investment loss
 
$
(2,467,102
)
 
$
(1,965,063
)
Net realized gain on investments and foreign currency
   
5,704,436
     
59,202,184
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(238,588,089
)
   
65,225,704
 
Net increase (decrease) in net assets resulting from operations
   
(235,350,755
)
   
122,462,825
 
                 
Dividends and distributions to shareholders:
               
Class A
   
(21,314,734
)
   
(1,079,051
)
Class B
   
(673,335
)
   
(39,964
)
Class C
   
(4,854,023
)
   
(177,822
)
Class Z
   
(30,391,004
)
   
(1,109,231
)
Total dividends and distributions to shareholders
   
(57,233,096
)
   
(2,406,068
)
                 
Increase (decrease) from shares of beneficial interest transactions:
               
Class A
   
6,350,589
     
21,347,746
 
Class B
   
32,913
     
(695,421
)
Class C
   
3,211,428
     
15,105,566
 
Class Y
   
500,000
     
 
Class Z
   
31,723,970
     
145,384,763
 
Net increase from shares of beneficial interest transactions -Note 6
   
41,818,900
     
181,142,654
 
Total increase (decrease)
   
(250,764,951
)
   
301,199,411
 
                 
Net Assets:
               
Beginning of period
   
691,424,303
     
390,224,892
 
END OF PERIOD
 
$
440,659,352
   
$
691,424,303
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)
 
   
Alger Small Cap Focus Fund
 
   
For the
Six Months Ended
   
For the
Year Ended
 
   
April 30, 2022
   
October 31, 2021
 
Net investment loss
 
$
(17,917,855
)
 
$
(56,943,544
)
Net realized gain (loss) on investments and foreign currency
   
(106,201,532
)
   
490,107,360
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(2,843,810,998
)
   
823,162,579
 
Net increase (decrease) in net assets resulting from operations
   
(2,967,930,385
)
   
1,256,326,395
 
                 
Dividends and distributions to shareholders:
               
Class A
   
(30,754,287
)
   
 
Class C
   
(16,779,423
)
   
 
Class I
   
(22,355,553
)
   
 
Class Y
   
(21,468,256
)
   
 
Class Z
   
(324,678,159
)
   
 
Total dividends and distributions to shareholders
   
(416,035,678
)
   
 
                 
Increase (decrease) from shares of beneficial interest transactions:
               
Class A
   
(40,335,062
)
   
(120,477,671
)
Class C
   
(14,382,788
)
   
(30,745,132
)
Class I
   
(70,852,378
)
   
(10,377,165
)
Class Y
   
60,246,342
     
71,307,361
 
Class Z
   
(654,686,646
)
   
732,504,935
 
Net Increase (decrease) from shares of beneficial interest transactions — Note 6
   
(720,010,532
)
   
642,212,328
 
Total increase (decrease)
   
(4,103,976,595
)
   
1,898,538,723
 
                 
Net Assets:
               
Beginning of period
   
7,840,879,302
     
5,942,340,579
 
END OF PERIOD
 
$
3,736,902,707
   
$
7,840,879,302
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)

   
Alger International Focus Fund
 
   
For the
Six Months Ended
April 30, 2022
   
For the
Year Ended
October 31, 2021
 
Net investment loss
 
$
(635,772
)
 
$
(885,412
)
Net realized gain (loss) on investments, forward foreign currency contracts and foreign currency
   
(2,208,350
)
   
30,418,574
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(50,165,792
)
   
24,822,002
 
Net increase (decrease) in net assets resulting from operations
   
(53,009,914
)
   
54,355,164
 
                 
Dividends and distributions to shareholders:
               
Class A
   
(12,365,251
)
   
 
Class B
   
(1,940,439
)
   
 
Class C
   
(400,190
)
   
 
Class I
   
(49,121
)
   
 
Class Z
   
(2,237,931
)
   
 
Total dividends and distributions to shareholders
   
(16,992,932
)
   
 
                 
Increase (decrease) from shares of beneficial interest transactions:
               
Class A
   
8,556,566
     
(3,992,372
)
Class B
   
534,026
     
(2,518,776
)
Class C
   
(590,651
)
   
613,764
 
Class I
   
1,190,229
     
(221,462
)
Class Z
   
996,657
     
10,073,982
 
Net increase from shares of beneficial interest transactions - Note 6
   
10,686,827
     
3,955,136
 
Total increase (decrease)
   
(59,316,019
)
   
58,310,300
 
                 
Net Assets:
               
Beginning of period
   
213,592,497
     
155,282,197
 
END OF PERIOD
 
$
154,276,478
   
$
213,592,497
 

See Notes to Financial Statements.

THE ALGER FUNDS
Statements of Changes in Net Assets (Unaudited) (Continued)

   
Alger Health Sciences Fund
 
   
For the
Six Months Ended
   
For the
Year Ended
 
   
April 30, 2022
   
October 31, 2021
 
Net investment loss
 
$
(427,975
)
 
$
(1,597,959
)
Net realized gain (loss) on investments and foreign currency
   
(15,607,117
)
   
76,778,620
 
Net change in unrealized appreciation (depreciation) on investments and foreign currency
   
(77,150,119
)
   
1,518,279
 
Net increase (decrease) in net assets resulting from operations
   
(93,185,211
)
   
76,698,940
 
                 
Dividends and distributions to shareholders:
               
Class A
   
(28,166,595
)
   
(14,998,910
)
Class C
   
(3,704,768
)
   
(1,922,517
)
Class Z
   
(34,925,658
)
   
(15,773,204
)
Total dividends and distributions to shareholders
   
(66,797,021
)
   
(32,694,631
)
                 
Increase (decrease) from shares of beneficial interest transactions:
               
Class A
   
14,749,269
     
2,966,483
 
Class C
   
1,691,231
     
1,074,596
 
Class Z
   
(5,055,785
)
   
31,879,794
 
Net increase from shares of beneficial interest transactions - Note 6
   
11,384,715
     
35,920,873
 
Total increase (decrease)
   
(148,597,517
)
   
79,925,182
 
                 
Net Assets:
               
Beginning of period
   
350,820,732
     
270,895,550
 
END OF PERIOD
 
$
202,223,215
   
$
350,820,732
 

See Notes to Financial Statements.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Capital Appreciation Fund
 
Class A
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
39.48
   
$
33.76
   
$
27.12
   
$
26.20
   
$
25.86
   
$
20.09
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.11
)
   
(0.24
)
   
(0.12
)
   
(0.07
)
   
(0.06
)
   
(0.02
)
Net realized and unrealized gain (loss) on investments
   
(8.57
)
   
11.11
     
8.96
     
3.53
     
2.07
     
5.96
 
Total from investment operations
   
(8.68
)
   
10.87
     
8.84
     
3.46
     
2.01
     
5.94
 
Distributions from net realized gains
   
(7.41
)
   
(5.15
)
   
(2.20
)
   
(2.54
)
   
(1.67
)
   
(0.17
)
Net asset value, end of period
 
$
23.39
   
$
39.48
   
$
33.76
   
$
27.12
   
$
26.20
   
$
25.86
 
Total return(iii)
   
(26.67
)%
   
35.41
%
   
34.79
%
   
15.29
%
   
8.15
%
   
29.84
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
926,445
    $ 1,523,572     $ 1,320,073     $ 1,174,346     $ 1,257,811     $ 1,506,389  
Ratio of gross expenses to average net assets
   
1.18
%
   
1.15
%
   
1.17
%
   
1.21
%
   
1.21
%
   
1.23
%
Ratio of net expenses to average net assets
   
1.18
%
   
1.15
%
   
1.17
%
   
1.21
%
   
1.21
%
   
1.23
%
Ratio of net investment loss to average net assets
   
(0.72
)%
   
(0.67
)%
   
(0.41
)%
   
(0.27
)%
   
(0.23
)%
   
(0.10
)%
Portfolio turnover rate
   
60.24
%
   
78.77
%
   
89.91
%
   
77.04
%
   
67.33
%
   
72.99
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Capital Appreciation Fund
 
Class C
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
27.13
   
$
24.79
   
$
20.60
   
$
20.69
   
$
20.91
   
$
16.39
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.14
)
   
(0.35
)
   
(0.25
)
   
(0.20
)
   
(0.20
)
   
(0.15
)
Net realized and unrealized gain (loss) on investments
   
(5.30
)
   
7.84
     
6.64
     
2.65
     
1.65
     
4.84
 
Total from investment operations
   
(5.44
)
   
7.49
     
6.39
     
2.45
     
1.45
     
4.69
 
Distributions from net realized gains
   
(7.41
)
   
(5.15
)
   
(2.20
)
   
(2.54
)
   
(1.67
)
   
(0.17
)
Net asset value, end of period
 
$
14.28
   
$
27.13
   
$
24.79
   
$
20.60
   
$
20.69
   
$
20.91
 
Total return(iii)
   
(26.92
)%
   
34.43
%
   
33.82
%
   
14.44
%
   
7.35
%
   
28.88
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
121,683
   
$
211,972
   
$
204,909
   
$
219,511
   
$
243,523
   
$
297,044
 
Ratio of gross expenses to average net assets
   
1.92
%
   
1.90
%
   
1.91
%
   
1.95
%
   
1.94
%
   
1.97
%
Ratio of net expenses to average net assets
   
1.92
%
   
1.90
%
   
1.91
%
   
1.95
%
   
1.94
%
   
1.97
%
Ratio of net investment loss to average net assets
   
(1.46
)%
   
(1.42
)%
   
(1.13

)%
    (1.01 )%    
(0.96
)%
   
(0.83
)%
Portfolio turnover rate
   
60.24
%
   
78.77
%
   
89.91
%
   
77.04
%
   
67.33
%
   
72.99
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Capital Appreciation Fund
 
Class Z
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
41.50
   
$
35.15
   
$
28.06
   
$
26.94
   
$
26.46
   
$
20.48
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.06
)
   
(0.13
)
   
(0.03
)
   
0.02
     
0.03
     
0.05
 
Net realized and unrealized gain (loss) on investments
   
(9.11
)
   
11.63
     
9.32
     
3.64
     
2.12
     
6.10
 
Total from investment operations
   
(9.17
)
   
11.50
     
9.29
     
3.66
     
2.15
     
6.15
 
Distributions from net realized gains
   
(7.41
)
   
(5.15
)
   
(2.20
)
   
(2.54
)
   
(1.67
)
   
(0.17
)
Net asset value, end of period
 
$
24.92
   
$
41.50
   
$
35.15
   
$
28.06
   
$
26.94
   
$
26.46
 
Total return(iii)
   
(26.53
)%
   
35.85
%
   
35.26
%
   
15.69
%
   
8.51
%
   
30.25
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
1,167,790
   
$
1,687,179
   
$
1,823,041
   
$
1,409,374
   
$
1,240,605
   
$
983,006
 
Ratio of gross expenses to average net assets
   
0.84
%
   
0.83
%
   
0.84
%
   
0.87
%
   
0.87
%
   
0.88
%
Ratio of net expenses to average net assets
   
0.84
%
   
0.83
%
   
0.84
%
   
0.87
%
   
0.87
%
   
0.88
%
Ratio of net investment income (loss) to average net assets
   
(0.38
)%
   
(0.34
)%
   
(0.09
)%
   
0.06
%
   
0.10
%
   
0.23
%
Portfolio turnover rate
   
60.24
%
   
78.77
%
   
89.91
%
   
77.04
%
   
67.33
%
   
72.99
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger 35 Fund
 
Class Z
 

 
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021(ii)
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
From 3/29/2018
(commencement
of operations) to
10/31/2018(iii)
 
Net asset value, beginning of period
 
$
21.33
   
$
17.41
   
$
11.61
   
$
10.38
   
$
10.00
 
INCOME FROM INVESTMENT OPERATIONS:
                                       
Net investment income (loss)(iv)
   
(0.01
)
   
(0.01
)
   
(0.05
)
   
0.03
     
0.01
 
Net realized and unrealized gain (loss) on investments
   
(5.56
)
   
6.95
     
5.87
     
1.31
     
0.37
 
Total from investment operations
   
(5.57
)
   
6.94
     
5.82
     
1.34
     
0.38
 
Dividends from net investment income
   
     
(v)
   
(0.02
)
   
(0.04
)
   
 
Distributions from net realized gains
   
(5.10
)
   
(3.02
)
   
     
(0.07
)
   
 
Net asset value, end of period
 
$
10.66
   
$
21.33
   
$
17.41
   
$
11.61
   
$
10.38
 
Total return(vi)
   
(32.01
)%
   
44.27
%
   
50.22
%
   
13.19
%
   
3.80
%
RATIOS/SUPPLEMENTAL DATA:
                                       
Net assets, end of period (000’s omitted)
 
$
29,889
   
$
44,159
   
$
14,128
   
$
9,094
   
$
7,782
 
Ratio of gross expenses to average net assets
   
0.98
%
   
0.92
%
   
2.02
%
   
2.37
%
   
2.46
%
Ratio of expense reimbursements to average net assets
   
(0.43
)%
   
(0.52
)%
   
(1.12
)%
   
(1.97
)%
   
(2.06
)%
Ratio of net expenses to average net assets
   
0.55
%
   
0.40
%
   
0.90
%
   
0.40
%
   
0.40
%
Ratio of net investment income (loss) to average net assets
   
(0.16
)%
   
(0.07
)%
   
0.36
%
   
0.30
%
   
0.23
%
Portfolio turnover rate
   
93.80
%
   
136.61
%
   
121.74
%
   
115.25
%
   
31.20
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Class P Shares were reclassified as Class Z Shares on May 7, 2021 and after the close of business on October 29, 2021, Class P-2 Shares were converted to Class Z Shares.
(iii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the seven months then ended.
(iv)
Amount was computed based on average shares outstanding during the period.
(v)
Amount was more than $(0.01) per share.
(vi)
Does not reflect the effect of sales charges, if applicable.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Growth & Income Fund
 
Class A
 

 
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
61.76
   
$
43.88
   
$
43.55
   
$
40.77
   
$
39.68
   
$
32.66
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income(ii)
   
0.32
     
0.63
     
0.69
     
0.70
     
0.65
     
0.56
 
Net realized and unrealized gain (loss) on investments
   
(4.11
)
   
18.47
     
1.88
     
4.54
     
1.64
     
6.97
 
Total from investment operations
   
(3.79
)
   
19.10
     
2.57
     
5.24
     
2.29
     
7.53
 
Dividends from net investment income
   
(0.25
)
   
(0.55
)
   
(0.66
)
   
(0.61
)
   
(0.57
)
   
(0.50
)
Distributions from net realized gains
   
(2.07
)
   
(0.67
)
   
(1.58
)
   
(1.85
)
   
(0.63
)
   
(0.01
)
Net asset value, end of period
 
$
55.65
   
$
61.76
   
$
43.88
   
$
43.55
   
$
40.77
   
$
39.68
 
Total return(iii)
   
(6.49
)%
   
44.12
%
   
5.98
%
   
13.94
%
   
5.78
%
   
23.22
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
107,650
   
$
106,439
   
$
74,251
   
$
74,924
   
$
70,859
   
$
72,427
 
Ratio of gross expenses to average net assets
   
0.97
%
   
0.98
%
   
1.06
%
   
1.07
%
   
1.06
%
   
1.19
%
Ratio of net expenses to average net assets
   
0.97
%
   
0.98
%
   
1.06
%
   
1.07
%
   
1.06
%
   
1.19
%
Ratio of net investment income to average net assets
   
1.07
%
   
1.15
%
   
1.60
%
   
1.72
%
   
1.59
%
   
1.52
%
Portfolio turnover rate
   
0.82
%
   
8.40
%
   
9.29
%
   
7.30
%
   
11.05
%
   
7.78
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Growth & Income Fund
 
Class C
 

 
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
60.77
   
$
43.22
   
$
42.93
   
$
40.20
   
$
39.14
   
$
32.23
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income(ii)
   
0.09
     
0.21
     
0.36
     
0.39
     
0.34
     
0.28
 
Net realized and unrealized gain (loss) on investments
   
(4.03
)
   
18.18
     
1.85
     
4.49
     
1.60
     
6.88
 
Total from investment operations
   
(3.94
)
   
18.39
     
2.21
     
4.88
     
1.94
     
7.16
 
Dividends from net investment income
   
(0.04
)
   
(0.17
)
   
(0.34
)
   
(0.30
)
   
(0.25
)
   
(0.24
)
Distributions from net realized gains
   
(2.07
)
   
(0.67
)
   
(1.58
)
   
(1.85
)
   
(0.63
)
   
(0.01
)
Net asset value, end of period
 
$
54.72
   
$
60.77
   
$
43.22
   
$
42.93
   
$
40.20
    $ 39.14  
Total return(iii)
   
(6.83
)%
   
43.01
%
   
5.19
%
   
13.12
%
   
4.96
%
   
22.28
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
19,374
   
$
18,194
   
$
13,127
   
$
14,946
   
$
16,074
   
$
22,266
 
Ratio of gross expenses to average net assets
   
1.72
%
   
1.73
%
   
1.81
%
   
1.82
%
   
1.82
%
   
1.94
%
Ratio of net expenses to average net assets
   
1.72
%
   
1.73
%
   
1.81
%
   
1.82
%
   
1.82
%
   
1.94
%
Ratio of net investment income to average net assets
   
0.31
%
   
0.40
%
   
0.86
%
   
0.97
%
   
0.84
%
   
0.76
%
Portfolio turnover rate
   
0.82
%
   
8.40
%
   
9.29
%
   
7.30
%
   
11.05
%
   
7.78
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
 
Alger Growth & Income Fund
 
Class Z
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
61.84
   
$
43.94
   
$
43.60
   
$
40.81
   
$
39.71
   
$
32.69
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income(ii)
   
0.41
     
0.80
     
0.86
     
0.85
     
0.80
     
0.65
 
Net realized and unrealized gain (loss) on investments
   
(4.10
)
   
18.49
     
1.88
     
4.56
     
1.64
     
6.99
 
Total from investment operations
   
(3.69
)
   
19.29
     
2.74
     
5.41
     
2.44
     
7.64
 
Dividends from net investment income
   
(0.35
)
   
(0.72
)
   
(0.82
)
   
(0.77
)
   
(0.71
)
   
(0.61
)
Distributions from net realized gains
   
(2.07
)
   
(0.67
)
   
(1.58
)
   
(1.85
)
   
(0.63
)
   
(0.01
)
Net asset value, end of period
 
$
55.73
   
$
61.84
   
$
43.94
   
$
43.60
   
$
40.81
   
$
39.71
 
Total return(iii)
   
(6.33
)%
   
44.54
%
   
6.39
%
   
14.39
%
   
6.16
%
   
23.55
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
55,498
   
$
38,021
   
$
21,672
   
$
26,979
   
$
24,604
   
$
22,487
 
Ratio of gross expenses to average net assets
   
0.66
%
   
0.66
%
   
0.73
%
   
0.76
%
   
0.76
%
   
0.90
%
Ratio of expense reimbursements to average net assets
   
   
(iv)    
(0.04
)%
   
(0.07
)%
   
(0.05
)%
   
 
Ratio of net expenses to average net assets
   
0.66
%
   
0.66
%
   
0.69
%
   
0.69
%
   
0.71
%
   
0.90
%
Ratio of net investment income to average net assets
   
1.38
%
   
1.45
%
   
2.00
%
   
2.10
%
   
1.96
%
   
1.75
%
Portfolio turnover rate
   
0.82
%
   
8.40
%
   
9.29
%
   
7.30
%
   
11.05
%
   
7.78
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Amount was less than 0.005%.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Growth Fund
 
Class A
 

 
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
25.20
   
$
19.29
   
$
14.81
   
$
14.13
   
$
13.47
   
$
10.20
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.07
)
   
0.48
     
(0.12
)
   
(0.09
)
   
(0.11
)
   
(0.07
)
Net realized and unrealized gain (loss) on investments
   
(6.85
)
   
7.58
     
5.80
     
1.48
     
0.88
     
3.34
 
Total from investment operations
   
(6.92
)
   
8.06
     
5.68
     
1.39
     
0.77
     
3.27
 
Dividends from net investment income
   
(0.45
)
   
     
     
     
     
 
Distributions from net realized gains
   
(6.13
)
   
(2.15
)
   
(1.20
)
   
(0.71
)
   
(0.11
)
   
 
Net asset value, end of period
 
$
11.70
   
$
25.20
   
$
19.29
   
$
14.81
   
$
14.13
   
$
13.47
 
Total return(iii)
   
(34.18
)%
 
44.05%
(iv)    
41.34
%
   
10.95
%
   
5.78
%
   
32.06
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
162,257
   
$
259,895
   
$
187,552
   
$
139,110
   
$
138,370
   
$
136,795
 
Ratio of gross expenses to average net assets
   
1.22
%
   
1.21
%
   
1.30
%
   
1.30
%
   
1.30
%
   
1.32
%
Ratio of net expenses to average net assets
   
1.22
%
   
1.21
%
   
1.30
%
   
1.30
%
   
1.30
%
   
1.32
%
Ratio of net investment income (loss) to average net assets
   
(0.91
)%
   
2.15
%
   
(0.76
)%
   
(0.65
)%
   
(0.77
)%
   
(0.55
)%
Portfolio turnover rate
   
127.82
%
   
170.96
%
   
181.73
%
   
182.97
%
   
125.34
%
   
162.65
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Mid Cap Growth Fund received a Fair Fund distribution of $9,346,397, which contributed approximately 3.89% to its annual return.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Growth Fund
 
Class B
 

 
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
18.60
   
$
14.70
   
$
11.55
   
$
11.22
   
$
10.80
   
$
8.23
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.05
)
   
0.35
     
(0.08
)
   
(0.10
)
   
(0.17
)
   
(0.12
)
Net realized and unrealized gain (loss) on investments
   
(4.61
)
   
5.70
     
4.43
     
1.14
     
0.70
     
2.69
 
Total from investment operations
   
(4.66
)
   
6.05
     
4.35
     
1.04
     
0.53
     
2.57
 
Dividends from net investment income
   
(0.48
)
   
     
     
     
     
 
Distributions from net realized gains
   
(6.13
)
   
(2.15
)
   
(1.20
)
   
(0.71
)
   
(0.11
)
   
 
Net asset value, end of period
 
$
7.33
   
$
18.60
   
$
14.70
   
$
11.55
   
$
11.22
   
$
10.80
 
Total return(iii)
   
(34.23
)%
 
44.24%(iv)
     
41.41
%
   
10.66
%
   
4.98
%
   
31.23
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
10,018
   
$
18,276
   
$
15,411
   
$
13,772
   
$
15,361
   
$
18,375
 
Ratio of gross expenses to average net assets
   
1.93
%
   
1.93
%
   
2.03
%
   
2.04
%
   
2.05
%
   
2.05
%
Ratio of expense reimbursements to average net assets
   
(0.66
)%
   
(0.76
)%
   
(0.82
)%
   
(0.47
)%
   
     
 
Ratio of net expenses to average net assets
   
1.27
%
   
1.17
%
   
1.21
%
   
1.57
%
   
2.05
%
   
2.05
%
Ratio of net investment income (loss) to average net assets
   
(0.97
)%
   
2.08
%
   
(0.66
)%
   
(0.92
)%
   
(1.50
)%
   
(1.28
)%
Portfolio turnover rate
   
127.82
%
   
170.96
%
   
181.73
%
   
182.97
%
   
125.34
%
   
162.65
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Mid Cap Growth Fund received a Fair Fund distribution of $9,346,397, which contributed approximately 3.89% to its annual return.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Mid Cap Growth Fund
 
Class C
 

 
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
17.82
   
$
14.26
   
$
11.33
   
$
11.08
   
$
10.67
    $ 8.15  
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.08
)
   
0.23
     
(0.18
)
   
(0.16
)
   
(0.18
)
   
(0.13
)
Net realized and unrealized gain (loss) on investments
   
(4.38
)
   
5.48
     
4.31
     
1.12
     
0.70
     
2.65
 
Total from investment operations
   
(4.46
)
   
5.71
     
4.13
     
0.96
     
0.52
     
2.52
 
Dividends from net investment income
   
(0.35
)
   
     
     
     
     
 
Distributions from net realized gains
   
(6.13
)
   
(2.15
)
   
(1.20
)
   
(0.71
)
   
(0.11
)
   
 
Net asset value, end of period
 
$
6.88
   
$
17.82
   
$
14.26
   
$
11.33
   
$
11.08
   
$
10.67
 
Total return(iii)
   
(34.45
)%
 
42.91%
(iv)
   
40.26
%
   
10.03
%
   
4.94
%
   
30.92
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
5,267
   
$
8,244
   
$
5,691
   
$
6,014 $ 7,647
   
$
15,438
         
Ratio of gross expenses to average net assets
   
2.05
%
   
2.00
%
   
2.10
%
   
2.14
%
   
2.11
%
   
2.13
%
Ratio of net expenses to average net assets
   
2.05
%
   
2.00
%
   
2.10
%
   
2.14
%
   
2.11
%
   
2.13
%
Ratio of net investment income (loss) to average net assets
   
(1.74
)%
   
1.41
%
   
(1.52
)%
   
(1.48
)%
   
(1.55
)%
   
(1.35
)%
Portfolio turnover rate
   
127.82
%
   
170.96
%
   
181.73
%
   
182.97
%
   
125.34
%
    162.65 %

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Mid Cap Growth Fund received a Fair Fund distribution of $9,346,397, which contributed approximately 3.89% to its annual return.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Growth Fund
 
Class Z
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
25.78
   
$
19.63
   
$
15.01
   
$
14.27
   
$
13.56
   
$
10.24
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.05
)
   
0.63
     
(0.07
)
   
(0.06
)
   
(0.07
)
   
(0.04
)
Net realized and unrealized gain (loss) on investments
   
(7.03
)
   
7.67
     
5.89
     
1.51
     
0.89
     
3.36
 
Total from investment operations
   
(7.08
)
   
8.30
     
5.82
     
1.45
     
0.82
     
3.32
 
Dividends from net investment income
   
(0.52
)
   
     
     
     
     
 
Distributions from net realized gains
   
(6.13
)
   
(2.15
)
   
(1.20
)
   
(0.71
)
   
(0.11
)
   
 
Net asset value, end of period
 
$
12.05
   
$
25.78
   
$
19.63
   
$
15.01
   
$
14.27
   
$
13.56
 
Total return(iii)
   
(34.13
)%
 
44.55%(iv)
     
41.75
%
   
11.27
%
   
6.03
%
   
32.52
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
37,584
   
$
52,746
   
$
26,804
   
$
17,558
   
$
14,230
   
$
13,306
 
Ratio of gross expenses to average net assets
   
0.91
%
   
0.92
%
   
0.99
%
   
1.03
%
   
1.03
%
   
1.07
%
Ratio of expense reimbursements to average net assets
   
     
     
     
     
     
(0.02
)%
Ratio of net expenses to average net assets
   
0.91
%
   
0.92
%
   
0.99
%
   
1.03
%
   
1.03
%
   
1.05
%
Ratio of net investment income (loss) to average net assets
   
(0.60
)%
   
2.75
%
   
(0.46
)%
   
(0.38
)%
   
(0.49
)%
   
(0.29
)%
Portfolio turnover rate
   
127.82
%
   
170.96
%
   
181.73
%
   
182.97
%
   
125.34
%
   
162.65
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Mid Cap Growth Fund received a Fair Fund distribution of $9,346,397, which contributed approximately 3.89% to its annual return.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Focus Fund
 
Class A
 

 
Six months
ended
4/30/2022(i)
   
From 7/29/2021
(commencement
of operations) to
10/31/2021(ii)
 
Net asset value, beginning of period
 
$
23.43
   
$
20.67
 
INCOME FROM INVESTMENT OPERATIONS:
               
Net investment loss(iii)
   
(0.06
)
   
(0.04
)
Net realized and unrealized gain (loss) on investments
   
(7.30
)
   
2.80
 
Total from investment operations
   
(7.36
)
   
2.76
 
Distributions from net realized gains
   
(2.06
)
   
 
Net asset value, end of period
 
$
14.01
   
$
23.43
 
Total return(iv)
   
(33.38
)%
   
13.35
%
RATIOS/SUPPLEMENTAL DATA:
               
Net assets, end of period (000’s omitted)
 
$
3,271
   
$
1,669
 
Ratio of gross expenses to average net assets
   
0.96
%
   
0.96
%
Ratio of net expenses to average net assets
   
0.96
%
   
0.96
%
Ratio of net investment loss to average net assets
   
(0.68
)%
   
(0.72
)%
Portfolio turnover rate
   
199.27
%
   
250.31
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii)
Amount was computed based on average shares outstanding during the period.
(iv)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Mid Cap Focus Fund
 
Class C
 
   
Six months
ended
4/30/2022(i)
   
From 7/29/2021
(commencement
of operations) to
10/31/2021(ii)
 
Net asset value, beginning of period
 
$
23.38
   
$
20.67
 
INCOME FROM INVESTMENT OPERATIONS:
               
Net investment loss(iii)
   
(0.13
)
   
(0.09
)
Net realized and unrealized gain (loss) on investments
   
(7.26
)
   
2.80
 
Total from investment operations
   
(7.39
)
   
2.71
 
Distributions from net realized gains
   
(2.06
)
   
 
Net asset value, end of period
 
$
13.93
   
$
23.38
 
Total return(iv)
   
(33.63
)%
   
13.16
%
RATIOS/SUPPLEMENTAL DATA:
               
Net assets, end of period (000’s omitted)
 
$
2,934
   
$
2,317
 
Ratio of gross expenses to average net assets
   
1.73
%
   
1.76
%
Ratio of net expenses to average net assets
   
1.73
%
   
1.76
%
Ratio of net investment loss to average net assets
   
(1.46
)%
   
(1.50
)%
Portfolio turnover rate
   
199.27
%
   
250.31
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii)
Amount was computed based on average shares outstanding during the period.
(iv)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
 
Alger Mid Cap Focus Fund
 
Class I
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
From 6/14/2019
(commencement
of operations) to
10/31/2019(ii)
 
Net asset value, beginning of period
 
$
23.43
   
$
15.10
   
$
9.70
   
$
10.00
 
INCOME FROM INVESTMENT OPERATIONS:
                               
Net investment loss(iii)
   
(0.06
)
   
(0.17
)
   
(0.14
)
   
(0.04
)
Net realized and unrealized gain (loss) on investments
   
(7.30
)
   
8.76
     
5.54
     
(0.26
)
Total from investment operations
   
(7.36
)
   
8.59
     
5.40
     
(0.30
)
Distributions from net realized gains
   
(2.06
)
   
(0.26
)
   
     
 
Net asset value, end of period
 
$
14.01
   
$
23.43
   
$
15.10
   
$
9.70
 
Total return(iv)
   
(33.39
)%
   
57.36
%
   
55.35
%
   
(3.00
)%
RATIOS/SUPPLEMENTAL DATA:
                               
Net assets, end of period (000’s omitted)
 
$
86,918
   
$
145,539
   
$
67,796
   
$
2,023
 
Ratio of gross expenses to average net assets
   
0.99
%
   
0.95
%
   
1.14
%
   
1.91
%
Ratio of expense reimbursements to average net assets
   
     
     
(0.03
)%
   
(0.71
)%
Ratio of net expenses to average net assets
   
0.99
%
   
0.95
%
   
1.11
%
   
1.20
%
Ratio of net investment loss to average net assets
   
(0.72
)%
   
(0.85
)%
   
(1.04
)%
   
(0.97
)%
Portfolio turnover rate
   
199.27
%
   
250.31
%
   
123.43
%
   
65.50
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the five months then ended.
(iii)
Amount was computed based on average shares outstanding during the period.
(iv)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
 
Alger Mid Cap Focus Fund
 
Class Y
 
   
Six months
ended
4/30/2022(i)
   
From 2/26/2021
(commencement
of operations) to
10/31/2021(ii)
 
Net asset value, beginning of period
 
$
23.56
   
$
20.65
 
INCOME FROM INVESTMENT OPERATIONS:
               
Net investment loss(iii)
   
(0.04
)
   
(0.08
)
Net realized and unrealized gain (loss) on investments
   
(7.34
)
   
2.99
 
Total from investment operations
   
(7.38
)
   
2.91
 
Distributions from net realized gains
   
(2.06
)
   
 
Net asset value, end of period
 
$
14.12
   
$
23.56
 
Total return(iv)
   
(33.28
)%
   
14.09
%
RATIOS/SUPPLEMENTAL DATA:
               
Net assets, end of period (000’s omitted)
 
$
90
   
$
137
 
Ratio of gross expenses to average net assets
   
0.69
%
   
0.72
%
Ratio of expense reimbursements to average net assets
   
     
(0.02
)%
Ratio of net expenses to average net assets
   
0.69
%
   
0.70
%
Ratio of net investment loss to average net assets
   
(0.42
)%
   
(0.57
)%
Portfolio turnover rate
   
199.27
%
   
250.31
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii)
Amount was computed based on average shares outstanding during the period.
(iv)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Mid Cap Focus Fund
 
Class Z
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
From 6/14/2019
(commencement
of operations) to
10/31/2019(ii)
 
Net asset value, beginning of period
 
$
23.57
   
$
15.15
   
$
9.71
   
$
10.00
 
INCOME FROM INVESTMENT OPERATIONS:
                               
Net investment loss(iii)
   
(0.04
)
   
(0.12
)
   
(0.10
)
   
(0.03
)
Net realized and unrealized gain (loss) on investments
   
(7.34
)
   
8.80
     
5.54
     
(0.26
)
Total from investment operations
   
(7.38
)
   
8.68
     
5.44
     
(0.29
)
Distributions from net realized gains
   
(2.06
)
   
(0.26
)
   
     
 
Net asset value, end of period
 
$
14.13
   
$
23.57
   
$
15.15
   
$
9.71
 
Total return(iv)
   
(33.26
)%
   
57.77
%
   
55.70
%
   
(2.80
)%
RATIOS/SUPPLEMENTAL DATA:
                               
Net assets, end of period (000’s omitted)
 
$
490,652
   
$
795,479
   
$
307,532
   
$
28,230
 
Ratio of gross expenses to average net assets
   
0.69
%
   
0.68
%
   
0.91
%
   
1.86
%
Ratio of expense reimbursements to average net assets
   
     
     
(0.05
)%
   
(0.87
)%
Ratio of net expenses to average net assets
   
0.69
%
   
0.68
%
   
0.86
%
   
0.99
%
Ratio of net investment income (loss) to average net assets
   
(0.41
)%
   
(0.58
)%
    (0.77 )%    
(0.74
)%
Portfolio turnover rate
   
199.27
%
   
250.31
%
   
123.43
%
   
65.50
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the five months then ended.
(iii)
Amount was computed based on average shares outstanding during the period.
(iv)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
 
Alger Weatherbie Enduring Growth Fund
 
Class A
 

 
From 12/17/2021
(commencement
of operations) to
4/30/2022(i)
 
Net asset value, beginning of period
 
$
10.00
 
INCOME FROM INVESTMENT OPERATIONS:
       
Net investment loss(ii)
   
(0.03
)
Net realized and unrealized loss on investments
   
(2.17
)
Total from investment operations
   
(2.20
)
Net asset value, end of period
 
$
7.80
 
Total return(iii)
   
(22.00
)%
RATIOS/SUPPLEMENTAL DATA:
       
Net assets, end of period (000’s omitted)
 
$
126
 
Ratio of gross expenses to average net assets
   
5.12
%
Ratio of expense reimbursements to average net assets
   
(3.97
)%
Ratio of net expenses to average net assets
   
1.15
%
Ratio of net investment loss to average net assets
   
(0.92
)%
Portfolio turnover rate
   
17.12
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the six months then ended.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
 
Alger Weatherbie Enduring Growth Fund
 
Class C
 

 
From 12/17/2021
(commencement
of operations) to
4/30/2022(i)
 
Net asset value, beginning of period
 
$
10.00
 
INCOME FROM INVESTMENT OPERATIONS:
       
Net investment loss(ii)
   
(0.05
)
Net realized and unrealized loss on investments
   
(2.17
)
Total from investment operations
   
(2.22
)
Net asset value, end of period
 
$
7.78
 
Total return(iii)
   
(22.20
)%
RATIOS/SUPPLEMENTAL DATA:
       
Net assets, end of period (000’s omitted)
 
$
78
 
Ratio of gross expenses to average net assets
   
5.55
%
Ratio of expense reimbursements to average net assets
   
(3.70
)%
Ratio of net expenses to average net assets
   
1.85
%
Ratio of net investment loss to average net assets
   
(1.63
)%
Portfolio turnover rate
   
17.12
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the six months then ended.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Weatherbie Enduring Growth Fund
 
Class I
 

 
From 12/17/2021
(commencement
of operations) to
4/30/2022(i)
 
Net asset value, beginning of period
 
$
10.00
 
INCOME FROM INVESTMENT OPERATIONS:
       
Net investment loss(ii)
   
(0.03
)
Net realized and unrealized loss on investments
   
(2.17
)
Total from investment operations
   
(2.20
)
Net asset value, end of period
  $ 7.80  
Total return(iii)
   
(22.00
)%
RATIOS/SUPPLEMENTAL DATA:
       
Net assets, end of period (000’s omitted)
 
$
78
 
Ratio of gross expenses to average net assets
   
4.79
%
Ratio of expense reimbursements to average net assets
   
(3.69
)%
Ratio of net expenses to average net assets
   
1.10
%
Ratio of net investment loss to average net assets
   
(0.88
)%
Portfolio turnover rate
   
17.12
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the six months then ended.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
 
Alger Weatherbie Enduring Growth Fund
 
Class Y
 

 
From 12/17/2021
(commencement
of operations) to
4/30/2022(i)
 
Net asset value, beginning of period
 
$
10.00
 
INCOME FROM INVESTMENT OPERATIONS:
       
Net investment loss(ii)
   
(0.02
)
Net realized and unrealized loss on investments
   
(2.17
)
Total from investment operations
   
(2.19
)
Net asset value, end of period
 
$
7.81
 
Total return(iii)
   
(21.90
)%
RATIOS/SUPPLEMENTAL DATA:
       
Net assets, end of period (000’s omitted)
 
$
391
 
Ratio of gross expenses to average net assets
   
4.51
%
Ratio of expense reimbursements to average net assets
   
(3.81
)%
Ratio of net expenses to average net assets
   
0.70
%
Ratio of net investment loss to average net assets
   
(0.49
)%
Portfolio turnover rate
   
17.12
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the six months then ended.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
 
Alger Weatherbie Enduring Growth Fund
 
Class Z
 

 
From 12/17/2021
(commencement
of operations) to
4/30/2022(i)
 
Net asset value, beginning of period
 
$
10.00
 
INCOME FROM INVESTMENT OPERATIONS:
       
Net investment loss(ii)
   
(0.02
)
Net realized and unrealized loss on investments
   
(2.17
)
Total from investment operations
   
(2.19
)
Net asset value, end of period
 
$
7.81
 
Total return(iii)
   
(21.90
)%
RATIOS/SUPPLEMENTAL DATA:
       
Net assets, end of period (000’s omitted)
 
$
3,591
 
Ratio of gross expenses to average net assets
   
4.52
%
Ratio of expense reimbursements to average net assets
   
(3.77
)%
Ratio of net expenses to average net assets
   
0.75
%
Ratio of net investment loss to average net assets
   
(0.54
)%
Portfolio turnover rate
   
17.12
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the six months then ended.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)
 
Alger Weatherbie Specialized Growth Fund
 
Class A
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
24.96
   
$
17.46
   
$
13.30
   
$
13.08
   
$
12.87
   
$
10.64
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.09
)
   
(0.23
)
   
(0.16
)
   
(0.14
)
   
(0.15
)
   
(0.12
)
Net realized and unrealized gain (loss) on investments
   
(7.98
)
   
8.70
     
4.88
     
1.39
     
1.90
     
3.58
 
Total from investment operations
   
(8.07
)
   
8.47
     
4.72
     
1.25
     
1.75
     
3.46
 
Distributions from net realized gains
   
(4.34
)
   
(0.97
)
   
(0.56
)
   
(1.03
)
   
(1.54
)
   
(1.23
)
Net asset value, end of period
 
$
12.55
   
$
24.96
   
$
17.46
   
$
13.30
   
$
13.08
   
$
12.87
 
Total return(iii)
   
(37.12
)%
   
49.80
%
   
36.57
%
   
11.57
%
   
15.02
%
   
35.64
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
144,960
   
$
259,394
   
$
174,709
   
$
140,368
   
$
111,456
   
$
84,644
 
Ratio of gross expenses to average net assets
   
1.23
%
   
1.20
%
   
1.27
%
   
1.31
%
   
1.33
%
   
1.35
%
Ratio of net expenses to average net assets
   
1.23
%
   
1.20
%
   
1.27
%
   
1.31
%
   
1.33
%
   
1.35
%
Ratio of net investment loss to average net assets
   
(1.02
)%
   
(1.03
)%
   
(1.09
)%
   
(1.08
)%
   
(1.16
)%
   
(1.02
)%
Portfolio turnover rate
   
31.59
%
   
61.53
%
   
66.84
%
   
64.83
%
   
42.56
%
   
157.39
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Weatherbie Specialized 
Growth Fund
  Class C  
     
Six months
ended 4/30/2022(i)
      Year ended 10/31/2021
      Year ended 10/31/2020
      Year ended 10/31/2019
      Year ended 10/31/2018
      Year ended 10/31/2017
 
Net asset value, beginning of period
 
$
15.93
   
$
11.52
   
$
9.01
   
$
9.30
   
$
9.65
   
$
8.32
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.09
)
   
(0.25
)
   
(0.19
)
   
(0.17
)
   
(0.18
)
   
(0.15
)
Net realized and unrealized gain (loss) on investments
   
(4.66
)
   
5.63
     
3.26
     
0.91
     
1.37
     
2.71
 
Total from investment operations
   
(4.75
)
   
5.38
     
3.07
     
0.74
     
1.19
     
2.56
 
Distributions from net realized gains
   
(4.34
)
   
(0.97
)
   
(0.56
)
   
(1.03
)
   
(1.54
)
   
(1.23
)
Net asset value, end of period
 
$
6.84
   
$
15.93
   
$
11.52
   
$
9.01
   
$
9.30
   
$
9.65
 
Total return(iii)
   
(37.42
)%
   
48.68
%
   
35.62
%
   
10.70
%
   
14.11
%
   
34.64
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
55,627
   
$
103,331
   
$
64,497
   
$
44,908
   
$
36,325
   
$
31,651
 
Ratio of gross expenses to average net assets
   
2.01
%
   
1.95
%
   
2.03
%
   
2.05
%
   
2.08
%
   
2.12
%
Ratio of net expenses to average net assets
   
2.01
%
   
1.95
%
   
2.03
%
   
2.05
%
   
2.08
%
   
2.12
%
Ratio of net investment loss to average net assets
   
(1.79
)%
   
(1.79
)%
   
(1.85
)%
   
(1.82
)%
   
(1.91
)%
   
(1.79
)%
Portfolio turnover rate
   
31.59
%
   
61.53
%
   
66.84
%
   
64.83
%
   
42.56
%
   
157.39
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Weatherbie Specialized
Growth Fund
  Class I  
     
Six months
ended 4/30/2022(i)
      Year ended 10/31/2021
      Year ended 10/31/2020
     
Year ended 10/31/2019
     
Year ended 10/31/2018
      Year ended 10/31/2017
 
Net asset value, beginning of period INCOME
 
$
25.67
   
$
17.94
   
$
13.64
   
$
13.38
   
$
13.14
   
$
10.84
 
FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.09
)
   
(0.23
)
   
(0.16
)
   
(0.14
)
   
(0.16
)
   
(0.11
)
Net realized and unrealized gain (loss) on investments
   
(8.24
)
   
8.93
     
5.02
     
1.43
     
1.94
     
3.64
 
Total from investment operations
   
(8.33
)
   
8.70
     
4.86
     
1.29
     
1.78
     
3.53
 
Distributions from net realized gains
   
(4.34
)
   
(0.97
)
   
(0.56
)
   
(1.03
)
   
(1.54
)
   
(1.23
)
Net asset value, end of period
 
$
13.00
   
$
25.67
   
$
17.94
   
$
13.64
   
$
13.38
   
$
13.14
 
Total return(iii)
   
(37.13
)%
   
49.81
%
   
36.69
%
   
11.61
%
   
14.94
%
   
35.63
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
40,920
    $
77,214
    $
66,294
    $
58,615
     $
35,669
     $
23,374
 
Ratio of gross expenses to average net assets
   
1.23
%
   
1.19
%
   
1.24
%
   
1.26
%
   
1.35
%
   
1.35
%
Ratio of net expenses to average net assets
   
1.23
%
   
1.19
%
   
1.24
%
   
1.26
%
   
1.35
%
   
1.35
%
Ratio of net investment loss to average net assets
   
(1.01
)%
   
(1.02
)%
   
(1.07
)%
   
(1.03
)%
   
(1.18
)%
   
(0.99
)%
Portfolio turnover rate
   
31.59
%
   
61.53
%
   
66.84
%
   
64.83
%
   
42.56
%
   
157.39
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger Weatherbie Specialized
Growth Fund
 
Class Y
 
 
 
Six months ended 4/30/2022(i)
   
Year ended 10/31/2021
   
Year ended 10/31/2020
   
Year ended 10/31/2019
   
Year ended 10/31/2018
   
From 8/31/2017 (commencement of operations) to 10/31/2017(ii)
 
Net asset value, beginning of period
 
$
26.12
   
$
18.17
   
$
13.77
   
$
13.44
   
$
13.14
   
$
12.27
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(iii)
   
(0.06
)
   
(0.16
)
   
(0.11
)
   
(0.09
)
   
(0.10
)
   
(0.02
)
Net realized and unrealized gain (loss) on investments
   
(8.42
)
   
9.08
     
5.07
     
1.45
     
1.94
     
0.89
 
Total from investment operations
   
(8.48
)
   
8.92
     
4.96
     
1.36
     
1.84
     
0.87
 
Distributions from net realized gains
   
(4.34
)
   
(0.97
)
   
(0.56
)
   
(1.03
)
   
(1.54
)
   
 
Net asset value, end of period
 
$
13.30
   
$
26.12
   
$
18.17
   
$
13.77
   
$
13.44
   
$
13.14
 
Total return(iv)
   
(37.03
)%
   
50.35
%
   
37.08
%
   
12.12
%
   
15.45
%
   
7.09
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
53,758
   
$
61,163
   
$
32,702
   
$
12,903
   
$
3,832
   
$
107
 
Ratio of gross expenses to average net assets
   
0.90
%
   
0.89
%
   
0.94
%
   
0.97
%
   
1.05
%
   
9.54
%
Ratio of expense reimbursements to average net assets
   
(0.03
)%
   
(0.02
)%
   
(0.07
)%
   
(0.10
)%
   
(0.18
)%
   
(8.67
)%
Ratio of net expenses to average net assets
   
0.87
%
   
0.87
%
   
0.87
%
   
0.87
%
   
0.87
%
   
0.87
%
Ratio of net investment loss to average net assets
   
(0.65
)%
   
(0.70
)%
   
(0.69
)%
   
(0.64
)%
   
(0.67
)%
   
(0.78
)%
Portfolio turnover rate
   
31.59
%
   
61.53
%
   
66.84
%
   
64.83
%
   
42.56
%
   
157.39
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii)
Amount was computed based on average shares outstanding during the period.
(iv)
Does not reflect the effect of sales charges, if applicable.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Weatherbie Specialized
Growth Fund

Class Z

 

Six months ended 4/30/2022(i)


Year ended 10/31/2021


Year ended 10/31/2020


Year ended 10/31/2019


Year ended 10/31/2018


Year ended 10/31/2017
Net asset value, beginning of period
 
$
26.87
   
$
18.68
   
$
14.15
   
$
13.80
   
$
13.46
   
$
11.04
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.06
)
   
(0.17
)
   
(0.12
)
   
(0.10
)
   
(0.12
)
   
(0.09
)
Net realized and unrealized gain (loss) on investments
   
(8.69
)
   
9.33
     
5.21
     
1.48
     
2.00
     
3.74
 
Total from investment operations
   
(8.75
)
   
9.16
     
5.09
     
1.38
     
1.88
     
3.65
 
Distributions from net realized gains
   
(4.34
)
   
(0.97
)
   
(0.56
)
   
(1.03
)
   
(1.54
)
   
(1.23
)
Net asset value, end of period
 
$
13.78
   
$
26.87
   
$
18.68
   
$
14.15
   
$
13.80
   
$
13.46
 
Total return(iii)
   
(37.02
)%
   
50.32
%
   
37.00
%
   
11.94
%
   
15.37
%
   
36.11
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
677,564

$ 1,277,576

$ 620,005

$ 284,393

$ 147,665

$ 52,736
Ratio of gross expenses to average net assets


0.90
%

0.88
%

0.94
%

0.97
%

1.00
%

1.06
%
Ratio of expense reimbursements to average net assets














(0.01) %


Ratio of net expenses to average net assets


0.90
%

0.88
%

0.94
%

0.97
%

0.99 %

1.06 %
Ratio of net investment loss to average
net assets


(0.68) %

(0.72)
%

(0.76)
%

(0.73)
%

(0.82) %

(0.77) %
Portfolio turnover rate


31.59
%

61.53
%

66.84 %

64.83
%

42.56 %

157.39 %

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.

- 137 -

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Growth Fund

Class A
 



Six months ended 4/30/2022(i)


Year ended 10/31/2021



Year ended 10/31/2020


Year ended 10/31/2019


Year ended 10/31/2018


Year ended 10/31/2017  
Net asset value, beginning of period
 
$
16.21
   
$
12.59
     
$
9.34
   
$
9.54
   
$
8.40
   
$
6.15
 
INCOME FROM INVESTMENT OPERATIONS:
                                                 
Net investment loss(ii)
   
(0.06
)
   
(0.07
)
     
(0.12
)
   
(0.11
)
   
(0.10
)
   
(0.06
)
Net realized and unrealized gain (loss) on investments
   
(5.19
)
   
3.76
       
3.91
     
0.85
     
1.34
     
2.31
 
Total from investment operations
   
(5.25
)
   
3.69
       
3.79
     
0.74
     
1.24
     
2.25
 
Distributions from net realized gains
   
(1.34
)
   
(0.07
)
     
(0.54
)
   
(0.94
)
   
(0.10
)
   
 
Net asset value, end of period
 
$
9.62
   
$
16.21
     
$
12.59
   
$
9.34
   
$
9.54
   
$
8.40
 
Total return(iii)


(34.49
)%


29.27
% (iv)

42.80
%

9.94
%

14.94
%

36.59
%
RATIOS/SUPPLEMENTAL DATA:








 















Net assets, end of period (000’s omitted)

$
159,924

$
262,708
 
$
187,489

$
116,308

$
111,271

$
102,318
Ratio of gross expenses to average net assets


1.27
%

1.23
%  

1.33
%

1.39
%

1.38
%

1.38
%
Ratio of net expenses to average net assets


1.27
%

1.23
%  

1.33
%

1.39
%

1.38
%

1.38
%
Ratio of net investment loss to average net assets


(1.04
)%

(0.46
)%  

(1.11
)%

(1.17
)%

(1.06
)%

(0.88
)%
Portfolio turnover rate


8.21
%

34.85
%  

12.67
%

17.09
%

28.68
%

30.32
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Small Cap Growth Fund received a Fair Fund distribution of $3,738,004, which contributed approximately 0.72% to its annual return.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Growth Fund

Class B
 



Six months ended 4/30/2022(i)


Year ended 10/31/2021



Year ended 10/31/2020


Year ended 10/31/2019


Year ended 10/31/2018


Year ended 10/31/2017  
Net asset value, beginning of period
 
$
11.41
   
$
8.88
     
$
6.74
   
$
7.20
   
$
6.42
   
$
4.73
 
INCOME FROM INVESTMENT OPERATIONS:
                                                 
Net investment loss(ii)
   
(0.05
)
   
(0.05
)
     
(0.08
)
   
(0.11
)
   
(0.13
)
   
(0.09
)
Net realized and unrealized gain (loss) on investments
   
(3.55
)
   
2.65
       
2.76
     
0.59
     
1.01
     
1.78
 
Total from investment operations
   
(3.60
)
   
2.60
       
2.68
     
0.48
     
0.88
     
1.69
 
Distributions from net realized gains
   
(1.34
)
   
(0.07
)
     
(0.54
)
   
(0.94
)
   
(0.10
)
   
 
Net asset value, end of period
 
$
6.47
   
$
11.41
     
$
8.88
   
$
6.74
   
$
7.20
   
$
6.42
 
Total return(iii)


(34.55 )%

29.38
% (iv)  
42.68
%


9.51
%


13.93
%


35.73
%
RATIOS/SUPPLEMENTAL DATA:









 













 
Net assets, end of period (000’s omitted)

$
3,315

$
5,821

 
$
5,095

$
4,523

$
4,958

$
5,397  
Ratio of gross expenses to average net assets


1.96
%

1.96
%
 
2.07
%

2.19
%

2.23
%

2.19
 %
Ratio of expense reimbursements to average net assets


(0.62
)%

(0.74
)%
 
(0.73
)%

(0.41
)%




 
Ratio of net expenses to average net assets


1.34
%

1.22
%
 
1.34
%

1.78
%

2.23%
%

2.19
%
Ratio of net investment loss to average net assets


(1.11
)%

(0.48
)%
 
(1.11
)%

(1.57
)%

(1.90
)%

(1.68
)%
Portfolio turnover rate


8.21
%

34.85
%
 
12.67
%

17.09
%

28.68
%

30.32
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Small Cap Growth Fund received a Fair Fund distribution of $3,738,004, which contributed approximately 0.72% to its annual return.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Growth Fund

Class C  



Six months ended 4/30/2022(i)


Year ended 10/31/2021


Year ended 10/31/2020


Year ended 10/31/2019


Year ended 10/31/2018


Year ended 10/31/2017  
Net asset value, beginning of period
 
$
10.76
   
$
8.44
   
$
6.47
   
$
6.99
   
$
6.22
   
$
4.59
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.07
)
   
(0.13
)
   
(0.14
)
   
(0.13
)
   
(0.12
)
   
(0.09
)
Net realized and unrealized gain (loss) on investments
   
(3.33
)
   
2.52
     
2.65
     
0.55
     
0.99
     
1.72
 
Total from investment operations
   
(3.40
)
   
2.39
     
2.51
     
0.42
     
0.87
     
1.63
 
Distributions from net realized gains
   
(1.34
)
   
(0.07
)
   
(0.54
)
   
(0.94
)
   
(0.10
)
   
 
Net asset value, end of period
 
$
6.02
   
$
10.76
   
$
8.44
   
$
6.47
   
$
6.99
   
$
6.22
 
Total return(iii)


(34.80
)%


28.41
%(iv)

41.76
%


8.87
%


14.22
%


35.51
%
RATIOS/SUPPLEMENTAL DATA:























 
Net assets, end of period (000’s omitted)

$
24,194


$
39,148


$
18,365


$
6,257


$
5,837


$
8,007
 
Ratio of gross expenses to average net assets


2.09
%

2.00
%

2.09
%

2.20
%

2.16
%

2.17
%
Ratio of net expenses to average net assets


2.09
%

2.00
%

2.09
%

2.20
%

2.16
%

2.17
%
Ratio of net investment loss to average net assets


(1.86
)%

(1.21
)%

(1.90
)%

(1.98
)%

(1.82
)%

(1.64
)%
Portfolio turnover rate


8.21
%

34.85
%

12.67
%

17.09



28.68
%

30.32
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(ii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Small Cap Growth Fund received a Fair Fund distribution of $3,738,004, which contributed approximately 0.72% to its annual return.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Growth Fund
 
Class Y
 

 
From 12/31/2021
(commencement
of operations) to
4/30/2022(i)
 
Net asset value, beginning of period
 
$
13.84
 
INCOME FROM INVESTMENT OPERATIONS:
       
Net investment loss(ii)
   
(0.02
)
Net realized and unrealized loss on investments
   
(3.71
)
Total from investment operations
   
(3.73
)
Net asset value, end of period
 
$
10.11  
Total return(iii)
   
(26.95
)%
RATIOS/SUPPLEMENTAL DATA:
       
Net assets, end of period (000’s omitted)
 
$
365
 
Ratio of gross expenses to average net assets
   
0.96
%
Ratio of expense reimbursements to average net assets
   
(0.12
)%
Ratio of net expenses to average net assets
   
0.84
%
Ratio of net investment loss to average net assets
   
(0.54
)%
Portfolio turnover rate
   
8.21
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the six months then ended.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.

- 141 -

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Growth Fund

Class Z
 



Six months ended 4/30/2022(i)


Year ended 10/31/2021


Year ended 10/31/2020


Year ended 10/31/2019


Year ended 10/31/2018


Year ended 10/31/2017  
Net asset value, beginning of period
 
$
16.92
   
$
13.10
   
$
9.66
   
$
9.80
   
$
8.60
   
$
6.27
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.05
)
   
(0.02
)
   
(0.10
)
   
(0.07
)
   
(0.06
)
   
(0.04
)
Net realized and unrealized gain (loss) on investments
   
(5.43
)
   
3.91
     
4.08
     
0.87
     
1.36
     
2.37
 
Total from investment operations
   
(5.48
)
   
3.89
     
3.98
     
0.80
     
1.30
     
2.33
 
Distributions from net realized gains
   
(1.34
)
   
(0.07
)
   
(0.54
)
   
(0.94
)
   
(0.10
)
   
 
Net asset value, end of period
 
$
10.10
   
$
16.92
   
$
13.10
   
$
9.66
   
$
9.80
   
$
8.60
 
Total return(iii)

(34.40 )%

29.66
%(iv)

43.38
%

10.33
%

15.30
%

37.16
%
RATIOS/SUPPLEMENTAL DATA:























 
Net assets, end of period (000’s omitted)
  $ 252,861

$ 383,748

$ 179,276

$ 21,782

$ 13,179

$ 26,953  
Ratio of gross expenses to average net assets


0.94 %

0.93 %

1.00 %

1.12 %

1.12 %

1.08 %
Ratio of expense reimbursements to average net assets








(0.03) %

(0.13) %

(0.13) %

(0.09) %
Ratio of net investment loss to average net assets


(0.71) %

(0.12 )%

(0.81 )%

(0.78 )%

(0.65 )%

(0.50 )%
Portfolio turnover rate


8.21 %

34.85 %

12.67 %

17.09 %

28.68 %

30.32 %

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Small Cap Growth Fund received a Fair Fund distribution of $3,738,004, which contributed approximately 0.72% to its annual return.
 
- 142 -

Table of Contents
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Focus Fund

Class A  



Six months ended 4/30/2022(i)


Year ended 10/31/2021


Year ended 10/31/2020


Year ended 10/31/2019


Year ended 10/31/2018


Year ended 10/31/2017  
Net asset value, beginning of period
 
$
31.74
   
$
26.22
   
$
19.93
   
$
18.86
   
$
14.91
   
$
11.16
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.12
)
   
(0.31
)
   
(0.25
)
   
(0.19
)
   
(0.17
)
   
(0.11
)
Net realized and unrealized gain (loss) on investments
   
(12.34
)
   
5.83
     
7.03
     
1.41
     
4.26
     
3.86
 
Total from investment operations
   
(12.46
)
   
5.52
     
6.78
     
1.22
     
4.09
     
3.75
 
Dividends from net investment income
   
     
     
(0.19
)
   
     
     
 
Distributions from net realized gains
   
(1.80
)
   
     
(0.30
)
   
(0.15
)
   
(0.14
)
   
 
Net asset value, end of period
 
$
17.48
   
$
31.74
   
$
26.22
   
$
19.93
   
$
18.86
   
$
14.91
 
Total return(iii)


(40.96 )%

21.05 %

34.74 %

6.59 %

27.72 %

33.60 %
RATIOS/SUPPLEMENTAL DATA:
























Net assets, end of period (000’s omitted)

$ 276,127

$ 560,577

$ 566,606

$ 523,291

$ 300,066

$ 77,791
Ratio of gross expenses to average net assets


1.30 %

1.18 %

1.22 %

1.19 %

1.18 %

1.22 %
Ratio of expense reimbursements to average net assets

















(0.02 )%
Ratio of net expenses to average net assets


1.30 %

1.18 %

1.22 %

1.19 %

1.18 %

1.20 %
Ratio of net investment loss to average net assets


 (1.03 )%

(0.98 )%

(1.11 )%

(0.95 )%

(0.92 )%

(0.86 )%
Portfolio turnover rate


20.46 %

56.71 %

37.49 %

48.84 %

27.04 %

44.56 %

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.

- 143 -

Table of Contents
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Focus Fund

Class C
 



Six months ended 4/30/2022(i)


Year ended 10/31/2021


Year ended 10/31/2020


Year ended 10/31/2019


Year ended 10/31/2018


Year ended 10/31/2017  
Net asset value, beginning of period
 
$
28.12
   
$
23.40
   
$
17.85
   
$
17.04
   
$
13.58
   
$
10.25
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.17
)
   
(0.47
)
   
(0.37
)
   
(0.31
)
   
(0.27
)
   
(0.20
)
Net realized and unrealized gain (loss) on investments
   
(10.86
)
   
5.19
     
6.30
     
1.27
     
3.87
     
3.53
 
Total from investment operations
   
(11.03
)
   
4.72
     
5.93
     
0.96
     
3.60
     
3.33
 
Dividends from net investment income
   
     
     
(0.08
)
   
     
     
 
Distributions from net realized gains
   
(1.80
)
   
     
(0.30
)
   
(0.15
)
   
(0.14
)
   
 
Net asset value, end of period
 
$
15.29
   
$
28.12
   
$
23.40
   
$
17.85
   
$
17.04
   
$
13.58
 
Total return(iii)


(41.15 )%

20.17 %

33.85 %

5.76 %

26.82 %

32.49 %
RATIOS/SUPPLEMENTAL DATA:
























Net assets, end of period (000’s omitted)

$ 132,930

$ 267,800

$ 248,577

$ 212,737

$ 131,655

$ 48,345
Ratio of gross expenses to average net assets


1.94 %

1.90 %

1.94 %

1.95 %

1.94 %

1.97 %
Ratio of expense reimbursements to average net assets

















(0.02
)%
Ratio of net expenses to average net assets


1.94 %

1.90 %

1.94 %

1.95 %

1.94 %

1.95 %
Ratio of net investment loss to average net assets


 (1.67 )%

(1.70 )%

(1.83 )%

(1.71 )%

(1.66 )%

(1.61 )%
Portfolio turnover rate


20.46 %

56.71 %

37.49 %

48.84 %

27.04 %

44.56  %

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Focus Fund

Class I
 



Six months ended 4/30/2022(i)


Year ended 10/31/2021


Year ended 10/31/2020


Year ended 10/31/2019


Year ended 10/31/2018


Year ended 10/31/2017  
Net asset value, beginning of period
 
$
32.61
   
$
26.93
   
$
20.44
   
$
19.34
   
$
15.28
   
$
11.44
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.11
)
   
(0.31
)
   
(0.24
)
   
(0.19
)
   
(0.17
)
   
(0.11
)
Net realized and unrealized gain (loss) on investments
   
(12.69
)
   
5.99
     
7.22
     
1.44
     
4.37
     
3.95
 
Total from investment operations
   
(12.80
)
   
5.68
     
6.98
     
1.25
     
4.20
     
3.84
 
Dividends from net investment income
   
     
     
(0.19
)
   
     
     
 
Distributions from net realized gains
   
(1.80
)
   
     
(0.30
)
   
(0.15
)
   
(0.14
)
   
 
Net asset value, end of period
 
$
18.01
   
$
32.61
   
$
26.93
   
$
20.44
   
$
19.34
   
$
15.28
 
Total return(iii)
   
(40.93
)%
   
21.09
%
   
34.86
%
   
6.58
%
   
27.77
%
   
33.57
%
RATIOS/SUPPLEMENTAL DATA:
























Net assets, end of period (000’s omitted)

$
177,353

$ 421,986

$ 360,756

$ 455,937

$ 340,636

$ 109,146
Ratio of gross expenses to average net assets


1.20 %

1.14 %

1.15 %

1.18 %

1.17 %

1.21 %
Ratio of expense reimbursements to average net assets

















(0.01 )%
Ratio of net expenses to average net assets


1.20 %

1.14 %

1.15 %

1.18 %

1.17 %

1.20 %
Ratio of net investment loss to average net assets


(0.95 )%

(0.95 )%

(1.04 )%

(0.93 )%

(0.90 )%

(0.80 )%
Portfolio turnover rate
 
20.46 %

56.71 %

37.49 %

48.84 %

27.04 %

44.56 %

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Focus Fund
 
Class Y
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
From 3/1/2017
(commencement
of operations) to
10/31/2017(ii)
 
Net asset value, beginning of period
 
$
33.29
   
$
27.41
   
$
20.79
   
$
19.60
   
$
15.44
   
$
12.93
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(iii)
   
(0.07
)
   
(0.21
)
   
(0.18
)
   
(0.14
)
   
(0.12
)
   
(0.08
)
Net realized and unrealized gain (loss) on investments
   
(12.98
)
   
6.09
     
7.36
     
1.48
     
4.42
     
2.59
 
Total from investment operations
   
(13.05
)
   
5.88
     
7.18
     
1.34
     
4.30
     
2.51
 
Dividends from net investment income
   
     
     
(0.26
)
   
     
     
 
Distributions from net realized gains
   
(1.80
)
   
     
(0.30
)
   
(0.15
)
   
(0.14
)
   
 
Net asset value, end of period
 
$
18.44
   
$
33.29
   
$
27.41
   
$
20.79
   
$
19.60
   
$
15.44
 
Total return(iv)
   
(40.81
)%
   
21.45
%
   
35.32
%
   
6.96
%
   
28.13
%
   
19.41
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
267,292
    $ 394,801     $ 266,570     $ 94,694     $ 25,691       3,279
 
Ratio of gross expenses to average net assets
   
0.84
%     0.83 %     0.84 %     0.87 %     0.88 %     1.51 %
Ratio of expense reimbursements to average net assets
    -
      -
      - (v)      (0.02 )%     -
      (0.61 )%
Ratio of net expenses to average net assets
    0.84 %     0.83 %     0.84 %     0.85 %     0.88 %     0.90 %
Ratio of net investment loss to average net assets
   
(0.54
)%     (0.65 )%     (0.74 )%     (0.64 )%     (0.63 )%     (0.83 )%
Portfolio turnover rate
    20.46 %     56.71 %     37.49 %     48.84 %     27.04 %     44.56 %
 
See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Ratios have been annualized; total return has not been annualized; portfolio turnover is for the twelve months then ended.
(iii)
Amount was computed based on average shares outstanding during the period.
(iv)
Does not reflect the effect of sales charges, if applicable.
(v)
Amount was more than (0.005)% per share.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Small Cap Focus Fund
   
Class Z
 
     
Six months
ended
4/30/2022(i)
     
Year ended
10/31/2021
     
Year ended
10/31/2020
     
Year ended
10/31/2019
     
Year ended
10/31/2018
     
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
33.29
   
$
27.41
   
$
20.79
   
$
19.60
   
$
15.44
   
$
11.53
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.07
)
   
(0.21
)
   
(0.18
)
   
(0.13
)
   
(0.12
)
   
(0.08
)
Net realized and unrealized gain (loss) on investments
   
(12.98
)
   
6.09
     
7.36
     
1.47
     
4.42
     
3.99
 
Total from investment operations
   
(13.05
)
   
5.88
     
7.18
     
1.34
     
4.30
     
3.91
 
Dividends from net investment income
   
     
     
(0.26
)
   
     
     
 
Distributions from net realized gains
   
(1.80
)
   
     
(0.30
)
   
(0.15
)
   
(0.14
)
   
 
Net asset value, end of period
 
$
18.44
   
$
33.29
   
$
27.41
   
$
20.79
   
$
19.60
   
$
15.44
 
Total return(iii)
   
(40.81
)%
   
21.45
%
   
35.30
%
   
6.96
%
   
28.13
%
   
33.91
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
2,883,200
   
$
$ 6,195,714
   
$
4,499,832
   
$
2,459,793
   
$
1,329,712
   
$
350,097
 
Ratio of gross expenses to average net assets
   
0.83
%
   
0.83
%
   
0.85
%
   
0.86
%
   
0.87
%
   
0.90
%
Ratio of net expenses to average net assets
   
0.83
%
   
0.83
%
   
0.85
%
   
0.86
%
   
0.87
%
   
0.90
%
Ratio of net investment loss to average net assets
   
(0.57
)%
   
(0.65
)%
   
(0.74
)%
   
(0.62
)%
   
(0.61
)%
   
(0.58
)%
Portfolio turnover rate
   
20.46
%
   
56.71
%
   
37.49
%
   
48.84
%
   
27.04
%
   
44.56
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.

- 147 -

Table of Contents
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Alger International Focus Fund
 
Class A
 
   
Six months
ended 4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
    Year ended 10/31/2018
    Year ended 10/31/2017
 
Net asset value, beginning of period
 
$
25.12
   
$
18.67    
$
15.51    
$
14.30    
$
17.58    
$
14.58
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.07
)
   
(0.11
)
   
(0.06
)
   
(0.02
)
   
(0.06
)
   
0.13
 
Net realized and unrealized gain (loss) on investments
   
(5.78
)
    6.56       3.91       1.66      
(2.46
)
    3.11  
Total from investment operations
   
(5.85
)
   
6.45
     
3.85
     
1.64
     
(2.40
)
    3.24  
Dividends from net investment income
   
     
     
(0.69
)
   
(0.43
)
   
(0.88
)
   
(0.24
)
Distributions from net realized gains
   
(1.97
)
   
     
     
     
     
 
Net asset value, end of period
 
$
17.30    
$
25.12    
$
18.67    
$
15.51    
$
14.30    
$
17.58  
Total return(iii)
   
(25.33
)%
 
34.87
%(iv)    
25.69
%
   
11.99
%
   
(14.35
)%
    22.63
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
  $ 115,194    
$
158,223    
$
120,832    
$
100,814    
$
98,105       119,477  
Ratio of gross expenses to average net assets
   
1.24
%     1.22 %     1.34
%     1.37 %     1.29 %     1.34 %
Ratio of net expenses to average net assets
    1.24 %     1.22 %     1.34 %     1.37 %     1.29
%
    1.34 %
Ratio of net investment income (loss) average net assets
    (0.71 )%     (0.49 )%     (0.37 )%     (0.11 )%     0.38 %     0.83 %
Portfolio turnover rate
    26.06 %     75.27 %     105.22 %     151.99 %     207.22 %     148.35 %

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger International Focus Fund received a Fair Fund distribution of $159,091, which contributed approximately 0.11% to its annual return.

- 148 -

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger International Focus Fund
 
Class B
 


Six months ended 4/30/2022(i)


Year ended
10/31/2021


Year ended
10/31/2020


Year ended
10/31/2019


Year ended 10/31/2018

Year ended 10/31/2017  
Net asset value, beginning of period

$
21.81


$
16.19


$
13.44


$
12.38


$
15.35


$
12.76
 
INCOME FROM INVESTMENT OPERATIONS:
 





















 
Net investment income (loss)(ii)
   
(0.07
)
   
(0.08
)
   
(0.02
)
   
(0.04
)
   
(0.06
)
   
0.02
 
Net realized and unrealized gain (loss) on investments
   
(4.96
)
   
5.70
     
3.38
     
1.44
     
(2.13
)
   
2.73
 
Total from investment operations
   
(5.03
)
   
5.62
     
3.36
     
1.40
     
(2.19
)
   
2.75
 
Dividends from net investment income
   
     
     
(0.61
)
   
(0.34
)
   
(0.78
)
   
(0.16
)
Distributions from net realized gains
   
(1.97
)
   
     
     
     
     
 
Net asset value, end of period
 
$
14.81
   
$
21.81
   
$
16.19
   
$
13.44
   
$
12.38
   
$
15.35
 
Total return(iii)


 (25.33 )%

35.02 %(iv)

25.83 %

11.82 %

(15.00 )%

21.71 %
RATIOS/SUPPLEMENTAL DATA:























 
Net assets, end of period (000’s omitted)

$ 15,440

$ 22,147

$ 18,427

$ 17,646

$ 17,639

$ 24,777  
Ratio of gross expenses to average net assets


1.95 %

1.94 %

 2.05 %

2.09 %

2.01 %

2.05 %
Ratio of expense reimbursements to average net assets


(0.69 )%

(0.82 )%

(0.88 )%

 (0.51 )%




 
Ratio of net expenses to average net assets


1.26 %

1.12 %

1.17 %

1.58 %

2.01 %

2.05 %
Ratio of net investment income (loss) to average net assets


(0.73 )%

(0.39 )%

(0.18 )%

(0.30 )%

(0.40 )%

0.13 %
Portfolio turnover rate


26.06 %

75.27 %

105.22 %

151.99 %

207.22 %

148.35 %

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger International Focus Fund received a Fair Fund distribution of $159,091, which contributed approximately 0.11% to its annual return.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger International Focus Fund

Class C
 


Six months ended 4/30/2022(i)

Year ended
10/31/2021


Year ended
10/31/2020


Year ended
10/31/2019


Year ended
10/31/2018


Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
20.94
   
$
15.68
   
$
13.11
   
$
12.07
   
$
14.98
   
$
12.44
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.13
)
   
(0.24
)
   
(0.15
)
   
(0.12
)
   
(0.06
)
   
0.01
 
Net realized and unrealized gain (loss) on investments
   
(4.73
)
   
5.50
     
3.29
     
1.41
     
(2.09
)
   
2.66
 
Total from investment operations
   
(4.86
)
   
5.26
     
3.14
     
1.29
     
(2.15
)
   
2.67
 
Dividends from net investment income
   
     
     
(0.57
)
   
(0.25
)
   
(0.76
)
   
(0.13
)
Distributions from net realized gains
   
(1.97
)
   
     
     
     
     
 
Net asset value, end of period
 
$
14.11
   
$
20.94
   
$
15.68
   
$
13.11
   
$
12.07
   
$
14.98
 
Total return(iii)


 (25.65 )%

33.86 %(iv)

24.68 %

11.07 %

(15.08 )%

21.70 %
RATIOS/SUPPLEMENTAL DATA:























 
Net assets, end of period (000’s omitted)

$ 2,362

$ 4,368

$ 2,760

$ 3,603

$ 4,712

$ 12,130  
Ratio of gross expenses to average net assets


2.03 %

1.97 %

2.13 %

2.23 %

2.09 %

2.13 %
Ratio of net expenses to average net assets


2.03 %

1.97 %

2.13 %

2.23 %

2.09 %

2.13 %
Ratio of net investment income (loss) to average net assets


(1.53 )%

(1.23 )%

(1.13 )%

(0.99 )%

(0.41 )%

0.06 %
Portfolio turnover rate


26.06 %

75.27 %

105.22 %

151.99 %

207.22 %

148.35 %

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger International Focus Fund received a Fair Fund distribution of $159,091, which contributed approximately 0.11% to its annual return.

- 150 -

Table of Contents
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger International Focus Fund
 
Class I
 

 
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
25.20
   
$
18.72
   
$
15.54
   
$
14.31
   
$
17.54
   
$
14.55
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.06
)
   
(0.10
)
   
(0.02
)
   
0.01
     
0.09
     
0.17
 
Net realized and unrealized gain (loss) on investments
   
(5.82
)
   
6.58
     
3.93
     
1.67
     
(2.48
)
   
3.09
 
Total from investment operations
   
(5.88
)
   
6.48
     
3.91
     
1.68
     
(2.39
)
   
3.26
 
Dividends from net investment income
   
     
     
(0.73
)
   
(0.45
)
   
(0.84
)
   
(0.27
)
Distributions from net realized gains
   
(1.97
)
   
     
     
     
     
 
Net asset value, end of period
 
$
17.35
   
$
25.20
   
$
18.72
   
$
15.54
   
$
14.31
   
$
17.54
 
Total return(iii)
   
(25.37
)%
 
34.94
%(iv)    
25.98
%
   
12.41
%
   
(14.27
)%
   
22.84
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
1,284
   
$
591
   
$
642
   
$
970
   
$
2,156
   
$
1,742
 
Ratio of gross expenses to average net assets
   
1.24
%
   
1.24
%
   
1.34
%
   
1.48
%
   
1.19
%
   
1.48
%
Ratio of expense reimbursements to average net assets
   
     
(0.05
)%
   
(0.27
)%
   
(0.36
)%
   
(0.04
)%
   
(0.33
)%
Ratio of net expenses to average net assets
   
1.24
%
   
1.19
%
   
1.07
%
   
1.12
%
   
1.15
%
   
1.15
%
Ratio of net investment income (loss) to average net assets
   
(0.63
)%
   
(0.45
)%
   
(0.10
)%
   
0.06
%
   
0.51
%
   
1.14
%
Portfolio turnover rate
   
26.06
%
   
75.27
%
   
105.22
%
   
151.99
%
   
207.22
%
   
148.35
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger International Focus Fund received a Fair Fund distribution of $159,091, which contributed approximately 0.11% to its annual return.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger International Focus Fund
 
Class Z
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
25.52
   
$
18.90
   
$
15.69
   
$
14.46
   
$
17.77
   
$
14.74
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.04
)
   
(0.03
)
 
(iii)
     
0.05
     
0.12
     
0.20
 
Net realized and unrealized gain (loss) on investments
   
(5.88
)
   
6.65
     
3.98
     
1.67
     
(2.48
)
   
3.14
 
Total from investment operations
   
(5.92
)
   
6.62
     
3.98
     
1.72
     
(2.36
)
   
3.34
 
Dividends from net investment income
   
     
     
(0.77
)
   
(0.49
)
   
(0.95
)
   
(0.31
)
Distributions from net realized gains
   
(1.97
)
   
     
     
     
     
 
Net asset value, end of period
 
$
17.63
   
$
25.52
   
$
18.90
   
$
15.69
   
$
14.46
   
$
17.77
 
Total return(iv)

     (25.20)
%    
35.34
%(v)
   
26.23
%
   
12.64
%
   
(14.03
)%
   
23.16
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
19,996
   
$
28,264
   
$
12,621
   
$
13,462
   
$
14,597
   
$
21,317
 
Ratio of gross expenses to average net assets
   
0.94
%
   
0.92
%
   
1.02
%
   
1.10
%
   
1.01
%
   
1.03
%
Ratio of expense reimbursements to average net assets
   
(0.06
)%
   
(0.03
)%
   
(0.13
)%
   
(0.21
)%
   
(0.12
)%
   
(0.14
)%
Ratio of net expenses to average net assets
   
0.88
%
   
0.89
%
   
0.89
%
   
0.89
%
   
0.89
%
   
0.89
%
Ratio of net investment income (loss) to average net assets
   
(0.36
)%
   
(0.13
)%
   
0.01
%
   
0.36
%
   
0.71
%
   
1.27
%
Portfolio turnover rate
   
26.06
%
   
75.27
%
   
105.22
%
   
151.99
%
   
207.22
%
   
148.35
%

See Notes to Financial Statements.

(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Amount was less than $0.005 per share.
(iv)
Does not reflect the effect of sales charges, if applicable.
(v)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger International Focus Fund received a Fair Fund distribution of $159,091, which contributed approximately 0.11% to its annual return.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Health Sciences Fund
 
Class A
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
36.66
   
$
31.75
   
$
26.55
   
$
28.04
   
$
25.16
   
$
16.01
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.06
)
   
(0.21
)
   
(0.09
)
   
(0.09
)
   
(0.19
)
   
(0.19
)
Net realized and unrealized gain (loss) on investments
   
(9.06
)
   
8.87
     
7.20
     
0.48
     
3.82
     
9.34
 
Total from investment operations
   
(9.12
)
   
8.66
     
7.11
     
0.39
     
3.63
     
9.15
 
Distributions from net realized gains
   
(7.00
)
   
(3.75
)
   
(1.91
)
   
(1.88
)
   
(0.75
)
   
 
Net asset value, end of period
 
$
20.54
   
$
36.66
   
$
31.75
   
$
26.55
   
$
28.04
   
$
25.16
 
Total return(iii)
   
(28.50
)%
 
29.12%(iv)
     
28.09
%
   
1.96
%
   
14.92
%
   
57.15
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
96,939
   
$
151,514
   
$
127,925
   
$
108,095
   
$
131,731
   
$
95,913
 
Ratio of gross expenses to average net assets
   
1.02
%
   
1.00
%
   
1.04
%
   
1.12
%
   
1.15
%
   
1.38
%
Ratio of net expenses to average net assets
   
1.02
%
   
1.00
%
   
1.04
%
   
1.12
%
   
1.15
%
   
1.38
%
Ratio of net investment loss to average net assets
   
(0.45
)%
   
(0.63
)%
   
(0.30
)%
   
(0.34
)%
   
(0.68
)%
   
(0.86
)%
Portfolio turnover rate
   
133.90
%
   
152.78
%
   
131.29
%
   
148.78
%
   
89.73
%
   
106.66
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Health Sciences Fund received a Fair Fund distribution of $179,832, which contributed approximately 0.07% to its annual return.
 
THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

 
Alger Health Sciences Fund
 
Class C
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
 
 
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
26.11
   
$
23.74
   
$
20.44
   
$
22.21
   
$
20.23
   
$
12.98
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment loss(ii)
   
(0.10
)
   
(0.34
)
   
(0.23
)
   
(0.23
)
   
(0.31
)
   
(0.28
)
Net realized and unrealized gain (loss) on investments
   
(6.08
)
   
6.46
     
5.44
     
0.34
     
3.04
     
7.53
 
Total from investment operations
   
(6.18
)
   
6.12
     
5.21
     
0.11
     
2.73
     
7.25
 
Distributions from net realized gains
   
(7.00
)
   
(3.75
)
   
(1.91
)
   
(1.88
)
   
(0.75
)
   
 
Net asset value, end of period
 
$
12.93
   
$
26.11
   
$
23.74
   
$
20.44
   
$
22.21
   
$
20.23
 
Total return(iii)
   
(28.78
)%
 
28.11%(iv)
     
27.12
%
   
1.20
%
   
14.03
%
   
55.86
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
8,495
   
$
14,334
   
$
11,862
   
$
10,963
   
$
15,322
   
$
31,148
 
Ratio of gross expenses to average net assets
   
1.82
%
   
1.76
%
   
1.81
%
   
1.89
%
   
1.93
%
   
2.15
%
Ratio of net expenses to average net assets
   
1.82
%
   
1.76
%
   
1.81
%
   
1.89
%
   
1.93
%
   
2.15
%
Ratio of net investment loss to average net assets
   
(1.25
)%
   
(1.39
)%
   
(1.07
)%
   
(1.12
)%
   
(1.46
)%
   
(1.63
)%
Portfolio turnover rate
   
133.90
%
   
152.78
%
   
131.29
%
   
148.78
%
   
89.73
%
   
106.66
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Does not reflect the effect of sales charges, if applicable.
(iv)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Health Sciences Fund received a Fair Fund distribution of $179,832, which contributed approximately 0.07% to its annual return.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)


Alger Health Sciences Fund
 
Class Z
 
   
Six months
ended
4/30/2022(i)
   
Year ended
10/31/2021
   
Year ended
10/31/2020
   
Year ended
10/31/2019
   
Year ended
10/31/2018
   
Year ended
10/31/2017
 
Net asset value, beginning of period
 
$
37.09
   
$
31.99
   
$
26.69
   
$
28.09
   
$
25.11
   
$
15.92
 
INCOME FROM INVESTMENT OPERATIONS:
                                               
Net investment income (loss)(ii)
   
(0.02
)
   
(0.11
)
 
(iii)

   
0.01
     
(0.09
)
   
(0.11
)
Net realized and unrealized gain (loss) on investments
   
(9.19
)
   
8.96
     
7.25
     
0.47
     
3.82
     
9.30
 
Total from investment operations
   
(9.21
)
   
8.85
     
7.25
     
0.48
     
3.73
     
9.19
 
Dividends from net investment income
   
     
     
(0.04
)
   
     
     
 
Distributions from net realized gains
   
(7.00
)
   
(3.75
)
   
(1.91
)
   
(1.88
)
   
(0.75
)
   
 
Net asset value, end of period
 
$
20.88
   
$
37.09
   
$
31.99
   
$
26.69
   
$
28.09
   
$
25.11
 
Total return(iv)
   
(28.39
)%
   
29.53
%(v)
   
28.50
%
   
2.34
%
   
15.32
%
   
57.73
%
RATIOS/SUPPLEMENTAL DATA:
                                               
Net assets, end of period (000’s omitted)
 
$
96,789
   
$
184,972
   
$
131,109
   
$
77,023
   
$
57,640
   
$
25,644
 
Ratio of gross expenses to average net assets
   
0.70
%
   
0.68
%
   
0.71
%
   
0.79
%
   
0.84
%
   
1.12
%
Ratio of expense reimbursements to average net assets
   
     
     
     
(0.04
)%
   
(0.06
)%
   
(0.13
)%
Ratio of net expenses to average net assets
   
0.70
%
   
0.68
%
   
0.71
%
   
0.75
%
   
0.78
%
   
0.99
%
Ratio of net investment income (loss) to average net assets
   
(0.15
)%
   
(0.31
)%
   
(0.01
)%
   
0.02
%
   
(0.32
)%
   
(0.48
)%
Portfolio turnover rate
   
133.90
%
   
152.78
%
   
131.29
%
   
148.78
%
   
89.73
%
   
106.66
%

See Notes to Financial Statements.
 
(i)
Ratios have been annualized; total return and portfolio turnover rate have not been annualized.
(ii)
Amount was computed based on average shares outstanding during the period.
(iii)
Amount was less than $0.005 per share.
(iv)
Does not reflect the effect of sales charges, if applicable.
(v)
Pursuant to the U.S. Securities and Exchange Commission’s Rules on Fair Fund and Disgorgement Plans, the Alger Health Sciences Fund received a Fair Fund distribution of $179,832, which contributed approximately 0.07% to its annual return.
 
THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


NOTE 1 — General:


The Alger Funds (the “Trust”) is an open-end registered investment company organized as a business trust under the laws of the Commonwealth of Massachusetts. The Trust qualifies as an investment company as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 946 – Financial Services – Investment Companies. The Trust operates as a series company currently offering an unlimited number of shares of beneficial interest in eleven series — Alger Capital Appreciation Fund, Alger 35 Fund, Alger Growth & Income Fund, Alger Mid Cap Growth Fund, Alger Mid Cap Focus Fund, Alger Weatherbie Enduring Growth Fund, Alger Weatherbie Specialized Growth Fund, Alger Small Cap Growth Fund, Alger Small Cap Focus Fund, Alger International Focus Fund and Alger Health Sciences Fund (collectively, the “Funds” or individually, each a “Fund”). Alger Capital Appreciation Fund, Alger 35 Fund, Alger Mid Cap Growth Fund, Alger Mid Cap Focus Fund, Alger Weatherbie Enduring Growth Fund, Alger Weatherbie Specialized Growth Fund, Alger Small Cap Growth Fund, Alger Small Cap Focus Fund, Alger International Focus Fund and Alger Health Sciences Fund normally invest primarily in equity securities and each has an investment objective of long-term capital appreciation. Alger Growth & Income Fund also normally invests primarily in equity securities and has an investment objective of both capital appreciation and current income.
 
Each Fund offers one or more of the following share classes: Class A, B, C, I, Y and Z. Class A shares are generally subject to an initial sales charge while Class B and C shares are generally subject to a deferred sales charge. Class B shares will automatically convert to Class A shares eight years after the end of the calendar month in which the order to purchase was accepted. The conversion is completed without the imposition of any sales charges or other fees. Class C shares will automatically convert to Class A shares on the fifth business day of the month following the eighth anniversary of the purchase date of a shareholder’s Class C shares, without the imposition of any sales load, fee or other charge. Class C shares held at certain dealers may not convert to Class A shares or may be converted on a different schedule. At conversion, a proportionate amount of shares representing reinvested dividends and distributions will also be converted into Class A shares. Class I, Y and Z shares are sold to investors without an initial or deferred sales charge. Each class has identical rights to assets and earnings, except that each share class bears the pro rata allocation of the Fund’s expenses other than a class expense (not including advisory or custodial fees or other expenses related to the management of the Fund’s assets).
 
The Board of Trustees of the Trust (the “Board”) has authorized a partial closing of the Alger Small Cap Focus Fund effective July 31, 2019. Class A, C, I and Z shares are available for purchase by existing shareholders who maintain open accounts and new investors that utilize certain retirement record keeping platforms identified by Fred Alger & Company, LLC, the Fund’s distributor (the “Distributor” or “Alger LLC”). Class I shares are also available for purchase by investors who transact with certain brokers identified by the distributor. Class Y shares remain open to all qualifying investors and Class Y and Class Z Shares are generally subject to a minimum initial investment of $500,000.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


Class P-2 Shares of the Alger 35 Fund were converted to Class Z shares after the close of business on October 29, 2021.
 
Alger Weatherbie Enduring Growth Fund launched on December 17, 2021.

The Board approved a Plan of Reorganization dated as of February 11, 2021 (the “Plan”), adopted with respect to Alger 25 Fund and Alger 35 Fund. The Plan provides for the transfer of the Alger 25 Fund’s assets to the Alger 35 Fund in a tax-free exchange for shares of the Alger 35 Fund and the assumption by the Alger 35 Fund of the Alger 25 Fund’s stated liabilities, the distribution of such shares of the Alger 35 Fund to Alger 25 Fund shareholders and the subsequent termination of the Alger 25 Fund (the “Reorganization”). Because the Reorganization satisfies the requisite conditions of Rule 17a-8 under the Investment Company Act of 1940 (the “1940 Act”), as amended, in accordance with the Trust’s Amended and Restated Agreement and Declaration of Trust, and applicable Massachusetts state and U.S. federal law (including Rule 17a-8), the Reorganization may be effected without the approval of shareholders of either fund. The Reorganization became effective after the close of business on May 7, 2021.
 
After the close of business on May 7, 2021, the Alger 35 Fund acquired substantially all of the assets and liabilities of the Alger 25 Fund in exchange for Class P shares of the Alger 35 Fund, which were distributed to the Alger 25 Fund’s shareholders. Upon completion of the Reorganization, Class P shares were reclassified as Class Z shares. The investment portfolio of the Alger 25 Fund, with a fair value of $25,885,380 and identified cost of $17,519,227 as of the date of the Reorganization, was the principal asset acquired by the Alger 35 Fund. The acquisition was accomplished by a tax-free exchange of 1,536,300 shares of the Alger 25 Fund, valued at $26,249,571 for 1,429,347 shares of the Alger 35 Fund. The net assets of the Alger 25 Fund and the Alger 35 Fund immediately before the acquisition were $26,249,571 (including $8,366,153 of net unrealized appreciation) and $18,981,690, respectively. The combined net assets of the Alger 35 Fund immediately following the acquisition were $45,231,261. For financial reporting purposes, assets received and shares issued by the Alger 35 Fund were recorded at fair value; however the cost basis of the investments received from the Alger 25 Fund was carried forward to align ongoing reporting of the Alger 35 Fund’s realized and unrealized gains and losses with amounts distributable to shareholders for tax purposes.
 
Fred Alger Management, LLC (“Alger Management” or the “Investment Manager”) and/ or its affiliates paid the expenses directly relating to the Reorganization. Assuming the acquisition had been completed on November 1, 2020, the Alger 35 Fund’s pro-forma results of operations for the year ended October 31, 2021, are as follows:
 
Net investment loss
 
$
(32,302
)
Net realized and unrealized gain on investments in securities
   
13,917,443
 
Net increase in net assets resulting from operations
 
$
13,885,141
 
Undistributed net investment loss
 
$
(115,723
)

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


Because the combined investment portfolios have been managed as a single integrated portfolio since the acquisition was completed, it is not practicable to separate the amounts of changes in revenue and earnings attributable to the Alger 25 Fund that have been included in the Alger 35 Fund’s Statement of Operations since May 7, 2021.
 
The Class Y shares of Alger Small Cap Growth Fund launched on December 31, 2021.
 
NOTE 2 - Significant Accounting Policies:


(a) Investment Valuation: The Funds value their financial instruments at fair value using independent dealers or pricing services under policies approved by the Board. Investments held by the Funds are valued on each day the New York Stock Exchange (the “NYSE”) is open, as of the close of the NYSE (normally 4:00 p.m. Eastern Time).
 
Investments in money market funds and short-term securities held by the Funds having a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.
 
Equity securities, including traded rights, warrants and option contracts for which valuation information is readily available, are valued at the last quoted sales price or official closing price on the primary market or exchange on which they are traded as reported by an independent pricing service. In the absence of quoted sales, such securities are valued at the bid price or, in the absence of a recent bid price, the equivalent as obtained from one or more of the major market makers for the securities to be valued.
 
Debt securities generally trade in the over-the-counter market. Debt securities with remaining maturities of more than sixty days at the time of acquisition are valued on the basis of the last available bid prices or current market quotations provided by dealers or pricing services. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrixes, market transactions in comparable investments, various relationships observed in the market between investments and calculated yield measures based on valuation technology commonly employed in the market for such investments. Asset-backed and mortgage-backed securities are valued by independent pricing services using models that consider estimated cash flows of each tranche of the security, establish a benchmark yield and develop an estimated tranche-specific spread to the benchmark yield based on the unique attributes of the tranche. Debt securities with a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.
 
Securities for which market quotations are not readily available are valued at fair value, as determined in good faith pursuant to procedures established by the Board and described further herein.
 
Securities in which the Funds invest may be traded in foreign markets that close before the close of the NYSE. Developments that occur between the close of the foreign markets and the close of the NYSE may result in adjustments to the closing foreign prices to reflect what the Trust’s investment adviser, pursuant to policies established by the Board, believes to be the fair value of these securities as of the close of the NYSE. The Funds may also fair value securities in other situations, for example, when a particular foreign market is closed but the Funds are open.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
FASB Accounting Standards Codification 820 - Fair Value Measurements and Disclosures (“ASC 820”) defines fair value as the price that the Funds would receive upon selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability and may be observable or unobservable. Observable inputs are based on market data obtained from sources independent of the Funds. Unobservable inputs are inputs that reflect the Funds’ own assumptions based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad Levels listed below.

 
Level 1 - quoted prices in active markets for identical investments

 
Level 2 - significant other observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
 
 
Level 3 - significant unobservable inputs (including the Funds’ own assumptions in determining the fair value of investments)
 
The Funds’ valuation techniques are generally consistent with either the market or the income approach to fair value. The market approach considers prices and other relevant information generated by market transactions involving identical or comparable assets to measure fair value. The income approach converts future amounts to a current, or discounted, single amount. These fair value measurements are determined on the basis of the value indicated by current market expectations about such future events. Inputs for Level 1 include exchange-listed prices and broker quotes in an active market. Inputs for Level 2 include the last trade price in the case of a halted security, an exchange-listed price which has been adjusted for fair value factors, and prices of closely related securities. Additional Level 2 inputs include an evaluated price which is based upon a compilation of observable market information such as spreads for fixed income and preferred securities. Inputs for Level 3 include, but are not limited to, revenue multiples, earnings before interest, taxes, depreciation and amortization (“EBITDA”) multiples, discount rates, time to exit and the probabilities of success of certain outcomes. Such unobservable market information may be obtained from a company’s financial statements and from industry studies, market data, and market indicators such as benchmarks and indexes. Because of the inherent uncertainty and often limited markets for restricted securities, the valuations assigned to such securities by the Funds may significantly differ from the valuations that would have been assigned by the Funds had there been an active market for such securities.
 
Valuation processes are determined by a Valuation Committee (“Committee”) authorized by the Board and comprised of representatives of the Trust’s investment adviser and officers of the Trust. The Committee reports its fair value determinations and related valuation information to the Board. The Board is responsible for approving the valuation policy and procedures.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


While Committee meetings are held on an as-needed basis, the Committee generally meets quarterly to review and evaluate the effectiveness of the procedures for making fair value determinations. The Committee considers, among other things, the results of quarterly back testing of the fair value model for foreign securities, pricing comparisons between primary and secondary price sources, the outcome of price challenges put to the Funds’ pricing vendor, and variances between transactional prices and the previous day’s prices.
 
In December 2020, the Securities and Exchange Commission adopted Rule 2a-5 under the 1940 Act, which is intended to address valuation practices and the role of the board of directors with respect to the fair value of the investments of a registered investment company. Among other things, Rule 2a-5 will permit the Board to designate the Funds’ investment adviser, Alger Management, to perform the Funds’ fair value determinations, which will be subject to the Board’s oversight and certain reporting and other requirements intended to ensure that the Board receives the information it needs to oversee the Investment Manager’s fair value determinations. Compliance with Rule 2a-5 will not be required until September 2022. The Funds, the Board, and the Investment Manager are currently in the process of implementing the requirements of Rule 2a-5 for compliance with these requirements by the September 2022 compliance deadline.

(b) Cash and Cash Equivalents: Cash and cash equivalents include U.S. dollars, foreign cash and overnight time deposits.

(c) Securities Transactions and Investment Income: Securities transactions are recorded on a trade date basis. Realized gains and losses from securities transactions are recorded on the identified cost basis. Dividend income is recognized on the ex-dividend date and interest income is recognized on the accrual basis.
 
Premiums and discounts on debt securities purchased are amortized or accreted over the lives of the respective securities.

(d) Foreign Currency Transactions: The books and records of the Funds are maintained in U.S. dollars. Foreign currencies, investments and other assets and liabilities are translated into U.S. dollars at the prevailing rates of exchange on the valuation date. Purchases and sales of investment securities and income and expenses are translated into U.S. dollars at the prevailing exchange rates on the respective dates of such transactions.
 
Net realized gains and losses on foreign currency transactions represent net gains and losses from the disposition of foreign currencies, currency gains and losses realized between the trade dates and settlement dates of security transactions, and the difference between the amount of net investment income accrued and the U.S. dollar amount actually received. The effects of changes in foreign currency exchange rates on investments in securities are included in realized and unrealized gain or loss on investments in the accompanying Statements of Operations.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


(e) Forward Foreign Exchange Contracts: Certain Funds may enter into forward foreign currency contracts to hedge against foreign currency exchange rate risk on their non-U.S. dollar denominated securities or to facilitate settlement of foreign currency denominated portfolio transactions. A forward foreign currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date. The contract is marked-to-market daily and the change in value is recorded by a Fund as an unrealized gain or loss. Realized gains or losses equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed are recorded upon delivery or receipt of the currency.
 
These contracts may involve market risk in excess of the unrealized gain or loss reflected on the Statements of Assets and Liabilities. In addition, the Funds could be exposed to risk if the counterparties are unable to meet the terms of the contracts or if the value of the currency changes unfavorably to the base currency.

(f) Lending of Fund Securities: The Funds may lend their securities to financial institutions, provided that the market value of the securities loaned will not at any time exceed one third of a Fund’s total assets including borrowings, as defined in its prospectuses. The Funds earn fees on the securities loaned, which are included in interest income in the accompanying Statements of Operations. In order to protect against the risk of failure by the borrower to return the securities loaned or any delay in the delivery of such securities, the loan is collateralized by cash or securities that are maintained with Brown Brothers Harriman & Company, the Funds’ custodian (“BBH” or the “Custodian”), in an amount equal to at least 102 percent of the current market value of U.S. loaned securities or 105 percent for non-U.S. loaned securities. The market value of the loaned securities is determined at the close of business of the Funds. Any required additional collateral is delivered to the Custodian each day and any excess collateral is returned to the borrower on the next business day. In the event the borrower fails to return the loaned securities when due, the Funds may take the collateral to replace the securities. If the value of the collateral is less than the purchase cost of replacement securities, the Custodian shall be responsible for any shortfall, but only to the extent that the shortfall is not due to any diminution in collateral value, as defined in the securities lending agreement. The Funds are required to maintain the collateral in a segregated account and determine its value each day until the loaned securities are returned. Cash collateral may be invested as determined by the Funds. Collateral is returned to the borrower upon settlement of the loan. There were no securities loaned as of April 30, 2022.

(g) Dividends to Shareholders: Dividends and distributions payable to shareholders are recorded on the ex-dividend date. The Funds declare and pay dividends from net investment income, if available, annually except that Alger Growth & Income Fund declares and pays such dividends quarterly. With respect to all Funds, dividends from net realized gains, offset by any loss carryforward, are declared and paid annually after the end of the fiscal year in which earned.
 
Each share class is treated separately in determining the amount of dividends from net investment income payable to holders of its shares.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


The characterization of distributions to shareholders for financial reporting purposes is determined in accordance with federal income tax rules. Therefore, the source of a Fund’s distributions may be shown in the accompanying financial statements as either from, or in excess of, net investment income, net realized gain on investment transactions, or return of capital, depending on the type of book/tax differences that may exist. Capital accounts within the financial statements are adjusted for permanent book/tax differences. Reclassifications result primarily from the differences in tax treatment of net operating losses, passive foreign investment companies, and foreign currency transactions. The reclassifications are done annually at year-end and have no impact on the net asset values of the Funds and are designed to present each Fund’s capital accounts on a tax basis.

(h) Federal Income Taxes: It is each Fund’s policy to comply with the requirements of the Internal Revenue Code Subchapter M applicable to regulated investment companies and to distribute all of its taxable income to its shareholders. Provided that the Funds maintain such compliance, no federal income tax is required. Each Fund is treated as a separate entity for the purpose of determining such compliance.
 
FASB Accounting Standards Codification 740 - Income Taxes (“ASC 740”) requires the Funds to measure and recognize in their financial statements the benefit of a tax position taken (or expected to be taken) on an income tax return if such position will more likely than not be sustained upon examination based on the technical merits of the position. No tax years are currently under investigation. The Funds file income tax returns in the U.S. Federal jurisdiction, as well as the New York State and New York City jurisdictions. The statute of limitations on the Funds’ tax returns remains open for the tax years 2018-2021. Management does not believe there are any uncertain tax positions that require recognition of a tax liability.

(i) Allocation Methods: The Trust accounts separately for the assets, liabilities and operations of each Fund. Expenses directly attributable to each Fund are charged to that Fund’s operations; expenses which are applicable to all Funds are allocated among them based on net assets. Income, realized and unrealized gains and losses, and expenses of each Fund are allocated among the Fund’s classes based on relative net assets, with the exception of distribution fees, transfer agency fees, and shareholder servicing and related fees.

(j) Estimates: These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require using estimates and assumptions that affect the reported amounts therein. These unaudited interim financial statements reflect all adjustments that are, in the opinion of management, necessary to present a fair statement of results for the interim period. Actual results may differ from those estimates. All such estimates are of a normal recurring nature.
 
NOTE 3 - Investment Advisory Fees and Other Transactions with Affiliates:


(a) Investment Advisory Fees: Fees incurred by each Fund, pursuant to the provisions of the Trust’s Investment Advisory Agreement with the Investment Manager, are payable monthly and computed based on the following rates. The actual rate paid as a percentage of average daily net assets, for the six months ended April 30, 2022, is set forth below under the heading “Actual Rate”:
 
THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)



 
Tier 1
   
Tier 2
   
Tier 3
   
Tier 4
   
Tier 5
   
Actual Rate
 
Alger Capital Appreciation Fund(a)
   
0.81
%
   
0.65
%
   
0.60
%
   
0.55
%
   
0.45
%
   
0.76
%
Alger 35 Fund(b)
   
0.45
     
     
     
     
     
0.45
 
Alger Growth & Income Fund(b)
   
0.50
     
     
     
     
     
0.50
 
Alger Mid Cap Growth Fund(c)
   
0.76
     
0.70
     
     
     
     
0.76
 
Alger Mid Cap Focus Fund(d)
   
0.70
     
0.50
     
     
     
     
0.57
 
Alger Weatherbie Enduring Growth Fund(d)
   
0.70
     
0.50
     
     
     
     
0.70
 
Alger Weatherbie Specialized Growth Fund(c)
   
0.81
     
0.75
     
     
     
     
0.79
 
Alger Small Cap Growth Fund(c)
   
0.81
     
0.75
     
     
     
     
0.81
 
Alger Small Cap Focus Fund(b)
   
0.75
     
     
     
     
     
0.75
 
Alger International Focus Fund(c)
   
0.71
     
0.60
     
     
     
     
0.71
 
Alger Health Sciences Fund(b)
   
0.55
     
     
     
     
     
0.55
 

(a)
Tier 1 rate is paid on assets up to $2 billion, Tier 2 rate is paid on assets between $2 billion and $3 billion, Tier 3 rate is paid on assets between $3 billion and $4 billion, Tier 4 rate is paid on assets between $4 billion and $5 billion, and Tier 5 rate is paid on assets in excess of $5 billion.
(b)
Tier 1 rate is paid on all assets.
(c)
Tier 1 rate is paid on assets up to $1 billion and Tier 2 rate is paid on assets in excess of $1 billion.
(d)
Tier 1 rate is paid on assets up to $250 million, and Tier 2 rate is paid on assets in excess of $250 million.
 
The sub-advisor to the Alger Weatherbie Enduring Growth Fund and the Alger Weatherbie Specialized Growth Fund, Weatherbie Capital, LLC (“Weatherbie” or the “Sub-Advisor”), an affiliate of Alger Management, is paid a fee out of the advisory fee that Alger Management receives at no additional cost to the Alger Weatherbie Enduring Growth Fund and the Alger Weatherbie Specialized Growth Fund. The sub-advisory fee is equal to 70% of the net management fee paid by each of Alger Weatherbie Enduring Growth Fund and the Alger Weatherbie Specialized Growth Fund to Alger Management with respect to the sub-advised assets. For the six months ended April 30, 2022, Alger Management paid a sub-advisory fee of $0 and $3,721,513 for the Alger Weatherbie Enduring Growth Fund and Alger Weatherbie Specialized Growth Fund, respectively, to Weatherbie.
 
Alger Management has contractually agreed to waive fees or to reimburse Fund expenses (excluding acquired fund fees and expenses, dividend expense on short sales, borrowing costs, interest, taxes, brokerage and extraordinary expenses) for certain Funds through February 29, 2024 to the extent necessary to limit the total annual fund operating expenses exceed the rates, based on average daily net assets, as listed in the table below:

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


   
CLASS
   
FEES WAIVED /
REIMBURSED
FOR THE SIX
MONTHS ENDED
 
      A

    C

    I

    Y

    Z

  APRIL 30, 2022  
Alger Capital Appreciation Fund
   
     
     
     
     
0.85
%
  $  
Alger Mid Cap Growth Fund
   
     
     
     
     
0.99
      44,286  
Alger Mid Cap Focus Fund
   
1.15
%
   
1.90
%
    1.20 %    
0.69
%
   
0.99
     
 
Alger Weatherbie Enduring Growth Fund
   
1.15
(a)
   
1.85
(a)
    1.10 (a)    
0.70
(a)
   
0.75
(a)
   
67,472
 
Alger Weatherbie Specialized Growth Fund
   
     
           
0.87
     
     
7,565
 
Alger Small Cap Growth Fund
   
     

           
0.84
(b)
   
0.99
     
13,736
 
Alger Small Cap Focus Fund
   
     

           
0.85
     
     
 
Alger International Focus Fund
   
     
      1.25      
     
0.84
(c)
   
72,639
 
Alger Health Sciences Fund
   
     
           
     
0.75
     
 

(a)
Effective December 17, 2021, inception of the Fund.
(b)
Effective December 31, 2021, inception of the Class.
(c)
Prior to March 1, 2022, the expense cap for Alger International Focus Fund, Class Z, was 0.89%.

Alger Management may, during the term of the contract, recoup any fees waived or expenses reimbursed pursuant to the contract; however, a Fund will only make repayments to the Investment Manager if such repayment does not cause a Fund’s expense ratio after the repayment is taken into account, to exceed both (i) the expense cap in place at the time such amounts were waived or reimbursed, and (ii) a Fund’s current expense cap. Such recoupment is limited to two years from the date the amount is initially waived or reimbursed. For the six months ended April 30, 2022, there were no recoupments made to the Investment Manager.
 
Alger Management has also agreed to limit expenses of the Class Z shares (formerly class P shares) of Alger 35 Fund, for the life of the Fund, whereby it reimburses expenses to the extent Fund operating expenses, excluding advisory fees, exceed 0.10%, based on average daily net assets. The expense reimbursement arrangement does not include interest, taxes, brokerage, dividend expense on short sales, borrowing costs and extraordinary expenses. Fees waived for the Alger 35 Fund were $79,319 for the six months ended April 30, 2022.
 
In addition, Alger Management voluntarily reduced its 12b-1 fee effective April 1, 2019, for the Class B shares of the Alger Mid Cap Growth Fund, Alger Small Cap Growth Fund and Alger International Focus Fund by $44,286, $13,576 and $64,673, respectively, for the six months ended April 30, 2022.

(b) Administration Fees: Fees incurred by each Fund, pursuant to the provisions of the Trust’s Fund Administration Agreement with Alger Management, are payable monthly and computed based on the average daily net assets of each Fund at the annual rate of 0.0275%.

(c) Distribution Fees:
 
Class A Shares: The Trust has adopted a Plan of Distribution pursuant to which each Fund pays Alger LLC a fee at the annual rate of 0.25% of the respective average daily net assets of the Class A shares of the designated Fund to compensate Alger LLC for its activities and expenses incurred in distributing and/or administering the Class A shares and/or shareholder servicing. The fees paid may be more or less than the expenses incurred by Alger LLC.
 
THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Class B Shares: The Trust has adopted a Plan of Distribution pursuant to which Class B shares of each Fund issuing such shares reimburse Alger LLC for costs and expenses incurred by Alger LLC in connection with advertising, marketing and selling the Class B shares, and shareholder servicing, not to exceed an annual rate of 1% of the respective average daily net assets of the Class B shares of the designated Fund. If in any month, the costs incurred by Alger LLC relating to the Class B shares are in excess of the distribution fees charged to the Class B shares of the Fund, the excess may be carried forward, with interest, and sought to be reimbursed in future periods. As of April 30, 2022, such excess carried forward was $12,171,385, $19,194,754 and $18,967,813 for Class B shares of Alger Mid Cap Growth Fund, Alger Small Cap Growth Fund and Alger International Focus Fund, respectively. Contingent deferred sales charges imposed on redemptions of Class B shares will reduce the amount of distribution expenses for which reimbursement may be sought. See Note 3(d) below.
 
Class C Shares: The Trust has adopted a Distribution Plan pursuant to which Class C shares of each Fund pays Alger LLC a fee at the annual rate of 1% of the respective average daily net assets of the Class C shares of the designated Fund to compensate Alger LLC for its activities and expenses incurred in distributing the Class C shares and/or shareholder servicing. Fees paid may be more or less than the expenses incurred by Alger LLC.
 
Class I Shares: The Trust has adopted a Distribution Plan pursuant to which Class I shares of each Fund issuing such shares pays Alger LLC a fee at the annual rate of 0.25% of the average daily net assets of the Fund’s Class I shares to compensate Alger LLC for its activities and expenses incurred in distributing the Class I shares and/or shareholder servicing. Fees paid may be more or less than the expenses incurred by Alger LLC.

(d) Sales Charges: Sales of shares of the Funds may be subject to contingent deferred sales charges. The contingent deferred sales charges are used by Alger LLC to offset distribution expenses previously incurred. Sales charges do not represent expenses of the Trust. For the six months ended April 30, 2022, contingent deferred sales charges imposed, all of which were retained by Alger LLC, were as follows:
 
   
CONTINGENT
DEFERRED SALES
CHARGES
 
Alger Capital Appreciation Fund
 
$
8,598
 
Alger Growth & Income Fund
   
2,015
 
Alger Mid Cap Growth Fund
   
1,007
 
Alger Mid Cap Focus Fund
   
321
 
Alger Weatherbie Specialized Growth Fund
   
10,961
 
Alger Small Cap Growth Fund
   
10,324
 
Alger Small Cap Focus Fund
   
7,725
 
Alger International Focus Fund
   
683
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


 
CONTINGENT
DEFERRED SALES
CHARGES
 
 Alger Health Sciences Fund
    869  

(e) Brokerage Commissions: During the six months ended April 30, 2022, Alger Capital Appreciation Fund, Alger 35 Fund, Alger Growth & Income Fund, Alger Mid Cap Growth Fund, Alger Mid Cap Focus Fund, Alger Small Cap Growth Fund, Alger Small Cap Focus Fund, Alger International Focus Fund and Alger Health Sciences Fund paid Alger LLC, $153,577, $2,737, $125, $63,541, $158,152, $11,775, $243,942, $300 and $80,715, respectively, in connection with securities transactions.

(f) Shareholder Administrative Fees: The Trust has entered into a Shareholder Administrative Services Agreement with Alger Management to compensate Alger Management for liaising with, and providing administrative oversight of, the Trust’s transfer agent, and for other related services. The Funds compensate Alger Management at the annual rate of 0.0165% of their respective average daily net assets for the Class A, Class B and Class C shares and 0.01% of their respective average daily net assets for the Class I, Class Y and Class Z shares for these services.
 
Alger Management makes payments to intermediaries that provide sub-accounting services to omnibus accounts invested in the Funds. A portion of the fees paid by Alger Management to intermediaries that provide sub-accounting services are charged back to the appropriate Fund, subject to certain limitations, as approved by the Board. For the six months ended April 30, 2022, Alger Management charged back to Alger Capital Appreciation Fund, Alger Growth & Income Fund, Alger Mid Cap Growth Fund, Alger Mid Cap Focus Fund, Alger Weatherbie Specialized Growth Fund, Alger Small Cap Growth Fund, Alger Small Cap Focus Fund, Alger International Focus Fund and Alger Health Sciences Fund, $482,651, $21,278, $30,066, $15,902, $109,360, $55,264, $537,921, $15,133 and $36,576, respectively, for these services, which are included in transfer agent fees in the accompanying Statements of Operations.

(g) Trustee Fees: Each trustee who is not an “interested person” of the Trust, as defined in the 1940 Act (“Independent Trustee”), receives a fee of $156,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex, plus travel expenses incurred for attending board meetings. The term “Alger Fund Complex” refers to the Trust, The Alger Institutional Funds, The Alger Funds II, The Alger Portfolios, Alger Global Focus Fund and The Alger ETF Trust, each of which is a registered investment company managed by Alger Management. The Independent Trustee appointed as Chairman of the Board receives additional compensation of $22,000 per annum paid pro rata based on net assets by each fund in the Alger Fund Complex. Additionally, each member of the Audit Committee receives a fee of $13,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex.
 
Effective January 1, 2022, the Board adopted a policy requiring Trustees to receive a minimum of 10% of their annual compensation in shares of one or more of the funds in the Alger Fund Complex.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Prior to January 1, 2022, each Independent Trustee received a fee of $142,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex, plus travel expenses incurred for attending board meetings. The Independent Trustee appointed as Chairman of the Board received additional compensation of $20,000 per annum paid pro rata based on net assets by each fund in the Alger Fund Complex. Additionally, each member of the Audit Committee received a fee of $13,000 per annum, paid pro rata based on net assets by each fund in the Alger Fund Complex.

(h) Interfund Trades: The Funds may engage in purchase and sale transactions with other funds advised by Alger Management or Weatherbie. For the six months ended April 30, 2022, these purchases and sales were as follows:

   
PURCHASES
   
SALES
   
REALIZED GAIN
 
Alger Mid Cap Focus Fund
 
$
   
$
16,578,285
   
$
(1,955,173
)
Alger Small Cap Growth Fund
   
3,400,732
     
     
 
Alger Small Cap Focus Fund
   
9,120,808
     
     
 

(i) Interfund Loans: The Funds, along with other funds in the Alger Fund Complex, may borrow money from and lend money to each other for temporary or emergency purposes with the exception of the Alger International Focus Fund, which can only borrow for temporary or emergency purposes. To the extent permitted under its investment restrictions, each Fund may lend uninvested cash in an amount up to 15% of its net assets to other funds in the Alger Fund Complex. If a Fund has borrowed from other funds in the Alger Fund Complex and has borrowings from all sources that exceed 10% of the Fund’s total assets, such Fund will secure all of its loans from other funds in the Alger Fund Complex. The interest rate charged on interfund loans is equal to the average of the overnight time deposit rate and bank loan rate available to the Funds. There were no interfund loans outstanding as of April 30, 2022.
 
During the six months ended April 30, 2022, Alger Capital Appreciation Fund, Alger Mid Cap Focus Fund, Alger Weatherbie Specialized Growth Fund and Alger Small Cap Focus Fund earned interfund loan interest income of $11, $583, $12,063 and $31,805, respectively, and Alger Capital Appreciation Fund, Alger Mid Cap Growth Fund, Alger Weatherbie Specialized Growth Fund, Alger Small Cap Growth Fund, Alger Small Cap Focus Fund and Alger Health Sciences Fund incurred interfund loan interest expenses of $17,169, $355, $49, $65, $3,163 and $1,081, respectively, which are included in interest income and interest expenses, respectively, in the accompanying Statements of Operations.

(j) Other Transactions with Affiliates: Certain officers and one Trustee of the Trust are directors and/or officers of Alger Management, the Distributor, or their affiliates. At April 30, 2022, Alger Management and its affiliated entities owned the following shares:

   
SHARE CLASS
 
      A

    C

    I

    Y

    Z

Alger Capital Appreciation Fund
   
73,980
     
     
     
     
44,857
 
Alger 35 Fund
   
     
     
     
     
2,152,689
 
Alger Growth & Income Fund
   
     
     
     
     
32,241
 
Alger Mid Cap Growth Fund
   
     
     
     
     
149,032
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
SHARE CLASS
 
      A



C



I



Y



Z

Alger Mid Cap Focus Fund
   
     
     
100,035
     
4,843
     
937,772
 
Alger Weatherbie Enduring Growth Fund
   
10,000
     
10,000
     
10,000
     
50,000
     
420,000
 
Alger Weatherbie Specialized Growth Fund
   
187,751
     
     
     
10,066
     
185
 
Alger Small Cap Growth Fund
   
71,040
     
     
     
36,127
     
115,717
 
Alger Small Cap Focus Fund
   
     
     
     
787
     
317,534
 
Alger International Focus Fund
   
     
     
     
     
90,832
 
 
NOTE 4 — Securities Transactions:
 
The following summarizes the securities transactions by each Fund, other than U.S. Government securities, short-term securities and forward foreign currency contracts, for the six months ended April 30, 2022:
 
   
PURCHASES
   
SALES
 
Alger Capital Appreciation Fund
 
$
1,750,561,254
   
$
2,094,698,962
 
Alger 35 Fund
   
34,650,525
     
34,530,613
 
Alger Growth & Income Fund
   
31,365,786
     
1,385,188
 
Alger Mid Cap Growth Fund
   
344,293,263
     
363,858,426
 

   
PURCHASES
   
SALES
 
Alger Mid Cap Focus Fund
 
$
1,452,617,982
   
$
1,510,506,895
 
Alger Weatherbie Enduring Growth Fund
   
5,845,114
     
764,510
 
Alger Weatherbie Specialized Growth Fund
   
413,540,165
     
518,100,490
 
Alger Small Cap Growth Fund
   
68,132,237
     
43,952,797
 
Alger Small Cap Focus Fund
   
1,122,358,148
     
2,245,039,756
 
Alger International Focus Fund
   
48,112,804
     
53,524,633
 
Alger Health Sciences Fund
   
350,185,393
     
409,700,656
 
 
NOTE 5 — Borrowing:
 
The Funds may borrow from the Custodian on an uncommitted basis. Each Fund pays the Custodian a market rate of interest, generally based upon a rate of return with respect to each respective currency borrowed, taking into consideration relevant overnight and short-term reference rates and the range of distribution between and among the interest rates paid on deposits to other institutions, less applicable commissions, if any. The Funds may also borrow from other funds in the Alger Fund Complex, as discussed in Note 3(i). For the six months ended April 30, 2022, the Funds had the following borrowings from the Custodian and other funds in the Alger Fund Complex:
 
   
AVERAGE DAILY
BORROWING
   
WEIGHTED AVERAGE
INTEREST RATE
 
Alger Capital Appreciation Fund
 
$
5,668,397
     
1.50
%
Alger 35 Fund
   
16,758
     
2.27
 
Alger Mid Cap Growth Fund
   
214,391
     
1.77
 
Alger Weatherbie Specialized Growth Fund
   
174,660
     
2.05
 
Alger Small Cap Growth Fund
   
12,691
     
1.04
 
Alger Small Cap Focus Fund
   
949,576
     
1.42
 
Alger International Focus Fund
   
1,773
     
2.11
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
 

 
AVERAGE DAILY
BORROWING
   
WEIGHTED AVERAGE
INTEREST RATE
 
Alger Health Sciences Fund
    299,339       1.40  
 
The highest amount borrowed from the Custodian and other funds in the Alger Fund Complex during the six months ended April 30, 2022 by each Fund was as follows:
 
   
HIGHEST BORROWING
 
Alger Capital Appreciation Fund
 
$
68,253,982
 
Alger 35 Fund
   
402,979
 
Alger Mid Cap Growth Fund
   
5,271,001
 
Alger Weatherbie Specialized Growth Fund
   
11,838,394
 
Alger Small Cap Growth Fund
   
2,297,000
 
Alger Small Cap Focus Fund
   
33,426,745
 
Alger International Focus Fund
   
92,245
 
Alger Health Sciences Fund
   
5,578,344
 
 
On September 7, 2021, BBH, the Fund’s custodian, announced that it had entered into an agreement with State Street Bank and Trust Company (“State Street”) to sell BBH’s Investor Services business to State Street (the “Transaction”). The completion of the Transaction is subject to customary closing conditions and regulatory approvals. As a result of the Transaction, it is expected that State Street will replace BBH as the Fund’s custodian effective as of the completion of the Transaction, the timing of which is not currently finalized.

NOTE 6 — Share Capital:

The Trust has an unlimited number of authorized shares of beneficial interest of $.001 par value which are presently divided into eleven series. Each series is divided into separate classes. During the six months ended April 30, 2022, and the year ended October 30, 2021, transactions of shares of beneficial interest were as follows:

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FOR THE SIX MONTHS ENDED
APRIL 30, 2022
   
FOR THE YEAR ENDED
OCTOBER 31, 2021
 
   
SHARES
   
AMOUNT
    SHARES    
AMOUNT
 
Alger Capital Appreciation Fund
                       
Class A:
                       
Shares sold
   
3,347,498
   
$
103,451,770
     
4,903,852
   
$
171,217,144
 
Shares converted from Class C
   
57,494
     
1,699,067
     
193,285
     
6,736,530
 
Dividends reinvested
   
7,597,941
     
236,675,867
     
4,906,578
     
160,052,587
 
Shares redeemed
   
(9,987,645
)
   
(277,473,665
)
   
(10,514,085
)
   
(373,806,874
)
Net increase (decrease)
   
1,015,288
   
$
64,353,039
     
(510,370
)
 
$
(35,800,613
)
Class C:
                               
Shares sold
   
500,185
   
$
9,243,543
     
611,212
   
$
14,822,713
 
Shares converted to Class A
   
(92,360
)
   
(1,699,067
)
   
(279,454
)
   
(6,736,530
)
Dividends reinvested
   
2,637,277
     
50,292,867
     
1,702,406
     
38,406,276
 
Shares redeemed
   
(2,335,469
)
   
(45,748,708
)
   
(2,485,325
)
   
(61,180,206
)
Net increase (decrease)
   
709,633
   
$
12,088,635
     
(451,161
)
 
$
(14,687,747
)
Class Z:
                               
Shares sold
   
5,246,964
   
$
163,136,094
     
8,958,009
   
$
331,347,123
 
Dividends reinvested
   
7,554,946
     
250,370,897
     
4,753,533
     
162,570,831
 
Shares redeemed
   
(6,589,453
)
   
(207,924,507
)
   
(24,919,637
)
   
(947,567,494
)
Net increase (decrease)
   
6,212,457
   
$
205,582,484
     
(11,208,095
)
 
$
(453,649,540
)
                                 
Alger 35 Fund*
                               
Class Z:
                               
Shares sold
   
29,682
   
$
382,748
     
192,476
   
$
3,393,415
 
Shares from the Reorganization**
   
     
     
1,429,347
     
26,249,571
 
Shares converted from Class P-2
   
     
     
18,102
     
386,258
 
Dividends reinvested
   
747,268
     
10,551,417
     
9,316
     
159,019
 
Shares redeemed
   
(42,033
)
   
(516,195
)
   
(390,886
)
   
(7,004,609
)
Net increase
   
734,917
   
$
10,417,970
     
1,258,355
   
$
23,183,654
 
Class P-2:
                               
Shares sold
   
   
$
     
9,353
   
$
179,455
 
Shares converted to Class Z
   
     
     
(18,083
)
   
(386,258
)
Dividends reinvested
   
     
     
1,272
     
21,760
 
Shares redeemed
   
     
     
(6,943
)
   
(136,393
)
Net decrease
   
   
$
     
(14,401
)
 
$
(321,436
)

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


 
FOR THE SIX MONTHS ENDED
APRIL 30, 2022
   
FOR THE YEAR ENDED
OCTOBER 31, 2021
 

 
SHARES
   
AMOUNT
   
SHARES
   
AMOUNT
 
Alger Growth & Income Fund
                       
Class A:
                       
Shares sold
   
261,775
   
$
15,795,256
     
187,753
   
$
10,422,890
 
Shares converted from Class C
   
1,030
     
63,190
     
9,932
     
526,506
 
Dividends reinvested
   
60,938
     
3,749,308
     
35,990
     
1,847,272
 
Shares redeemed
   
(112,843
)
   
(6,746,129
)
   
(202,222
)
   
(11,022,607
)
Net increase
   
210,900
   
$
12,861,625
     
31,453
   
$
1,774,061
 
Class C:
                               
Shares sold
   
74,835
   
$
4,430,016
     
60,755
   
$
3,319,485
 
Shares converted to Class A
   
(1,046
)
   
(63,190
)
   
(10,088
)
   
(526,506
)
Dividends reinvested
   
10,389
     
631,309
     
5,024
     
247,364
 
Shares redeemed
   
(29,511
)
   
(1,748,863
)
   
(60,069
)
   
(3,212,364
)
Net increase (decrease)
   
54,667
   
$
3,249,272
     
(4,378
)
 
$
(172,021
)
Class Z:
                               
Shares sold
   
477,113
   
$
28,762,042
     
231,639
   
$
12,822,447
 
Dividends reinvested
   
23,052
     
1,415,496
     
12,292
     
636,900
 
Shares redeemed
   
(119,087
)
   
(6,973,415
)
   
(122,372
)
   
(6,508,944
)
Net increase
   
381,078
   
$
23,204,123
     
121,559
   
$
6,950,403
 
                                 
Alger Mid Cap Growth Fund
                               
Class A:
                               
Shares sold
   
522,330
   
$
8,453,268
     
914,462
   
$
20,634,057
 
Shares converted from Class B
   
11,862
     
196,286
     
82,391
     
1,863,637
 
Shares converted from Class C
   
2,326
     
38,155
     
18,436
     
428,750
 
Dividends reinvested
   
3,949,371
     
62,202,597
     
919,277
     
19,139,352
 
Shares redeemed
   
(928,737
)
   
(14,961,732
)
   
(1,345,940
)
   
(29,992,059
)
Net increase
   
3,557,152
   
$
55,928,574
     
588,626
   
$
12,073,737
 
Class B:
                               
Shares sold
   
34,976
   
$
439,929
     
24,929
   
$
412,167
 
Shares converted to Class A
   
(18,297
)
   
(196,286
)
   
(111,173
)
   
(1,863,637
)
Dividends reinvested
   
648,341
     
6,399,126
     
139,453
     
2,141,998
 
Shares redeemed
   
(280,986
)
   
(2,774,403
)
   
(118,881
)
   
(1,959,022
)
Net increase (decrease)
   
384,034
   
$
3,868,366
     
(65,672
)
 
$
(1,268,494
)
Class C:
                               
Shares sold
   
102,590
   
$
981,898
     
143,711
   
$
2,319,146
 
Shares converted to Class A
   
(3,747
)
   
(38,155
)
   
(25,839
)
   
(428,750
)
Dividends reinvested
   
312,841
     
2,906,295
     
55,517
     
822,766
 
Shares redeemed
   
(108,901
)
   
(1,066,803
)
   
(109,683
)
   
(1,763,897
)
Net increase
   
302,783
   
$
2,783,235
     
63,706
   
$
949,265
 
Class Z:
                               
Shares sold
   
1,222,513
   
$
21,999,705
     
1,002,401
   
$
22,629,348
 
Dividends reinvested
   
730,557
     
11,835,012
     
96,479
     
2,049,208
 
Shares redeemed
   
(879,446
)
   
(13,328,626
)
   
(418,013
)
   
(9,396,307
)
Net increase
   
1,073,624
   
$
20,506,091
     
680,867
   
$
15,282,249
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


 
FOR THE SIX MONTHS ENDED
APRIL 30, 2022
   
FOR THE YEAR ENDED
OCTOBER 31, 2021
 

 
SHARES
   
AMOUNT
   
SHARES
   
AMOUNT
 
Alger Mid Cap Focus Fund
                       
Class A:***
                       
Shares sold
   
182,714
   
$
3,313,649
     
71,524
   
$
1,568,079
 
Dividends reinvested
   
12,507
     
226,139
     
     
 
Shares redeemed
   
(32,984
)
   
(576,473
)
   
(282
)
   
(6,378
)
Net increase
   
162,237
   
$
2,963,315
     
71,242
   
$
1,561,701
 
Class C:***
                               
Shares sold
   
143,064
   
$
2,645,556
     
99,334
   
$
2,230,152
 
Dividends reinvested
   
12,103
     
218,218
     
     
 
Shares redeemed
   
(43,585
)
   
(810,781
)
   
(235
)
   
(5,074
)
Net increase
   
111,582
   
$
2,052,993
     
99,099
   
$
2,225,078
 
Class I:
                               
Shares sold
   
753,258
   
$
13,890,378
     
3,340,683
   
$
67,099,072
 
Dividends reinvested
   
678,515
     
12,274,335
     
68,847
     
1,263,336
 
Shares redeemed
   
(1,439,167
)
   
(25,248,715
)
   
(1,688,941
)
   
(32,678,718
)
Net increase (decrease)
   
(7,394
)
 
$
915,998
     
1,720,589
   
$
35,683,690
 
Class Y:****
                               
Shares sold
   
422
   
$
7,200
     
5,822
   
$
119,925
 
Dividends reinvested
   
115
     
2,107
     
     
 
Net increase
   
537
   
$
9,307
     
5,822
   
$
119,925
 
Class Z:
                               
Shares sold
   
8,455,129
   
$
154,398,682
     
20,605,283
   
$
415,538,623
 
Dividends reinvested
   
3,770,479
     
68,698,120
     
320,018
     
5,894,736
 
Shares redeemed
   
(11,238,654
)
   
(194,850,215
)
   
(7,483,745
)
   
(151,083,036
)
Net increase
   
986,954
   
$
28,246,587
     
13,441,556
   
$
270,350,323
 
                                 
Alger Weatherbie Enduring Growth Fund*****
                               
Class A:
                               
Shares sold
   
16,209
   
$
152,000
     
   
$
 
Net increase
   
16,209
   
$
152,000
     
   
$
 
Class C:
                               
Shares sold
   
10,000
   
$
100,000
     
   
$
 
Net increase
   
10,000
   
$
100,000
     
   
$
 
Class I:
                               
Shares sold
   
10,000
   
$
100,000
     
   
$
 
Net increase
   
10,000
   
$
100,000
     
   
$
 
Class Y:
                               
Shares sold
   
50,000
   
$
500,000
     
   
$
 
Net increase
   
50,000
   
$
500,000
     
   
$
 
Class Z:
                               
Shares sold
   
459,708
   
$
4,600,241
     
   
$
 
Net increase
   
459,708
   
$
4,600,241
     
   
$
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


 
FOR THE SIX MONTHS ENDED
APRIL 30, 2022
   
FOR THE YEAR ENDED
OCTOBER 31, 2021
 

 
SHARES
   
AMOUNT
   
SHARES
   
AMOUNT
 
Alger Weatherbie Specialized Growth Fund
 
               
 
Class A:
                       
Shares sold
   
952,369
   
$
16,983,830
     
2,777,160
   
$
60,409,142
 
Shares converted from Class C
   
6,874
     
156,481
     
65,661
     
1,472,818
 
Dividends reinvested
   
2,355,077
     
40,837,032
     
438,339
     
8,823,757
 
Shares redeemed
   
(2,157,190
)
   
(35,112,974
)
   
(2,894,846
)
   
(62,323,010
)
Net increase
   
1,157,130
   
$
22,864,369
     
386,314
   
$
8,382,707
 
Class C:
                               
Shares sold
   
744,241
   
$
7,270,260
     
1,791,191
   
$
25,231,160
 
Shares converted to Class A
   
(11,007
)
   
(156,481
)
   
(102,088
)
   
(1,472,818
)
Dividends reinvested
   
2,635,295
     
24,982,600
     
412,015
     
5,327,351
 
Shares redeemed
   
(1,727,617
)
   
(16,191,582
)
   
(1,215,169
)
   
(17,245,234
)
Net increase
   
1,640,912
   
$
15,904,797
     
885,949
   
$
11,840,459
 
Class I:
                               
Shares sold
   
263,942
   
$
5,106,251
     
1,135,719
   
$
25,501,619
 
Dividends reinvested
   
505,518
     
9,079,102
     
127,791
     
2,646,555
 
Shares redeemed
   
(629,358
)
   
(10,999,405
)
   
(1,952,131
)
   
(42,735,229
)
Net increase (decrease)
   
140,102
   
$
3,185,948
     
(688,621
)
 
$
(14,587,055
)
Class Y:
                               
Shares sold
   
1,895,379
   
$
32,271,542
     
837,092
   
$
19,514,973
 
Dividends reinvested
   
343,617
     
6,305,382
     
45,583
     
957,251
 
Shares redeemed
   
(539,979
)
   
(9,497,698
)
   
(340,146
)
   
(7,860,565
)
Net increase
   
1,699,017
   
$
29,079,226
     
542,529
   
$
12,611,659
 
Class Z:
                               
Shares sold
   
15,094,941
   
$
272,957,807
     
23,475,062
   
$
551,582,721
 
Dividends reinvested
   
9,047,802
     
171,998,723
     
1,449,362
     
31,335,212
 
Shares redeemed
   
(22,507,315
)
   
(393,490,563
)
   
(10,574,421
)
   
(248,570,390
)
Net increase
   
1,635,428
   
$
51,465,967
     
14,350,003
   
$
334,347,543
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)



 
FOR THE SIX MONTHS ENDED
APRIL 30, 2022
   
FOR THE YEAR ENDED
OCTOBER 31, 2021
 

  SHARES     AMOUNT     SHARES     AMOUNT  
Alger Small Cap Growth Fund
 
               
 
Class A:
                       
Shares sold
   
1,230,588
   
$
15,674,190
     
4,316,492
   
$
67,234,025
 
Shares converted from Class B
   
43,668
     
495,537
     
9,900
     
151,028
 
Shares converted from Class C
   
454
     
5,808
     
9,831
     
156,933
 
Dividends reinvested
   
1,565,131
     
20,221,493
     
69,156
     
1,020,044
 
Shares redeemed
   
(2,419,500
)
   
(30,046,439
)
   
(3,086,481
)
   
(47,214,284
)
Net increase
   
420,341
   
$
6,350,589
     
1,318,898
   
$
21,347,746
 
Class B:
                               
Shares sold
   
56,801
   
$
409,119
     
18,146
   
$
202,310
 
Shares converted to Class A
   
(64,876
)
   
(495,537
)
   
(14,060
)
   
(151,028
)
Dividends reinvested
   
77,256
     
672,125
     
3,843
     
39,897
 
Shares redeemed
   
(67,221
)
   
(552,794
)
   
(71,442
)
   
(786,600
)
Net increase (decrease)
   
1,960
   
$
32,913
     
(63,513
)
 
$
(695,421
)
Class C:
                               
Shares sold
   
398,037
   
$
3,153,545
     
2,192,233
   
$
22,769,276
 
Shares converted to Class A
   
(711
)
   
(5,808
)
   
(14,746
)
   
(156,933
)
Dividends reinvested
   
590,149
     
4,786,108
     
17,615
     
173,504
 
Shares redeemed
   
(608,217
)
   
(4,722,417
)
   
(731,088
)
   
(7,680,281
)
Net increase
   
379,258
   
$
3,211,428
     
1,464,014
   
$
15,105,566
 
Class Y:******
                               
Shares sold
   
36,127
   
$
500,000
     
   
$
 
Net increase
   
36,127
   
$
500,000
     
   
$
 
Class Z:
                               
Shares sold
   
8,592,233
   
$
108,535,211
     
16,501,975
   
$
267,006,423
 
Dividends reinvested
   
2,222,719
     
30,117,848
     
71,444
     
1,096,671
 
Shares redeemed
   
(8,460,872
)
   
(106,929,089
)
   
(7,573,401
)
   
(122,718,331
)
Net increase
   
2,354,080
   
$
31,723,970
     
9,000,018
   
$
145,384,763
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


 
FOR THE SIX MONTHS ENDED
APRIL 30, 2022
   
FOR THE YEAR ENDED
OCTOBER 31, 2021
 

 
SHARES
   
AMOUNT
   
SHARES
   
AMOUNT
 
Alger Small Cap Focus Fund
 
               
 
Class A:
                       
Shares sold
   
1,188,082
   
$
27,562,715
     
2,869,366
   
$
90,147,930
 
Shares converted from Class C
   
2,829
     
81,163
     
15,477
     
522,326
 
Dividends reinvested
   
1,045,786
     
26,134,180
     
     
 
Shares redeemed
   
(4,101,958
)
   
(94,113,120
)
   
(6,829,853
)
   
(211,147,927
)
Net decrease
   
(1,865,261
)
 
$
(40,335,062
)
   
(3,945,010
)
 
$
(120,477,671
)
Class C:
                               
Shares sold
   
220,467
   
$
4,699,028
     
412,494
   
$
11,510,179
 
Shares converted to Class A
   
(3,203
)
   
(81,163
)
   
(17,406
)
   
(522,326
)
Dividends reinvested
   
669,148
     
14,661,030
     
     
 
Shares redeemed
   
(1,718,328
)
   
(33,661,683
)
   
(1,494,411
)
   
(41,732,985
)
Net decrease
   
(831,916
)
 
$
(14,382,788
)
   
(1,099,323
)
 
$
(30,745,132
)
Class I:
                               
Shares sold
   
1,625,500
   
$
39,053,392
     
5,521,632
   
$
177,853,968
 
Dividends reinvested
   
817,179
     
21,017,843
     
     
 
Shares redeemed
   
(5,531,508
)
   
(130,923,613
)
   
(5,977,164
)
   
(188,231,133
)
Net decrease
   
(3,088,829
)
 
$
(70,852,378
)
   
(455,532
)
 
$
(10,377,165
)
Class Y:
                               
Shares sold
   
3,837,133
   
$
88,288,381
     
5,833,923
   
$
191,192,930
 
Dividends reinvested
   
722,905
     
19,019,637
     
     
 
Shares redeemed
   
(1,924,997
)
   
(47,061,676
)
   
(3,700,823
)
   
(119,885,569
)
Net increase
   
2,635,041
   
$
60,246,342
     
2,133,100
   
$
71,307,361
 
Class Z:
                               
Shares sold
   
34,465,836
   
$
825,511,260
     
76,188,007
   
$
2,500,577,465
 
Dividends reinvested
   
10,465,710
     
275,248,186
     
     
 
Shares redeemed
   
(74,694,001
)
   
(1,755,446,092
)
   
(54,259,719
)
   
(1,768,072,530
)
Net increase (decrease)
   
(29,762,455
)
 
$
(654,686,646
)
   
21,928,288
   
$
732,504,935
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


 
FOR THE SIX MONTHS ENDED
APRIL 30, 2022
   
FOR THE YEAR ENDED
OCTOBER 31, 2021
 

 
SHARES
   
AMOUNT
   
SHARES
   
AMOUNT
 
Alger International Focus Fund
 
               
 
Class A:
                       
Shares sold
   
131,714
   
$
2,837,050
     
308,062
   
$
7,102,758
 
Shares converted from Class B
   
6,137
     
133,578
     
15,746
     
357,201
 
Shares converted from Class C
   
1,746
     
34,951
     
9,648
     
226,184
 
Dividends reinvested
   
517,441
     
11,740,746
     
     
 
Shares redeemed
   
(295,848
)
   
(6,189,759
)
   
(507,496
)
   
(11,678,515
)
Net increase (decrease)
   
361,190
   
$
8,556,566
     
(174,040
)
 
$
(3,992,372
)
Class B:
                               
Shares sold
   
2,630
   
$
45,078
     
24,912
   
$
439,834
 
Shares converted to Class A
   
(7,139
)
   
(133,578
)
   
(18,146
)
   
(357,201
)
Dividends reinvested
   
99,778
     
1,938,691
     
     
 
Shares redeemed
   
(68,690
)
   
(1,316,165
)
   
(129,422
)
   
(2,601,409
)
Net increase (decrease)
   
26,579
   
$
534,026
     
(122,656
)
 
$
(2,518,776
)
Class C:
                               
Shares sold
   
10,585
   
$
197,361
     
71,044
   
$
1,356,820
 
Shares converted to Class A
   
(2,133
)
   
(34,951
)
   
(11,520
)
   
(226,184
)
Dividends reinvested
   
21,218
     
393,811
     
     
 
Shares redeemed
   
(70,903
)
   
(1,146,872
)
   
(26,935
)
   
(516,872
)
Net increase (decrease)
   
(41,233
)
 
$
(590,651
)
   
32,589
   
$
613,764
 
Class I:
                               
Shares sold
   
63,741
   
$
1,444,477
     
15,704
   
$
367,108
 
Dividends reinvested
   
2,147
     
48,866
     
     
 
Shares redeemed
   
(15,338
)
   
(303,114
)
   
(26,546
)
   
(588,570
)
Net increase (decrease)
   
50,550
   
$
1,190,229
     
(10,842
)
 
$
(221,462
)
Class Z:
                               
Shares sold
   
276,429
   
$
5,690,218
     
684,090
   
$
15,690,006
 
Dividends reinvested
   
90,502
     
2,089,683
     
     
 
Shares redeemed
   
(340,170
)
   
(6,783,244
)
   
(244,218
)
   
(5,616,024
)
Net increase
   
26,761
   
$
996,657
     
439,872
   
$
10,073,982
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
 
FOR THE SIX MONTHS ENDED
APRIL 30, 2022
   
FOR THE YEAR ENDED
OCTOBER 31, 2021
 
 
 
SHARES
   
AMOUNT
   
SHARES
   
AMOUNT
 
Alger Health Sciences Fund
                       
Class A:
                       
Shares sold
   
422,424
   
$
10,376,403
     
647,684
   
$
21,813,029
 
Shares converted from Class C
   
6,521
     
152,719
     
19,072
     
665,710
 
Dividends reinvested
   
974,154
     
24,529,213
     
417,346
     
13,167,263
 
Shares redeemed
   
(815,940
)
   
(20,309,066
)
   
(979,932
)
   
(32,679,519
)
Net increase
   
587,159
   
$
14,749,269
     
104,170
   
$
2,966,483
 
Class C:
                               
Shares sold
   
40,291
   
$
705,139
     
151,682
   
$
3,657,493
 
Shares converted to Class A
   
(10,305
)
   
(152,719
)
   
(26,699
)
   
(665,710
)
Dividends reinvested
   
226,913
     
3,607,916
     
82,622
     
1,869,732
 
Shares redeemed
   
(148,804
)
   
(2,469,105
)
   
(158,253
)
   
(3,786,919
)
Net increase
   
108,095
   
$
1,691,231
     
49,352
   
$
1,074,596
 
Class Z:
                               
Shares sold
   
874,823
   
$
23,652,278
     
2,662,275
   
$
91,145,762
 
Dividends reinvested
   
1,302,121
     
33,295,227
     
490,804
     
15,627,187
 
Shares redeemed
   
(2,528,841
)
   
(62,003,290
)
   
(2,264,211
)
   
(74,893,155
)
Net increase (decrease)
   
(351,897
)
 
$
(5,055,785
)
   
888,868
   
$
31,879,794
 

*
On May 7, 2021, Class P Shares of Alger 35 Fund were reclassified as Class Z Shares. After the close of business on October 29, 2021, Class P-2 Shares of the Alger 35 Fund were converted to Class Z Shares.
**
Includes shares and amounts from the Reorganization.
***
Inception date July 29, 2021.
****
Inception date February 26, 2021.
*****
Inception date December 17, 2021.
******
Inception date December 31, 2021.
 
NOTE 7 — Income Tax Information:
 
At October 31, 2021, the Funds, for federal income tax purposes, had no capital loss carryforwards.
 
The difference between book-basis and tax-basis unrealized appreciation (depreciation) is determined annually and is attributable primarily to the tax deferral of losses on wash sales, U.S. Internal Revenue Code Section 988 currency transactions, nondeductible expenses on dividends sold short, tax treatment of partnership investments, realization of unrealized appreciation of passive foreign investment companies, and return of capital from real estate investment trust investments.
 
The Funds accrue tax on unrealized gains in foreign jurisdictions that impose a foreign capital tax.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


NOTE 8 — Fair Value Measurements:
 
The following is a summary of the inputs used as of April 30, 2022, in valuing the Funds’ investments carried at fair value on a recurring basis. Based upon the nature, characteristics, and risks associated with their investments, the Funds have determined that presenting them by security type and sector is appropriate.

Alger Capital Appreciation Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
 
$
161,663,915
   
$
161,663,915
   
$
   
$
 
Consumer Discretionary
   
436,507,600
     
416,470,956
     
19,124,658
     
911,986
 
Consumer Staples
   
8,914,817
     
8,914,817
     
     
 
Energy
   
54,542,332
     
54,542,332
     
     
 
Financials
   
69,500,346
     
69,500,346
     
     
 
Healthcare
   
326,301,400
     
292,868,828
     
33,432,572
     
 
Industrials
   
185,169,479
     
185,169,479
     
     
 
Information Technology
   
927,194,891
     
927,194,891
     
     
 
Materials
   
23,042,479
     
23,042,479
     
     
 
Utilities
   
7,345,528
     
7,345,528
     
     
 
TOTAL COMMON STOCKS
 
$
2,200,182,787
   
$
2,146,713,571
   
$
52,557,230
   
$
911,986
 
PREFERRED STOCKS
                               
Information Technology
   
1,656,261
     
     
     
1,656,261
 
REAL ESTATE INVESTMENT TRUST
                               
Real Estate
   
7,867,350
     
7,867,350
     
     
 
SPECIAL PURPOSE VEHICLE
                               
Information Technology
   
3,874,677
     
     
     
3,874,677
 
TOTAL INVESTMENTS IN SECURITIES
 
$
2,213,581,075
   
$
2,154,580,921
   
$
52,557,230
   
$
6,442,924
 

Alger 35 Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
   
2,801,448
     
2,801,448
     
     
 
Consumer Discretionary
   
4,730,501
     
4,730,501
     
     
 
Consumer Staples
   
673,689
     
673,689
     
     
 
Energy
   
1,579,140
     
1,579,140
     
     
 
Financials
   
2,117,994
     
2,117,994
     
     
 
Healthcare
   
3,491,743
     
3,491,743
     
     
 
Industrials
   
1,661,995
     
1,661,995
     
     
 
Information Technology
   
10,637,090
     
10,637,090
     
     
 
Real Estate
   
732,979
     
732,979
     
     
 
TOTAL COMMON STOCKS
 
$
28,426,579
   
$
28,426,579
   
$
   
$
 
REAL ESTATE INVESTMENT TRUST
                               
Real Estate
   
457,839
     
457,839
     
     
 
TOTAL INVESTMENTS IN SECURITIES
 
$
28,884,418
   
$
28,884,418
   
$
   
$
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


Alger Growth & Income Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
 
$
17,229,225
   
$
17,229,225
   
$
   
$
 
Consumer Discretionary
   
12,855,413
     
12,855,413
     
     
 
Consumer Staples
   
14,108,241
     
14,108,241
     
     
 
Energy
   
7,831,181
     
7,831,181
     
     
 
Financials
   
19,217,852
     
19,217,852
     
     
 
Healthcare
   
26,709,404
     
26,709,404
     
     
 
Industrials
   
11,295,839
     
11,295,839
     
     
 
Information Technology
   
46,555,452
     
46,555,452
     
     
 
Materials
   
3,899,233
     
3,899,233
     
     
 
Utilities
   
2,429,516
     
2,429,516
     
     
 
TOTAL COMMON STOCKS
 
$
162,131,356
   
$
162,131,356
   
$
   
$
 
MASTER LIMITED PARTNERSHIP
                               
Energy
   
1,028,536
     
1,028,536
     
     
 
REAL ESTATE INVESTMENT TRUST
                               
Financials
   
1,353,783
     
1,353,783
     
     
 
Real Estate
   
7,494,092
     
7,494,092
     
     
 
TOTAL REAL ESTATE INVESTMENT TRUST
 
$
8,847,875
   
$
8,847,875
   
$
   
$
 
TOTAL INVESTMENTS IN SECURITIES
 
$
172,007,767
   
$
172,007,767
   
$
   
$
 

Alger Mid Cap Growth Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
   
10,278,999
     
10,278,999
     
     
 
Consumer Discretionary
   
29,861,677
     
28,123,349
     
1,738,328
     
 
Consumer Staples
   
1,043,950
     
1,043,950
     
     
 
Energy
   
17,470,831
     
17,470,831
     
     
 
Financials
   
9,147,543
     
9,147,543
     
     
 
Healthcare
   
34,463,279
     
34,463,279
     
     
 
Industrials
   
24,522,077
     
24,522,077
     
     
 
Information Technology
   
60,157,399
     
60,157,399
     
     
 
Materials
   
3,394,271
     
3,394,271
     
     
 
Utilities
   
5,604,766
     
5,604,766
     
     
 
TOTAL COMMON STOCKS
 
$
195,944,792
   
$
194,206,464
   
$
1,738,328
   
$
 
PREFERRED STOCKS
                               
Healthcare
   
*
   
     
     
*
RIGHTS
                               
Healthcare
   
424,842
     
     
     
424,842
 
REAL ESTATE INVESTMENT TRUST
                               
Real Estate
   
1,133,485
     
1,133,485
     
     
 
SPECIAL PURPOSE VEHICLE
                               
Information Technology
   
2,365,711
     
     
     
2,365,711
 
TOTAL INVESTMENTS IN SECURITIES
 
$
199,868,830
   
$
195,339,949
   
$
1,738,328
   
$
2,790,553
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger Mid Cap Focus Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
 
$
5,731,368
   
$
5,731,368
   
$
   
$
 
Consumer Discretionary
   
83,933,544
     
83,933,544
     
     
 
Energy
   
27,983,547
     
27,983,547
     
     
 
Financials
   
17,997,237
     
17,997,237
     
     
 
Healthcare
   
94,351,770
     
94,351,770
     
     
 
Industrials
   
90,228,202
     
90,228,202
     
     
 
Information Technology
   
219,631,144
     
219,631,144
     
     
 
Materials
   
13,988,080
     
13,988,080
     
     
 
Utilities
   
15,363,219
     
15,363,219
     
     
 
TOTAL COMMON STOCKS
 
$
569,208,111
   
$
569,208,111
   
$
   
$
 
TOTAL INVESTMENTS IN SECURITIES
 
$
569,208,111
   
$
569,208,111
   
$
   
$
 

Alger Weatherbie Enduring Growth Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Consumer Discretionary
   
316,223
     
316,223
     
     
 
Energy
   
243,938
     
243,938
     
     
 
Financials
   
575,897
     
575,897
     
     
 
Healthcare
   
375,868
     
375,868
     
     
 
Industrials
   
1,292,417
     
1,292,417
     
     
 
Information Technology
   
767,830
     
767,830
     
     
 
Real Estate
   
330,584
     
330,584
     
     
 
TOTAL COMMON STOCKS
 
$
3,902,757
   
$
3,902,757
   
$
   
$
 
TOTAL INVESTMENTS IN SECURITIES
 
$
3,902,757
   
$
3,902,757
   
$
   
$
 

Alger Weatherbie Specialized Growth Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
   
3,294,219
     
3,294,219
     
     
 
Consumer Discretionary
   
123,520,379
     
123,520,379
     
     
 
Energy
   
59,669,244
     
59,669,244
     
     
 
Financials
   
126,942,102
     
126,942,102
     
     
 
Healthcare
   
148,603,619
     
145,617,409
     
     
2,986,210
 
Industrials
   
213,842,974
     
213,842,974
     
     
 
Information Technology
   
200,691,877
     
200,691,877
     
     
 
Materials
   
6,788,443
     
6,788,443
     
     
 
Real Estate
   
56,729,784
     
56,729,784
     
     
 
TOTAL COMMON STOCKS
 
$
940,082,641
   
$
937,096,431
   
$
   
$
2,986,210
 
PREFERRED STOCKS
                               
Healthcare
   
*
   
     
     
*
TOTAL INVESTMENTS IN SECURITIES
 
$
940,082,641
   
$
937,096,431
   
$
   
$
2,986,210
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger Small Cap Growth Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
 
$
27,955,134
   
$
27,955,134
   
$
   
$
 
Consumer Discretionary
   
53,321,397
     
53,321,397
     
     
 
Consumer Staples
   
22,822,397
     
22,822,397
     
     
 
Energy
   
23,807,766
     
23,807,766
     
     
 
Financials
   
5,026,621
     
5,026,621
     
     
 
Healthcare
   
133,157,415
     
129,510,417
     
     
3,646,998
 
Industrials
   
29,579,464
     
29,579,464
     
     
 
Information Technology
   
108,859,077
     
108,859,077
     
     
 
Materials
   
15,074,475
     
15,074,475
     
     
 
TOTAL COMMON STOCKS
 
$
419,603,746
   
$
415,956,748
   
$
   
$
3,646,998
 
PREFERRED STOCKS
                               
Healthcare
   
*
   
     
     
*
RIGHTS
                               
Healthcare
   
125,843
     
     
     
125,843
 
REAL ESTATE INVESTMENT TRUST
                               
Real Estate
   
4,227,157
     
4,227,157
     
     
 
SPECIAL PURPOSE VEHICLE
                               
Information Technology
   
3,203,479
     
     
     
3,203,479
 
TOTAL INVESTMENTS IN SECURITIES
 
$
427,160,225
   
$
420,183,905
   
$
   
$
6,976,320
 

Alger Small Cap Focus Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Communication Services
   
19,354,408
     
19,354,408
     
     
 
Consumer Discretionary
   
220,546,047
     
220,546,047
     
     
 
Consumer Staples
   
61,217,156
     
61,217,156
     
     
 
Energy
   
283,277,609
     
283,277,609
     
     
 
Financials
   
84,725,061
     
84,725,061
     
     
 
Healthcare
   
1,450,430,960
     
1,450,430,960
     
     
 
Industrials
   
552,706,030
     
552,706,030
     
     
 
Information Technology
   
1,005,763,945
     
1,005,763,945
     
     
 
TOTAL COMMON STOCKS
 
$
3,678,021,216
   
$
3,678,021,216
   
$
   
$
 
RIGHTS
                               
Healthcare
   
8,572
     
     
     
8,572
 
TOTAL INVESTMENTS IN SECURITIES
 
$
3,678,029,788
   
$
3,678,021,216
   
$
   
$
8,572
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Alger International Focus Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Consumer Discretionary
 
$
32,584,354
   
$
6,936,288
   
$
25,648,066
   
$
 
Consumer Staples
   
6,933,082
     
     
6,933,082
     
 
Energy
   
8,717,101
     
3,686,445
     
5,030,656
     
 
Financials
   
24,273,344
     
5,809,120
     
18,464,224
     
 
Healthcare
   
19,349,945
     
3,323,521
     
16,026,424
     
 
Industrials
   
27,877,945
     
     
27,877,945
     
 
Information Technology
   
21,326,174
     
7,028,466
     
14,297,708
     
 
Materials
   
9,015,540
     
     
9,015,540
     
 
TOTAL COMMON STOCKS
 
$
150,077,485
   
$
26,783,840
   
$
123,293,645
   
$
 
TOTAL INVESTMENTS IN SECURITIES
 
$
150,077,485
   
$
26,783,840
   
$
123,293,645
   
$
 

Alger Health Sciences Fund
 
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
COMMON STOCKS
                       
Healthcare
   
191,985,362
     
161,636,930
     
25,348,430
     
5,000,002
 
Information Technology
   
1,832,439
     
1,832,439
     
     
 
Materials
   
3,385,307
     
3,385,307
     
— —
         
TOTAL COMMON STOCKS
 
$
197,203,108
   
$
166,854,676
   
$
25,348,430
   
$
5,000,002
 
PREFERRED STOCKS
                               
Healthcare
   
*
   
     
     
*
RIGHTS
                               
Healthcare
   
1,409,037
     
     
     
1,409,037
 
TOTAL INVESTMENTS IN SECURITIES
 
$
198,612,145
   
$
166,854,676
   
$
25,348,430
   
$
6,409,039
 

*
Alger Mid Cap Growth Fund’s, Alger Weatherbie Specialized Growth Fund’s, Alger Small Cap Growth Fund’s and Alger Health Sciences Fund’s holdings of Prosetta Biosciences, Inc., Series D shares are classified as a Level 3 investment and are fair valued at zero as of April 30, 2022.

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Fund
  Common Stocks  
Opening balance at November 1, 2021
 
$
1,015,916
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(103,930
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
911,986
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
(103,930
)

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Fund
 
Preferred Stocks
 
Opening balance at November 1, 2021
 
$
1,922,972
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(266,711
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
1,656,261
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
(266,711
)

Alger Capital Appreciation Fund
 
Special Purpose Vehicle
 
Opening balance at November 1, 2021
 
$
4,443,108
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(568,431
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
3,874,677
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
(568,431
)

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Fund
 
Preferred Stocks
 
Opening balance at November 1, 2021
 
$
0
**
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
0
**
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
 

Alger Mid Cap Growth Fund
 
Rights
 
Opening balance at November 1, 2021
 
$
442,544
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(17,702
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
424,842
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
(17,702
)

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Fund
 
Special Purpose Vehicle
 
Opening balance at November 1, 2021
 
$
2,722,707
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(356,996
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
2,365,711
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
(356,996
)

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Weatherbie Specialized Growth Fund
 
Common Stocks
 
Opening balance at November 1, 2021
 
$
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
2,986,210
 
Sales
   
 
Closing balance at April 30, 2022
   
2,986,210
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)


 
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Weatherbie Specialized Growth Fund
 
Preferred Stocks
 
Opening balance at November 1, 2021
 
$
0
**
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
0
**
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
 

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Fund
 
Common Stocks
 
Opening balance at November 1, 2021
 
$
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
3,646,998
 
Sales
   
 
Closing balance at April 30, 2022
   
3,646,998
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Fund
 
Preferred Stocks
 
Opening balance at November 1, 2021
 
$
0
**
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
0
**
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
 

Alger Small Cap Growth Fund
 
Rights
 
Opening balance at November 1, 2021
 
$
131,087
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(5,244
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
125,843
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
(5,244
)

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Fund
 
Special Purpose Vehicle
 
Opening balance at November 1, 2021
 
$
3,683,379
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(479,900
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
3,203,479
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
(479,900
)

   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Focus Fund
 
Rights
 
Opening balance at November 1, 2021
 
$
8,929
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(357
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
8,572
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
(357
)

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Health Sciences Fund
 
Common Stocks
 
Opening balance at November 1, 2021
 
$
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
5,000,002
 
Sales
   
 
Closing balance at April 30, 2022
   
5,000,002
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
 

Alger Health Sciences Fund
 
Preferred Stocks
 
Opening balance at November 1, 2021
 
$
0
**
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
 
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
0
**
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
   
FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Health Sciences Fund
 
Rights
 
Opening balance at November 1, 2021
 
$
1,467,747
 
Transfers into Level 3
   
 
Transfers out of Level 3
   
 
Total gains or losses
       
Included in net realized gain (loss) on investments
   
 
Included in net change in unrealized appreciation (depreciation) on investments
   
(58,710
)
Purchases and sales
       
Purchases
   
 
Sales
   
 
Closing balance at April 30, 2022
   
1,409,037
 
Net change in unrealized appreciation (depreciation) attributable to investments still held at April 30, 2022*
   
(58,710
)

*
Net change in unrealized appreciation (depreciation) is included in net change in unrealized appreciation (depreciation) on investments in the accompanying statement of operations.
**
Includes securities that are fair valued at zero.

The following table provides quantitative information about each Fund’s Level 3 fair value measurements of its investments as of April 30, 2022. The table below is not intended to be all-inclusive, but rather provides information on the Level 3 inputs as they relate to each Fund’s fair value measurements.

   
Fair Value
April 30, 2022
 
Valuation
Methodology
Unobservable
Input
 
Input/Range
   
Weighted
Average Inputs
 
Alger Capital Appreciation Fund
 
Common Stocks
 
$
911,986
 
Income
Approach
Discount Rate
   
0.00%-4.70
%  
N/A
 
           
Probability of Success
   
15.00%-50.00
%  
N/A
 
Preferred Stocks
   
1,656,261
 
Market
Approach
Transaction Price
   
N/A
   
N/A
 
         
Revenue Multiple
   
26.0x-30.57
x
 
N/A
 
Special Purpose Vehicle
   
3,874,677
 
Market
Approach
Transaction Price
   
N/A
 
 
N/A
 
           
Revenue Multiple
   
26.0x-30.57
x  
N/A
 

Alger Mid Cap Growth Fund
 
Preferred Stocks
 
$
*
Income
Approach
Discount Rate
   
100.00
%
 
N/A
 
Rights
   
424,842
 
Income
Approach
Discount Rate
   
5.67%-6.01
%
 
N/A
 
 
       
 
Probability of Success
   
0.00%-60.00
%
 
N/A
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 
Fair Value
April 30, 2022
 
Valuation
Methodology
Unobservable
Input
 
Input/Range
 
Weighted
Average Inputs
 
Alger Mid Cap Growth Fund (continued)
               
Special Purpose Vehicle
   
2,365,711
 
Market
Approach
Transaction Price
   
N/A
   
N/A
 
         
Revenue Multiple
   
26.0x-30.57
x
 
N/A
 

Alger Weatherbie Specialized Growth Fund
 
Common Stocks
 
$
2,986,210
 
Market
Approach
Priced at Cost
   
N/A
   
N/A
 
Preferred Stocks
   
*
Income
Approach
Discount Rate
   
100.00
%
 
N/A
 

Alger Small Cap Growth Fund
 
Common Stocks
 
$
3,646,998
 
Market
Approach
Priced at Cost
   
N/A
   
N/A
 
Preferred Stocks
   
*
Income
Approach
Discount Rate
   
100.00
%
 
N/A
 
Rights
   
125,843
 
Income
Approach
Discount Rate
   
5.67%-6.01
%
 
N/A
 
           
Probability of Success
   
0.00%-60.00
%
 
N/A
 
Special Purpose Vehicle
   
3,203,479
 
Market
Approach
Transaction Price
   
N/A
   
N/A
 
           
Revenue Multiple
   
26.0x-30.57
x
 
N/A
 

Alger Small Cap Focus Fund
 
Rights
   
8,572
 
Income
Approach
Discount Rate
   
5.67%-6.01
%
 
N/A
 

         
Probability of Success
   
0.00%-60.00
%
 
N/A
 

Alger Health Sciences Fund
 
Common Stocks
 
$
5,000,002
 
Market
Approach
Priced at Cost
   
N/A
   
N/A
 
Preferred Stocks
   
*
Income
Approach
Discount Rate
   
100.00
%
 
N/A
 
Rights
   
1,409,037
 
Income
Approach
Discount Rate
   
5.67%-6.01
%
 
N/A
 
           
Probability of Success
   
0.00%-60.00
%
 
N/A
 

*
Prosetta Biosciences, Inc., Series D shares are classified as a Level 3 investment and are fair valued at zero as of April 30, 2022.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
The significant unobservable inputs used in the fair value measurement of each Fund’s securities are revenue and EBITDA multiples, discount rates, and the probability of success of certain outcomes. Significant increases and decreases in these inputs in isolation and interrelationships between these inputs would have resulted in significantly higher or lower

fair value measurements than those noted in the table above. Generally, all other things being equal, increases in revenue and EBITDA multiples, decreases in discount rates, and increases in the probability of success result in higher fair value measurements, whereas decreases in revenues and EBITDA multiples, increases in discount rates, and decreases in the probability of success result in lower fair value measurements.
 
Certain of the Funds’ assets and liabilities are held at carrying amount or face value, which approximates fair value for financial statements purposes. As of April 30, 2022, such assets were categorized within the ASC 820 disclosure hierarchy as follows:
 
   
TOTAL
   
LEVEL 1
   
LEVEL 2
   
LEVEL 3
 
Cash, Foreign Cash and Cash Equivalents:
                       
Alger Capital Appreciation Fund
 
$
35,241,367
   
$
257,323
   
$
34,984,044
   
$
 
Alger 35 Fund
   
10,183
     
     
10,183
     
 
Alger Growth & Income Fund
   
10,098,440
     
     
10,098,440
     
 
Alger Mid Cap Growth Fund
   
7,457,733
     
     
7,457,733
     
 
Alger Mid Cap Focus Fund
   
17,373,428
     
345
     
17,373,083
     
 
Alger Weatherbie Enduring Growth Fund
   
295,078
     
     
295,078
     
 
Alger Weatherbie Specialized Growth Fund
   
34,529,431
     
     
34,529,431
     
 
Alger Small Cap Growth Fund
   
13,616,237
     
     
13,616,237
     
 
Alger Small Cap Focus Fund
   
2,281,562
     
     
2,281,562
     
 
Alger International Focus Fund
   
4,786,162
     
83,010
     
4,703,152
     
 
Alger Health Sciences Fund
   
3,211,001
     
     
3,211,001
     
 

NOTE 9 — Derivatives:


FASB Accounting Standards Codification 815 - Derivatives and Hedging (“ASC 815”) requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.
 
Options—The Funds seek to capture the majority of the returns associated with equity market investments. To meet this investment goal, the Funds invest in a broadly diversified portfolio of common stocks, the Funds may also buy and sell call and put options on equities and equity indexes. The Funds may also purchase call options to increase their exposure to the stock market and also provide diversification of risk. The Funds may also purchase put options in order to protect from significant market declines that may occur over a short period of time. The Funds may also write covered call and cash secured put options to generate cash flows while reducing the volatility of the Funds’ portfolios. The cash flows may be an important source of the Funds’ returns, although written call options may reduce the Funds’ ability to profit from increases in the value of the underlying security or equity portfolio. The value of a call option generally increases as the price of the underlying stock increases and decreases as the stock decreases in price. Conversely, the value of a put option generally increases as the price of the underlying stock decreases and decreases as the stock increases in price. The combination of the diversified stock portfolio and the purchase and sale of options is intended to provide the Funds with the majority of the returns associated with equity market investments but with reduced volatility and returns that are augmented with the cash flows from the sale of options.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
The Funds’ option contracts were not subject to any rights of offset with any counterparty. All of the Funds’ options were exchange traded which utilize a clearinghouse that acts as an intermediary between buyer and seller, receiving initial and maintenance margin from both, and guaranteeing performance of the option contract.
 
Forward Foreign Currency Contracts—In connection with portfolio purchases and sales of securities denominated in foreign currencies, the Funds may enter into forward foreign currency contracts. Additionally, each Fund may enter into such contracts to economically hedge certain other foreign currency denominated investments. These contracts are valued at the current cost of covering or offsetting such contracts and the related realized and unrealized foreign exchange gains and losses are included in the Statements of Operations. In the event that counterparties fail to settle these currency contracts or the related foreign security trades, a Fund could be exposed to foreign currency fluctuations.
 
For the six months ended April 30, 2022, the average notional amount of forward foreign currency contracts outstanding for Alger International Focus Fund was $3,024,447. Forward foreign currency contracts were held during 1 month of the period. The effect of derivative instruments on the accompanying Statements of Operations for the six months ended April 30, 2022, is as follows:
 
NET REALIZED GAIN ON DERIVATIVES
Alger International Focus Fund
     
Derivatives not accounted for as hedging instruments Forward Foreign Currency Contracts
 
$
219
 
Total
 
$
219
 
 
The Funds’ Forward Foreign Currency Contracts were not subject to any right of offset with any Counterparty.
 
There were no open derivative instruments as of April 30, 2022.
 
NOTE 10 — Principal Risks:


Alger Capital Appreciation Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
Alger 35 Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of small and medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. The Fund is classified as a “non-diversified fund” under federal securities laws because it can invest in fewer individual companies than a diversified fund. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.
 
Alger Growth & Income Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Income-producing securities may cut or fail to declare dividends due to market downturns or for other reasons. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
Alger Mid Cap Growth Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.
 
Alger Mid Cap Focus Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Investing in companies of medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. A significant portion of assets may be invested in securities of companies in related sectors or industries, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector or industry developments. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. The Fund is classified as a “non-diversified fund” under federal securities laws because it can invest in fewer individual companies than a diversified fund. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
Alger Weatherbie Enduring Growth Fund - Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into
account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. The Sub-Adviser’s use of an environmental, social, and governance (“ESG”) rating agency to implement the investment strategy may result in the selection or exclusion of securities for reasons other than financial performance and the strategy may underperform strategies that do not utilize an ESG rating agency or employ another type of ESG investment strategy. In evaluating a particular issuer’s ESG rating, as well as the account’s weighted average ESG rating, the Sub-Adviser relies exclusively on the ESG rating agency and, therefore, is dependent upon information and data from the ESG rating agency that may be incomplete or inaccurate, or that may present conflicting information and data with respect to an issuer than other third party ESG data providers utilized throughout the industry. Investing in companies of medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Investing in new issues involves special risks including lack of trading history, limited information and availability, and volatility. Cash positions may underperform relative to equity and fixed-income securities. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment. The Fund is classified as a “non-diversified fund” under federal securities laws because it can invest in fewer individual companies than a diversified fund.
 
Alger Weatherbie Specialized Growth Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of small and medium capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Foreign securities and Emerging Markets involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
Alger Small Cap Growth Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.
 
Alger Small Cap Focus Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility A significant portion of assets may be invested in securities of companies in related sectors or industries, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector or industry developments. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 
Alger International Focus Fund — Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets may be invested in securities of companies in related sectors, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable sector developments. Assets may be focused in a small number of holdings, making them susceptible to risks associated with a single economic, political or regulatory event than a more diversified portfolio. Foreign securities and Emerging Markets involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment.

Alger Health Sciences Fund - Investing in the stock market involves risks, including the potential loss of principal. The value of these securities, like other investments, may move up or down, sometimes rapidly and unpredictably. Your Fund shares at any point in time may be worth less than what you invested, even after taking into account the reinvestment of Fund dividends and distributions. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. A significant portion of assets will be invested in healthcare companies, which may be significantly affected by competition, innovation, regulation, and product obsolescence, and may be more volatile than the securities of other companies. A significant portion of assets may be invested in securities of companies in related industries, and may be similarly affected by economic, political, or market events and conditions and may be more vulnerable to unfavorable industry developments. Investing in companies of small capitalizations involves the risk that such issuers may have limited product lines or financial resources, lack management depth, or have limited liquidity. Private placements are offerings of a company’s securities not registered with the SEC and not offered to the public, for which limited information may be available. Such investments are generally considered to be illiquid. Foreign securities involve special risks including currency fluctuations, inefficient trading, political and economic instability, and increased volatility. Active trading may increase transaction costs, brokerage commissions, and taxes, which can lower the return on investment. At times, the Fund may hold a large cash position, which may underperform relative to equity securities.
 
Transactions in foreign securities may involve certain considerations and risks not typically associated with those of U.S. companies because of, among other factors, the level of governmental supervision and regulation of foreign security markets, and the possibility of political or economic instability. Additional risks associated with investing in emerging markets include increased volatility, limited liquidity, and less stringent regulatory and legal systems.

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)
 
NOTE 11 - Affiliated Securities:
 
The issuers of the securities listed below are deemed to be affiliates of the Funds because the Funds and their affiliates, collectively, owned 5% or more of the issuer’s voting securities during all or part of the six months ended April 30, 2022. Information regarding the Funds’ holdings of such securities is set forth in the following table:

Security
 
Value at
October 31,
2021
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net Change
In
Unrealized
App(Dep)
   
Value at
April 30,
2022
 
Alger Capital Appreciation Fund Special Purpose Vehicle 
                                         
Crosslink Ventures Capital LLC,
                                         
Cl. A
 
$
4,443,108
   
$
-
   
$
-
   
$
-
   
$
-
   
$
(568,431
)
  $ 3,874,677  
Total
 
$
4,443,108
   
$
-
   
$
-
   
$
-
   
$
-
   
$
(568,431
)
  $ 3,874,677  

Security
 
Value at
October 31,
2021


Purchases/
Conversion


Sales/
Conversion


Dividend/
Interest
Income


Realized
Gain (Loss)


Net Change
In
Unrealized
App(Dep)


Value at
April 30,
2022
 
Alger Mid Cap Growth Fund Preferred Stocks
                                         
Prosetta Biosciences, Inc., Series D
 
$
-
*
 
$
-
   
$
-
   
$
-
   
$
-
   
$
-
   
$
-
*
Special Purpose Vehicle
                                                       
Crosslink Ventures Capital LLC, Cl. A
   
1,921,344
     
-
     
-
     
-
     
-
     
(245,808
)
   
1,675,536
 
Crosslink Ventures Capital LLC, Cl. B
   
801,363
     
-
     
-
     
-
     
-
     
(111,188
)
   
690,175
 
Total
 
$
2,722,707
   
$
-
   
$
-
   
$
-
   
$
-
    $
(356,996
)
 
$
2,365,711
 

Security
 
Value at
October 31,
2021
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net Change
In
Unrealized
App(Dep)
   
Value at
April 30,
2022
 
Alger Weatherbie Specialized Growth Fund Preferred Stocks
 
                                 
 
Prosetta Biosciences, Inc., Series D
 
$
-
*
 
$
-
   
$
-
   
$
-
   
$
-
   
$
-
   
$
-
*
Total
 
$
-
   
$
-
   
$
-
   
$
-
   
$
-
   
$
-
   
$
-
 

THE ALGER FUNDS
NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

Security
 
Value at
October 31,
2021
   
Purchases/
Conversion
   
Sales/
Conversion
   
Dividend/
Interest
Income
   
Realized
Gain (Loss)
   
Net Change
In
Unrealized
App(Dep)
   
Value at
April 30,
2022
 
Alger Small Cap Growth Fund Preferred Stocks
                                         
Prosetta Biosciences, Inc., Series D
 
$
-
*
 
$
-
   
$
-
   
$
-
   
$
-
   
$
-
   
$
-
*
Special Purpose Vehicle
                                                       
Crosslink Ventures Capital LLC, Cl. A
   
2,882,016
     
-
     
-
     
-
     
-
     
(368,712
)
   
2,513,304
 
Crosslink Ventures Capital LLC, Cl. B
   
801,363
     
-
     
-
     
-
     
-
     
(111,188
)
   
690,175
 
Total
 
$
3,683,379
   
$
-
   
$
-
   
$
-
   
$
-
   
$
(479,900
)
 
$
3,203,479
 

Security
Value at
October 31,
2021
 
Purchases/
Conversion
 
Sales/
Conversion
 
Dividend/
Interest
Income
 
Realized
Gain (Loss)
 
Net Change
In
Unrealized
App(Dep)
 
Value at
April 30,
2022
 
Alger Health Sciences Fund Preferred Stocks

                         
Prosetta Biosciences, Inc., Series D
 
$
-
*
 
$
-
   
$
-
   
$
-
   
$
-
   
$
-
   
$
-
*
Total
 
$
-
   
$
-
   
$
-
   
$
-
   
$
-
   
$
-
   
$
-
 

*
Prosetta Biosciences, Inc. Series D shares are classified as a Level 3 investment and are fair valued at zero as of April 30, 2022.
 
NOTE 12 — Subsequent Events:

 
Management of each Fund has evaluated events that have occurred subsequent to April 30, 2022, through the issuance date of the Financial Statements. No such events have been identified which require recognition and/or disclosure.

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited)

Shareholder Expense Example
 
As a shareholder of a Fund, you incur two types of costs: transaction costs, if applicable, including sales charges (loads) and redemption fees; and ongoing costs, including management fees, distribution (12b-1) fees, if applicable, and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in a Fund and to compare these costs with the ongoing costs of investing in other mutual funds.
 
The example below is based on an investment of $1,000 invested at the beginning of the six-month period starting November 1, 2021 and ending April 30, 2022 and held for the entire period.
 
Actual Expenses

 
The first line for each class of shares in the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled “Expenses Paid During the Six Months Ended April 30, 2022” to estimate the expenses you paid on your account during this period.
 
Hypothetical Example for Comparison Purposes

 
The second line for each class of shares in the table below provides information about hypothetical account values and hypothetical expenses based on the actual expense ratio for each class of the Fund’s shares and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
 
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads) and redemption fees. Therefore, the second line under each class of shares in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


   
Beginning
Account
Value
November 1, 2021
   
Ending
Account
Value
April 30, 2022
   
Expenses
Paid During
the Six Months
Ended
April 30, 2022(a)
   
Annualized
Expense Ratio
For the
Six Months
Ended
April 30, 2022(b)
 
Alger Capital Appreciation Fund
 
Class A
Actual
 
$
1,000.00
   
$
694.80
   
$
4.96
     
1.18
%

Hypothetical(c)
   
1,000.00
     
1,018.94
     
5.91
     
1.18
 
Class C
Actual
   
1,000.00
     
725.50
     
8.21
     
1.92
 

Hypothetical(c)
   
1,000.00
     
1,015.27
     
9.59
     
1.92
 
Class Z
Actual
   
1,000.00
     
734.70
     
3.61
     
0.84
 

Hypothetical(c)
   
1,000.00
     
1,020.63
     
4.21
     
0.84
 

Alger 35 Fund
 
Class Z 
Actual  
$
1,000.00
   
$
679.90
   
$
2.29
     
0.55
%

Hypothetical(c)
   
1,000.00
     
1,022.07
     
2.76
     
0.55
 

Alger Growth & Income Fund
 
Class A
Actual
 
$
1,000.00
   
$
886.10
   
$
4.54
     
0.97
%

Hypothetical(c)
   
1,000.00
     
1,019.98
     
4.86
     
0.97
 
Class C
Actual
   
1,000.00
     
922.70
     
8.20
     
1.72
 

Hypothetical(c)
   
1,000.00
     
1,016.27
     
8.60
     
1.72
 
Class Z
Actual
   
1,000.00
     
936.70
     
3.17
     
0.66
 

Hypothetical(c)
   
1,000.00
     
1,021.52
     
3.31
     
0.66
 

Alger Mid Cap Growth Fund
 
Class A
Actual
 
$
1,000.00
   
$
623.60
   
$
4.91
     
1.22
%

Hypothetical(c)
   
1,000.00
     
1,018.74
     
6.11
     
1.22
 
Class B
Actual
   
1,000.00
     
638.00
     
5.16
     
1.27
 

Hypothetical(c)
   
1,000.00
     
1,018.50
     
6.36
     
1.27
 
Class C
Actual
   
1,000.00
     
651.60
     
8.39
     
2.05
 

Hypothetical(c)
   
1,000.00
     
1,014.63
     
10.24
     
2.05
 
Class Z
Actual
   
1,000.00
     
658.70
     
3.74
     
0.91
 

Hypothetical(c)
   
1,000.00
     
1,020.28
     
4.56
     
0.91
 

Alger Mid Cap Focus Fund
 
Class A
Actual
 
$
1,000.00
   
$
631.20
   
$
3.88
     
0.96
%

Hypothetical(c)
   
1,000.00
     
1,020.03
     
4.81
     
0.96
 
Class C
Actual
   
1,000.00
     
657.70
     
7.11
     
1.73
 

Hypothetical(c)
   
1,000.00
     
1,016.22
     
8.65
     
1.73
 
Class I
Actual
   
1,000.00
     
666.10
     
4.09
     
0.99
 

Hypothetical(c)
   
1,000.00
     
1,019.89
     
4.96
     
0.99
 
Class Y
Actual
   
1,000.00
     
667.20
     
2.85
     
0.69
 

Hypothetical(c)
   
1,000.00
     
1,021.37
     
3.46
     
0.69
 
Class Z
Actual
   
1,000.00
     
667.40
     
2.85
     
0.69
 

Hypothetical(c)
   
1,000.00
     
1,021.37
     
3.46
     
0.69
 

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


   
Beginning
Account
Value
November 1, 2021
   
Ending
Account
Value
April 30, 2022
   
Expenses
Paid During
the Six Months
Ended
April 30, 2022(a)
   
Annualized
Expense Ratio
For the
Six Months
Ended
April 30, 2022(b)
 
Alger Weatherbie Enduring Growth Fund
                       
Class A
Actual(d),(e)  
$
1,000.00
   
$
739.30
   
$
3.70
     
1.15
%

Hypothetical(d),(e)
   
1,000.00
     
1,014.24
     
4.28
     
1.15
 
Class C
Actual(d),(e)    
1,000.00
     
770.20
     
6.06
     
1.85
 

Hypothetical(d),(e)
   
1,000.00
     
1,011.65
     
6.88
     
1.85
 
Class I
Actual(d),(e)    
1,000.00
     
780.00
     
3.62
     
1.10
 

Hypothetical(d),(e)
   
1,000.00
     
1,014.42
     
4.10
     
1.10
 
Class Y
Actual(d),(e)    
1,000.00
     
781.00
     
2.31
     
0.70
 

Hypothetical(d),(e)
   
1,000.00
     
1,015.90
     
2.61
     
0.70
 
Class Z
Actual(d),(e)    
1,000.00
     
781.00
     
2.47
     
0.75
 

Hypothetical(d),(e)
   
1,000.00
     
1,015.72
     
2.80
     
0.75
 
                                   
Alger Weatherbie Specialized Growth Fund
                         
Class A
Actual
 
$
1,000.00
   
$
595.80
   
$
4.87
     
1.23
%

Hypothetical(c)
   
1,000.00
     
1,018.70
     
6.16
     
1.23
 
Class C
Actual
   
1,000.00
     
621.50
     
8.08
     
2.01
 

Hypothetical(c)
   
1,000.00
     
1,014.83
     
10.04
     
2.01
 
Class I
Actual
   
1,000.00
     
628.70
     
4.97
     
1.23
 

Hypothetical(c)
   
1,000.00
     
1,018.70
     
6.16
     
1.23
 
Class Y
Actual
   
1,000.00
     
629.70
     
3.52
     
0.87
 

Hypothetical(c)
   
1,000.00
     
1,020.48
     
4.36
     
0.87
 
Class Z
Actual
   
1,000.00
     
629.80
     
3.64
     
0.90
 

Hypothetical(c)
   
1,000.00
     
1,020.33
     
4.51
     
0.90
 
   
Alger Small Cap Growth Fund
 
Class A
Actual
 
$
1,000.00
   
$
620.60
   
$
5.10
     
1.27
%

Hypothetical(c)
   
1,000.00
     
1,018.50
     
6.36
     
1.27
 
Class B
Actual
   
1,000.00
     
626.10
     
5.40
     
1.34
 

Hypothetical(c)
   
1,000.00
     
1,018.15
     
6.71
     
1.34
 
Class C
Actual
   
1,000.00
     
646.40
     
8.53
     
2.09
 

Hypothetical(c)
   
1,000.00
     
1,014.43
     
10.44
     
2.09
 
Class Y
Actual(f),(g)
   
1,000.00
     
730.50
     
2.41
     
0.84
 

Hypothetical(f),(g)
   
1,000.00
     
1,013.79
     
2.80
     
0.84
 
Class Z
Actual
   
1,000.00
     
656.00
     
3.86
     
0.94
 

Hypothetical(c)
   
1,000.00
     
1,020.13
     
4.71
     
0.94
 

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


   
Beginning
Account
Value
November 1, 2021
   
Ending
Account
Value
April 30, 2022
   
Expenses
Paid During
the Six Months
Ended
April 30, 2022(a)
   
Annualized
Expense Ratio
For the
Six Months
Ended
April 30, 2022(b)
 
Alger Small Cap Focus Fund
                       
Class A
Actual
 
$
1,000.00
   
$
559.40
   
$
5.03
     
1.30
%

Hypothetical(c)
   
1,000.00
     
1,018.35
     
6.51
     
1.30
 
Class C
Actual
   
1,000.00
     
583.00
     
7.61
     
1.94
 

Hypothetical(c)
   
1,000.00
     
1,015.17
     
9.69
     
1.94
 
Class I
Actual
   
1,000.00
     
590.70
     
4.73
     
1.20
 

Hypothetical(c)
   
1,000.00
     
1,018.84
     
6.01
     
1.20
 
Class Y
Actual
   
1,000.00
     
591.90
     
3.32
     
0.84
 

Hypothetical(c)
   
1,000.00
     
1,020.63
     
4.21
     
0.84
 
Class Z
Actual
   
1,000.00
     
591.90
     
3.28
     
0.83
 

Hypothetical(c)
   
1,000.00
     
1,020.68
     
4.16
     
0.83
 
                                   
Alger International Focus Fund
 
Class A
Actual
 
$
1,000.00
   
$
707.30
   
$
5.25
     
1.24
%

Hypothetical(c)
   
1,000.00
     
1,018.65
     
6.21
     
1.24
 
Class B
Actual
   
1,000.00
     
712.80
     
5.35
     
1.26
 

Hypothetical(c)
   
1,000.00
     
1,018.55
     
6.31
     
1.26
 
Class C
Actual
   
1,000.00
     
736.80
     
8.74
     
2.03
 

Hypothetical(c)
   
1,000.00
     
1,014.73
     
10.14
     
2.03
 
Class I
Actual
   
1,000.00
     
746.30
     
5.37
     
1.24
 

Hypothetical(c)
   
1,000.00
     
1,018.65
     
6.21
     
1.24
 
Class Z
Actual
   
1,000.00
     
748.00
     
3.81
     
0.88
 

Hypothetical(c)
   
1,000.00
     
1,020.43
     
4.41
     
0.88
 
   
Alger Health Sciences Fund
 
Class A
Actual
 
$
1,000.00
   
$
677.50
   
$
4.24
     
1.02
%

Hypothetical(c)
   
1,000.00
     
1,019.74
     
5.11
     
1.02
 
Class C
Actual
   
1,000.00
     
707.20
     
7.70
     
1.82
 

Hypothetical(c)
   
1,000.00
     
1,015.77
     
9.10
     
1.82
 
Class Z
Actual
   
1,000.00
     
716.10
     
2.98
     
0.70
 

Hypothetical(c)
   
1,000.00
     
1,021.32
     
3.51
     
0.70
 

(a)
Expenses are equal to the annualized expense ratio of the respective share class, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period).
(b)
Annualized.
(c)
5% annual return before expenses.
(d)
For the period from December 17, 2021 to April 30, 2022.
(e)
Beginning account value December 17, 2021.
(f)
For the period from December 31, 2021 to April 30, 2022.
(g)
Beginning account value December 31, 2021.

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


Board Approval of Investment Advisory Agreements


THE ALGER FUNDS

Alger Weatherbie Enduring Growth Fund
(the Fund)

At a meeting held on September 22, 2021 (Meeting), the Board of Trustees (Board) of The Alger Funds (Trust), including a majority of the trustees who are not “interested persons” (as defined in the Investment Company Act of 1940, as amended) of the Trust (Independent Trustees), reviewed and approved the investment advisory agreement between Fred Alger Management, LLC (Fred Alger Management) and the Trust, on behalf of the Fund, and the investment sub-advisory agreement between Fred Alger Management and Weatherbie Capital, LLC (Sub-Adviser an affiliate of Fred Alger Management, on behalf of the Fund (each, a Management Agreement), for an initial two-year term through September 2023. Fred Alger Management and the Sub-Adviser are collectively referred to herein as the “Manager.” The Independent Trustees received advice from, and met separately with, their Independent Trustee counsel in considering whether to approve the Management Agreement.
 
In considering each Management Agreement, the Board reviewed and considered information provided by the Manager and its representatives at the Meeting, as well as throughout the year at meetings of the Board and its committees in their capacity as members of the boards of trustees of the Alger Family of Funds, including the other series of the Trust. In addition, the Board took into account the information that it previously reviewed and considered in response to detailed requests for information submitted to the Manager by Independent Trustee counsel on behalf of the Independent Trustees in connection with such other funds’ annual contract renewal process, and reviewed and considered at this Meeting the Manager’s response to a supplemental request. The Board noted that the terms of the Management Agreements and the services to be provided thereunder are identical to the terms of the existing Management Agreements between the Trust and Fred Alger Management and between Fred Alger Management and the Sub-Adviser.
 
The Independent Trustees also received advice from, and met separately with, their Independent Trustee counsel in considering whether to initially approve each Management Agreement with respect to the Fund. The Independent Trustees also received a memorandum from Independent Trustee counsel discussing their duties in considering the initial approval of the Management Agreements.
 
The Board reviewed the materials provided and considered all of the factors it deemed relevant in approving each Management Agreement with respect to the Fund, including, but not limited to: (i) the nature, extent and quality of the services to be provided by the Manager; (ii) the estimated costs of the services to be provided by the Manager and estimated profits; (iii) the extent to which economies of scale may be realized as the Fund grows; and (iv) whether the proposed fee levels reflect these estimated economies of scale for the benefit of Fund shareholders. The Board did not identify any one factor as dispositive, and each Board member may have attributed different weights to the factors considered.

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


In particular, in initially approving each Management Agreement, the Board considered the following factors:
 
Nature, Extent and Quality of Services
The Board reviewed and considered information regarding the nature, extent and quality of investment management services to be provided by the Manager to the Fund. This information included, among other things, the qualifications, background and experience of the professional personnel who will perform services for the Fund; the structure of investment professional compensation; oversight of third-party service providers; fee information for the Fund and proposed payments to intermediaries for fund administration, transfer agency and shareholder services; legal and compliance matters; risk controls; pricing and other services to be provided by the Manager; and the range of advisory fees charged by the Manager to other funds and accounts, including the Manager’s explanation of differences among accounts where relevant.
 
The Board noted Fred Alger Management’s history and expertise in the “growth” style of investment management and Fred Alger Management’s ongoing efforts to develop strategies and products, and adjust portfolios as necessary, as well as to address the changing investment landscape. The Board also considered the investment approach of the Sub-Adviser, which takes a fundamental, bottom-up research approach to investing in growth equities, similar to that of Fred Alger Management, as well as the Sub-Adviser’s experience in managing strategies with an environmental, social, and governance (ESG) component. The Board also noted the length of time Fred Alger Management and the Sub-Adviser have provided services as investment adviser and sub-adviser, respectively, to the Alger Family of Funds.
 
The Board also considered information provided by the Manager with respect to its business continuity plan, including the continued effectiveness of the plan throughout the ongoing COVID-19 pandemic. The Board further noted the Manager’s ongoing engagement with key service providers with respect to their operations and personnel supporting the Alger Family of Funds during the COVID-19 pandemic.
 
The Board also reviewed and considered the potential benefits to be provided to Fund shareholders of investing in a Fund that is part of the Alger Family of Funds. The Board noted the financial position of the Manager and its commitment to the fund business as evidenced, in part, by a continued focus on offerings in focused strategies, as well as its financial commitment to the establishment and launch of the Fund. The Board also noted that certain administrative, compliance, reporting and accounting services necessary for the conduct of the Fund’s affairs are separately provided under a Fund Administration Agreement and a Shareholder Administrative Services Agreement with Fred Alger Management.
 
Following consideration of such information, each Trustee was satisfied with the nature, extent and quality of services to be provided by the Manager to the Fund under each Management Agreement.

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


Fund Performance
In their capacity as members of the boards of trustees of the Alger Family of Funds, the Board, including the Independent Trustees, received and considered information about the Manager’s investment performance for the other funds in the Alger Family of Funds at their 2021 15(c) meeting, which occurred on the same date as the Meeting. The Board noted that, as the Fund had not yet commenced investment operations, there was no investment performance for the Fund for the Board to consider.
 
Comparative Fees and Expenses
The Board reviewed and considered the proposed contractual advisory fee to be paid by the Fund to Fred Alger Management in light of the nature, extent, and quality of services proposed to be provided pursuant to the Management Agreement with Fred Alger Management. The Board also reviewed and considered the proposed fee waiver and/or expense reimbursement arrangement (Expense Reimbursement Agreement) for the Fund, including with respect to specific Fund share classes, and considered the estimated fee rate (after taking any waivers and reimbursements into account) to be paid by the Fund.
 
In connection with its consideration of the Fund’s advisory fee payable under the Management Agreement with Fred Alger Management, the Board also received information on Fred Alger Management’s standard institutional account fees for accounts of a similar investment type to the Fund. The Board noted management’s explanation that comparisons with such accounts may be of limited relevance given the different structures and regulatory requirements of mutual funds, such as the Fund, versus those accounts and the differences in the levels of services required by the Fund and those accounts. The Board also received information on fees charged to other funds managed by Fred Alger Management.
 
The Board reviewed and considered the proposed contractual sub-advisory fee in light of the nature, extent, and quality of services proposed to be provided by the Sub-Adviser pursuant to the Management Agreement between Fred Alger Management and the Sub-Adviser. The Board noted that the Sub-Adviser will be paid by Fred Alger Management out of the advisory fee Fred Alger Management receives from the Fund.
 
Profitability
The Board then noted that the Manager could not report any financial results from their relationships with the Fund because the Fund had not yet commenced investment operations, and thus, the Board could not evaluate the Manager’s profitability with respect to the Fund. Nevertheless, the Board reviewed and considered information regarding the estimated profits to be realized by the Manager in connection with the operation of the Fund. In this respect, the Board considered management’s representations that Fred Alger Management is not expected to be profitable with respect to the Fund for some time, until the Fund reaches scale. The Board further noted Fred Alger Management’s commitment to waive fees and reimburse certain expenses in order to maintain certain net expense ratios during the term of the proposed Expense Reimbursement Agreement.
 
THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


The Board also considered the extent to which the Manager might derive ancillary benefits from Fund operations, including, for example, through soft dollar arrangements. Based upon its consideration of all these factors, the Trustees concluded that the level of estimated profits to be realized by Fred Alger Management from providing services to the Fund, which is anticipated to be negative until the Fund reaches scale, was not excessive in view of the nature, extent and quality of services to be provided to the Fund.
 
Economies of Scale
The Board reviewed and considered the extent to which Fred Alger Management may be able to realize economies of scale, if any, as the Fund grows larger and whether the Fund’s advisory fee structure reflects any economies of scale for the benefit of shareholders. The Board noted the existence of proposed advisory fee breakpoints for the Fund, which would operate to share economies of scale with the Fund’s shareholders by reducing the Fund’s effective advisory fees as the Fund grows in size. The Board considered Fred Alger Management’s view that the overall size of Fred Alger Management allows it to realize other economies of scale, such as with office space, purchases of technology, and other general business expenses. Because the Fund had not commenced operations, the Board determined to monitor whether Fred Alger Management may share with the Fund any benefits that occur if the Fund experiences economies of scale.
 
Conclusion
Based on its review, consideration and evaluation of all factors it believed relevant, including the above-described factors and conclusions, the Board, including the Independent Trustees voting separately, unanimously approved each Management Agreement for an initial two-year term through September 2023.

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


Privacy Policy


U.S. Consumer Privacy Notice
Rev. 6/22/21
FACTS
WHAT DOES ALGER DO WITH YOUR PERSONAL INFORMATION?


Why?
Financial companies choose how they share your personal information. Federal law gives consumers the right to limit some but not all sharing. Federal law also requires us to tell you how we collect, share, and protect your personal information. Please read this notice carefully to understand what we do.
What?
The types of personal information we collect and share depend on the product or service you have with us.
This information can include:
•  Social Security number and
•  Account balances and
•  Transaction history and
•  Purchase history and
•  Assets
When you are no longer our customer, we continue to share your information as described in this notice.
How?
All financial companies need to share personal information to run their everyday business In the section below, we list the reasons financial companies can share personal information; the reasons Alger chooses to share; and whether you can limit this sharing.
 
Reasons we can share your personal
information
Does
Alger share?
Can you limit this sharing?
For our everyday business purposes — such as to process your transactions, maintain your account(s), respond to court orders and legal investigations, or report to credit bureaus
Yes
No
For our marketing purposes — to offer our products and services to you
Yes
No
For joint marketing with other financial
companies
No
We don’t share
For our affiliates’ everyday business purposes — information about your transactions and experiences
Yes
No
For our affiliates’ everyday business purposes — information about your creditworthiness
No
We don’t share
For nonaffiliates to market to you
No
We don’t share
Questions? Call 1-800-223-3810
   

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)


Who we are
 
Who is providing this notice?
Alger includes Fred Alger Management, LLC and Fred Alger & Company, LLC as well as the following funds: The Alger Funds, The Alger Funds II, The Alger Institutional Funds, The Alger Portfolios, Alger Global Focus Fund, and The Alger ETF Trust.
 
What we do
 
How does Alger protect my personal information?
To protect your personal information from unauthorized access and use, we use security measures that comply with federal law. These measures include computer safeguards and secured files and buildings
How does Alger collect my personal information?
We collect your personal information, for example, when you:
Open an account or
Make deposits or withdrawals from your account or
Give us your contact information or
Provide account information or
Pay us by check.
Why can’t I limit all sharing?
Federal law gives you the right to limit some but not all sharing related to:
sharing for affiliates’ everyday business purposes -
information about your credit worthiness
affiliates from using your information to market to you
sharing for nonaffiliates to market to you
State laws and individual companies may give you additional rights to limit sharing.
 
Definitions
 
Affiliates
Companies related by common ownership or control.
They can be financial and nonfinancial companies
Our affiliates include Fred Alger Management, LLC, Weatherbie Capital, LLC and Fred Alger & Company, LLC as well as the following funds: The Alger Funds, The Alger Funds II, The Alger Institutional Funds, The Alger Portfolios, Alger Global Focus Fund, and The Alger ETF Trust.
Nonaffiliates
Companies not related by common ownership or control They can be financial and nonfinancial companies.
Joint marketing
A formal agreement between nonaffiliated financial companies that together market financial products or services to you.

THE ALGER FUNDS
Financial Highlights for a share outstanding throughout the period (Unaudited)

Proxy Voting Policies


A description of the policies and procedures the Funds use to determine how to vote proxies relating to portfolio securities and the proxy voting record is available, without charge, by calling (800) 992-3863 or online on the Funds’ website at http://www.alger.com or on the SEC’s website at http://www.sec.gov.
 
Fund Holdings


The Board has adopted policies and procedures relating to disclosure of the Funds’ portfolio securities. These policies and procedures recognize that there may be legitimate business reasons for holdings to be disclosed and seek to balance those interests to protect the proprietary nature of the trading strategies and implementation thereof by the Funds.
 
Generally, the policies prohibit the release of information concerning portfolio holdings, which have not previously been made public, to individual investors, institutional investors, intermediaries that distribute the Funds’ shares and other parties which are not employed by the Investment Manager or its affiliates except when the legitimate business purposes for selective disclosure and other conditions (designed to protect the Funds) are acceptable.
 
The Funds file their complete schedules of portfolio holdings with the SEC semi-annually in shareholder reports on Form N-CSR and after the first and third fiscal quarters as an exhibit to their reports on Form N-PORT. The Funds’ Forms N-CSR and N-PORT are available online on the SEC’s website at www.sec.gov.
 
In addition, the Funds make publicly available their month-end top 10 holdings (top 5 holdings with respect to Alger 35 Fund and Alger Weatherbie Enduring Growth Fund) with a 10 day lag and their month-end full portfolios with a 60 day lag on their website www.alger.com and through other marketing communications (including printed advertising/sales literature and/or shareholder telephone customer service centers). No compensation or other consideration is directly received for the non-public disclosure of portfolio holdings information.
 
In accordance with the foregoing, the Funds provide portfolio holdings information to third parties including financial intermediaries and service providers who need access to this information in the performance of their services and are subject to duties of confidentiality (1) imposed by law, including a duty not to trade on non-public information, and/or (2) pursuant to an agreement that confidential information is not to be disclosed or used (including trading on such information) other than as required by law. From time to time, the Funds will communicate with these third parties to confirm that they understand the Funds’ policies and procedures regarding such disclosure. These agreements must be approved by the Trust’s Chief Compliance Officer.
 
The Board periodically reviews a report disclosing the third parties to whom each Fund’s holdings information has been disclosed and the purpose for such disclosure, and it considers whether or not the release of information to such third parties is in the best interest of the Fund and its shareholders.

THE ALGER FUNDS
ADDITIONAL INFORMATION (Unaudited) (Continued)

 
In addition to material the Funds routinely provide to shareholders, the Investment Manager may make additional statistical information available regarding the Alger Family of Funds. Such information may include, but not be limited to, relative weightings and characteristics of a Fund versus an index (such as P/E ratio, alpha, beta, capture ratio, maximum drawdown, standard deviation, EPS forecasts, Sharpe ratio, information ratio, R-squared, and market cap analysis), security specific impact on overall portfolio performance, month-end top ten contributors to and detractors from performance, portfolio turnover, and other similar information. Shareholders should visit www.alger.com or may also contact the Funds at (800) 992-3863 to obtain such information.

Liquidity Risk Management Program


In accordance with Rule 22e-4 under the 1940 Act (the “Liquidity Rule”), the Trust has adopted and implemented a liquidity risk management program (the “LRMP”), which is reasonably designed to assess and manage the Funds’ liquidity risk.
 
The Board met on December 15, 2021 (the “Meeting”) to review the LRMP. The Board previously appointed Alger Management as the program administrator for the LRMP and approved an agreement with ICE Data Services (“ICE”), a third party vendor that assists the Funds with liquidity classifications required by the Liquidity Rule. Alger Management also previously delegated oversight of the LRMP to the Liquidity Risk Committee. At the Meeting, the Liquidity Risk Committee, on behalf of Alger Management, provided the Board with a report that addressed the operation of the LRMP and assessed its adequacy and effectiveness of implementation, and any material changes to the LRMP (the “Report”). The Report covered the period from December 1, 2020 through November 30, 2021 (the “Review Period”).
 
The Report stated that the Liquidity Risk Committee assessed the Funds’ liquidity risk by considering qualitative factors such as the Funds’ investment strategy, holdings, diversification of investments, redemption policies, cash flows, cash levels, shareholder concentration, and access to borrowings, among others, in conjunction with the quantitative classifications generated by ICE. In addition, in connection with the review of the Funds’ liquidity risks and the operation of the LRMP and the adequacy and effectiveness of its implementation, the Liquidity Risk Committee also evaluated the levels at which to set the reasonably anticipated trade size and market price impact. The Report described the process for determining that the Funds primarily holds investments that are highly liquid. The Report noted that the Liquidity Risk Committee also performed stress tests on certain Funds in light of the market volatility caused by the COVID-19 pandemic, and it was concluded that the Funds remained primarily highly liquid.
 
There were no material changes to the LRMP during the Review Period, except that certain changes were made to the LRMP to add liquidity considerations for certain exchange-traded funds managed by Alger Management. The Report provided to the Board stated that the Committee concluded that, based on the operation of the functions, as described in the Report, during the Review Period, the Trust’s LRMP was operating effectively and adequately with respect to the Funds and has been effectively implemented during the Review Period.

THE ALGER FUNDS

 
100 Pearl Street, 27th Floor
New York, NY 10004
(800) 992-3863
www.alger.com

Investment Manager

 
Fred Alger Management, LLC
100 Pearl Street, 27th Floor
New York, NY 10004

Sub-Advisor

 
Weatherbie Capital, LLC
265 Franklin Street, Suite 1603
Boston, MA 02110
 
Distributor

 
Fred Alger & Company, LLC
100 Pearl Street, 27th Floor
New York, NY 10004
 
Transfer Agent and Dividend Disbursing Agent

 
UMB Fund Services, Inc.
235 W. Galena Street
Milwaukee, WI 53212
 
Custodian

 
Brown Brothers Harriman & Company
50 Post Office Square
Boston, MA 02110

Independent Registered Public Accounting Firm

 
Deloitte & Touche LLP
30 Rockefeller Plaza
New York, NY 10112
 
This report is submitted for the general information of the shareholders of The Alger Funds. It is not authorized for distribution to prospective investors unless accompanied by an effective Prospectus for the Trust, which contains information concerning the Trust’s investment policies, fees and expenses as well as other pertinent information.



Table of Contents

(b)
Include a copy of each notice transmitted to stockholders in reliance on Rule 30e-3 under the Act (17 CFR 270.30e-3) that contains disclosures specified by paragraph (c)(3) of that rule.
 
Not applicable.

ITEM 2.
CODE OF ETHICS.

Not applicable.

ITEM 3.
AUDIT COMMITTEE FINANCIAL EXPERT.

Not applicable.

ITEM 4.
PRINCIPAL ACCOUNTANT FEES AND SERVICES.

Not applicable.

ITEM 5.
AUDIT COMMITTEE OF LISTED REGISTRANTS.

Not applicable.

ITEM 6.
INVESTMENTS.

Not applicable.

ITEM 7.
DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.

Not applicable.

ITEM 8.
PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.

Not applicable.

ITEM 9.
PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.

Not applicable.

ITEM 10.
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

Not applicable.

ITEM 11.
CONTROLS AND PROCEDURES.

(a) The Registrant’s principal executive officer and principal financial officer have concluded that the Registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended) are effective based on their evaluation of the disclosure controls and procedures as of a date within 90 days of the filing date of this document.

(b) No changes in the Registrant’s internal control over financial reporting occurred during the Registrant’s second fiscal quarter of the period covered by this report that materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

ITEM 12.
Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

- 106-

ITEM 13.
EXHIBITS.

(a) (1) Not applicable

(a) (2) Certifications of principal executive officer and principal financial officer as required by rule 30a-2(a) under the Investment Company Act of 1940 are attached as Exhibit 99.CERT

(a) (3) Not applicable
(a) (4) Not applicable

(b) Certifications of principal executive officer and principal financial officer as required by rule 30a-2(b) under the Investment Company Act of 1940 are attached as Exhibit 99.906CERT

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

The Alger Funds
 
By:
/s/ Hal Liebes
   
 
Hal Liebes
   
 
President

Date:  June 22, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:
/s/ Hal Liebes
   
 
Hal Liebes
   
 
President
   
Date:  June 22, 2022
   
By:
/s/ Michael D. Martins
   
 
Michael D. Martins
   
 
Treasurer
   
Date:  June 22, 2022


- 107-



Exhibit 99.CERT

Rule 30a-2(a) CERTIFICATIONS
 
I, Hal Liebes, certify that:
 
1. I have reviewed this report on Form N-CSR of The Alger Funds;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date: June 22, 2022

/s/ Hal Liebes
Hal Liebes
President
 

Rule 30a-2(a) CERTIFICATIONS
 
I, Michael D. Martins, certify that:
 
1. I have reviewed this report on Form N-CSR of The Alger Funds;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date: June 22, 2022

/s/ Michael D. Martins
Michael D. Martins
Treasurer





Exhibit 99.906CERT
Rule 30a-2(b) CERTIFICATIONS
 
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of The Alger Funds, do hereby certify, to such officer's knowledge, that:
 
(1)
The semi-annual report on Form N-CSR of the Registrant for the period ended April 30, 2022 (the "Form N-CSR") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
(2)
the information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of The Alger Funds.
 
Dated: June 22, 2022

/s/ Hal Liebes
Hal Liebes
President
The Alger Funds
 
Dated: June 22, 2022
 
/s/ Michael D. Martins
Michael D. Martins
Treasurer
The Alger Funds
 
Dated: June 22, 2022
 
This certification is being furnished solely pursuant to 18 U.S.C. ss. 1350 and is not being filed as part of the Report or as a separate disclosure document.